drug_concept_id,outcome_concept_id,lrt_p,adj_p,group,sig_group,drug_concept,outcome_concept,SOC,Level_4_Des,Level_3_Des,Level_2_Des,Level_1_Des
1550023,36314160,0,0,adult_children_senior_youth,children,insulin lispro,blood glucose increased,Investigations,"$Insulins and analogues for injection, intermediate-acting$Insulins and analogues for injection, fast-acting$Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting",$INSULINS AND ANALOGUES$INSULINS AND ANALOGUES$INSULINS AND ANALOGUES,$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1304107,35809059,0,0,adult_children_senior_youth,youth,imatinib,death,General disorders and administration site conditions,Protein kinase inhibitors,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
735979,36919045,0,0,adult_children_senior_youth,children,risperidone,emotional disorder,Psychiatric disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
40241331,35707864,0,0,adult_children_senior_youth,children,rivaroxaban,gastrointestinal haemorrhage,Gastrointestinal disorders,Direct factor Xa inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1151789,35809005,0,0,adult_children_senior_youth,children_youth,etanercept,injection site pain,General disorders and administration site conditions,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1107830,36211496,0,0,adult_children_senior_youth,children,loratadine,overdose,"Injury, poisoning and procedural complications",Other antihistamines for systemic use,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,RESPIRATORY SYSTEM
1150871,37622518,1.56E-298,7.15E-291,adult_children_senior_youth,youth,misoprostol,haemorrhage,Vascular disorders,$Prostaglandins$Prostaglandins$Propionic acid derivatives,"$UTEROTONICS$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$DRUGS FOR ACID RELATED DISORDERS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$ALIMENTARY TRACT AND METABOLISM$MUSCULO-SKELETAL SYSTEM
1112807,35205189,3.56E-286,1.63E-278,adult_children_senior_youth,adult,aspirin,myocardial infarction,Vascular disorders,0,0,0,0
1119119,35809005,1.05E-284,4.82E-277,adult_children_senior_youth,children,adalimumab,injection site pain,General disorders and administration site conditions,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1308290,35104877,7.00E-264,3.21E-256,adult_children_senior_youth,senior,vincristine,febrile neutropenia,General disorders and administration site conditions,Vinca alkaloids and analogues,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
722424,36718112,2.88E-261,1.32E-253,adult_children_senior_youth,children_youth,interferon beta-1a,multiple sclerosis relapse,Nervous system disorders,Interferons,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1310149,36313050,8.33E-258,3.82E-250,adult_children_senior_youth,children,warfarin,international normalised ratio increased,Investigations,Vitamin K antagonists,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
735979,35506601,9.54E-258,4.38E-250,adult_children_senior_youth,children,risperidone,gynaecomastia,$Endocrine disorders$Reproductive system and breast disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
984232,36818844,3.83E-256,1.76E-248,adult_children_youth,adult,isotretinoin,unintended pregnancy,"Pregnancy, puerperium and perinatal conditions",$Retinoids for topical use in acne$Retinoids for topical use in acne$Retinoids for treatment of acne,$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE,$ANTI-ACNE PREPARATIONS$ANTI-ACNE PREPARATIONS$ANTI-ACNE PREPARATIONS,$DERMATOLOGICALS$DERMATOLOGICALS$DERMATOLOGICALS
1589505,37320257,6.05E-225,2.78E-217,adult_children_youth,adult,levonorgestrel,acne,Skin and subcutaneous tissue disorders,"$Progestogens and estrogens, sequential preparations$Emergency contraceptives$Progestogens$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations",$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1107830,36211491,7.27E-222,3.34E-214,adult_children_senior_youth,children,loratadine,accidental overdose,"Injury, poisoning and procedural complications",Other antihistamines for systemic use,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,RESPIRATORY SYSTEM
956874,35205243,2.16E-220,9.90E-213,adult_children_senior_youth,adult,furosemide,cardiac failure congestive,Cardiac disorders,"$High-ceiling diuretics and potassium-sparing agents$Sulfonamides, plain$Sulfonamides$Sulfonamides and potassium in combination","$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$HIGH-CEILING DIURETICS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$HIGH-CEILING DIURETICS",$DIURETICS$DIURETICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$DIURETICS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
735979,36919046,9.73E-212,4.47E-204,adult_children_senior_youth,children,risperidone,emotional distress,Psychiatric disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1154161,36918942,2.26E-203,1.04E-195,adult_children_senior_youth,children_youth,montelukast,depression,Psychiatric disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
19026972,43053715,1.68E-194,7.71E-187,adult_children_senior_youth,children,lenalidomide,plasma cell myeloma,"$Blood and lymphatic system disorders$Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Other immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
996416,36919183,3.21E-187,1.48E-179,adult_senior_youth,youth,finasteride,erectile dysfunction,$Psychiatric disorders$Reproductive system and breast disorders,$Other dermatologicals$Alpha-adrenoreceptor antagonists$Testosterone-5-alpha reductase inhibitors,$OTHER DERMATOLOGICAL PREPARATIONS$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,$OTHER DERMATOLOGICAL PREPARATIONS$UROLOGICALS$UROLOGICALS,$DERMATOLOGICALS$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1508439,36818629,8.45E-187,3.88E-179,adult_children_youth,youth,mifepristone,abortion incomplete,"Pregnancy, puerperium and perinatal conditions",$Progesterone receptor modulators$Progesterone receptor modulators,$OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
781039,35809059,5.40E-185,2.48E-177,adult_children_senior_youth,youth,alprazolam,death,General disorders and administration site conditions,Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1151789,36009833,2.07E-184,9.51E-177,adult_children_senior_youth,senior,etanercept,rheumatoid arthritis,Immune system disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
735979,36315381,1.29E-179,5.93E-172,adult_children_senior_youth,children,risperidone,weight increased,Investigations,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1154161,36918858,1.56E-177,7.18E-170,adult_children_senior_youth,children_youth,montelukast,anxiety,Psychiatric disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1154161,36919059,1.88E-175,8.63E-168,adult_children_senior_youth,children,montelukast,aggression,Psychiatric disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1112807,35205243,2.15E-174,9.88E-167,adult_children_senior_youth,adult,aspirin,cardiac failure congestive,Cardiac disorders,0,0,0,0
964407,36919230,2.59E-174,1.19E-166,adult_children_senior_youth,senior,salicylic acid,completed suicide,General disorders and administration site conditions,"$Other antifungals for topical use$Salicylic acid and derivatives$Salicylic acid and derivatives$Antiinflammatory agents, non-steroids",$ANTIFUNGALS FOR TOPICAL USE$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$ANTIINFLAMMATORY AGENTS,$ANTIFUNGALS FOR DERMATOLOGICAL USE$ANALGESICS$ANALGESICS$OPHTHALMOLOGICALS,$DERMATOLOGICALS$NERVOUS SYSTEM$NERVOUS SYSTEM$SENSORY ORGANS
781039,35204966,1.68E-173,7.70E-166,adult_children_senior_youth,youth,alprazolam,cardiac arrest,Cardiac disorders,Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
705944,35808800,1.11E-170,5.08E-163,adult_children_senior_youth,children,methylphenidate,application site erythema,General disorders and administration site conditions,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
1332418,37622449,1.02E-157,4.66E-150,adult_children_senior_youth,youth,amlodipine,hypotension,Vascular disorders,"$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$Beta blocking agents and calcium channel blockers$Dihydropyridine derivatives$ACE inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$Calcium channel blockers and diuretics$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs), other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers","$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS$ACE INHIBITORS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$CALCIUM CHANNEL BLOCKERS AND DIURETICS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$BETA BLOCKING AGENTS$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1154161,36919235,1.40E-151,6.44E-144,adult_children_senior_youth,children,montelukast,suicidal ideation,Psychiatric disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1437379,35104199,6.81E-148,3.13E-140,adult_senior_youth,adult_senior,thioguanine,haematotoxicity,"Injury, poisoning and procedural complications",0,0,0,0
19010482,35607122,2.84E-147,1.30E-139,adult_children_senior_youth,senior,cyclosporine,eye irritation,Eye disorders,$Calcineurin inhibitors$Other ophthalmologicals,$IMMUNOSUPPRESSANTS$OTHER OPHTHALMOLOGICALS,$IMMUNOSUPPRESSANTS$OPHTHALMOLOGICALS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$SENSORY ORGANS
1502905,36314160,1.03E-144,4.71E-137,adult_children_senior_youth,children,insulin glargine,blood glucose increased,Investigations,"$Insulins and analogues for injection, long-acting$Insulins and analogues for injection, long-acting",$INSULINS AND ANALOGUES$INSULINS AND ANALOGUES,$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
955372,36919230,5.16E-144,2.37E-136,adult_children_senior_youth,senior,ethanol,completed suicide,General disorders and administration site conditions,$Antidotes$Nerve depressants$Other antiseptics and disinfectants,$ALL OTHER THERAPEUTIC PRODUCTS$ALL OTHER THERAPEUTIC PRODUCTS$ANTISEPTICS AND DISINFECTANTS,$ALL OTHER THERAPEUTIC PRODUCTS$ALL OTHER THERAPEUTIC PRODUCTS$ANTISEPTICS AND DISINFECTANTS,$VARIOUS$VARIOUS$DERMATOLOGICALS
715233,36516868,2.49E-142,1.14E-134,adult_children_senior_youth,children_youth,baclofen,muscle spasticity,Nervous system disorders,Other centrally acting agents,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",MUSCLE RELAXANTS,MUSCULO-SKELETAL SYSTEM
781039,37219893,4.98E-137,2.29E-129,adult_children_senior_youth,youth,alprazolam,respiratory arrest,"Respiratory, thoracic and mediastinal disorders",Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1738521,37622518,5.29E-136,2.43E-128,adult_children_senior_youth,youth,doxycycline,haemorrhage,Vascular disorders,$Tetracyclines$Antiinfectives and antiseptics for local oral treatment$Tetracyclines,$TETRACYCLINES$STOMATOLOGICAL PREPARATIONS$TETRACYCLINES,$ANTIBACTERIALS FOR SYSTEMIC USE$STOMATOLOGICAL PREPARATIONS$ANTIBACTERIALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ALIMENTARY TRACT AND METABOLISM$ANTIINFECTIVES FOR SYSTEMIC USE
1589505,36211582,1.93E-133,8.84E-126,adult_children_youth,adult,levonorgestrel,complication of device removal,General disorders and administration site conditions,"$Progestogens and estrogens, sequential preparations$Emergency contraceptives$Progestogens$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations",$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
40241331,37219871,1.20E-131,5.52E-124,adult_children_senior_youth,youth,rivaroxaban,pulmonary embolism,"$Respiratory, thoracic and mediastinal disorders$Vascular disorders",Direct factor Xa inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1305058,35104877,1.21E-131,5.53E-124,adult_children_senior_youth,children,methotrexate,febrile neutropenia,General disorders and administration site conditions,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1119119,35809059,1.49E-130,6.84E-123,adult_children_senior_youth,senior,adalimumab,death,General disorders and administration site conditions,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1584910,35809005,1.58E-130,7.25E-123,adult_children_senior_youth,children,somatropin,injection site pain,General disorders and administration site conditions,0,0,0,0
1322184,35205180,5.02E-130,2.31E-122,adult_children_senior_youth,adult,clopidogrel,acute myocardial infarction,Vascular disorders,Platelet aggregation inhibitors excl. heparin,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1124957,36919128,8.80E-130,4.04E-122,adult_children_senior_youth,youth,oxycodone,drug dependence,Psychiatric disorders,$Natural opium alkaloids$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
19012585,35104199,7.49E-128,3.44E-120,adult_children_senior_youth,adult_senior,asparaginase,haematotoxicity,"Injury, poisoning and procedural complications",0,0,0,0
1351541,35809059,2.50E-127,1.15E-119,adult_children_senior_youth,senior,leuprolide,death,General disorders and administration site conditions,$Gonadotropin releasing hormone analogues$Gonadotropin releasing hormone analogues,$HORMONES AND RELATED AGENTS$HORMONES AND RELATED AGENTS,$ENDOCRINE THERAPY$ENDOCRINE THERAPY,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
40222444,42890501,6.78E-126,3.11E-118,adult_children_senior_youth,children,denosumab,osteonecrosis of jaw,Vascular disorders,Other drugs affecting bone structure and mineralization,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,DRUGS FOR TREATMENT OF BONE DISEASES,MUSCULO-SKELETAL SYSTEM
1177480,36009762,1.99E-125,9.14E-118,adult_children_senior_youth,children,ibuprofen,angioedema,Immune system disorders,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
715233,35809369,1.13E-124,5.19E-117,adult_children_senior_youth,youth,baclofen,drug withdrawal syndrome,General disorders and administration site conditions,Other centrally acting agents,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",MUSCLE RELAXANTS,MUSCULO-SKELETAL SYSTEM
705944,35808822,1.38E-123,6.35E-116,adult_children_senior_youth,children,methylphenidate,application site pruritus,General disorders and administration site conditions,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
40241331,37622465,2.88E-123,1.32E-115,adult_children_senior_youth,children_youth,rivaroxaban,deep vein thrombosis,Vascular disorders,Direct factor Xa inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1500211,36617163,7.65E-122,3.51E-114,adult_children_senior_youth,senior,medroxyprogesterone,breast cancer female,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",0,0,0,0
1112807,36009762,9.40E-122,4.31E-114,adult_children_senior_youth,children_youth,aspirin,angioedema,Immune system disorders,0,0,0,0
19010482,35607483,4.41E-121,2.02E-113,adult_children_senior_youth,senior,cyclosporine,vision blurred,Eye disorders,$Calcineurin inhibitors$Other ophthalmologicals,$IMMUNOSUPPRESSANTS$OTHER OPHTHALMOLOGICALS,$IMMUNOSUPPRESSANTS$OPHTHALMOLOGICALS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$SENSORY ORGANS
1119119,36009833,1.19E-118,5.44E-111,adult_children_senior_youth,senior,adalimumab,rheumatoid arthritis,Immune system disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
708298,36211303,1.16E-117,5.31E-110,adult_children_senior_youth,senior,midazolam,injury,"Injury, poisoning and procedural complications",Benzodiazepine derivatives,HYPNOTICS AND SEDATIVES,PSYCHOLEPTICS,NERVOUS SYSTEM
1326303,35204953,1.19E-115,5.46E-108,adult_children_senior_youth,children,digoxin,atrial fibrillation,Cardiac disorders,Digitalis glycosides,CARDIAC GLYCOSIDES,CARDIAC THERAPY,CARDIOVASCULAR SYSTEM
1151789,37320205,1.27E-115,5.83E-108,adult_children_senior_youth,adult_youth,etanercept,psoriasis,$Immune system disorders$Skin and subcutaneous tissue disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
915542,37320158,3.98E-115,1.83E-107,adult_children_senior_youth,youth,brimonidine,erythema,Skin and subcutaneous tissue disorders,$Other dermatologicals$Sympathomimetics in glaucoma therapy,$OTHER DERMATOLOGICAL PREPARATIONS$ANTIGLAUCOMA PREPARATIONS AND MIOTICS,$OTHER DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS,$DERMATOLOGICALS$SENSORY ORGANS
937368,35708063,1.28E-114,5.87E-107,adult_children_senior_youth,children_youth,infliximab,crohn's disease,$Gastrointestinal disorders$Immune system disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1154161,36919098,1.73E-113,7.93E-106,adult_children_senior_youth,children,montelukast,abnormal behaviour,Psychiatric disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1519936,37219871,4.34E-113,1.99E-105,adult_children_senior_youth,adult,etonogestrel,pulmonary embolism,"$Respiratory, thoracic and mediastinal disorders$Vascular disorders",Progestogens,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,GENITO URINARY SYSTEM AND SEX HORMONES
781039,35204970,5.76E-112,2.65E-104,adult_children_senior_youth,youth,alprazolam,cardio-respiratory arrest,Cardiac disorders,Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1589505,35708202,6.03E-112,2.77E-104,adult_children_senior_youth,children_youth,levonorgestrel,nausea,Gastrointestinal disorders,"$Progestogens and estrogens, sequential preparations$Emergency contraceptives$Progestogens$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations",$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
984232,36818833,1.22E-111,5.59E-104,adult_children_youth,adult,isotretinoin,pregnancy,"Pregnancy, puerperium and perinatal conditions",$Retinoids for topical use in acne$Retinoids for topical use in acne$Retinoids for treatment of acne,$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE,$ANTI-ACNE PREPARATIONS$ANTI-ACNE PREPARATIONS$ANTI-ACNE PREPARATIONS,$DERMATOLOGICALS$DERMATOLOGICALS$DERMATOLOGICALS
1311276,36919183,8.14E-111,3.74E-103,adult_senior_youth,senior,vardenafil,erectile dysfunction,$Psychiatric disorders$Reproductive system and breast disorders,Drugs used in erectile dysfunction,UROLOGICALS,UROLOGICALS,GENITO URINARY SYSTEM AND SEX HORMONES
1322184,35205164,1.52E-110,6.96E-103,adult_children_senior_youth,adult,clopidogrel,coronary artery disease,Vascular disorders,Platelet aggregation inhibitors excl. heparin,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
964407,42889647,2.77E-109,1.27E-101,adult_children_senior_youth,adult_senior,salicylic acid,toxicity to various agents,"Injury, poisoning and procedural complications","$Other antifungals for topical use$Salicylic acid and derivatives$Salicylic acid and derivatives$Antiinflammatory agents, non-steroids",$ANTIFUNGALS FOR TOPICAL USE$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$ANTIINFLAMMATORY AGENTS,$ANTIFUNGALS FOR DERMATOLOGICAL USE$ANALGESICS$ANALGESICS$OPHTHALMOLOGICALS,$DERMATOLOGICALS$NERVOUS SYSTEM$NERVOUS SYSTEM$SENSORY ORGANS
1112807,35205180,3.66E-109,1.68E-101,adult_children_senior_youth,adult,aspirin,acute myocardial infarction,Vascular disorders,0,0,0,0
708298,36919046,8.61E-108,3.95E-100,adult_children_senior_youth,senior,midazolam,emotional distress,Psychiatric disorders,Benzodiazepine derivatives,HYPNOTICS AND SEDATIVES,PSYCHOLEPTICS,NERVOUS SYSTEM
968426,35708044,2.13E-106,9.76E-99,adult_children_senior_youth,children,mesalamine,colitis ulcerative,Gastrointestinal disorders,0,0,0,0
1151789,35808976,2.52E-106,1.16E-98,adult_children_senior_youth,youth,etanercept,injection site erythema,General disorders and administration site conditions,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1567198,36314160,1.27E-104,5.84E-97,adult_children_senior_youth,children,insulin aspart,blood glucose increased,Investigations,"$Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting$Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting$Insulins and analogues for injection, fast-acting",$INSULINS AND ANALOGUES$INSULINS AND ANALOGUES$INSULINS AND ANALOGUES,$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1150871,35104074,2.74E-104,1.26E-96,adult_senior_youth,youth,misoprostol,anaemia,Blood and lymphatic system disorders,$Prostaglandins$Prostaglandins$Propionic acid derivatives,"$UTEROTONICS$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$DRUGS FOR ACID RELATED DISORDERS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$ALIMENTARY TRACT AND METABOLISM$MUSCULO-SKELETAL SYSTEM
1525215,36617459,1.36E-102,6.24E-95,adult_children_senior_youth,children,pioglitazone,bladder cancer,Renal and urinary disorders,$Combinations of oral blood glucose lowering drugs$Thiazolidinediones$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1119119,35808976,1.85E-101,8.51E-94,adult_children_senior_youth,children_youth,adalimumab,injection site erythema,General disorders and administration site conditions,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1119119,36211465,4.31E-101,1.98E-93,adult_children_senior_youth,youth,adalimumab,incorrect dose administered,"Injury, poisoning and procedural complications",Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1151789,35809243,1.13E-100,5.18E-93,adult_children_senior_youth,adult_senior,etanercept,pain,General disorders and administration site conditions,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
40228152,35707864,1.13E-99,5.20E-92,adult_children_senior_youth,children,dabigatran etexilate,gastrointestinal haemorrhage,Gastrointestinal disorders,Direct thrombin inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1311078,35104103,3.77E-99,1.73E-91,adult_children_senior_youth,adult,cytarabine,bone marrow failure,Blood and lymphatic system disorders,$Pyrimidine analogues$Combinations of antineoplastic agents,$ANTIMETABOLITES$OTHER ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AGENTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
19010482,35606964,3.65E-98,1.67E-90,adult_children_senior_youth,senior,cyclosporine,eye pain,Eye disorders,$Calcineurin inhibitors$Other ophthalmologicals,$IMMUNOSUPPRESSANTS$OTHER OPHTHALMOLOGICALS,$IMMUNOSUPPRESSANTS$OPHTHALMOLOGICALS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$SENSORY ORGANS
1500211,36617162,5.17E-98,2.37E-90,adult_children_senior,senior,medroxyprogesterone,breast cancer,Reproductive system and breast disorders,0,0,0,0
1351541,35809005,7.42E-98,3.41E-90,adult_children_senior_youth,children,leuprolide,injection site pain,General disorders and administration site conditions,$Gonadotropin releasing hormone analogues$Gonadotropin releasing hormone analogues,$HORMONES AND RELATED AGENTS$HORMONES AND RELATED AGENTS,$ENDOCRINE THERAPY$ENDOCRINE THERAPY,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1151789,35809014,3.64E-97,1.67E-89,adult_children_senior_youth,youth,etanercept,injection site reaction,General disorders and administration site conditions,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
40241331,35707871,5.49E-97,2.52E-89,adult_children_senior_youth,senior,rivaroxaban,upper gastrointestinal haemorrhage,Gastrointestinal disorders,Direct factor Xa inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1107830,36254981,6.92E-96,3.18E-88,adult_children_senior_youth,children,loratadine,extra dose administered,"Injury, poisoning and procedural complications",Other antihistamines for systemic use,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,RESPIRATORY SYSTEM
1154161,36918869,8.62E-96,3.96E-88,adult_children_senior_youth,children,montelukast,fear,Psychiatric disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
40241331,36718005,1.35E-95,6.18E-88,adult_children_senior_youth,children,rivaroxaban,cerebrovascular accident,Vascular disorders,Direct factor Xa inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
40244464,35104877,5.09E-95,2.34E-87,adult_children_senior_youth,children,ruxolitinib,febrile neutropenia,General disorders and administration site conditions,Protein kinase inhibitors,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1322184,35205243,8.29E-95,3.80E-87,adult_children_senior_youth,adult,clopidogrel,cardiac failure congestive,Cardiac disorders,Platelet aggregation inhibitors excl. heparin,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1351541,37119745,2.19E-94,1.01E-86,adult_children_youth,youth,leuprolide,vaginal haemorrhage,Reproductive system and breast disorders,$Gonadotropin releasing hormone analogues$Gonadotropin releasing hormone analogues,$HORMONES AND RELATED AGENTS$HORMONES AND RELATED AGENTS,$ENDOCRINE THERAPY$ENDOCRINE THERAPY,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1119119,35808981,1.67E-93,7.68E-86,adult_children_senior_youth,youth,adalimumab,injection site haemorrhage,General disorders and administration site conditions,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1361711,35205189,2.47E-93,1.14E-85,adult_children_senior_youth,adult_youth,glyceryl trinitrate,myocardial infarction,Vascular disorders,0,0,0,0
735979,36416534,6.11E-93,2.80E-85,adult_children_senior_youth,children,risperidone,obesity,Metabolism and nutrition disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1124957,35204966,3.34E-92,1.53E-84,adult_children_senior_youth,children_youth,oxycodone,cardiac arrest,Cardiac disorders,$Natural opium alkaloids$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
43526424,36718112,5.63E-92,2.58E-84,adult_children_senior_youth,youth,dimethyl fumarate,multiple sclerosis relapse,Nervous system disorders,Other immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1151789,35809011,9.28E-92,4.26E-84,adult_children_senior_youth,youth,etanercept,injection site pruritus,General disorders and administration site conditions,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1502905,35506494,1.16E-91,5.34E-84,adult_children_senior_youth,children_youth,insulin glargine,diabetic ketoacidosis,$Endocrine disorders$Metabolism and nutrition disorders,"$Insulins and analogues for injection, long-acting$Insulins and analogues for injection, long-acting",$INSULINS AND ANALOGUES$INSULINS AND ANALOGUES,$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1332418,37622446,4.02E-91,1.85E-83,adult_children_senior_youth,youth,amlodipine,shock,Vascular disorders,"$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$Beta blocking agents and calcium channel blockers$Dihydropyridine derivatives$ACE inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$Calcium channel blockers and diuretics$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs), other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers","$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS$ACE INHIBITORS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$CALCIUM CHANNEL BLOCKERS AND DIURETICS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$BETA BLOCKING AGENTS$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1310317,37320268,3.33E-90,1.53E-82,adult_children_senior_youth,adult,cyclophosphamide,alopecia,Skin and subcutaneous tissue disorders,Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
708298,36918858,4.70E-90,2.16E-82,adult_children_senior_youth,senior,midazolam,anxiety,Psychiatric disorders,Benzodiazepine derivatives,HYPNOTICS AND SEDATIVES,PSYCHOLEPTICS,NERVOUS SYSTEM
1112807,35707864,9.97E-90,4.58E-82,adult_children_senior_youth,senior,aspirin,gastrointestinal haemorrhage,Gastrointestinal disorders,0,0,0,0
1154161,36919042,2.94E-89,1.35E-81,adult_children_senior_youth,children,montelukast,anger,Psychiatric disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
757352,36718555,3.18E-89,1.46E-81,adult_children_senior_youth,senior_youth,eszopiclone,insomnia,$Nervous system disorders$Psychiatric disorders,Benzodiazepine related drugs,HYPNOTICS AND SEDATIVES,PSYCHOLEPTICS,NERVOUS SYSTEM
1502905,35506636,3.93E-89,1.80E-81,adult_children_senior_youth,children_youth,insulin glargine,hypoglycaemia,Endocrine disorders,"$Insulins and analogues for injection, long-acting$Insulins and analogues for injection, long-acting",$INSULINS AND ANALOGUES$INSULINS AND ANALOGUES,$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
800878,35809059,9.42E-89,4.32E-81,adult_children_senior_youth,senior,clozapine,death,General disorders and administration site conditions,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1336926,37119607,5.81E-87,2.67E-79,adult_senior_youth,adult,tadalafil,benign prostatic hyperplasia,Reproductive system and breast disorders,$Drugs used in erectile dysfunction$Antihypertensives for pulmonary arterial hypertension,$UROLOGICALS$OTHER ANTIHYPERTENSIVES,$UROLOGICALS$ANTIHYPERTENSIVES,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
757688,36315381,8.18E-87,3.75E-79,adult_children_senior_youth,children,aripiprazole,weight increased,Investigations,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1151789,43053808,8.79E-86,4.03E-78,adult_children_senior_youth,children_youth,etanercept,injection site bruising,General disorders and administration site conditions,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
40228152,36718005,1.70E-85,7.82E-78,adult_children_senior_youth,children,dabigatran etexilate,cerebrovascular accident,Vascular disorders,Direct thrombin inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1715117,35306246,1.14E-83,5.26E-76,adult_children_senior_youth,children_youth,aztreonam,cystic fibrosis,"Respiratory, thoracic and mediastinal disorders",Monobactams,OTHER BETA-LACTAM ANTIBACTERIALS,ANTIBACTERIALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
1112807,36211188,1.55E-83,7.10E-76,adult_children_senior_youth,children,aspirin,therapeutic agent toxicity,0,0,0,0,0
19010482,37622529,2.14E-83,9.82E-76,adult_children_senior_youth,children,cyclosporine,hypertension,Vascular disorders,$Calcineurin inhibitors$Other ophthalmologicals,$IMMUNOSUPPRESSANTS$OTHER OPHTHALMOLOGICALS,$IMMUNOSUPPRESSANTS$OPHTHALMOLOGICALS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$SENSORY ORGANS
1154161,36918949,3.87E-82,1.78E-74,adult_children_senior_youth,children,montelukast,depressed mood,Psychiatric disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
984232,37521612,4.18E-82,1.92E-74,adult_children_youth,adult,isotretinoin,abortion induced,Surgical and medical procedures,$Retinoids for topical use in acne$Retinoids for topical use in acne$Retinoids for treatment of acne,$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE,$ANTI-ACNE PREPARATIONS$ANTI-ACNE PREPARATIONS$ANTI-ACNE PREPARATIONS,$DERMATOLOGICALS$DERMATOLOGICALS$DERMATOLOGICALS
1545958,35205189,7.66E-82,3.52E-74,adult_children_senior_youth,adult_children,atorvastatin,myocardial infarction,Vascular disorders,"$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations","$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS",$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1777806,35909445,9.00E-82,4.13E-74,adult_children_senior_youth,children,ceftriaxone,cholelithiasis,Hepatobiliary disorders,$Third-generation cephalosporins$Third-generation cephalosporins,$OTHER BETA-LACTAM ANTIBACTERIALS$OTHER BETA-LACTAM ANTIBACTERIALS,$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIBACTERIALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
1589505,36918858,1.79E-81,8.23E-74,adult_children_youth,adult,levonorgestrel,anxiety,Psychiatric disorders,"$Progestogens and estrogens, sequential preparations$Emergency contraceptives$Progestogens$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations",$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1310317,37622529,2.21E-81,1.01E-73,adult_children_senior_youth,children,cyclophosphamide,hypertension,Vascular disorders,Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
40241331,37622460,3.99E-81,1.83E-73,adult_children_senior_youth,children_youth,rivaroxaban,thrombosis,Vascular disorders,Direct factor Xa inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1589505,35708208,4.00E-80,1.84E-72,adult_children_senior_youth,children_youth,levonorgestrel,vomiting,Gastrointestinal disorders,"$Progestogens and estrogens, sequential preparations$Emergency contraceptives$Progestogens$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations",$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1315942,37320268,4.57E-80,2.10E-72,adult_children_senior_youth,adult,docetaxel,alopecia,Skin and subcutaneous tissue disorders,Taxanes,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1177480,37622465,1.91E-79,8.76E-72,adult_children_senior_youth,youth,ibuprofen,deep vein thrombosis,Vascular disorders,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
1326303,42889647,2.03E-79,9.33E-72,adult_children_senior_youth,children_senior,digoxin,toxicity to various agents,"Injury, poisoning and procedural complications",Digitalis glycosides,CARDIAC GLYCOSIDES,CARDIAC THERAPY,CARDIOVASCULAR SYSTEM
723013,35809059,5.32E-79,2.44E-71,adult_children_senior_youth,youth,diazepam,death,General disorders and administration site conditions,Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
968426,35708063,1.70E-78,7.80E-71,adult_children_senior_youth,children,mesalamine,crohn's disease,$Gastrointestinal disorders$Immune system disorders,0,0,0,0
1336926,36315262,2.27E-78,1.04E-70,adult_senior,adult,tadalafil,body height decreased,Investigations,$Drugs used in erectile dysfunction$Antihypertensives for pulmonary arterial hypertension,$UROLOGICALS$OTHER ANTIHYPERTENSIVES,$UROLOGICALS$ANTIHYPERTENSIVES,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
1119119,35708063,3.54E-78,1.63E-70,adult_children_senior_youth,children_youth,adalimumab,crohn's disease,$Gastrointestinal disorders$Immune system disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1395557,36009891,1.55E-77,7.13E-70,adult_children_senior_youth,children_youth,fludarabine,acute graft versus host disease,"Injury, poisoning and procedural complications",Purine analogues,ANTIMETABOLITES,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1584910,36718132,3.46E-77,1.59E-69,adult_children_senior_youth,children_youth,somatropin,headache,Nervous system disorders,0,0,0,0
1154161,36919052,7.33E-77,3.36E-69,adult_children_senior_youth,children,montelukast,mood swings,Psychiatric disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1311799,35104199,1.46E-76,6.72E-69,adult_children_senior_youth,adult_youth,daunorubicin,haematotoxicity,"Injury, poisoning and procedural complications",$Anthracyclines and related substances$Combinations of antineoplastic agents,$CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES$OTHER ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AGENTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1103640,35204966,1.70E-76,7.80E-69,adult_children_senior_youth,youth,methadone,cardiac arrest,Cardiac disorders,$Drugs used in opioid dependence$Diphenylpropylamine derivatives,$DRUGS USED IN ADDICTIVE DISORDERS$OPIOIDS,$OTHER NERVOUS SYSTEM DRUGS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
1503297,36314160,3.75E-76,1.72E-68,adult_children_senior_youth,adult,metformin,blood glucose increased,Investigations,$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Biguanides$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
43013024,36718005,1.57E-75,7.21E-68,adult_children_senior_youth,children,apixaban,cerebrovascular accident,Vascular disorders,Direct factor Xa inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
937368,35205038,1.20E-74,5.51E-67,adult_children_senior_youth,children_youth,infliximab,dyspnoea,"$Cardiac disorders$Respiratory, thoracic and mediastinal disorders",Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
937368,35809131,1.27E-74,5.82E-67,adult_children_senior_youth,children_youth,infliximab,general physical health deterioration,General disorders and administration site conditions,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
937368,35707866,1.41E-74,6.45E-67,adult_children_senior_youth,children_youth,infliximab,haematochezia,Gastrointestinal disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1124957,37219893,1.44E-74,6.62E-67,adult_children_senior_youth,children_youth,oxycodone,respiratory arrest,"Respiratory, thoracic and mediastinal disorders",$Natural opium alkaloids$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1351541,35809133,2.21E-74,1.01E-66,adult_children_senior_youth,youth,leuprolide,hot flush,Reproductive system and breast disorders,$Gonadotropin releasing hormone analogues$Gonadotropin releasing hormone analogues,$HORMONES AND RELATED AGENTS$HORMONES AND RELATED AGENTS,$ENDOCRINE THERAPY$ENDOCRINE THERAPY,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
40170680,36718112,4.81E-74,2.21E-66,adult_senior_youth,youth,dalfampridine,multiple sclerosis relapse,Nervous system disorders,Other nervous system drugs,OTHER NERVOUS SYSTEM DRUGS,OTHER NERVOUS SYSTEM DRUGS,NERVOUS SYSTEM
1715117,42889536,1.70E-73,7.80E-66,adult_children_senior_youth,children_youth,aztreonam,infective pulmonary exacerbation of cystic fibrosis,"Respiratory, thoracic and mediastinal disorders",Monobactams,OTHER BETA-LACTAM ANTIBACTERIALS,ANTIBACTERIALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
1125315,35909513,1.40E-72,6.45E-65,adult_children_senior_youth,children_youth,acetaminophen,acute hepatic failure,Hepatobiliary disorders,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1305058,37622449,2.32E-72,1.06E-64,adult_children_senior_youth,children,methotrexate,hypotension,Vascular disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1547504,35204989,3.57E-72,1.64E-64,adult_children_senior_youth,adult,rosiglitazone,cardiac disorder,Cardiac disorders,$Combinations of oral blood glucose lowering drugs$Thiazolidinediones$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1149380,35809288,9.32E-72,4.28E-64,adult_senior_youth,adult,fluticasone,product odour abnormal,Product issues,"$Glucocorticoids$Corticosteroids, potent (group III)$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Corticosteroids$Corticosteroids","$OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS$CORTICOSTEROIDS, PLAIN$ADRENERGICS, INHALANTS$ADRENERGICS, INHALANTS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE","$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$NASAL PREPARATIONS$NASAL PREPARATIONS",$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1311078,35104351,1.08E-71,4.97E-64,adult_children_senior_youth,senior,cytarabine,acute myeloid leukaemia,Blood and lymphatic system disorders,$Pyrimidine analogues$Combinations of antineoplastic agents,$ANTIMETABOLITES$OTHER ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AGENTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
964407,37320158,2.19E-71,1.00E-63,adult_children_senior_youth,children,salicylic acid,erythema,Skin and subcutaneous tissue disorders,"$Other antifungals for topical use$Salicylic acid and derivatives$Salicylic acid and derivatives$Antiinflammatory agents, non-steroids",$ANTIFUNGALS FOR TOPICAL USE$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$ANTIINFLAMMATORY AGENTS,$ANTIFUNGALS FOR DERMATOLOGICAL USE$ANALGESICS$ANALGESICS$OPHTHALMOLOGICALS,$DERMATOLOGICALS$NERVOUS SYSTEM$NERVOUS SYSTEM$SENSORY ORGANS
19003999,36516828,2.70E-71,1.24E-63,adult_senior,senior,mycophenolate mofetil,psoriatic arthropathy,$Immune system disorders$Musculoskeletal and connective tissue disorders$Skin and subcutaneous tissue disorders,0,0,0,0
1154161,36919050,6.23E-70,2.86E-62,adult_children_senior_youth,children,montelukast,mood altered,Psychiatric disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
722031,35205243,1.35E-67,6.18E-60,adult_children_senior_youth,children,paroxetine,cardiac failure congestive,Cardiac disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1589505,35809071,1.45E-67,6.66E-60,adult_children_youth,children,levonorgestrel,no adverse event,General disorders and administration site conditions,"$Progestogens and estrogens, sequential preparations$Emergency contraceptives$Progestogens$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations",$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1436650,35104199,1.86E-67,8.54E-60,adult_children_senior_youth,children,mercaptopurine,haematotoxicity,"Injury, poisoning and procedural complications",$Purine analogues$Xanthines,$ANTIMETABOLITES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$ANTINEOPLASTIC AGENTS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$RESPIRATORY SYSTEM
1150871,36818629,2.10E-67,9.66E-60,adult_children_youth,youth,misoprostol,abortion incomplete,"Pregnancy, puerperium and perinatal conditions",$Prostaglandins$Prostaglandins$Propionic acid derivatives,"$UTEROTONICS$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$DRUGS FOR ACID RELATED DISORDERS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$ALIMENTARY TRACT AND METABOLISM$MUSCULO-SKELETAL SYSTEM
1124957,35204970,4.79E-67,2.20E-59,adult_children_senior_youth,children_youth,oxycodone,cardio-respiratory arrest,Cardiac disorders,$Natural opium alkaloids$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1305058,35104113,6.75E-67,3.10E-59,adult_children_senior_youth,senior,methotrexate,pancytopenia,Blood and lymphatic system disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
705944,35808810,1.80E-66,8.27E-59,adult_children_senior_youth,children,methylphenidate,application site irritation,General disorders and administration site conditions,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
955372,42889647,1.97E-66,9.05E-59,adult_children_senior_youth,children,ethanol,toxicity to various agents,"Injury, poisoning and procedural complications",$Antidotes$Nerve depressants$Other antiseptics and disinfectants,$ALL OTHER THERAPEUTIC PRODUCTS$ALL OTHER THERAPEUTIC PRODUCTS$ANTISEPTICS AND DISINFECTANTS,$ALL OTHER THERAPEUTIC PRODUCTS$ALL OTHER THERAPEUTIC PRODUCTS$ANTISEPTICS AND DISINFECTANTS,$VARIOUS$VARIOUS$DERMATOLOGICALS
1351541,35708154,1.40E-65,6.44E-58,adult_children_senior_youth,youth,leuprolide,abdominal pain,Gastrointestinal disorders,$Gonadotropin releasing hormone analogues$Gonadotropin releasing hormone analogues,$HORMONES AND RELATED AGENTS$HORMONES AND RELATED AGENTS,$ENDOCRINE THERAPY$ENDOCRINE THERAPY,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1436650,35708063,9.30E-65,4.27E-57,adult_children_senior_youth,youth,mercaptopurine,crohn's disease,$Gastrointestinal disorders$Immune system disorders,$Purine analogues$Xanthines,$ANTIMETABOLITES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$ANTINEOPLASTIC AGENTS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$RESPIRATORY SYSTEM
1589505,35506587,9.85E-65,4.52E-57,adult_children_senior_youth,children,levonorgestrel,menstruation irregular,$Endocrine disorders$Reproductive system and breast disorders,"$Progestogens and estrogens, sequential preparations$Emergency contraceptives$Progestogens$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations",$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1305058,35104883,2.14E-64,9.84E-57,adult_children_senior_youth,children,methotrexate,neutropenia,Blood and lymphatic system disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
735979,36416524,4.55E-64,2.09E-56,adult_children_senior_youth,children,risperidone,abnormal weight gain,Metabolism and nutrition disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1307046,35205164,7.25E-64,3.33E-56,adult_children_senior_youth,adult,metoprolol,coronary artery disease,Vascular disorders,"$Beta blocking agents and calcium channel blockers$Beta blocking agents, other combinations$Beta blocking agents, other combinations$Beta blocking agents and calcium channel blockers$Beta blocking agents, selective$Beta blocking agents, selective, and thiazides$Beta blocking agents, selective, and other diuretics$Beta blocking agents, selective, and thiazides","$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS AND OTHER DIURETICS$BETA BLOCKING AGENTS AND THIAZIDES",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
705944,35808816,1.12E-63,5.15E-56,adult_children_youth,children,methylphenidate,application site pain,General disorders and administration site conditions,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
708298,36918869,2.15E-63,9.86E-56,adult_children_senior_youth,senior,midazolam,fear,Psychiatric disorders,Benzodiazepine derivatives,HYPNOTICS AND SEDATIVES,PSYCHOLEPTICS,NERVOUS SYSTEM
956874,35205240,2.50E-63,1.15E-55,adult_children_senior_youth,children_youth,furosemide,cardiac failure,Cardiac disorders,"$High-ceiling diuretics and potassium-sparing agents$Sulfonamides, plain$Sulfonamides$Sulfonamides and potassium in combination","$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$HIGH-CEILING DIURETICS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$HIGH-CEILING DIURETICS",$DIURETICS$DIURETICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$DIURETICS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
915542,35809115,6.76E-63,3.10E-55,adult_children_senior_youth,youth,brimonidine,condition aggravated,General disorders and administration site conditions,$Other dermatologicals$Sympathomimetics in glaucoma therapy,$OTHER DERMATOLOGICAL PREPARATIONS$ANTIGLAUCOMA PREPARATIONS AND MIOTICS,$OTHER DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS,$DERMATOLOGICALS$SENSORY ORGANS
1151789,35506609,1.62E-62,7.42E-55,adult_children_senior_youth,senior,etanercept,diabetes mellitus,Endocrine disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1338512,37320268,2.06E-62,9.45E-55,adult_children_senior_youth,adult,doxorubicin,alopecia,Skin and subcutaneous tissue disorders,Anthracyclines and related substances,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1519936,37622465,2.41E-62,1.11E-54,adult_children_senior_youth,adult,etonogestrel,deep vein thrombosis,Vascular disorders,Progestogens,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,GENITO URINARY SYSTEM AND SEX HORMONES
1154161,36718353,4.88E-62,2.24E-54,adult_children_senior_youth,children,montelukast,crying,"Injury, poisoning and procedural complications",$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1332418,35205246,1.34E-61,6.16E-54,adult_children_senior_youth,youth,amlodipine,cardiogenic shock,Vascular disorders,"$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$Beta blocking agents and calcium channel blockers$Dihydropyridine derivatives$ACE inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$Calcium channel blockers and diuretics$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs), other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers","$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS$ACE INHIBITORS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$CALCIUM CHANNEL BLOCKERS AND DIURETICS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$BETA BLOCKING AGENTS$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1336825,42889647,2.79E-61,1.28E-53,adult_children_senior_youth,senior,bortezomib,toxicity to various agents,"Injury, poisoning and procedural complications",Other antineoplastic agents,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
937368,35708044,3.76E-61,1.72E-53,adult_children_senior_youth,children,infliximab,colitis ulcerative,Gastrointestinal disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1307046,35205180,4.67E-61,2.14E-53,adult_children_senior_youth,adult,metoprolol,acute myocardial infarction,Vascular disorders,"$Beta blocking agents and calcium channel blockers$Beta blocking agents, other combinations$Beta blocking agents, other combinations$Beta blocking agents and calcium channel blockers$Beta blocking agents, selective$Beta blocking agents, selective, and thiazides$Beta blocking agents, selective, and other diuretics$Beta blocking agents, selective, and thiazides","$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS AND OTHER DIURETICS$BETA BLOCKING AGENTS AND THIAZIDES",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1589505,36919197,5.25E-61,2.41E-53,adult_children_youth,adult,levonorgestrel,loss of libido,Psychiatric disorders,"$Progestogens and estrogens, sequential preparations$Emergency contraceptives$Progestogens$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations",$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
904525,35607130,5.89E-61,2.70E-53,adult_children_senior_youth,children,bimatoprost,ocular hyperaemia,Eye disorders,Prostaglandin analogues,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,OPHTHALMOLOGICALS,SENSORY ORGANS
781039,42889647,9.17E-61,4.21E-53,adult_children_senior_youth,youth,alprazolam,toxicity to various agents,"Injury, poisoning and procedural complications",Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1151789,36718175,1.01E-60,4.66E-53,adult_children_senior_youth,senior,etanercept,memory impairment,$Nervous system disorders$Psychiatric disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1177480,37219871,3.51E-60,1.61E-52,adult_children_senior_youth,youth,ibuprofen,pulmonary embolism,"$Respiratory, thoracic and mediastinal disorders$Vascular disorders","$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
1305058,42889647,5.72E-60,2.63E-52,adult_children_senior_youth,children_youth,methotrexate,toxicity to various agents,"Injury, poisoning and procedural complications",$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1518254,35809310,6.59E-60,3.03E-52,adult_children_senior_youth,youth,dexamethasone,drug interaction,General disorders and administration site conditions,"$Corticosteroids$Corticosteroids, moderately potent, other combinations$Corticosteroids$Corticosteroids, combinations for treatment of acne$Corticosteroids/antiinfectives/mydriatics in combination$Corticosteroids and antiinfectives in combination$Corticosteroids and antiinfectives in combination$Corticosteroids$Corticosteroids and antiinfectives in combination$Corticosteroids, moderately potent, combinations with antibiotics$Glucocorticoids$Corticosteroids, plain$Corticosteroids for local oral treatment$Corticosteroids$Corticosteroids, moderately potent (group II)$Corticosteroids","$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$CORTICOSTEROIDS, OTHER COMBINATIONS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$ANTIINFLAMMATORY AGENTS$STOMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS$CORTICOSTEROIDS, PLAIN$CORTICOSTEROIDS","$NASAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$NASAL PREPARATIONS$ANTI-ACNE PREPARATIONS$OPHTHALMOLOGICALS$OTOLOGICALS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$VASOPROTECTIVES$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS FOR SYSTEMIC USE$OPHTHALMOLOGICALS$STOMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OTOLOGICALS","$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$DERMATOLOGICALS$SENSORY ORGANS$SENSORY ORGANS$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS$DERMATOLOGICALS$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$SENSORY ORGANS$DERMATOLOGICALS$SENSORY ORGANS"
915542,35809130,1.90E-59,8.71E-52,adult_children_senior_youth,youth,brimonidine,flushing,Vascular disorders,$Other dermatologicals$Sympathomimetics in glaucoma therapy,$OTHER DERMATOLOGICAL PREPARATIONS$ANTIGLAUCOMA PREPARATIONS AND MIOTICS,$OTHER DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS,$DERMATOLOGICALS$SENSORY ORGANS
1332418,36416487,2.54E-59,1.17E-51,adult_children_senior_youth,youth,amlodipine,metabolic acidosis,Metabolism and nutrition disorders,"$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$Beta blocking agents and calcium channel blockers$Dihydropyridine derivatives$ACE inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$Calcium channel blockers and diuretics$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs), other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers","$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS$ACE INHIBITORS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$CALCIUM CHANNEL BLOCKERS AND DIURETICS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$BETA BLOCKING AGENTS$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1119119,35708044,3.15E-59,1.45E-51,adult_children_senior_youth,children_youth,adalimumab,colitis ulcerative,Gastrointestinal disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
735979,36919098,4.24E-59,1.95E-51,adult_children_senior_youth,children,risperidone,abnormal behaviour,Psychiatric disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1395557,36009895,1.74E-58,7.99E-51,adult_children_senior_youth,children_youth,fludarabine,graft versus host disease,"Injury, poisoning and procedural complications",Purine analogues,ANTIMETABOLITES,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1177480,35809041,1.87E-58,8.59E-51,adult_children_senior_youth,children,ibuprofen,hypothermia,General disorders and administration site conditions,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
780442,35708208,3.82E-58,1.75E-50,adult_children_senior_youth,children_senior,varenicline,vomiting,Gastrointestinal disorders,Drugs used in nicotine dependence,DRUGS USED IN ADDICTIVE DISORDERS,OTHER NERVOUS SYSTEM DRUGS,NERVOUS SYSTEM
1519936,35506577,5.22E-58,2.40E-50,adult_children_youth,children_youth,etonogestrel,amenorrhoea,$Endocrine disorders$Reproductive system and breast disorders,Progestogens,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,GENITO URINARY SYSTEM AND SEX HORMONES
1177480,36009754,8.23E-58,3.78E-50,adult_children_senior_youth,children,ibuprofen,toxic epidermal necrolysis,Immune system disorders,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
1305058,35809243,2.46E-57,1.13E-49,adult_children_senior_youth,adult,methotrexate,pain,General disorders and administration site conditions,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1567198,35506494,3.02E-57,1.39E-49,adult_children_senior_youth,children_youth,insulin aspart,diabetic ketoacidosis,$Endocrine disorders$Metabolism and nutrition disorders,"$Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting$Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting$Insulins and analogues for injection, fast-acting",$INSULINS AND ANALOGUES$INSULINS AND ANALOGUES$INSULINS AND ANALOGUES,$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1503297,36416514,5.92E-57,2.72E-49,adult_children_senior_youth,senior,metformin,decreased appetite,General disorders and administration site conditions,$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Biguanides$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
735979,35506609,7.39E-57,3.39E-49,adult_children_senior_youth,adult,risperidone,diabetes mellitus,Endocrine disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1103640,35607284,8.06E-57,3.70E-49,adult_children_youth,children,methadone,nystagmus,Eye disorders,$Drugs used in opioid dependence$Diphenylpropylamine derivatives,$DRUGS USED IN ADDICTIVE DISORDERS$OPIOIDS,$OTHER NERVOUS SYSTEM DRUGS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
950637,36009901,3.61E-56,1.66E-48,adult_children_senior_youth,youth,tacrolimus,transplant rejection,"Injury, poisoning and procedural complications","$Agents for dermatitis, excluding corticosteroids$Calcineurin inhibitors",$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$DERMATOLOGICALS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
735979,35707713,4.53E-56,2.08E-48,adult_children_senior_youth,adult,risperidone,pancreatitis,Gastrointestinal disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1151789,35809019,5.47E-56,2.51E-48,adult_children_senior_youth,youth,etanercept,injection site swelling,General disorders and administration site conditions,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1367268,43053848,6.85E-56,3.15E-48,adult_children_senior_youth,children_youth,irinotecan,drug effect incomplete,General disorders and administration site conditions,Other antineoplastic agents,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1589505,35809139,1.28E-55,5.88E-48,adult_children_senior_youth,adult,levonorgestrel,irritability,$General disorders and administration site conditions$Psychiatric disorders,"$Progestogens and estrogens, sequential preparations$Emergency contraceptives$Progestogens$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations",$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1336539,36617495,1.91E-55,8.78E-48,adult_children_senior_youth,children_youth,sunitinib,renal cell carcinoma,"$Neoplasms benign, malignant and unspecified (incl cysts and polyps)$Renal and urinary disorders",Protein kinase inhibitors,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
742185,35708156,2.21E-55,1.01E-47,adult_children_senior_youth,children_senior,atomoxetine,abdominal pain upper,Gastrointestinal disorders,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
950637,36009895,2.34E-55,1.07E-47,adult_children_senior_youth,children_youth,tacrolimus,graft versus host disease,"Injury, poisoning and procedural complications","$Agents for dermatitis, excluding corticosteroids$Calcineurin inhibitors",$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$DERMATOLOGICALS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1103640,35607450,4.49E-55,2.06E-47,adult_children_senior,children,methadone,visual acuity reduced,Nervous system disorders,$Drugs used in opioid dependence$Diphenylpropylamine derivatives,$DRUGS USED IN ADDICTIVE DISORDERS$OPIOIDS,$OTHER NERVOUS SYSTEM DRUGS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
1383815,35205189,8.86E-55,4.07E-47,adult_children_senior,adult,isosorbide,myocardial infarction,Vascular disorders,0,0,0,0
1397141,35809120,1.05E-54,4.80E-47,adult_children_senior_youth,children_youth,bevacizumab,disease progression,General disorders and administration site conditions,Monoclonal antibodies,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1503297,35506636,1.25E-54,5.76E-47,adult_children_senior_youth,children_youth,metformin,hypoglycaemia,Endocrine disorders,$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Biguanides$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1557272,36211099,1.27E-54,5.83E-47,adult_children_senior_youth,children,alendronate,femur fracture,"Injury, poisoning and procedural complications",0,0,0,0
1336926,37622529,1.46E-54,6.68E-47,adult_children_senior_youth,adult,tadalafil,hypertension,Vascular disorders,$Drugs used in erectile dysfunction$Antihypertensives for pulmonary arterial hypertension,$UROLOGICALS$OTHER ANTIHYPERTENSIVES,$UROLOGICALS$ANTIHYPERTENSIVES,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
735979,35809041,1.99E-54,9.15E-47,adult_children_senior_youth,senior,risperidone,hypothermia,General disorders and administration site conditions,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1560171,35506636,4.39E-54,2.02E-46,adult_children_senior_youth,children,glipizide,hypoglycaemia,Endocrine disorders,Sulfonylureas,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",DRUGS USED IN DIABETES,ALIMENTARY TRACT AND METABOLISM
1119119,35205189,8.30E-54,3.81E-46,adult_children_senior_youth,senior,adalimumab,myocardial infarction,Vascular disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1001419,36919230,1.19E-53,5.44E-46,adult_children_senior_youth,adult,cocaine,completed suicide,General disorders and administration site conditions,"$Local anesthetics$Analgesics and anesthetics$Esters of benzoic acid$Anesthetics, local","$LOCAL ANESTHETICS$OTHER OTOLOGICALS$ANESTHETICS, LOCAL$THROAT PREPARATIONS",$OPHTHALMOLOGICALS$OTOLOGICALS$ANESTHETICS$THROAT PREPARATIONS,$SENSORY ORGANS$SENSORY ORGANS$NERVOUS SYSTEM$RESPIRATORY SYSTEM
1119119,35707866,1.34E-53,6.16E-46,adult_children_senior_youth,children,adalimumab,haematochezia,Gastrointestinal disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1346823,35205240,1.67E-53,7.65E-46,adult_children_senior_youth,children,carvedilol,cardiac failure,Cardiac disorders,"$Alpha and beta blocking agents$Beta blocking agents, other combinations","$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS, OTHER COMBINATIONS",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1707687,36211303,2.18E-53,1.00E-45,adult_children_senior_youth,senior,vancomycin,injury,"Injury, poisoning and procedural complications",$Glycopeptide antibacterials$Antibiotics,$OTHER ANTIBACTERIALS$INTESTINAL ANTIINFECTIVES,"$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",$ANTIINFECTIVES FOR SYSTEMIC USE$ALIMENTARY TRACT AND METABOLISM
19022417,42889647,2.56E-53,1.18E-45,adult_children_senior_youth,adult,diamorphine,toxicity to various agents,"Injury, poisoning and procedural complications",Drugs used in opioid dependence,DRUGS USED IN ADDICTIVE DISORDERS,OTHER NERVOUS SYSTEM DRUGS,NERVOUS SYSTEM
1500211,36312409,3.86E-53,1.77E-45,adult_senior,senior,medroxyprogesterone,oestrogen receptor assay positive,Investigations,0,0,0,0
1539403,35809130,8.82E-53,4.05E-45,adult_children_senior_youth,adult,simvastatin,flushing,Vascular disorders,"$Dipeptidyl peptidase 4 (DPP-4) inhibitors$HMG CoA reductase inhibitors$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents","$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS",$DRUGS USED IN DIABETES$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS,$ALIMENTARY TRACT AND METABOLISM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1351541,35808976,1.06E-52,4.87E-45,adult_children_senior_youth,children,leuprolide,injection site erythema,General disorders and administration site conditions,$Gonadotropin releasing hormone analogues$Gonadotropin releasing hormone analogues,$HORMONES AND RELATED AGENTS$HORMONES AND RELATED AGENTS,$ENDOCRINE THERAPY$ENDOCRINE THERAPY,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
956874,37219868,2.87E-52,1.32E-44,adult_children_senior_youth,children_youth,furosemide,pulmonary hypertension,Vascular disorders,"$High-ceiling diuretics and potassium-sparing agents$Sulfonamides, plain$Sulfonamides$Sulfonamides and potassium in combination","$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$HIGH-CEILING DIURETICS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$HIGH-CEILING DIURETICS",$DIURETICS$DIURETICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$DIURETICS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
711584,36718526,3.21E-52,1.47E-44,adult_children_senior_youth,children_youth,levetiracetam,convulsion,0,Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
1310149,37219871,5.09E-52,2.34E-44,adult_children_senior_youth,youth,warfarin,pulmonary embolism,"$Respiratory, thoracic and mediastinal disorders$Vascular disorders",Vitamin K antagonists,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
956874,35204953,5.70E-52,2.62E-44,adult_children_senior_youth,senior,furosemide,atrial fibrillation,Cardiac disorders,"$High-ceiling diuretics and potassium-sparing agents$Sulfonamides, plain$Sulfonamides$Sulfonamides and potassium in combination","$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$HIGH-CEILING DIURETICS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$HIGH-CEILING DIURETICS",$DIURETICS$DIURETICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$DIURETICS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
708298,35809243,6.79E-52,3.12E-44,adult_children_senior_youth,senior,midazolam,pain,General disorders and administration site conditions,Benzodiazepine derivatives,HYPNOTICS AND SEDATIVES,PSYCHOLEPTICS,NERVOUS SYSTEM
40226579,36718112,8.36E-52,3.84E-44,adult_children_senior_youth,youth,fingolimod,multiple sclerosis relapse,Nervous system disorders,Selective immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
40241331,35707868,1.66E-51,7.63E-44,adult_children_senior_youth,senior,rivaroxaban,lower gastrointestinal haemorrhage,Gastrointestinal disorders,Direct factor Xa inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
19010482,36315575,2.06E-51,9.45E-44,adult_children_senior_youth,adult_youth,cyclosporine,blood creatinine increased,Investigations,$Calcineurin inhibitors$Other ophthalmologicals,$IMMUNOSUPPRESSANTS$OTHER OPHTHALMOLOGICALS,$IMMUNOSUPPRESSANTS$OPHTHALMOLOGICALS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$SENSORY ORGANS
722031,35205113,4.04E-51,1.85E-43,adult_children_senior,children,paroxetine,tricuspid valve incompetence,Cardiac disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1502905,36416482,4.37E-51,2.01E-43,adult_children_senior_youth,children_youth,insulin glargine,ketoacidosis,Metabolism and nutrition disorders,"$Insulins and analogues for injection, long-acting$Insulins and analogues for injection, long-acting",$INSULINS AND ANALOGUES$INSULINS AND ANALOGUES,$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
722031,42889640,5.36E-51,2.46E-43,adult_children_senior_youth,children,paroxetine,maternal exposure during pregnancy,"Injury, poisoning and procedural complications",Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1115008,37622465,6.39E-51,2.93E-43,adult_children_senior_youth,youth,naproxen,deep vein thrombosis,Vascular disorders,"$Antiinflammatory products for vaginal administration$Antiinflammatory preparations, non-steroids for topical use$Propionic acid derivatives$Propionic acid derivatives$Propionic acid derivatives","$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
996416,36918942,7.50E-51,3.44E-43,adult_children_senior_youth,youth,finasteride,depression,Psychiatric disorders,$Other dermatologicals$Alpha-adrenoreceptor antagonists$Testosterone-5-alpha reductase inhibitors,$OTHER DERMATOLOGICAL PREPARATIONS$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,$OTHER DERMATOLOGICAL PREPARATIONS$UROLOGICALS$UROLOGICALS,$DERMATOLOGICALS$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1124957,36211496,1.21E-50,5.57E-43,adult_children_senior_youth,children_youth,oxycodone,overdose,"Injury, poisoning and procedural complications",$Natural opium alkaloids$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1332418,36211496,1.39E-50,6.38E-43,adult_children_senior_youth,youth,amlodipine,overdose,"Injury, poisoning and procedural complications","$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$Beta blocking agents and calcium channel blockers$Dihydropyridine derivatives$ACE inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$Calcium channel blockers and diuretics$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs), other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers","$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS$ACE INHIBITORS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$CALCIUM CHANNEL BLOCKERS AND DIURETICS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$BETA BLOCKING AGENTS$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1310149,37219867,2.38E-50,1.09E-42,adult_children_senior_youth,children_youth,warfarin,pulmonary arterial hypertension,Vascular disorders,Vitamin K antagonists,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1310149,37219868,2.75E-50,1.26E-42,adult_children_senior_youth,children_youth,warfarin,pulmonary hypertension,Vascular disorders,Vitamin K antagonists,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1177480,36211303,4.03E-50,1.85E-42,adult_children_senior_youth,youth,ibuprofen,injury,"Injury, poisoning and procedural complications","$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
705944,36416514,4.27E-50,1.96E-42,adult_children_senior_youth,children_senior,methylphenidate,decreased appetite,General disorders and administration site conditions,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
739138,42889640,4.33E-50,1.99E-42,adult_children_senior_youth,children,sertraline,maternal exposure during pregnancy,"Injury, poisoning and procedural complications",Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
711584,36776613,4.44E-50,2.04E-42,adult_children_senior_youth,children,levetiracetam,seizure,Nervous system disorders,Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
1742253,36516812,5.02E-50,2.30E-42,adult_children_senior_youth,children,levofloxacin,arthralgia,Musculoskeletal and connective tissue disorders,$Fluoroquinolones$Combinations for eradication of Helicobacter pylori$Combinations of antibacterials$Fluoroquinolones,$QUINOLONE ANTIBACTERIALS$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$COMBINATIONS OF ANTIBACTERIALS$ANTIINFECTIVES,$ANTIBACTERIALS FOR SYSTEMIC USE$DRUGS FOR ACID RELATED DISORDERS$ANTIBACTERIALS FOR SYSTEMIC USE$OPHTHALMOLOGICALS,$ANTIINFECTIVES FOR SYSTEMIC USE$ALIMENTARY TRACT AND METABOLISM$ANTIINFECTIVES FOR SYSTEMIC USE$SENSORY ORGANS
1305058,36211181,7.75E-50,3.56E-42,adult_children_senior_youth,children_youth,methotrexate,neurotoxicity,"Injury, poisoning and procedural complications",$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1125315,36211465,1.05E-49,4.82E-42,adult_children_senior_youth,children,acetaminophen,incorrect dose administered,"Injury, poisoning and procedural complications",$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1124300,35809357,1.22E-49,5.62E-42,adult_children_senior_youth,senior,diclofenac,therapeutic response unexpected,General disorders and administration site conditions,"$Antiinflammatory agents, non-steroids and antiinfectives in combination$Antiinflammatory agents, non-steroids$Acetic acid derivatives and related substances$Antiinflammatory preparations, non-steroids for topical use$Acetic acid derivatives and related substances$Other dermatologicals","$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$ANTIINFLAMMATORY AGENTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$OTHER DERMATOLOGICAL PREPARATIONS",$OPHTHALMOLOGICALS$OPHTHALMOLOGICALS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$OTHER DERMATOLOGICAL PREPARATIONS,$SENSORY ORGANS$SENSORY ORGANS$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$DERMATOLOGICALS
1150871,36516848,1.34E-49,6.17E-42,adult_children_senior_youth,youth,misoprostol,muscle spasms,Musculoskeletal and connective tissue disorders,$Prostaglandins$Prostaglandins$Propionic acid derivatives,"$UTEROTONICS$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$DRUGS FOR ACID RELATED DISORDERS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$ALIMENTARY TRACT AND METABOLISM$MUSCULO-SKELETAL SYSTEM
19010482,35607130,1.53E-49,7.00E-42,adult_children_senior_youth,senior,cyclosporine,ocular hyperaemia,Eye disorders,$Calcineurin inhibitors$Other ophthalmologicals,$IMMUNOSUPPRESSANTS$OTHER OPHTHALMOLOGICALS,$IMMUNOSUPPRESSANTS$OPHTHALMOLOGICALS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$SENSORY ORGANS
1311078,35104109,2.24E-49,1.03E-41,adult_children_senior_youth,children,cytarabine,febrile bone marrow aplasia,Blood and lymphatic system disorders,$Pyrimidine analogues$Combinations of antineoplastic agents,$ANTIMETABOLITES$OTHER ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AGENTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1125315,36211496,3.27E-49,1.50E-41,adult_children_senior_youth,youth,acetaminophen,overdose,"Injury, poisoning and procedural complications",$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1351541,35808960,4.19E-49,1.93E-41,adult_children_senior_youth,children,leuprolide,injection site abscess,General disorders and administration site conditions,$Gonadotropin releasing hormone analogues$Gonadotropin releasing hormone analogues,$HORMONES AND RELATED AGENTS$HORMONES AND RELATED AGENTS,$ENDOCRINE THERAPY$ENDOCRINE THERAPY,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
40171288,36516828,5.08E-49,2.33E-41,adult_children_senior,senior,tocilizumab,psoriatic arthropathy,$Immune system disorders$Musculoskeletal and connective tissue disorders$Skin and subcutaneous tissue disorders,Interleukin inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1717704,36718312,5.21E-49,2.39E-41,adult_children_senior_youth,children_senior,valacyclovir,altered state of consciousness,Nervous system disorders,0,0,0,0
1154343,37219871,6.07E-49,2.79E-41,adult_children_senior_youth,youth,albuterol,pulmonary embolism,"$Respiratory, thoracic and mediastinal disorders$Vascular disorders",0,0,0,0
1177480,37019319,7.18E-49,3.30E-41,adult_children_senior_youth,children,ibuprofen,renal failure acute,0,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
1395557,36009894,7.75E-49,3.56E-41,adult_children_senior_youth,children_youth,fludarabine,chronic graft versus host disease,"Injury, poisoning and procedural complications",Purine analogues,ANTIMETABOLITES,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
998415,35506447,7.85E-49,3.60E-41,adult_children_senior_youth,children,clobetasol,cushing's syndrome,$Endocrine disorders$Metabolism and nutrition disorders$Psychiatric disorders$Vascular disorders,"$Corticosteroids, very potent (group IV)$Corticosteroids, very potent, combinations with antibiotics","$CORTICOSTEROIDS, PLAIN$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS","$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",$DERMATOLOGICALS$DERMATOLOGICALS
1589505,35204948,1.86E-48,8.55E-41,adult_youth,adult,levonorgestrel,tachycardia,Cardiac disorders,"$Progestogens and estrogens, sequential preparations$Emergency contraceptives$Progestogens$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations",$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
708298,36918947,2.34E-48,1.08E-40,adult_children_senior_youth,senior,midazolam,anhedonia,Psychiatric disorders,Benzodiazepine derivatives,HYPNOTICS AND SEDATIVES,PSYCHOLEPTICS,NERVOUS SYSTEM
1549080,36617162,3.36E-48,1.54E-40,adult_children_senior_youth,adult,conjugated estrogens,breast cancer,Reproductive system and breast disorders,"$Natural and semisynthetic estrogens, plain$Estrogens, combinations with other drugs",$ESTROGENS$ESTROGENS,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1151789,35708202,3.43E-48,1.57E-40,adult_children_senior_youth,children_youth,etanercept,nausea,Gastrointestinal disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
984232,43053904,3.63E-48,1.67E-40,adult_children_youth,adult,isotretinoin,exposure during pregnancy,"Injury, poisoning and procedural complications",$Retinoids for topical use in acne$Retinoids for topical use in acne$Retinoids for treatment of acne,$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE,$ANTI-ACNE PREPARATIONS$ANTI-ACNE PREPARATIONS$ANTI-ACNE PREPARATIONS,$DERMATOLOGICALS$DERMATOLOGICALS$DERMATOLOGICALS
986417,36919042,4.47E-48,2.05E-40,adult_children_senior_youth,children,polyethylene glycol 3350,anger,Psychiatric disorders,0,0,0,0
954688,36315155,5.23E-48,2.40E-40,adult_children_senior_youth,children_youth,latanoprost,intraocular pressure increased,Investigations,Prostaglandin analogues,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,OPHTHALMOLOGICALS,SENSORY ORGANS
40242675,35708642,5.67E-48,2.60E-40,adult_children_senior_youth,youth,crizotinib,stomatitis,Gastrointestinal disorders,Protein kinase inhibitors,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1103640,42889640,7.83E-48,3.60E-40,adult_children_senior_youth,children,methadone,maternal exposure during pregnancy,"Injury, poisoning and procedural complications",$Drugs used in opioid dependence$Diphenylpropylamine derivatives,$DRUGS USED IN ADDICTIVE DISORDERS$OPIOIDS,$OTHER NERVOUS SYSTEM DRUGS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
44785094,35809076,1.03E-47,4.72E-40,adult_children_senior_youth,youth,sofosbuvir,fatigue,General disorders and administration site conditions,$Antivirals for treatment of HCV infections$Antivirals for treatment of HCV infections$Antivirals for treatment of HCV infections$Antivirals for treatment of HCV infections,$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS,$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
1115008,37219871,1.10E-47,5.03E-40,adult_senior_youth,youth,naproxen,pulmonary embolism,"$Respiratory, thoracic and mediastinal disorders$Vascular disorders","$Antiinflammatory products for vaginal administration$Antiinflammatory preparations, non-steroids for topical use$Propionic acid derivatives$Propionic acid derivatives$Propionic acid derivatives","$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
1310149,36516765,1.38E-47,6.32E-40,adult_children_senior_youth,adult_youth,warfarin,pain in jaw,Musculoskeletal and connective tissue disorders,Vitamin K antagonists,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1503297,36211492,1.55E-47,7.10E-40,adult_children_senior_youth,youth,metformin,intentional overdose,"Injury, poisoning and procedural complications",$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Biguanides$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
19017742,36416695,1.81E-47,8.33E-40,adult_children_senior_youth,children,febuxostat,gout,Metabolism and nutrition disorders,Preparations inhibiting uric acid production,ANTIGOUT PREPARATIONS,ANTIGOUT PREPARATIONS,MUSCULO-SKELETAL SYSTEM
19010482,35606950,3.08E-47,1.41E-39,adult_children_senior_youth,senior,cyclosporine,lacrimation increased,Eye disorders,$Calcineurin inhibitors$Other ophthalmologicals,$IMMUNOSUPPRESSANTS$OTHER OPHTHALMOLOGICALS,$IMMUNOSUPPRESSANTS$OPHTHALMOLOGICALS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$SENSORY ORGANS
1112807,36919230,4.41E-47,2.03E-39,adult_children_senior_youth,youth,aspirin,completed suicide,General disorders and administration site conditions,0,0,0,0
1395557,36009892,7.61E-47,3.49E-39,adult_children_senior_youth,children_youth,fludarabine,acute graft versus host disease in skin,"Injury, poisoning and procedural complications",Purine analogues,ANTIMETABOLITES,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1125315,36211303,1.36E-46,6.23E-39,adult_children_senior_youth,youth,acetaminophen,injury,"Injury, poisoning and procedural complications",$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1521987,35808976,1.51E-46,6.93E-39,adult_children_senior,adult,teriparatide,injection site erythema,General disorders and administration site conditions,Parathyroid hormones and analogues,PARATHYROID HORMONES AND ANALOGUES,CALCIUM HOMEOSTASIS,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
931973,37522181,1.63E-46,7.47E-39,adult_children_senior_youth,children_youth,protease,hospitalisation,Surgical and medical procedures,0,0,0,0
1545958,35205164,1.74E-46,7.99E-39,adult_senior_youth,adult,atorvastatin,coronary artery disease,Vascular disorders,"$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations","$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS",$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
40228152,36718007,3.27E-46,1.50E-38,adult_children_senior_youth,children,dabigatran etexilate,embolic stroke,Vascular disorders,Direct thrombin inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1110410,36009738,3.54E-46,1.63E-38,adult_children_senior_youth,senior,morphine,drug hypersensitivity,Immune system disorders,$Antipropulsives$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with antispasmodics,$ANTIPROPULSIVES$OPIOIDS$OPIOIDS$OPIOIDS,"$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$ANALGESICS$ANALGESICS$ANALGESICS",$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1351541,35708187,3.61E-46,1.66E-38,adult_senior_youth,youth,leuprolide,pelvic pain,Gastrointestinal disorders,$Gonadotropin releasing hormone analogues$Gonadotropin releasing hormone analogues,$HORMONES AND RELATED AGENTS$HORMONES AND RELATED AGENTS,$ENDOCRINE THERAPY$ENDOCRINE THERAPY,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1506270,37622529,4.76E-46,2.18E-38,adult_children_senior_youth,children,methylprednisolone,hypertension,Vascular disorders,"$Corticosteroids, combinations for treatment of acne$Glucocorticoids$Corticosteroids for systemic use, combinations$Corticosteroids, weak, combinations with antibiotics$Corticosteroids and antiinfectives in combination$Corticosteroids, weak (group I)","$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS, PLAIN","$ANTI-ACNE PREPARATIONS$CORTICOSTEROIDS FOR SYSTEMIC USE$CORTICOSTEROIDS FOR SYSTEMIC USE$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS","$DERMATOLOGICALS$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$DERMATOLOGICALS$SENSORY ORGANS$DERMATOLOGICALS"
1124300,46276591,7.09E-46,3.25E-38,adult_children_senior_youth,senior,diclofenac,wrong technique in product usage process,"Injury, poisoning and procedural complications","$Antiinflammatory agents, non-steroids and antiinfectives in combination$Antiinflammatory agents, non-steroids$Acetic acid derivatives and related substances$Antiinflammatory preparations, non-steroids for topical use$Acetic acid derivatives and related substances$Other dermatologicals","$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$ANTIINFLAMMATORY AGENTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$OTHER DERMATOLOGICAL PREPARATIONS",$OPHTHALMOLOGICALS$OPHTHALMOLOGICALS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$OTHER DERMATOLOGICAL PREPARATIONS,$SENSORY ORGANS$SENSORY ORGANS$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$DERMATOLOGICALS
1177480,35809243,8.55E-46,3.93E-38,adult_children_senior_youth,youth,ibuprofen,pain,General disorders and administration site conditions,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
708298,36918861,8.57E-46,3.93E-38,adult_children_senior_youth,senior,midazolam,stress,Psychiatric disorders,Benzodiazepine derivatives,HYPNOTICS AND SEDATIVES,PSYCHOLEPTICS,NERVOUS SYSTEM
970250,35205240,9.29E-46,4.26E-38,adult_children_senior_youth,children_youth,spironolactone,cardiac failure,Cardiac disorders,Aldosterone antagonists,POTASSIUM-SPARING AGENTS,DIURETICS,CARDIOVASCULAR SYSTEM
722031,36416600,9.48E-46,4.35E-38,adult_children_senior_youth,senior,paroxetine,hyponatraemia,Metabolism and nutrition disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1344905,37320268,1.18E-45,5.43E-38,adult_children_senior_youth,adult,carboplatin,alopecia,Skin and subcutaneous tissue disorders,Platinum compounds,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1351541,36211550,1.21E-45,5.55E-38,adult_children_senior,senior,leuprolide,syringe issue,Product issues,$Gonadotropin releasing hormone analogues$Gonadotropin releasing hormone analogues,$HORMONES AND RELATED AGENTS$HORMONES AND RELATED AGENTS,$ENDOCRINE THERAPY$ENDOCRINE THERAPY,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1314273,36110978,1.62E-45,7.45E-38,adult_children_senior_youth,senior,rituximab,progressive multifocal leukoencephalopathy,Infections and infestations,Monoclonal antibodies,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1332418,42889647,1.85E-45,8.51E-38,adult_children_senior_youth,youth,amlodipine,toxicity to various agents,"Injury, poisoning and procedural complications","$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$Beta blocking agents and calcium channel blockers$Dihydropyridine derivatives$ACE inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$Calcium channel blockers and diuretics$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs), other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers","$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS$ACE INHIBITORS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$CALCIUM CHANNEL BLOCKERS AND DIURETICS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$BETA BLOCKING AGENTS$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1351541,36718132,1.86E-45,8.52E-38,adult_children_senior_youth,children_youth,leuprolide,headache,Nervous system disorders,$Gonadotropin releasing hormone analogues$Gonadotropin releasing hormone analogues,$HORMONES AND RELATED AGENTS$HORMONES AND RELATED AGENTS,$ENDOCRINE THERAPY$ENDOCRINE THERAPY,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1119119,35809019,1.88E-45,8.62E-38,adult_children_senior_youth,youth,adalimumab,injection site swelling,General disorders and administration site conditions,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
735979,42889647,2.03E-45,9.31E-38,adult_children_senior_youth,adult,risperidone,toxicity to various agents,"Injury, poisoning and procedural complications",Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1177480,35909445,3.31E-45,1.52E-37,adult_children_senior_youth,youth,ibuprofen,cholelithiasis,Hepatobiliary disorders,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
705944,35808824,3.74E-45,1.72E-37,adult_children_youth,children,methylphenidate,application site rash,General disorders and administration site conditions,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
722031,35205305,4.03E-45,1.85E-37,adult_children_senior_youth,children,paroxetine,atrial septal defect,Cardiac disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1119119,35708202,4.04E-45,1.86E-37,adult_children_senior_youth,youth,adalimumab,nausea,Gastrointestinal disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
735979,37622449,4.71E-45,2.16E-37,adult_children_senior_youth,senior,risperidone,hypotension,Vascular disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
735979,36718288,4.77E-45,2.19E-37,adult_children_senior_youth,senior,risperidone,coma,Nervous system disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1305058,35104304,5.54E-45,2.54E-37,adult_children_senior_youth,children,methotrexate,hyperbilirubinaemia,Hepatobiliary disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1151789,36516812,6.73E-45,3.09E-37,adult_children_senior_youth,adult_senior,etanercept,arthralgia,Musculoskeletal and connective tissue disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
705944,37622529,6.92E-45,3.17E-37,adult_children_senior_youth,youth,methylphenidate,hypertension,Vascular disorders,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
967823,37522181,8.56E-45,3.93E-37,adult_children_senior_youth,youth,sodium chloride,hospitalisation,Surgical and medical procedures,$Electrolyte solutions$Salt solutions$Sodium,$I.V. SOLUTION ADDITIVES$IRRIGATING SOLUTIONS$OTHER MINERAL SUPPLEMENTS,$BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS$BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS$MINERAL SUPPLEMENTS,$BLOOD AND BLOOD FORMING ORGANS$BLOOD AND BLOOD FORMING ORGANS$ALIMENTARY TRACT AND METABOLISM
769935,35708202,1.02E-44,4.68E-37,adult_children_senior_youth,children_youth,sodium oxybate,nausea,Gastrointestinal disorders,$Other general anesthetics$Other nervous system drugs,"$ANESTHETICS, GENERAL$OTHER NERVOUS SYSTEM DRUGS",$ANESTHETICS$OTHER NERVOUS SYSTEM DRUGS,$NERVOUS SYSTEM$NERVOUS SYSTEM
1308290,35104199,1.23E-44,5.66E-37,adult_children_senior_youth,adult_youth,vincristine,haematotoxicity,"Injury, poisoning and procedural complications",Vinca alkaloids and analogues,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1177480,36009724,1.51E-44,6.94E-37,adult_children_senior_youth,children,ibuprofen,stevens-johnson syndrome,Infections and infestations,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
1103314,42889647,1.80E-44,8.28E-37,adult_children_senior_youth,children,tramadol,toxicity to various agents,"Injury, poisoning and procedural complications",$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Other opioids,$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
709567,36718555,1.81E-44,8.32E-37,adult_children_senior_youth,children_senior,lisdexamfetamine,insomnia,$Nervous system disorders$Psychiatric disorders,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
722424,35809059,1.92E-44,8.82E-37,adult_children_senior_youth,senior,interferon beta-1a,death,General disorders and administration site conditions,Interferons,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
902722,42889536,2.31E-44,1.06E-36,adult_children_senior_youth,youth,tobramycin,infective pulmonary exacerbation of cystic fibrosis,"Respiratory, thoracic and mediastinal disorders",$Antibiotics$Other aminoglycosides,$ANTIINFECTIVES$AMINOGLYCOSIDE ANTIBACTERIALS,$OPHTHALMOLOGICALS$ANTIBACTERIALS FOR SYSTEMIC USE,$SENSORY ORGANS$ANTIINFECTIVES FOR SYSTEMIC USE
1786055,35104271,2.65E-44,1.22E-36,adult_children_senior_youth,youth,deferasirox,sickle cell anaemia with crisis,Blood and lymphatic system disorders,Iron chelating agents,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,VARIOUS
1305058,36110888,3.94E-44,1.81E-36,adult_children_senior_youth,children_youth,methotrexate,epstein-barr virus infection,Infections and infestations,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1151789,36718005,4.57E-44,2.10E-36,adult_children_senior_youth,senior,etanercept,cerebrovascular accident,Vascular disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1112807,36211492,5.20E-44,2.39E-36,adult_children_senior_youth,youth,aspirin,intentional overdose,"Injury, poisoning and procedural complications",0,0,0,0
1336539,35809120,5.98E-44,2.75E-36,adult_children_senior_youth,children_youth,sunitinib,disease progression,General disorders and administration site conditions,Protein kinase inhibitors,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1119119,35506609,7.30E-44,3.35E-36,adult_children_senior_youth,senior,adalimumab,diabetes mellitus,Endocrine disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1201620,36009738,1.08E-43,4.98E-36,adult_children_senior_youth,senior,codeine,drug hypersensitivity,Immune system disorders,$Natural opium alkaloids$Opium alkaloids and derivatives$Natural opium alkaloids$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,"$OPIOIDS$COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS",$ANALGESICS$COUGH AND COLD PREPARATIONS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1322184,35205181,1.44E-43,6.61E-36,adult_children_senior_youth,youth,clopidogrel,angina pectoris,Vascular disorders,Platelet aggregation inhibitors excl. heparin,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
723013,42889647,1.74E-43,8.00E-36,adult_children_senior_youth,youth,diazepam,toxicity to various agents,"Injury, poisoning and procedural complications",Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
19011440,36110697,2.20E-43,1.01E-35,adult_children_senior_youth,children_youth,everolimus,nasopharyngitis,Infections and infestations,$Protein kinase inhibitors$Selective immunosuppressants,$OTHER ANTINEOPLASTIC AGENTS$IMMUNOSUPPRESSANTS,$ANTINEOPLASTIC AGENTS$IMMUNOSUPPRESSANTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
753626,36919046,2.36E-43,1.08E-35,adult_children_senior_youth,senior,propofol,emotional distress,Psychiatric disorders,Other general anesthetics,"ANESTHETICS, GENERAL",ANESTHETICS,NERVOUS SYSTEM
735979,35809131,2.57E-43,1.18E-35,adult_children_senior_youth,senior,risperidone,general physical health deterioration,General disorders and administration site conditions,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
742185,35708207,2.92E-43,1.34E-35,adult_children_youth,children,atomoxetine,retching,Gastrointestinal disorders,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
1103640,37219893,4.62E-43,2.12E-35,adult_children_senior_youth,youth,methadone,respiratory arrest,"Respiratory, thoracic and mediastinal disorders",$Drugs used in opioid dependence$Diphenylpropylamine derivatives,$DRUGS USED IN ADDICTIVE DISORDERS$OPIOIDS,$OTHER NERVOUS SYSTEM DRUGS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
1301267,35104877,4.83E-43,2.22E-35,adult_children_senior_youth,youth,melphalan,febrile neutropenia,General disorders and administration site conditions,Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1124957,36211491,6.68E-43,3.07E-35,adult_children_senior_youth,children_youth,oxycodone,accidental overdose,"Injury, poisoning and procedural complications",$Natural opium alkaloids$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
705103,36919230,1.10E-42,5.05E-35,adult_children_senior_youth,adult_youth,lamotrigine,completed suicide,General disorders and administration site conditions,Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
766814,35707713,1.29E-42,5.94E-35,adult_children_senior_youth,adult,quetiapine,pancreatitis,Gastrointestinal disorders,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
743670,42889640,1.38E-42,6.35E-35,adult_children_senior_youth,children,venlafaxine,maternal exposure during pregnancy,"Injury, poisoning and procedural complications",Other antidepressants,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1102527,36009738,1.65E-42,7.59E-35,adult_children_senior_youth,senior,meperidine,drug hypersensitivity,Immune system disorders,$Phenylpiperidine derivatives$Phenylpiperidine derivatives$Phenylpiperidine derivatives$Opioids in combination with antispasmodics,$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
715233,35809377,1.95E-42,8.96E-35,adult_children_senior_youth,children_youth,baclofen,withdrawal syndrome,General disorders and administration site conditions,Other centrally acting agents,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",MUSCLE RELAXANTS,MUSCULO-SKELETAL SYSTEM
931973,37219907,2.80E-42,1.29E-34,adult_children_senior_youth,children_youth,protease,cough,"Respiratory, thoracic and mediastinal disorders",0,0,0,0
1112807,36314160,2.94E-42,1.35E-34,adult_children_senior_youth,adult,aspirin,blood glucose increased,Investigations,0,0,0,0
1310317,36110978,3.22E-42,1.48E-34,adult_children_senior_youth,senior,cyclophosphamide,progressive multifocal leukoencephalopathy,Infections and infestations,Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
43013024,35707864,3.35E-42,1.54E-34,adult_children_senior_youth,children,apixaban,gastrointestinal haemorrhage,Gastrointestinal disorders,Direct factor Xa inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1547504,35204970,3.43E-42,1.57E-34,adult_senior,senior,rosiglitazone,cardio-respiratory arrest,Cardiac disorders,$Combinations of oral blood glucose lowering drugs$Thiazolidinediones$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1501700,35809076,4.32E-42,1.98E-34,adult_children_senior_youth,adult_youth,levothyroxine,fatigue,General disorders and administration site conditions,Thyroid hormones,THYROID PREPARATIONS,THYROID THERAPY,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
1550023,35506494,4.93E-42,2.26E-34,adult_children_senior_youth,youth,insulin lispro,diabetic ketoacidosis,$Endocrine disorders$Metabolism and nutrition disorders,"$Insulins and analogues for injection, intermediate-acting$Insulins and analogues for injection, fast-acting$Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting",$INSULINS AND ANALOGUES$INSULINS AND ANALOGUES$INSULINS AND ANALOGUES,$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1309944,35204985,5.12E-42,2.35E-34,adult_children_senior_youth,children_youth,amiodarone,ventricular tachycardia,Cardiac disorders,"Antiarrhythmics, class III","ANTIARRHYTHMICS, CLASS I AND III",CARDIAC THERAPY,CARDIOVASCULAR SYSTEM
964407,37320109,5.81E-42,2.67E-34,adult_children_senior_youth,children_youth,salicylic acid,dry skin,Skin and subcutaneous tissue disorders,"$Other antifungals for topical use$Salicylic acid and derivatives$Salicylic acid and derivatives$Antiinflammatory agents, non-steroids",$ANTIFUNGALS FOR TOPICAL USE$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$ANTIINFLAMMATORY AGENTS,$ANTIFUNGALS FOR DERMATOLOGICAL USE$ANALGESICS$ANALGESICS$OPHTHALMOLOGICALS,$DERMATOLOGICALS$NERVOUS SYSTEM$NERVOUS SYSTEM$SENSORY ORGANS
735979,36919059,5.89E-42,2.70E-34,adult_children_senior_youth,children,risperidone,aggression,Psychiatric disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1310317,36919046,6.47E-42,2.97E-34,adult_children_senior_youth,adult,cyclophosphamide,emotional distress,Psychiatric disorders,Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
739138,42889641,6.95E-42,3.19E-34,adult_children_youth,children,sertraline,maternal exposure timing unspecified,"Injury, poisoning and procedural complications",Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
902722,35306246,7.17E-42,3.29E-34,adult_children_senior_youth,children_youth,tobramycin,cystic fibrosis,"Respiratory, thoracic and mediastinal disorders",$Antibiotics$Other aminoglycosides,$ANTIINFECTIVES$AMINOGLYCOSIDE ANTIBACTERIALS,$OPHTHALMOLOGICALS$ANTIBACTERIALS FOR SYSTEMIC USE,$SENSORY ORGANS$ANTIINFECTIVES FOR SYSTEMIC USE
766814,36919059,7.38E-42,3.39E-34,adult_children_senior_youth,children,quetiapine,aggression,Psychiatric disorders,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1316262,35205240,1.37E-41,6.28E-34,adult_children_senior_youth,children_youth,sildenafil,cardiac failure,Cardiac disorders,$Sulfonamides$Drugs used in erectile dysfunction,"$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$UROLOGICALS",$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$UROLOGICALS,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1361711,35205164,1.81E-41,8.32E-34,adult_children_senior_youth,adult,glyceryl trinitrate,coronary artery disease,Vascular disorders,0,0,0,0
1799139,35809071,1.83E-41,8.39E-34,adult_children_senior_youth,youth,oseltamivir,no adverse event,General disorders and administration site conditions,Neuraminidase inhibitors,DIRECT ACTING ANTIVIRALS,ANTIVIRALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
1305058,36313550,2.36E-41,1.08E-33,adult_children_senior_youth,children_youth,methotrexate,blood bilirubin increased,Investigations,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1314273,36516828,2.96E-41,1.36E-33,adult_senior,senior,rituximab,psoriatic arthropathy,$Immune system disorders$Musculoskeletal and connective tissue disorders$Skin and subcutaneous tissue disorders,Monoclonal antibodies,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1550557,37622529,3.12E-41,1.43E-33,adult_children_senior_youth,children,prednisolone,hypertension,Vascular disorders,"$Corticosteroids, weak (group I)$Corticosteroids and antiinfectives in combination$Corticosteroids, weak, other combinations$Corticosteroids for local oral treatment$Corticosteroids$Corticosteroids and mydriatics in combination$Corticosteroids$Corticosteroids/antiinfectives/mydriatics in combination$Antidotes$Corticosteroids$Corticosteroids, weak, combinations with antiseptics$Corticosteroids, weak, combinations with antibiotics$Corticosteroids, plain$Corticosteroids$Corticosteroids acting locally$Glucocorticoids$Corticosteroids and antiinfectives in combination$Corticosteroids$Corticosteroids and antiinfectives in combination","$CORTICOSTEROIDS, PLAIN$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS, OTHER COMBINATIONS$STOMATOLOGICAL PREPARATIONS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$ALL OTHER THERAPEUTIC PRODUCTS$CORTICOSTEROIDS$CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS$INTESTINAL ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION","$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$STOMATOLOGICAL PREPARATIONS$NASAL PREPARATIONS$OPHTHALMOLOGICALS$NASAL PREPARATIONS$OPHTHALMOLOGICALS$ALL OTHER THERAPEUTIC PRODUCTS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS$OTOLOGICALS$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE$OTOLOGICALS$VASOPROTECTIVES$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS","$DERMATOLOGICALS$SENSORY ORGANS$DERMATOLOGICALS$ALIMENTARY TRACT AND METABOLISM$RESPIRATORY SYSTEM$SENSORY ORGANS$RESPIRATORY SYSTEM$SENSORY ORGANS$VARIOUS$SENSORY ORGANS$DERMATOLOGICALS$DERMATOLOGICALS$SENSORY ORGANS$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS"
1395557,37622529,3.40E-41,1.56E-33,adult_children_senior_youth,children,fludarabine,hypertension,Vascular disorders,Purine analogues,ANTIMETABOLITES,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
956874,36416595,3.48E-41,1.60E-33,adult_children_senior_youth,youth,furosemide,hypokalaemia,Metabolism and nutrition disorders,"$High-ceiling diuretics and potassium-sparing agents$Sulfonamides, plain$Sulfonamides$Sulfonamides and potassium in combination","$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$HIGH-CEILING DIURETICS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$HIGH-CEILING DIURETICS",$DIURETICS$DIURETICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$DIURETICS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
1305058,36110697,5.64E-41,2.59E-33,adult_children_senior_youth,adult,methotrexate,nasopharyngitis,Infections and infestations,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
723013,35607284,6.24E-41,2.86E-33,adult_children_senior_youth,children,diazepam,nystagmus,Eye disorders,Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1305058,36718418,6.96E-41,3.19E-33,adult_children_senior_youth,youth,methotrexate,dysarthria,Nervous system disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1151789,35708628,8.00E-41,3.67E-33,adult_children_senior_youth,youth,etanercept,oropharyngeal pain,"Respiratory, thoracic and mediastinal disorders",Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1309944,35204954,9.16E-41,4.21E-33,adult_children_senior_youth,adult,amiodarone,atrial flutter,Cardiac disorders,"Antiarrhythmics, class III","ANTIARRHYTHMICS, CLASS I AND III",CARDIAC THERAPY,CARDIOVASCULAR SYSTEM
1799139,36918984,1.36E-40,6.26E-33,adult_children_senior_youth,children,oseltamivir,hallucination,Psychiatric disorders,Neuraminidase inhibitors,DIRECT ACTING ANTIVIRALS,ANTIVIRALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
1343916,36918858,1.57E-40,7.19E-33,adult_children_senior_youth,senior_youth,epinephrine,anxiety,Psychiatric disorders,"$Other agents for local oral treatment$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Local hemostatics$Adrenergic and dopaminergic agents$Sympathomimetics in glaucoma therapy$Sympathomimetics, plain$Alpha- and beta-adrenoreceptor agonists$Sympathomimetics in glaucoma therapy","$STOMATOLOGICAL PREPARATIONS$ADRENERGICS, INHALANTS$VITAMIN K AND OTHER HEMOSTATICS$CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES$ANTIGLAUCOMA PREPARATIONS AND MIOTICS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ADRENERGICS, INHALANTS$ANTIGLAUCOMA PREPARATIONS AND MIOTICS",$STOMATOLOGICAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$ANTIHEMORRHAGICS$CARDIAC THERAPY$OPHTHALMOLOGICALS$NASAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OPHTHALMOLOGICALS,$ALIMENTARY TRACT AND METABOLISM$RESPIRATORY SYSTEM$BLOOD AND BLOOD FORMING ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$SENSORY ORGANS
1112807,36009738,1.59E-40,7.29E-33,adult_children_senior_youth,children_youth,aspirin,drug hypersensitivity,Immune system disorders,0,0,0,0
1322184,37522317,1.64E-40,7.51E-33,adult_senior_youth,adult,clopidogrel,coronary arterial stent insertion,Surgical and medical procedures,Platelet aggregation inhibitors excl. heparin,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
19010482,36009895,1.81E-40,8.32E-33,adult_children_senior_youth,children_youth,cyclosporine,graft versus host disease,"Injury, poisoning and procedural complications",$Calcineurin inhibitors$Other ophthalmologicals,$IMMUNOSUPPRESSANTS$OTHER OPHTHALMOLOGICALS,$IMMUNOSUPPRESSANTS$OPHTHALMOLOGICALS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$SENSORY ORGANS
1308290,35305470,2.04E-40,9.38E-33,adult_children_senior_youth,adult,vincristine,cytogenetic abnormality,"Congenital, familial and genetic disorders",Vinca alkaloids and analogues,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
757352,36718556,2.54E-40,1.17E-32,adult_children_senior_youth,senior,eszopiclone,middle insomnia,$Nervous system disorders$Psychiatric disorders,Benzodiazepine related drugs,HYPNOTICS AND SEDATIVES,PSYCHOLEPTICS,NERVOUS SYSTEM
904525,35606938,4.41E-40,2.02E-32,adult_children_senior_youth,youth,bimatoprost,madarosis,Eye disorders,Prostaglandin analogues,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,OPHTHALMOLOGICALS,SENSORY ORGANS
757688,36718218,4.86E-40,2.23E-32,adult_children_senior_youth,children,aripiprazole,tardive dyskinesia,Nervous system disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1103314,36211496,6.22E-40,2.85E-32,adult_children_senior_youth,children,tramadol,overdose,"Injury, poisoning and procedural complications",$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Other opioids,$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
996416,36718179,7.45E-40,3.42E-32,adult_senior_youth,youth,finasteride,cognitive disorder,Nervous system disorders,$Other dermatologicals$Alpha-adrenoreceptor antagonists$Testosterone-5-alpha reductase inhibitors,$OTHER DERMATOLOGICAL PREPARATIONS$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,$OTHER DERMATOLOGICAL PREPARATIONS$UROLOGICALS$UROLOGICALS,$DERMATOLOGICALS$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1332418,35205259,9.88E-40,4.54E-32,adult_children_senior_youth,youth,amlodipine,pulmonary oedema,"Respiratory, thoracic and mediastinal disorders","$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$Beta blocking agents and calcium channel blockers$Dihydropyridine derivatives$ACE inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$Calcium channel blockers and diuretics$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs), other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers","$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS$ACE INHIBITORS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$CALCIUM CHANNEL BLOCKERS AND DIURETICS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$BETA BLOCKING AGENTS$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1177480,35809131,1.15E-39,5.26E-32,adult_children_senior_youth,youth,ibuprofen,general physical health deterioration,General disorders and administration site conditions,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
1326303,37219868,1.35E-39,6.18E-32,adult_children_senior_youth,children_youth,digoxin,pulmonary hypertension,Vascular disorders,Digitalis glycosides,CARDIAC GLYCOSIDES,CARDIAC THERAPY,CARDIOVASCULAR SYSTEM
1519936,35809071,1.68E-39,7.72E-32,adult_children_senior_youth,children,etonogestrel,no adverse event,General disorders and administration site conditions,Progestogens,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,GENITO URINARY SYSTEM AND SEX HORMONES
19015523,43053923,2.35E-39,1.08E-31,adult_children_senior,children,bendamustine,prescribed underdose,"Injury, poisoning and procedural complications",Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1154161,36718365,2.55E-39,1.17E-31,adult_children_senior_youth,children,montelukast,personality change,Nervous system disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1332418,35506628,3.47E-39,1.59E-31,adult_children_senior_youth,youth,amlodipine,hyperglycaemia,Endocrine disorders,"$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$Beta blocking agents and calcium channel blockers$Dihydropyridine derivatives$ACE inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$Calcium channel blockers and diuretics$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs), other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers","$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS$ACE INHIBITORS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$CALCIUM CHANNEL BLOCKERS AND DIURETICS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$BETA BLOCKING AGENTS$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1305058,36416600,3.47E-39,1.59E-31,adult_children_senior_youth,children,methotrexate,hyponatraemia,Metabolism and nutrition disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1718517,36009762,3.49E-39,1.60E-31,adult_children_senior_youth,children_youth,acetylsalicylsalicylic acid,angioedema,Immune system disorders,0,0,0,0
1734104,37219871,4.50E-39,2.07E-31,adult_children_senior_youth,youth,azithromycin,pulmonary embolism,"$Respiratory, thoracic and mediastinal disorders$Vascular disorders",$Combinations of antibacterials$Antibiotics$Macrolides,"$COMBINATIONS OF ANTIBACTERIALS$ANTIINFECTIVES$MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",$ANTIBACTERIALS FOR SYSTEMIC USE$OPHTHALMOLOGICALS$ANTIBACTERIALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$SENSORY ORGANS$ANTIINFECTIVES FOR SYSTEMIC USE
40057995,37622465,4.88E-39,2.24E-31,adult_children_youth,adult,drospirenone / ethinyl estradiol Oral Tablet,deep vein thrombosis,Vascular disorders,0,0,0,0
991876,35809310,5.70E-39,2.61E-31,adult_children_senior_youth,youth,loperamide,drug interaction,General disorders and administration site conditions,$Antipropulsives$Antipropulsives,$ANTIPROPULSIVES$ANTIPROPULSIVES,"$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1112807,42889647,7.42E-39,3.41E-31,adult_children_senior_youth,youth,aspirin,toxicity to various agents,"Injury, poisoning and procedural complications",0,0,0,0
1103640,35204970,9.59E-39,4.40E-31,adult_children_senior_youth,youth,methadone,cardio-respiratory arrest,Cardiac disorders,$Drugs used in opioid dependence$Diphenylpropylamine derivatives,$DRUGS USED IN ADDICTIVE DISORDERS$OPIOIDS,$OTHER NERVOUS SYSTEM DRUGS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
40222444,35809059,9.82E-39,4.51E-31,adult_children_senior,senior,denosumab,death,General disorders and administration site conditions,Other drugs affecting bone structure and mineralization,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,DRUGS FOR TREATMENT OF BONE DISEASES,MUSCULO-SKELETAL SYSTEM
1112807,37522317,1.04E-38,4.79E-31,adult_senior,adult,aspirin,coronary arterial stent insertion,Surgical and medical procedures,0,0,0,0
1101554,42889647,1.04E-38,4.75E-31,adult_children_senior_youth,children,colchicine,toxicity to various agents,"Injury, poisoning and procedural complications",Preparations with no effect on uric acid metabolism,ANTIGOUT PREPARATIONS,ANTIGOUT PREPARATIONS,MUSCULO-SKELETAL SYSTEM
40057995,37219871,1.15E-38,5.27E-31,adult_children_youth,adult,drospirenone / ethinyl estradiol Oral Tablet,pulmonary embolism,"$Respiratory, thoracic and mediastinal disorders$Vascular disorders",0,0,0,0
984232,36818634,1.44E-38,6.60E-31,adult_children_youth,adult,isotretinoin,abortion spontaneous,"Pregnancy, puerperium and perinatal conditions",$Retinoids for topical use in acne$Retinoids for topical use in acne$Retinoids for treatment of acne,$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE,$ANTI-ACNE PREPARATIONS$ANTI-ACNE PREPARATIONS$ANTI-ACNE PREPARATIONS,$DERMATOLOGICALS$DERMATOLOGICALS$DERMATOLOGICALS
723013,36919230,1.54E-38,7.07E-31,adult_children_senior_youth,youth,diazepam,completed suicide,General disorders and administration site conditions,Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1777087,36314856,1.58E-38,7.27E-31,adult_children_senior,children,hydroxychloroquine,bone density decreased,Investigations,Aminoquinolines,ANTIMALARIALS,ANTIPROTOZOALS,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS"
1397599,35406368,1.59E-38,7.32E-31,adult_children_senior_youth,children,cisplatin,hearing impaired,0,Platinum compounds,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1518254,35809059,1.69E-38,7.74E-31,adult_children_senior_youth,senior,dexamethasone,death,General disorders and administration site conditions,"$Corticosteroids$Corticosteroids, moderately potent, other combinations$Corticosteroids$Corticosteroids, combinations for treatment of acne$Corticosteroids/antiinfectives/mydriatics in combination$Corticosteroids and antiinfectives in combination$Corticosteroids and antiinfectives in combination$Corticosteroids$Corticosteroids and antiinfectives in combination$Corticosteroids, moderately potent, combinations with antibiotics$Glucocorticoids$Corticosteroids, plain$Corticosteroids for local oral treatment$Corticosteroids$Corticosteroids, moderately potent (group II)$Corticosteroids","$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$CORTICOSTEROIDS, OTHER COMBINATIONS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$ANTIINFLAMMATORY AGENTS$STOMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS$CORTICOSTEROIDS, PLAIN$CORTICOSTEROIDS","$NASAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$NASAL PREPARATIONS$ANTI-ACNE PREPARATIONS$OPHTHALMOLOGICALS$OTOLOGICALS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$VASOPROTECTIVES$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS FOR SYSTEMIC USE$OPHTHALMOLOGICALS$STOMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OTOLOGICALS","$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$DERMATOLOGICALS$SENSORY ORGANS$SENSORY ORGANS$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS$DERMATOLOGICALS$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$SENSORY ORGANS$DERMATOLOGICALS$SENSORY ORGANS"
915542,35809372,1.74E-38,7.98E-31,adult_children_senior_youth,youth,brimonidine,rebound effect,General disorders and administration site conditions,$Other dermatologicals$Sympathomimetics in glaucoma therapy,$OTHER DERMATOLOGICAL PREPARATIONS$ANTIGLAUCOMA PREPARATIONS AND MIOTICS,$OTHER DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS,$DERMATOLOGICALS$SENSORY ORGANS
915542,35809086,2.19E-38,1.01E-30,adult_senior_youth,youth,brimonidine,feeling hot,General disorders and administration site conditions,$Other dermatologicals$Sympathomimetics in glaucoma therapy,$OTHER DERMATOLOGICAL PREPARATIONS$ANTIGLAUCOMA PREPARATIONS AND MIOTICS,$OTHER DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS,$DERMATOLOGICALS$SENSORY ORGANS
40241331,36211297,2.30E-38,1.06E-30,adult_children_senior_youth,children,rivaroxaban,fall,"Injury, poisoning and procedural complications",Direct factor Xa inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
723013,35607450,2.80E-38,1.28E-30,adult_children_senior_youth,children,diazepam,visual acuity reduced,Nervous system disorders,Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1704183,36416686,3.62E-38,1.66E-30,adult_children_senior,senior,lamivudine,fanconi syndrome acquired,Renal and urinary disorders,"$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Nucleoside and nucleotide reverse transcriptase inhibitors",$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS,$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
1734104,37622518,3.95E-38,1.81E-30,adult_children_senior_youth,youth,azithromycin,haemorrhage,Vascular disorders,$Combinations of antibacterials$Antibiotics$Macrolides,"$COMBINATIONS OF ANTIBACTERIALS$ANTIINFECTIVES$MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",$ANTIBACTERIALS FOR SYSTEMIC USE$OPHTHALMOLOGICALS$ANTIBACTERIALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$SENSORY ORGANS$ANTIINFECTIVES FOR SYSTEMIC USE
1119119,37219871,4.05E-38,1.86E-30,adult_children_senior_youth,senior,adalimumab,pulmonary embolism,"$Respiratory, thoracic and mediastinal disorders$Vascular disorders",Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1518254,35809076,4.09E-38,1.88E-30,adult_children_senior_youth,senior,dexamethasone,fatigue,General disorders and administration site conditions,"$Corticosteroids$Corticosteroids, moderately potent, other combinations$Corticosteroids$Corticosteroids, combinations for treatment of acne$Corticosteroids/antiinfectives/mydriatics in combination$Corticosteroids and antiinfectives in combination$Corticosteroids and antiinfectives in combination$Corticosteroids$Corticosteroids and antiinfectives in combination$Corticosteroids, moderately potent, combinations with antibiotics$Glucocorticoids$Corticosteroids, plain$Corticosteroids for local oral treatment$Corticosteroids$Corticosteroids, moderately potent (group II)$Corticosteroids","$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$CORTICOSTEROIDS, OTHER COMBINATIONS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$ANTIINFLAMMATORY AGENTS$STOMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS$CORTICOSTEROIDS, PLAIN$CORTICOSTEROIDS","$NASAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$NASAL PREPARATIONS$ANTI-ACNE PREPARATIONS$OPHTHALMOLOGICALS$OTOLOGICALS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$VASOPROTECTIVES$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS FOR SYSTEMIC USE$OPHTHALMOLOGICALS$STOMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OTOLOGICALS","$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$DERMATOLOGICALS$SENSORY ORGANS$SENSORY ORGANS$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS$DERMATOLOGICALS$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$SENSORY ORGANS$DERMATOLOGICALS$SENSORY ORGANS"
766529,36315381,4.26E-38,1.96E-30,adult_children_senior_youth,adult_youth,haloperidol,weight increased,Investigations,Butyrophenone derivatives,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
902427,36315155,4.35E-38,2.00E-30,adult_children_senior_youth,youth,timolol,intraocular pressure increased,Investigations,"$Beta blocking agents, non-selective$Beta blocking agents$Beta blocking agents, non-selective, and thiazides$Beta blocking agents, non-selective, thiazides and other diuretics$Beta blocking agents","$BETA BLOCKING AGENTS$ANTIGLAUCOMA PREPARATIONS AND MIOTICS$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS$ANTIGLAUCOMA PREPARATIONS AND MIOTICS",$BETA BLOCKING AGENTS$OPHTHALMOLOGICALS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$OPHTHALMOLOGICALS,$CARDIOVASCULAR SYSTEM$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$SENSORY ORGANS
956874,36416493,4.88E-38,2.24E-30,adult_children_senior_youth,youth,furosemide,metabolic alkalosis,Metabolism and nutrition disorders,"$High-ceiling diuretics and potassium-sparing agents$Sulfonamides, plain$Sulfonamides$Sulfonamides and potassium in combination","$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$HIGH-CEILING DIURETICS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$HIGH-CEILING DIURETICS",$DIURETICS$DIURETICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$DIURETICS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
991876,35809077,6.05E-38,2.78E-30,adult_children_senior_youth,youth,loperamide,lethargy,Nervous system disorders,$Antipropulsives$Antipropulsives,$ANTIPROPULSIVES$ANTIPROPULSIVES,"$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1717704,36211190,6.52E-38,2.99E-30,adult_children_senior,senior,valacyclovir,toxic encephalopathy,"Injury, poisoning and procedural complications",0,0,0,0
1762711,35104304,6.57E-38,3.02E-30,adult_children_senior_youth,senior,ribavirin,hyperbilirubinaemia,Hepatobiliary disorders,Antivirals for treatment of HCV infections,DIRECT ACTING ANTIVIRALS,ANTIVIRALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
937368,43053904,7.24E-38,3.32E-30,adult_children_youth,adult_youth,infliximab,exposure during pregnancy,"Injury, poisoning and procedural complications",Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
709567,36416514,8.90E-38,4.09E-30,adult_children_youth,children,lisdexamfetamine,decreased appetite,General disorders and administration site conditions,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
715233,36718111,1.20E-37,5.53E-30,adult_children_senior_youth,adult_senior,baclofen,multiple sclerosis,Nervous system disorders,Other centrally acting agents,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",MUSCLE RELAXANTS,MUSCULO-SKELETAL SYSTEM
1796458,35708147,1.25E-37,5.73E-30,adult_children_senior_youth,children,cefdinir,faeces discoloured,Gastrointestinal disorders,Third-generation cephalosporins,OTHER BETA-LACTAM ANTIBACTERIALS,ANTIBACTERIALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
1510813,35205189,1.52E-37,6.96E-30,adult_children_senior,adult,rosuvastatin,myocardial infarction,Vascular disorders,"$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors$Dipeptidyl peptidase 4 (DPP-4) inhibitors$Sulfonamides$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents","$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, PLAIN$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS",$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$DRUGS USED IN DIABETES$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$ALIMENTARY TRACT AND METABOLISM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
19011440,36313985,1.63E-37,7.50E-30,adult_children_senior_youth,children_youth,everolimus,blood cholesterol increased,Investigations,$Protein kinase inhibitors$Selective immunosuppressants,$OTHER ANTINEOPLASTIC AGENTS$IMMUNOSUPPRESSANTS,$ANTINEOPLASTIC AGENTS$IMMUNOSUPPRESSANTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1500211,36312432,2.59E-37,1.19E-29,adult_senior,senior,medroxyprogesterone,progesterone receptor assay positive,Investigations,0,0,0,0
44507700,35809072,2.69E-37,1.23E-29,adult_children_senior_youth,youth,vortioxetine,asthenia,General disorders and administration site conditions,Other antidepressants,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1332418,36211492,3.39E-37,1.56E-29,adult_children_senior_youth,youth,amlodipine,intentional overdose,"Injury, poisoning and procedural complications","$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$Beta blocking agents and calcium channel blockers$Dihydropyridine derivatives$ACE inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$Calcium channel blockers and diuretics$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs), other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers","$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS$ACE INHIBITORS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$CALCIUM CHANNEL BLOCKERS AND DIURETICS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$BETA BLOCKING AGENTS$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1308290,35909577,3.48E-37,1.60E-29,adult_children_senior_youth,senior,vincristine,hepatitis b,Infections and infestations,Vinca alkaloids and analogues,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1154161,36718180,3.50E-37,1.60E-29,adult_children_senior_youth,children,montelukast,disturbance in attention,Nervous system disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1119119,36718005,3.94E-37,1.81E-29,adult_children_senior_youth,senior,adalimumab,cerebrovascular accident,Vascular disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1336926,36313985,4.38E-37,2.01E-29,adult_senior_youth,adult,tadalafil,blood cholesterol increased,Investigations,$Drugs used in erectile dysfunction$Antihypertensives for pulmonary arterial hypertension,$UROLOGICALS$OTHER ANTIHYPERTENSIVES,$UROLOGICALS$ANTIHYPERTENSIVES,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
785788,35809041,4.42E-37,2.03E-29,adult_children_senior_youth,senior,olanzapine,hypothermia,General disorders and administration site conditions,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
724816,42889647,4.66E-37,2.14E-29,adult_children_senior_youth,youth,oxazepam,toxicity to various agents,"Injury, poisoning and procedural complications",Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1125315,35909517,5.05E-37,2.32E-29,adult_children_senior_youth,children_youth,acetaminophen,hepatic encephalopathy,$Hepatobiliary disorders$Nervous system disorders,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1351541,36516848,6.16E-37,2.83E-29,adult_children_senior_youth,youth,leuprolide,muscle spasms,Musculoskeletal and connective tissue disorders,$Gonadotropin releasing hormone analogues$Gonadotropin releasing hormone analogues,$HORMONES AND RELATED AGENTS$HORMONES AND RELATED AGENTS,$ENDOCRINE THERAPY$ENDOCRINE THERAPY,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1597756,36314160,6.28E-37,2.88E-29,adult_children_senior,adult,glimepiride,blood glucose increased,Investigations,$Combinations of oral blood glucose lowering drugs$Sulfonylureas$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
937368,37521618,6.78E-37,3.11E-29,adult_children_youth,adult,infliximab,caesarean section,Surgical and medical procedures,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1154161,36718369,7.04E-37,3.23E-29,adult_children_senior_youth,children,montelukast,thinking abnormal,Nervous system disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1305058,36919118,7.76E-37,3.56E-29,adult_children_senior_youth,children_youth,methotrexate,mental status changes,Psychiatric disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1307863,35204928,9.14E-37,4.20E-29,adult_children_senior_youth,children,verapamil,bradycardia,Cardiac disorders,$ACE inhibitors and calcium channel blockers$Phenylalkylamine derivatives$Phenylalkylamine derivatives,"$ACE INHIBITORS, COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$CALCIUM CHANNEL BLOCKERS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
735979,36211297,1.80E-36,8.26E-29,adult_children_senior_youth,senior,risperidone,fall,"Injury, poisoning and procedural complications",Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1308216,37080784,1.81E-36,8.29E-29,adult_children_senior_youth,children_youth,lisinopril,acute kidney injury,Renal and urinary disorders,"$ACE inhibitors and diuretics$HMG CoA reductase inhibitors, other combinations$ACE inhibitors, plain$ACE inhibitors and calcium channel blockers","$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, PLAIN$ACE INHIBITORS, COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
797617,35204970,2.18E-36,1.00E-28,adult_children_senior_youth,youth,citalopram,cardio-respiratory arrest,Cardiac disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
745466,36211492,3.04E-36,1.39E-28,adult_children_senior_youth,youth,valproate,intentional overdose,"Injury, poisoning and procedural complications",0,0,0,0
1797513,36718500,3.06E-36,1.40E-28,adult_children_senior_youth,adult,ciprofloxacin,neuropathy peripheral,Nervous system disorders,$Combinations of antibacterials$Antiinfectives$Fluoroquinolones$Antiinfectives$Combinations of antibacterials$Combinations of antibacterials$Fluoroquinolones,$COMBINATIONS OF ANTIBACTERIALS$ANTIINFECTIVES$QUINOLONE ANTIBACTERIALS$ANTIINFECTIVES$COMBINATIONS OF ANTIBACTERIALS$COMBINATIONS OF ANTIBACTERIALS$ANTIINFECTIVES,$ANTIBACTERIALS FOR SYSTEMIC USE$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$ANTIBACTERIALS FOR SYSTEMIC USE$OTOLOGICALS$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIBACTERIALS FOR SYSTEMIC USE$OPHTHALMOLOGICALS,$ANTIINFECTIVES FOR SYSTEMIC USE$SENSORY ORGANS$ANTIINFECTIVES FOR SYSTEMIC USE$SENSORY ORGANS$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$SENSORY ORGANS
1777806,37019330,3.17E-36,1.46E-28,adult_children_senior_youth,children,ceftriaxone,hydronephrosis,Renal and urinary disorders,$Third-generation cephalosporins$Third-generation cephalosporins,$OTHER BETA-LACTAM ANTIBACTERIALS$OTHER BETA-LACTAM ANTIBACTERIALS,$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIBACTERIALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
1112807,35205182,3.46E-36,1.59E-28,adult_senior,adult,aspirin,angina unstable,Vascular disorders,0,0,0,0
1503297,36416487,4.28E-36,1.97E-28,adult_children_senior_youth,youth,metformin,metabolic acidosis,Metabolism and nutrition disorders,$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Biguanides$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
745466,36211496,5.19E-36,2.38E-28,adult_children_senior_youth,youth,valproate,overdose,"Injury, poisoning and procedural complications",0,0,0,0
1125315,35708208,5.92E-36,2.72E-28,adult_children_senior_youth,children,acetaminophen,vomiting,Gastrointestinal disorders,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1338005,35204953,6.28E-36,2.88E-28,adult_children_senior_youth,senior,bisoprolol,atrial fibrillation,Cardiac disorders,"$Beta blocking agents, other combinations$Beta blocking agents, selective, and thiazides$Beta blocking agents, selective$ACE inhibitors, other combinations$Beta blocking agents and calcium channel blockers","$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS$ACE INHIBITORS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1547504,35204953,7.58E-36,3.48E-28,adult_children_senior,senior,rosiglitazone,atrial fibrillation,Cardiac disorders,$Combinations of oral blood glucose lowering drugs$Thiazolidinediones$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1154161,36718347,7.62E-36,3.50E-28,adult_children_senior_youth,children,montelukast,agitation,Nervous system disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1112807,37522318,7.64E-36,3.51E-28,adult_children_senior,adult,aspirin,coronary artery bypass,Surgical and medical procedures,0,0,0,0
1502905,35607485,7.95E-36,3.65E-28,adult_children_senior_youth,senior,insulin glargine,visual impairment,Eye disorders,"$Insulins and analogues for injection, long-acting$Insulins and analogues for injection, long-acting",$INSULINS AND ANALOGUES$INSULINS AND ANALOGUES,$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1125315,35909503,8.26E-36,3.79E-28,adult_children_senior_youth,children_youth,acetaminophen,liver injury,Hepatobiliary disorders,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1332418,35204928,8.46E-36,3.88E-28,adult_children_senior_youth,youth,amlodipine,bradycardia,Cardiac disorders,"$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$Beta blocking agents and calcium channel blockers$Dihydropyridine derivatives$ACE inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$Calcium channel blockers and diuretics$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs), other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers","$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS$ACE INHIBITORS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$CALCIUM CHANNEL BLOCKERS AND DIURETICS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$BETA BLOCKING AGENTS$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
950637,36009891,8.83E-36,4.05E-28,adult_children_senior_youth,children,tacrolimus,acute graft versus host disease,"Injury, poisoning and procedural complications","$Agents for dermatitis, excluding corticosteroids$Calcineurin inhibitors",$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$DERMATOLOGICALS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1106776,36009700,8.98E-36,4.12E-28,adult_children_senior_youth,youth,tiotropium,asthma,"Respiratory, thoracic and mediastinal disorders",$Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids$Anticholinergics$Anticholinergics,"$ADRENERGICS, INHALANTS$OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS$OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1154343,35809243,9.15E-36,4.20E-28,adult_children_senior_youth,youth,albuterol,pain,General disorders and administration site conditions,0,0,0,0
1308290,37521169,9.70E-36,4.45E-28,adult_children_senior_youth,adult,vincristine,stem cell transplant,Surgical and medical procedures,Vinca alkaloids and analogues,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
744740,36919230,1.02E-35,4.67E-28,adult_children_senior_youth,children_youth,zolpidem,completed suicide,General disorders and administration site conditions,Benzodiazepine related drugs,HYPNOTICS AND SEDATIVES,PSYCHOLEPTICS,NERVOUS SYSTEM
1395557,36110978,1.11E-35,5.09E-28,adult_children_senior_youth,senior,fludarabine,progressive multifocal leukoencephalopathy,Infections and infestations,Purine analogues,ANTIMETABOLITES,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
937368,36009833,1.15E-35,5.28E-28,adult_children_senior_youth,senior,infliximab,rheumatoid arthritis,Immune system disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1519936,37119548,1.35E-35,6.18E-28,adult_children_youth,children_youth,etonogestrel,menorrhagia,Reproductive system and breast disorders,Progestogens,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,GENITO URINARY SYSTEM AND SEX HORMONES
1103314,37219885,1.50E-35,6.87E-28,adult_children_senior_youth,children,tramadol,apnoea,"Respiratory, thoracic and mediastinal disorders",$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Other opioids,$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1762711,35205230,1.61E-35,7.39E-28,adult_children_senior_youth,senior,ribavirin,ascites,Gastrointestinal disorders,Antivirals for treatment of HCV infections,DIRECT ACTING ANTIVIRALS,ANTIVIRALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
956874,35205189,1.80E-35,8.25E-28,adult_children_senior_youth,adult,furosemide,myocardial infarction,Vascular disorders,"$High-ceiling diuretics and potassium-sparing agents$Sulfonamides, plain$Sulfonamides$Sulfonamides and potassium in combination","$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$HIGH-CEILING DIURETICS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$HIGH-CEILING DIURETICS",$DIURETICS$DIURETICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$DIURETICS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
1305058,35707713,1.95E-35,8.96E-28,adult_children_senior_youth,children_youth,methotrexate,pancreatitis,Gastrointestinal disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
986417,36918858,2.08E-35,9.57E-28,adult_children_senior_youth,children_youth,polyethylene glycol 3350,anxiety,Psychiatric disorders,0,0,0,0
1310317,35104236,2.08E-35,9.56E-28,adult_children_senior_youth,children_youth,cyclophosphamide,histiocytosis haematophagic,0,Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
40222444,35506742,2.20E-35,1.01E-27,adult_children_senior_youth,children,denosumab,hypercalcaemia,Metabolism and nutrition disorders,Other drugs affecting bone structure and mineralization,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,DRUGS FOR TREATMENT OF BONE DISEASES,MUSCULO-SKELETAL SYSTEM
1119119,35204966,2.70E-35,1.24E-27,adult_children_senior_youth,senior,adalimumab,cardiac arrest,Cardiac disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
735979,36416600,2.81E-35,1.29E-27,adult_children_senior_youth,senior,risperidone,hyponatraemia,Metabolism and nutrition disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1153428,36254981,3.27E-35,1.50E-27,adult_children_senior_youth,children,fexofenadine,extra dose administered,"Injury, poisoning and procedural complications",Other antihistamines for systemic use,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,RESPIRATORY SYSTEM
45892558,37019321,4.67E-35,2.14E-27,adult_senior,adult,dasabuvir,renal impairment,Renal and urinary disorders,$Antivirals for treatment of HCV infections$Antivirals for treatment of HCV infections,$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS,$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
1786055,35809243,4.91E-35,2.25E-27,adult_children_senior_youth,youth,deferasirox,pain,General disorders and administration site conditions,Iron chelating agents,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,VARIOUS
715233,36516863,5.03E-35,2.31E-27,adult_children_senior_youth,children_youth,baclofen,hypertonia,Nervous system disorders,Other centrally acting agents,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",MUSCLE RELAXANTS,MUSCULO-SKELETAL SYSTEM
1151789,35406369,9.76E-35,4.48E-27,adult_children_senior_youth,senior,etanercept,hypoacusis,Ear and labyrinth disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1777087,36416534,1.33E-34,6.13E-27,adult_children_senior_youth,children,hydroxychloroquine,obesity,Metabolism and nutrition disorders,Aminoquinolines,ANTIMALARIALS,ANTIPROTOZOALS,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS"
1151789,36516972,1.57E-34,7.21E-27,adult_children_senior_youth,senior,etanercept,musculoskeletal disorder,Musculoskeletal and connective tissue disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
950637,35104177,2.01E-34,9.23E-27,adult_children_senior_youth,children_youth,tacrolimus,thrombotic microangiopathy,Blood and lymphatic system disorders,"$Agents for dermatitis, excluding corticosteroids$Calcineurin inhibitors",$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$DERMATOLOGICALS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
996416,36919194,2.06E-34,9.47E-27,adult_children_senior_youth,youth,finasteride,libido decreased,$Psychiatric disorders$Reproductive system and breast disorders,$Other dermatologicals$Alpha-adrenoreceptor antagonists$Testosterone-5-alpha reductase inhibitors,$OTHER DERMATOLOGICAL PREPARATIONS$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,$OTHER DERMATOLOGICAL PREPARATIONS$UROLOGICALS$UROLOGICALS,$DERMATOLOGICALS$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1310317,42890655,2.13E-34,9.77E-27,adult_senior,adult,cyclophosphamide,psychological trauma,Psychiatric disorders,Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
735979,36919232,2.43E-34,1.12E-26,adult_children_senior_youth,youth,risperidone,self injurious behaviour,0,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1333357,37622529,2.61E-34,1.20E-26,adult_children_senior_youth,children_youth,busulfan,hypertension,Vascular disorders,Alkyl sulfonates,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1777806,35809237,2.74E-34,1.26E-26,adult_children_senior_youth,children,ceftriaxone,flank pain,Renal and urinary disorders,$Third-generation cephalosporins$Third-generation cephalosporins,$OTHER BETA-LACTAM ANTIBACTERIALS$OTHER BETA-LACTAM ANTIBACTERIALS,$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIBACTERIALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
1310149,37622465,2.94E-34,1.35E-26,adult_children_senior_youth,youth,warfarin,deep vein thrombosis,Vascular disorders,Vitamin K antagonists,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1129625,42889647,3.41E-34,1.56E-26,adult_children_senior_youth,youth,diphenhydramine,toxicity to various agents,"Injury, poisoning and procedural complications",$Antihistamines for topical use$Aminoalkyl ethers$Antihistamines for topical use$Aminoalkyl ethers,"$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ANTIHISTAMINES FOR SYSTEMIC USE$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ANTIHISTAMINES FOR SYSTEMIC USE","$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ANTIHISTAMINES FOR SYSTEMIC USE$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ANTIHISTAMINES FOR SYSTEMIC USE",$DERMATOLOGICALS$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM
1151789,36516828,4.59E-34,2.11E-26,adult_children_senior_youth,adult,etanercept,psoriatic arthropathy,$Immune system disorders$Musculoskeletal and connective tissue disorders$Skin and subcutaneous tissue disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
996416,37119688,5.26E-34,2.41E-26,adult_senior_youth,youth,finasteride,testicular pain,Reproductive system and breast disorders,$Other dermatologicals$Alpha-adrenoreceptor antagonists$Testosterone-5-alpha reductase inhibitors,$OTHER DERMATOLOGICAL PREPARATIONS$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,$OTHER DERMATOLOGICAL PREPARATIONS$UROLOGICALS$UROLOGICALS,$DERMATOLOGICALS$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1326303,37219867,5.69E-34,2.61E-26,adult_children_senior_youth,youth,digoxin,pulmonary arterial hypertension,Vascular disorders,Digitalis glycosides,CARDIAC GLYCOSIDES,CARDIAC THERAPY,CARDIOVASCULAR SYSTEM
705944,36110597,5.73E-34,2.63E-26,adult_children_senior_youth,senior,methylphenidate,pneumonia,Infections and infestations,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
1151789,35204989,5.85E-34,2.68E-26,adult_children_senior_youth,senior,etanercept,cardiac disorder,Cardiac disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1305058,37080784,6.44E-34,2.96E-26,adult_children_senior_youth,children_youth,methotrexate,acute kidney injury,Renal and urinary disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1301267,36516749,6.49E-34,2.98E-26,adult_children_senior,senior,melphalan,osteonecrosis,Vascular disorders,Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
991876,35204977,6.78E-34,3.11E-26,adult_children_senior_youth,youth,loperamide,torsade de pointes,Cardiac disorders,$Antipropulsives$Antipropulsives,$ANTIPROPULSIVES$ANTIPROPULSIVES,"$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1167322,35909625,8.46E-34,3.88E-26,adult_children_senior_youth,youth,allopurinol,hepatotoxicity,"Injury, poisoning and procedural complications",$Preparations inhibiting uric acid production$Preparations inhibiting uric acid production,$ANTIGOUT PREPARATIONS$ANTIGOUT PREPARATIONS,$ANTIGOUT PREPARATIONS$ANTIGOUT PREPARATIONS,$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
1154161,36919231,9.52E-34,4.37E-26,adult_children_youth,children_youth,montelukast,intentional self-injury,"$Injury, poisoning and procedural complications$Psychiatric disorders",$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
19011440,36776613,9.57E-34,4.39E-26,adult_children_senior_youth,children_youth,everolimus,seizure,Nervous system disorders,$Protein kinase inhibitors$Selective immunosuppressants,$OTHER ANTINEOPLASTIC AGENTS$IMMUNOSUPPRESSANTS,$ANTINEOPLASTIC AGENTS$IMMUNOSUPPRESSANTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1308290,35809207,9.62E-34,4.41E-26,adult_children_senior_youth,children_youth,vincristine,mucosal inflammation,General disorders and administration site conditions,Vinca alkaloids and analogues,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1177480,35104877,1.02E-33,4.68E-26,adult_children_senior_youth,senior,ibuprofen,febrile neutropenia,General disorders and administration site conditions,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
1351541,37622518,1.18E-33,5.43E-26,adult_children_senior_youth,adult_youth,leuprolide,haemorrhage,Vascular disorders,$Gonadotropin releasing hormone analogues$Gonadotropin releasing hormone analogues,$HORMONES AND RELATED AGENTS$HORMONES AND RELATED AGENTS,$ENDOCRINE THERAPY$ENDOCRINE THERAPY,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
750982,36311923,1.42E-33,6.51E-26,adult_children_senior_youth,children,bupropion,electrocardiogram qt prolonged,Investigations,$Centrally acting antiobesity products$Other antidepressants,"$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$ANTIDEPRESSANTS","$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$PSYCHOANALEPTICS",$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM
1350504,35809207,1.50E-33,6.88E-26,adult_children_senior_youth,children_youth,etoposide,mucosal inflammation,General disorders and administration site conditions,Podophyllotoxin derivatives,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
40241331,35809059,1.61E-33,7.39E-26,adult_children_senior_youth,children,rivaroxaban,death,General disorders and administration site conditions,Direct factor Xa inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1305058,35104691,1.91E-33,8.78E-26,adult_children_senior_youth,children_youth,methotrexate,thrombocytopenia,Blood and lymphatic system disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1322184,35205168,2.27E-33,1.04E-25,adult_children_senior_youth,children,clopidogrel,coronary artery occlusion,Vascular disorders,Platelet aggregation inhibitors excl. heparin,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1332418,37019315,2.33E-33,1.07E-25,adult_children_senior_youth,youth,amlodipine,anuria,Renal and urinary disorders,"$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$Beta blocking agents and calcium channel blockers$Dihydropyridine derivatives$ACE inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$Calcium channel blockers and diuretics$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs), other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers","$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS$ACE INHIBITORS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$CALCIUM CHANNEL BLOCKERS AND DIURETICS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$BETA BLOCKING AGENTS$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
735979,36919230,3.17E-33,1.45E-25,adult_children_senior_youth,adult,risperidone,completed suicide,General disorders and administration site conditions,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1336926,36918949,3.36E-33,1.54E-25,adult_senior_youth,adult,tadalafil,depressed mood,Psychiatric disorders,$Drugs used in erectile dysfunction$Antihypertensives for pulmonary arterial hypertension,$UROLOGICALS$OTHER ANTIHYPERTENSIVES,$UROLOGICALS$ANTIHYPERTENSIVES,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
1154029,35204970,3.69E-33,1.69E-25,adult_children_senior_youth,youth,fentanyl,cardio-respiratory arrest,Cardiac disorders,$Opioid anesthetics$Phenylpiperidine derivatives$Opioid anesthetics,"$ANESTHETICS, GENERAL$OPIOIDS$ANESTHETICS, GENERAL",$ANESTHETICS$ANALGESICS$ANESTHETICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1154161,36718552,4.72E-33,2.17E-25,adult_children_senior_youth,children,montelukast,somnambulism,$Nervous system disorders$Psychiatric disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1361711,35205180,5.06E-33,2.32E-25,adult_senior_youth,adult,glyceryl trinitrate,acute myocardial infarction,Vascular disorders,0,0,0,0
1378382,35809120,5.66E-33,2.60E-25,adult_children_senior_youth,youth,paclitaxel,disease progression,General disorders and administration site conditions,Taxanes,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
40228152,36211297,6.64E-33,3.05E-25,adult_children_senior,children,dabigatran etexilate,fall,"Injury, poisoning and procedural complications",Direct thrombin inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
19010482,35607109,7.53E-33,3.46E-25,adult_children_senior_youth,senior,cyclosporine,eye discharge,Eye disorders,$Calcineurin inhibitors$Other ophthalmologicals,$IMMUNOSUPPRESSANTS$OTHER OPHTHALMOLOGICALS,$IMMUNOSUPPRESSANTS$OPHTHALMOLOGICALS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$SENSORY ORGANS
785788,36211496,8.99E-33,4.13E-25,adult_children_senior_youth,youth,olanzapine,overdose,"Injury, poisoning and procedural complications","Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
766814,35506609,9.21E-33,4.23E-25,adult_children_senior_youth,adult,quetiapine,diabetes mellitus,Endocrine disorders,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1336539,35708395,9.52E-33,4.37E-25,adult_children_senior_youth,adult,sunitinib,gastrointestinal stromal tumour,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Protein kinase inhibitors,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1305058,36313176,9.59E-33,4.40E-25,adult_children_senior_youth,children_youth,methotrexate,platelet count decreased,Investigations,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
735979,35506636,1.10E-32,5.06E-25,adult_children_senior_youth,adult_senior,risperidone,hypoglycaemia,Endocrine disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1503297,36416485,1.17E-32,5.37E-25,adult_children_senior_youth,youth,metformin,lactic acidosis,Metabolism and nutrition disorders,$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Biguanides$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1154161,36718551,1.19E-32,5.45E-25,adult_children_senior_youth,children,montelukast,sleep terror,$Nervous system disorders$Psychiatric disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
984232,35708128,1.30E-32,5.95E-25,adult_children_senior_youth,adult,isotretinoin,irritable bowel syndrome,Psychiatric disorders,$Retinoids for topical use in acne$Retinoids for topical use in acne$Retinoids for treatment of acne,$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE,$ANTI-ACNE PREPARATIONS$ANTI-ACNE PREPARATIONS$ANTI-ACNE PREPARATIONS,$DERMATOLOGICALS$DERMATOLOGICALS$DERMATOLOGICALS
1124300,37019319,1.75E-32,8.01E-25,adult_children_senior_youth,children,diclofenac,renal failure acute,0,"$Antiinflammatory agents, non-steroids and antiinfectives in combination$Antiinflammatory agents, non-steroids$Acetic acid derivatives and related substances$Antiinflammatory preparations, non-steroids for topical use$Acetic acid derivatives and related substances$Other dermatologicals","$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$ANTIINFLAMMATORY AGENTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$OTHER DERMATOLOGICAL PREPARATIONS",$OPHTHALMOLOGICALS$OPHTHALMOLOGICALS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$OTHER DERMATOLOGICAL PREPARATIONS,$SENSORY ORGANS$SENSORY ORGANS$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$DERMATOLOGICALS
1154343,36919059,1.80E-32,8.26E-25,adult_children_senior_youth,children,albuterol,aggression,Psychiatric disorders,0,0,0,0
950637,36009897,1.89E-32,8.70E-25,adult_children_senior_youth,youth,tacrolimus,kidney transplant rejection,Renal and urinary disorders,"$Agents for dermatitis, excluding corticosteroids$Calcineurin inhibitors",$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$DERMATOLOGICALS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1125315,35909518,1.99E-32,9.13E-25,adult_children_senior_youth,children_youth,acetaminophen,hepatic failure,Hepatobiliary disorders,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1112807,35205181,2.39E-32,1.10E-24,adult_children_senior_youth,adult,aspirin,angina pectoris,Vascular disorders,0,0,0,0
735979,35809043,2.65E-32,1.21E-24,adult_children_senior_youth,youth,risperidone,neuroleptic malignant syndrome,General disorders and administration site conditions,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
705103,36919236,2.67E-32,1.23E-24,adult_children_senior_youth,youth,lamotrigine,suicide attempt,Psychiatric disorders,Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
708298,35809170,2.76E-32,1.27E-24,adult_children_senior_youth,senior,midazolam,unevaluable event,General disorders and administration site conditions,Benzodiazepine derivatives,HYPNOTICS AND SEDATIVES,PSYCHOLEPTICS,NERVOUS SYSTEM
904453,35708139,3.04E-32,1.40E-24,adult_children_senior_youth,adult_youth,esomeprazole,dyspepsia,Gastrointestinal disorders,$Combinations for eradication of Helicobacter pylori$Proton pump inhibitors$Propionic acid derivatives,"$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$MUSCULO-SKELETAL SYSTEM
745466,36919098,3.09E-32,1.42E-24,adult_children_senior_youth,children,valproate,abnormal behaviour,Psychiatric disorders,0,0,0,0
1332418,37622529,3.14E-32,1.44E-24,adult_children_senior_youth,children,amlodipine,hypertension,Vascular disorders,"$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$Beta blocking agents and calcium channel blockers$Dihydropyridine derivatives$ACE inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$Calcium channel blockers and diuretics$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs), other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers","$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS$ACE INHIBITORS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$CALCIUM CHANNEL BLOCKERS AND DIURETICS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$BETA BLOCKING AGENTS$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
722031,35205064,3.35E-32,1.54E-24,adult_children_senior,children,paroxetine,aortic valve incompetence,Cardiac disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
40241331,35204953,3.57E-32,1.64E-24,adult_children_senior_youth,senior,rivaroxaban,atrial fibrillation,Cardiac disorders,Direct factor Xa inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1151789,36918858,3.96E-32,1.82E-24,adult_children_senior_youth,children_youth,etanercept,anxiety,Psychiatric disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
703244,35506601,3.96E-32,1.82E-24,adult_children_senior_youth,children,paliperidone,gynaecomastia,$Endocrine disorders$Reproductive system and breast disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
715233,36718112,4.18E-32,1.92E-24,adult_senior_youth,adult,baclofen,multiple sclerosis relapse,Nervous system disorders,Other centrally acting agents,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",MUSCLE RELAXANTS,MUSCULO-SKELETAL SYSTEM
40002705,36919230,4.50E-32,2.07E-24,adult_children_senior_youth,youth,acetaminophen / hydrocodone Oral Solution,completed suicide,General disorders and administration site conditions,0,0,0,0
1305058,35506690,4.61E-32,2.12E-24,adult_children_senior_youth,children_youth,methotrexate,inappropriate antidiuretic hormone secretion,$Endocrine disorders$Metabolism and nutrition disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1112807,36919236,6.31E-32,2.89E-24,adult_children_senior_youth,youth,aspirin,suicide attempt,Psychiatric disorders,0,0,0,0
1321636,37520731,6.59E-32,3.02E-24,adult_children_senior_youth,children,bosentan,cardiac operation,Surgical and medical procedures,$Sulfonamides$Antihypertensives for pulmonary arterial hypertension,"$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$OTHER ANTIHYPERTENSIVES",$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$ANTIHYPERTENSIVES,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
1398937,36919059,6.82E-32,3.13E-24,adult_children_senior_youth,children,clonidine,aggression,Psychiatric disorders,$Sympathomimetics in glaucoma therapy$Imidazoline receptor agonists in combination with diuretics$Imidazoline receptor agonists$Other antimigraine preparations$Imidazoline receptor agonists in combination with diuretics,"$ANTIGLAUCOMA PREPARATIONS AND MIOTICS$ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION$ANTIADRENERGIC AGENTS, CENTRALLY ACTING$ANTIMIGRAINE PREPARATIONS$ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",$OPHTHALMOLOGICALS$ANTIHYPERTENSIVES$ANTIHYPERTENSIVES$ANALGESICS$ANTIHYPERTENSIVES,$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$NERVOUS SYSTEM$CARDIOVASCULAR SYSTEM
1309944,35204981,6.84E-32,3.14E-24,adult_children_senior_youth,children_youth,amiodarone,ventricular fibrillation,Cardiac disorders,"Antiarrhythmics, class III","ANTIARRHYTHMICS, CLASS I AND III",CARDIAC THERAPY,CARDIOVASCULAR SYSTEM
19010482,35607123,6.94E-32,3.19E-24,adult_children_senior_youth,senior,cyclosporine,eye pruritus,Eye disorders,$Calcineurin inhibitors$Other ophthalmologicals,$IMMUNOSUPPRESSANTS$OTHER OPHTHALMOLOGICALS,$IMMUNOSUPPRESSANTS$OPHTHALMOLOGICALS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$SENSORY ORGANS
19014878,35708063,7.05E-32,3.23E-24,adult_children_senior_youth,children_youth,azathioprine,crohn's disease,$Gastrointestinal disorders$Immune system disorders,Other immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
781039,36211491,7.56E-32,3.47E-24,adult_children_senior_youth,youth,alprazolam,accidental overdose,"Injury, poisoning and procedural complications",Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
937368,37320257,9.14E-32,4.19E-24,adult_children_senior_youth,adult_youth,infliximab,acne,Skin and subcutaneous tissue disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1508439,37622518,1.01E-31,4.62E-24,adult_children_senior_youth,youth,mifepristone,haemorrhage,Vascular disorders,$Progesterone receptor modulators$Progesterone receptor modulators,$OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1119119,36314856,1.10E-31,5.03E-24,adult_children_senior_youth,children,adalimumab,bone density decreased,Investigations,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1502905,35506628,1.36E-31,6.25E-24,adult_children_senior_youth,children,insulin glargine,hyperglycaemia,Endocrine disorders,"$Insulins and analogues for injection, long-acting$Insulins and analogues for injection, long-acting",$INSULINS AND ANALOGUES$INSULINS AND ANALOGUES,$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1351541,37119545,1.40E-31,6.40E-24,adult_children_youth,youth,leuprolide,metrorrhagia,Reproductive system and breast disorders,$Gonadotropin releasing hormone analogues$Gonadotropin releasing hormone analogues,$HORMONES AND RELATED AGENTS$HORMONES AND RELATED AGENTS,$ENDOCRINE THERAPY$ENDOCRINE THERAPY,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
705944,35809071,1.51E-31,6.93E-24,adult_children_senior_youth,children,methylphenidate,no adverse event,General disorders and administration site conditions,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
800878,36718256,1.58E-31,7.25E-24,adult_senior_youth,senior,clozapine,parkinson's disease,Nervous system disorders,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1151789,35606985,1.87E-31,8.61E-24,adult_children_senior_youth,senior,etanercept,glaucoma,Eye disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1103314,35809059,2.21E-31,1.01E-23,adult_children_senior_youth,children,tramadol,death,General disorders and administration site conditions,$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Other opioids,$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1119119,35809022,2.27E-31,1.04E-23,adult_children_senior_youth,children_youth,adalimumab,injection site urticaria,General disorders and administration site conditions,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1316262,37520731,2.60E-31,1.19E-23,adult_children_senior_youth,children,sildenafil,cardiac operation,Surgical and medical procedures,$Sulfonamides$Drugs used in erectile dysfunction,"$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$UROLOGICALS",$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$UROLOGICALS,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1305058,35809310,2.61E-31,1.20E-23,adult_children_senior_youth,children,methotrexate,drug interaction,General disorders and administration site conditions,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1309068,36211496,2.65E-31,1.22E-23,adult_children_senior_youth,children,minoxidil,overdose,"Injury, poisoning and procedural complications",$Other dermatologicals$Pyrimidine derivatives,"$OTHER DERMATOLOGICAL PREPARATIONS$ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON",$OTHER DERMATOLOGICAL PREPARATIONS$ANTIHYPERTENSIVES,$DERMATOLOGICALS$CARDIOVASCULAR SYSTEM
1119119,35708628,2.80E-31,1.28E-23,adult_children_senior_youth,children_youth,adalimumab,oropharyngeal pain,"Respiratory, thoracic and mediastinal disorders",Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1154161,36919077,2.86E-31,1.31E-23,adult_children_senior_youth,children,montelukast,social avoidant behaviour,Psychiatric disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
912263,35606985,3.06E-31,1.41E-23,adult_children_senior,senior,certolizumab pegol,glaucoma,Eye disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1151789,35607078,3.14E-31,1.44E-23,adult_children_senior_youth,children,etanercept,uveitis,Eye disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1314924,35809120,3.36E-31,1.54E-23,adult_children_senior_youth,children_youth,gemcitabine,disease progression,General disorders and administration site conditions,Pyrimidine analogues,ANTIMETABOLITES,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
753626,36918858,3.49E-31,1.60E-23,adult_children_senior_youth,senior,propofol,anxiety,Psychiatric disorders,Other general anesthetics,"ANESTHETICS, GENERAL",ANESTHETICS,NERVOUS SYSTEM
715259,36416600,3.63E-31,1.67E-23,adult_senior_youth,senior,duloxetine,hyponatraemia,Metabolism and nutrition disorders,Other antidepressants,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1762711,43053853,3.78E-31,1.73E-23,adult_children_senior,senior,ribavirin,hepatocellular carcinoma,Hepatobiliary disorders,Antivirals for treatment of HCV infections,DIRECT ACTING ANTIVIRALS,ANTIVIRALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
1338512,36919046,4.09E-31,1.88E-23,adult_senior_youth,adult,doxorubicin,emotional distress,Psychiatric disorders,Anthracyclines and related substances,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
950637,36009894,4.13E-31,1.90E-23,adult_children_senior_youth,children,tacrolimus,chronic graft versus host disease,"Injury, poisoning and procedural complications","$Agents for dermatitis, excluding corticosteroids$Calcineurin inhibitors",$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$DERMATOLOGICALS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1151789,35708208,4.49E-31,2.06E-23,adult_children_senior_youth,children,etanercept,vomiting,Gastrointestinal disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
757352,36718554,5.34E-31,2.45E-23,adult_senior_youth,senior_youth,eszopiclone,initial insomnia,$Nervous system disorders$Psychiatric disorders,Benzodiazepine related drugs,HYPNOTICS AND SEDATIVES,PSYCHOLEPTICS,NERVOUS SYSTEM
1503297,35205247,5.42E-31,2.49E-23,adult_senior_youth,youth,metformin,cardiopulmonary failure,"$Cardiac disorders$Respiratory, thoracic and mediastinal disorders",$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Biguanides$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1777087,36516828,5.72E-31,2.62E-23,adult_senior_youth,senior,hydroxychloroquine,psoriatic arthropathy,$Immune system disorders$Musculoskeletal and connective tissue disorders$Skin and subcutaneous tissue disorders,Aminoquinolines,ANTIMALARIALS,ANTIPROTOZOALS,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS"
735979,36919149,6.94E-31,3.19E-23,adult_children_senior_youth,youth,risperidone,psychotic disorder,Psychiatric disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1301267,36009891,7.10E-31,3.26E-23,adult_children_senior_youth,youth,melphalan,acute graft versus host disease,"Injury, poisoning and procedural complications",Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
991876,35204985,7.33E-31,3.36E-23,adult_children_senior_youth,youth,loperamide,ventricular tachycardia,Cardiac disorders,$Antipropulsives$Antipropulsives,$ANTIPROPULSIVES$ANTIPROPULSIVES,"$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1186087,36516828,9.01E-31,4.14E-23,adult_senior_youth,senior,abatacept,psoriatic arthropathy,$Immune system disorders$Musculoskeletal and connective tissue disorders$Skin and subcutaneous tissue disorders,Selective immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
800878,36315381,9.28E-31,4.26E-23,adult_children_senior_youth,children_youth,clozapine,weight increased,Investigations,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
766529,36919231,9.45E-31,4.34E-23,adult_children_senior_youth,adult_youth,haloperidol,intentional self-injury,"$Injury, poisoning and procedural complications$Psychiatric disorders",Butyrophenone derivatives,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1103640,35204977,1.05E-30,4.81E-23,adult_children_senior_youth,adult,methadone,torsade de pointes,Cardiac disorders,$Drugs used in opioid dependence$Diphenylpropylamine derivatives,$DRUGS USED IN ADDICTIVE DISORDERS$OPIOIDS,$OTHER NERVOUS SYSTEM DRUGS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
1149380,36919098,1.06E-30,4.86E-23,adult_children_senior_youth,children,fluticasone,abnormal behaviour,Psychiatric disorders,"$Glucocorticoids$Corticosteroids, potent (group III)$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Corticosteroids$Corticosteroids","$OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS$CORTICOSTEROIDS, PLAIN$ADRENERGICS, INHALANTS$ADRENERGICS, INHALANTS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE","$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$NASAL PREPARATIONS$NASAL PREPARATIONS",$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1305058,35104161,1.38E-30,6.35E-23,adult_children_senior_youth,children,methotrexate,coagulopathy,Blood and lymphatic system disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
40002705,35204970,1.39E-30,6.36E-23,adult_children_senior_youth,youth,acetaminophen / hydrocodone Oral Solution,cardio-respiratory arrest,Cardiac disorders,0,0,0,0
937368,36617162,1.44E-30,6.62E-23,adult_children_senior_youth,senior,infliximab,breast cancer,Reproductive system and breast disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1149380,36919059,1.61E-30,7.39E-23,adult_children_senior_youth,children,fluticasone,aggression,Psychiatric disorders,"$Glucocorticoids$Corticosteroids, potent (group III)$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Corticosteroids$Corticosteroids","$OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS$CORTICOSTEROIDS, PLAIN$ADRENERGICS, INHALANTS$ADRENERGICS, INHALANTS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE","$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$NASAL PREPARATIONS$NASAL PREPARATIONS",$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
996416,36919202,1.74E-30,7.97E-23,adult_senior_youth,youth,finasteride,sexual dysfunction,$Psychiatric disorders$Reproductive system and breast disorders,$Other dermatologicals$Alpha-adrenoreceptor antagonists$Testosterone-5-alpha reductase inhibitors,$OTHER DERMATOLOGICAL PREPARATIONS$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,$OTHER DERMATOLOGICAL PREPARATIONS$UROLOGICALS$UROLOGICALS,$DERMATOLOGICALS$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1332418,35204960,2.09E-30,9.58E-23,adult_children_senior_youth,youth,amlodipine,sinus tachycardia,Cardiac disorders,"$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$Beta blocking agents and calcium channel blockers$Dihydropyridine derivatives$ACE inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$Calcium channel blockers and diuretics$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs), other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers","$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS$ACE INHIBITORS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$CALCIUM CHANNEL BLOCKERS AND DIURETICS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$BETA BLOCKING AGENTS$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
19010482,35909571,2.15E-30,9.88E-23,adult_children_senior_youth,youth,cyclosporine,venoocclusive liver disease,Hepatobiliary disorders,$Calcineurin inhibitors$Other ophthalmologicals,$IMMUNOSUPPRESSANTS$OTHER OPHTHALMOLOGICALS,$IMMUNOSUPPRESSANTS$OPHTHALMOLOGICALS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$SENSORY ORGANS
1125315,36211492,2.51E-30,1.15E-22,adult_children_senior_youth,youth,acetaminophen,intentional overdose,"Injury, poisoning and procedural complications",$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1550557,36416551,2.95E-30,1.35E-22,adult_children_senior_youth,children_youth,prednisolone,osteoporosis,$Metabolism and nutrition disorders$Musculoskeletal and connective tissue disorders,"$Corticosteroids, weak (group I)$Corticosteroids and antiinfectives in combination$Corticosteroids, weak, other combinations$Corticosteroids for local oral treatment$Corticosteroids$Corticosteroids and mydriatics in combination$Corticosteroids$Corticosteroids/antiinfectives/mydriatics in combination$Antidotes$Corticosteroids$Corticosteroids, weak, combinations with antiseptics$Corticosteroids, weak, combinations with antibiotics$Corticosteroids, plain$Corticosteroids$Corticosteroids acting locally$Glucocorticoids$Corticosteroids and antiinfectives in combination$Corticosteroids$Corticosteroids and antiinfectives in combination","$CORTICOSTEROIDS, PLAIN$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS, OTHER COMBINATIONS$STOMATOLOGICAL PREPARATIONS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$ALL OTHER THERAPEUTIC PRODUCTS$CORTICOSTEROIDS$CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS$INTESTINAL ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION","$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$STOMATOLOGICAL PREPARATIONS$NASAL PREPARATIONS$OPHTHALMOLOGICALS$NASAL PREPARATIONS$OPHTHALMOLOGICALS$ALL OTHER THERAPEUTIC PRODUCTS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS$OTOLOGICALS$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE$OTOLOGICALS$VASOPROTECTIVES$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS","$DERMATOLOGICALS$SENSORY ORGANS$DERMATOLOGICALS$ALIMENTARY TRACT AND METABOLISM$RESPIRATORY SYSTEM$SENSORY ORGANS$RESPIRATORY SYSTEM$SENSORY ORGANS$VARIOUS$SENSORY ORGANS$DERMATOLOGICALS$DERMATOLOGICALS$SENSORY ORGANS$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS"
19111620,35205305,3.60E-30,1.65E-22,adult_children_senior,children,folic acid,atrial septal defect,Cardiac disorders,$Iron in other combinations$Folic acid and derivatives$Iron in other combinations$Folic acid and derivatives,$IRON PREPARATIONS$VITAMIN B12 AND FOLIC ACID$IRON PREPARATIONS$VITAMIN B12 AND FOLIC ACID,$ANTIANEMIC PREPARATIONS$ANTIANEMIC PREPARATIONS$ANTIANEMIC PREPARATIONS$ANTIANEMIC PREPARATIONS,$BLOOD AND BLOOD FORMING ORGANS$BLOOD AND BLOOD FORMING ORGANS$BLOOD AND BLOOD FORMING ORGANS$BLOOD AND BLOOD FORMING ORGANS
1177480,35708208,3.91E-30,1.80E-22,adult_children_senior_youth,children,ibuprofen,vomiting,Gastrointestinal disorders,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
1548111,36313968,4.87E-30,2.23E-22,adult_senior_youth,youth,cinacalcet,laboratory test abnormal,Investigations,Other anti-parathyroid agents,ANTI-PARATHYROID AGENTS,CALCIUM HOMEOSTASIS,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
1777087,35506459,5.08E-30,2.33E-22,adult_children_senior,children,hydroxychloroquine,adrenal insufficiency,$Endocrine disorders$Metabolism and nutrition disorders,Aminoquinolines,ANTIMALARIALS,ANTIPROTOZOALS,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS"
1560171,42889647,5.60E-30,2.57E-22,adult_children_senior_youth,children,glipizide,toxicity to various agents,"Injury, poisoning and procedural complications",Sulfonylureas,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",DRUGS USED IN DIABETES,ALIMENTARY TRACT AND METABOLISM
705944,35204948,5.88E-30,2.70E-22,adult_children_senior_youth,youth,methylphenidate,tachycardia,Cardiac disorders,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
1305058,43053848,6.69E-30,3.07E-22,adult_children_senior_youth,adult,methotrexate,drug effect incomplete,General disorders and administration site conditions,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
996416,37320268,7.63E-30,3.50E-22,adult_children_senior_youth,adult_youth,finasteride,alopecia,Skin and subcutaneous tissue disorders,$Other dermatologicals$Alpha-adrenoreceptor antagonists$Testosterone-5-alpha reductase inhibitors,$OTHER DERMATOLOGICAL PREPARATIONS$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,$OTHER DERMATOLOGICAL PREPARATIONS$UROLOGICALS$UROLOGICALS,$DERMATOLOGICALS$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1151789,36314856,7.82E-30,3.59E-22,adult_children_senior_youth,children,etanercept,bone density decreased,Investigations,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1503297,35205189,8.09E-30,3.71E-22,adult_children_senior_youth,adult,metformin,myocardial infarction,Vascular disorders,$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Biguanides$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
43013024,37219871,9.39E-30,4.31E-22,adult_children_senior_youth,youth,apixaban,pulmonary embolism,"$Respiratory, thoracic and mediastinal disorders$Vascular disorders",Direct factor Xa inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
745466,36718259,9.44E-30,4.33E-22,adult_children_senior_youth,senior,valproate,parkinsonism,Nervous system disorders,0,0,0,0
1305058,37019318,1.08E-29,4.97E-22,adult_children_senior_youth,youth,methotrexate,renal failure,Renal and urinary disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1151789,35205189,1.10E-29,5.06E-22,adult_children_senior_youth,senior,etanercept,myocardial infarction,Vascular disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1177480,37019371,1.19E-29,5.46E-22,adult_children_senior_youth,children,ibuprofen,ureteric obstruction,Renal and urinary disorders,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
1177480,36009738,1.23E-29,5.65E-22,adult_children_senior_youth,children_senior,ibuprofen,drug hypersensitivity,Immune system disorders,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
1332418,36919236,1.31E-29,6.00E-22,adult_children_senior_youth,youth,amlodipine,suicide attempt,Psychiatric disorders,"$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$Beta blocking agents and calcium channel blockers$Dihydropyridine derivatives$ACE inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$Calcium channel blockers and diuretics$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs), other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers","$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS$ACE INHIBITORS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$CALCIUM CHANNEL BLOCKERS AND DIURETICS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$BETA BLOCKING AGENTS$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1307046,37622449,1.32E-29,6.05E-22,adult_children_senior_youth,children_youth,metoprolol,hypotension,Vascular disorders,"$Beta blocking agents and calcium channel blockers$Beta blocking agents, other combinations$Beta blocking agents, other combinations$Beta blocking agents and calcium channel blockers$Beta blocking agents, selective$Beta blocking agents, selective, and thiazides$Beta blocking agents, selective, and other diuretics$Beta blocking agents, selective, and thiazides","$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS AND OTHER DIURETICS$BETA BLOCKING AGENTS AND THIAZIDES",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
19010482,36009894,1.43E-29,6.56E-22,adult_children_senior_youth,children,cyclosporine,chronic graft versus host disease,"Injury, poisoning and procedural complications",$Calcineurin inhibitors$Other ophthalmologicals,$IMMUNOSUPPRESSANTS$OTHER OPHTHALMOLOGICALS,$IMMUNOSUPPRESSANTS$OPHTHALMOLOGICALS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$SENSORY ORGANS
1501700,35506797,1.56E-29,7.15E-22,adult_children_senior_youth,children_youth,levothyroxine,hypothyroidism,$Endocrine disorders$Metabolism and nutrition disorders,Thyroid hormones,THYROID PREPARATIONS,THYROID THERAPY,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
1305058,36416589,1.57E-29,7.20E-22,adult_children_senior_youth,youth,methotrexate,tumour lysis syndrome,"$Metabolism and nutrition disorders$Neoplasms benign, malignant and unspecified (incl cysts and polyps)",$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1308290,37622529,2.26E-29,1.04E-21,adult_children_senior_youth,children,vincristine,hypertension,Vascular disorders,Vinca alkaloids and analogues,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1000560,36311923,2.28E-29,1.05E-21,adult_children_senior_youth,children,ondansetron,electrocardiogram qt prolonged,Investigations,Serotonin (5HT3) antagonists,ANTIEMETICS AND ANTINAUSEANTS,ANTIEMETICS AND ANTINAUSEANTS,ALIMENTARY TRACT AND METABOLISM
1000560,35809310,2.63E-29,1.21E-21,adult_children_senior_youth,children_youth,ondansetron,drug interaction,General disorders and administration site conditions,Serotonin (5HT3) antagonists,ANTIEMETICS AND ANTINAUSEANTS,ANTIEMETICS AND ANTINAUSEANTS,ALIMENTARY TRACT AND METABOLISM
766814,36211297,2.69E-29,1.24E-21,adult_children_senior_youth,senior,quetiapine,fall,"Injury, poisoning and procedural complications","Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1177480,36416487,2.76E-29,1.27E-21,adult_children_senior_youth,youth,ibuprofen,metabolic acidosis,Metabolism and nutrition disorders,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
1305058,36416595,2.85E-29,1.31E-21,adult_children_senior_youth,children,methotrexate,hypokalaemia,Metabolism and nutrition disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1309068,37320311,2.90E-29,1.33E-21,adult_children_senior_youth,children_senior,minoxidil,hair disorder,Skin and subcutaneous tissue disorders,$Other dermatologicals$Pyrimidine derivatives,"$OTHER DERMATOLOGICAL PREPARATIONS$ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON",$OTHER DERMATOLOGICAL PREPARATIONS$ANTIHYPERTENSIVES,$DERMATOLOGICALS$CARDIOVASCULAR SYSTEM
1119119,36416534,2.96E-29,1.36E-21,adult_children_senior_youth,children,adalimumab,obesity,Metabolism and nutrition disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1151789,36617162,3.19E-29,1.46E-21,adult_children_senior,senior,etanercept,breast cancer,Reproductive system and breast disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1177480,35708564,3.61E-29,1.66E-21,adult_children_senior_youth,children,ibuprofen,lip swelling,Immune system disorders,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
1715117,37219942,3.65E-29,1.67E-21,adult_children_senior_youth,children_youth,aztreonam,lung disorder,"Respiratory, thoracic and mediastinal disorders",Monobactams,OTHER BETA-LACTAM ANTIBACTERIALS,ANTIBACTERIALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
1334456,36718458,3.80E-29,1.74E-21,adult_senior_youth,youth,ramipril,serotonin syndrome,"Injury, poisoning and procedural complications","$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and diuretics$ACE inhibitors, plain","$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, PLAIN",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
950637,35809059,3.98E-29,1.82E-21,adult_children_senior_youth,senior,tacrolimus,death,General disorders and administration site conditions,"$Agents for dermatitis, excluding corticosteroids$Calcineurin inhibitors",$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$DERMATOLOGICALS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
735979,36718321,4.37E-29,2.01E-21,adult_children_senior_youth,senior,risperidone,somnolence,Nervous system disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
722031,36718379,5.09E-29,2.34E-21,adult_children_senior_youth,youth,paroxetine,paraesthesia,Nervous system disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1154161,36918904,5.23E-29,2.40E-21,adult_children_senior_youth,children_youth,montelukast,panic attack,Psychiatric disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
40222444,36416563,5.32E-29,2.44E-21,adult_children_senior_youth,children_youth,denosumab,hypocalcaemia,Metabolism and nutrition disorders,Other drugs affecting bone structure and mineralization,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,DRUGS FOR TREATMENT OF BONE DISEASES,MUSCULO-SKELETAL SYSTEM
1154161,36918936,5.80E-29,2.66E-21,adult_children_senior_youth,children,montelukast,screaming,$General disorders and administration site conditions$Psychiatric disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
904525,35607094,6.83E-29,3.13E-21,adult_children_senior_youth,children,bimatoprost,eyelid irritation,Skin and subcutaneous tissue disorders,Prostaglandin analogues,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,OPHTHALMOLOGICALS,SENSORY ORGANS
1305058,36718298,7.09E-29,3.25E-21,adult_children_senior_youth,youth,methotrexate,aphasia,Nervous system disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1119119,36516824,7.20E-29,3.31E-21,adult_children_senior_youth,senior,adalimumab,osteoarthritis,Musculoskeletal and connective tissue disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1589505,36718141,7.61E-29,3.49E-21,adult_children_youth,adult,levonorgestrel,migraine,Vascular disorders,"$Progestogens and estrogens, sequential preparations$Emergency contraceptives$Progestogens$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations",$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1395557,36110852,8.19E-29,3.76E-21,adult_children_senior_youth,children_youth,fludarabine,adenovirus infection,Infections and infestations,Purine analogues,ANTIMETABOLITES,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1332418,36416485,8.84E-29,4.06E-21,adult_children_senior_youth,children_youth,amlodipine,lactic acidosis,Metabolism and nutrition disorders,"$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$Beta blocking agents and calcium channel blockers$Dihydropyridine derivatives$ACE inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$Calcium channel blockers and diuretics$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs), other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers","$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS$ACE INHIBITORS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$CALCIUM CHANNEL BLOCKERS AND DIURETICS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$BETA BLOCKING AGENTS$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1518254,36416637,9.19E-29,4.22E-21,adult_children_senior_youth,children,dexamethasone,hypertriglyceridaemia,Metabolism and nutrition disorders,"$Corticosteroids$Corticosteroids, moderately potent, other combinations$Corticosteroids$Corticosteroids, combinations for treatment of acne$Corticosteroids/antiinfectives/mydriatics in combination$Corticosteroids and antiinfectives in combination$Corticosteroids and antiinfectives in combination$Corticosteroids$Corticosteroids and antiinfectives in combination$Corticosteroids, moderately potent, combinations with antibiotics$Glucocorticoids$Corticosteroids, plain$Corticosteroids for local oral treatment$Corticosteroids$Corticosteroids, moderately potent (group II)$Corticosteroids","$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$CORTICOSTEROIDS, OTHER COMBINATIONS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$ANTIINFLAMMATORY AGENTS$STOMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS$CORTICOSTEROIDS, PLAIN$CORTICOSTEROIDS","$NASAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$NASAL PREPARATIONS$ANTI-ACNE PREPARATIONS$OPHTHALMOLOGICALS$OTOLOGICALS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$VASOPROTECTIVES$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS FOR SYSTEMIC USE$OPHTHALMOLOGICALS$STOMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OTOLOGICALS","$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$DERMATOLOGICALS$SENSORY ORGANS$SENSORY ORGANS$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS$DERMATOLOGICALS$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$SENSORY ORGANS$DERMATOLOGICALS$SENSORY ORGANS"
1103640,35809310,1.04E-28,4.78E-21,adult_children_senior_youth,youth,methadone,drug interaction,General disorders and administration site conditions,$Drugs used in opioid dependence$Diphenylpropylamine derivatives,$DRUGS USED IN ADDICTIVE DISORDERS$OPIOIDS,$OTHER NERVOUS SYSTEM DRUGS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
1383815,35205164,1.08E-28,4.96E-21,adult_children_senior,adult,isosorbide,coronary artery disease,Vascular disorders,0,0,0,0
1344905,35809361,1.11E-28,5.11E-21,adult_children_senior_youth,youth,carboplatin,treatment failure,General disorders and administration site conditions,Platinum compounds,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
711584,36718530,1.13E-28,5.19E-21,adult_children_senior_youth,children_youth,levetiracetam,epilepsy,Nervous system disorders,Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
43526465,36110369,1.31E-28,6.00E-21,adult_children_senior,children,canagliflozin,fungal infection,Infections and infestations,$Combinations of oral blood glucose lowering drugs$Sodium-glucose co-transporter 2 (SGLT2) inhibitors,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
967823,37219907,1.40E-28,6.43E-21,adult_children_senior_youth,children_youth,sodium chloride,cough,"Respiratory, thoracic and mediastinal disorders",$Electrolyte solutions$Salt solutions$Sodium,$I.V. SOLUTION ADDITIVES$IRRIGATING SOLUTIONS$OTHER MINERAL SUPPLEMENTS,$BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS$BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS$MINERAL SUPPLEMENTS,$BLOOD AND BLOOD FORMING ORGANS$BLOOD AND BLOOD FORMING ORGANS$ALIMENTARY TRACT AND METABOLISM
1333357,36314622,1.64E-28,7.54E-21,adult_children_senior_youth,senior,busulfan,cytomegalovirus test positive,Investigations,Alkyl sulfonates,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
757688,42889640,1.67E-28,7.68E-21,adult_children_youth,adult_youth,aripiprazole,maternal exposure during pregnancy,"Injury, poisoning and procedural complications",Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1036525,37320257,1.68E-28,7.70E-21,adult_children_senior_youth,children_youth,sulfur,acne,Skin and subcutaneous tissue disorders,0,0,0,0
735979,36211492,1.77E-28,8.14E-21,adult_children_senior_youth,youth,risperidone,intentional overdose,"Injury, poisoning and procedural complications",Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1351541,35808984,1.97E-28,9.04E-21,adult_children_senior,children,leuprolide,injection site induration,General disorders and administration site conditions,$Gonadotropin releasing hormone analogues$Gonadotropin releasing hormone analogues,$HORMONES AND RELATED AGENTS$HORMONES AND RELATED AGENTS,$ENDOCRINE THERAPY$ENDOCRINE THERAPY,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1112807,35205185,2.24E-28,1.03E-20,adult_children_senior_youth,adult,aspirin,chest pain,"Respiratory, thoracic and mediastinal disorders",0,0,0,0
950637,36009892,2.33E-28,1.07E-20,adult_children_senior_youth,children,tacrolimus,acute graft versus host disease in skin,"Injury, poisoning and procedural complications","$Agents for dermatitis, excluding corticosteroids$Calcineurin inhibitors",$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$DERMATOLOGICALS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1305058,42890355,2.42E-28,1.11E-20,adult_children_senior_youth,children,methotrexate,posterior reversible encephalopathy syndrome,Nervous system disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
785649,37019330,2.56E-28,1.18E-20,adult_youth,youth,ketamine,hydronephrosis,Renal and urinary disorders,Other general anesthetics,"ANESTHETICS, GENERAL",ANESTHETICS,NERVOUS SYSTEM
1636780,43053920,2.66E-28,1.22E-20,adult_children_senior_youth,children,testosterone,accidental exposure to product,"Injury, poisoning and procedural complications",$3-oxoandrosten (4) derivatives$Androgens and estrogens,$ANDROGENS$ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1154343,36211303,2.72E-28,1.25E-20,adult_children_senior_youth,youth,albuterol,injury,"Injury, poisoning and procedural complications",0,0,0,0
1150871,35205037,2.73E-28,1.25E-20,adult_senior_youth,youth,misoprostol,syncope,Cardiac disorders,$Prostaglandins$Prostaglandins$Propionic acid derivatives,"$UTEROTONICS$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$DRUGS FOR ACID RELATED DISORDERS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$ALIMENTARY TRACT AND METABOLISM$MUSCULO-SKELETAL SYSTEM
1151789,35708156,2.95E-28,1.36E-20,adult_children_senior_youth,children,etanercept,abdominal pain upper,Gastrointestinal disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
19035344,37019425,3.05E-28,1.40E-20,adult_senior_youth,youth,phenprocoumon,haematuria,Reproductive system and breast disorders,Vitamin K antagonists,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1589505,36818729,3.09E-28,1.42E-20,adult_children_youth,children,levonorgestrel,premature baby,"Pregnancy, puerperium and perinatal conditions","$Progestogens and estrogens, sequential preparations$Emergency contraceptives$Progestogens$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations",$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1836948,36009738,3.18E-28,1.46E-20,adult_senior_youth,senior,tetracycline,drug hypersensitivity,Immune system disorders,$Antiinfectives$Combinations for eradication of Helicobacter pylori$Antiinfectives and antiseptics for local oral treatment$Tetracyclines$Antibiotics$Tetracyclines$Combinations of antibacterials$Antiinfectives$Tetracycline and derivatives$Combinations for eradication of Helicobacter pylori,$ANTIINFECTIVES$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$STOMATOLOGICAL PREPARATIONS$TETRACYCLINES$ANTIINFECTIVES$TETRACYCLINES$COMBINATIONS OF ANTIBACTERIALS$ANTIINFECTIVES$ANTIBIOTICS FOR TOPICAL USE$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),$OTOLOGICALS$DRUGS FOR ACID RELATED DISORDERS$STOMATOLOGICAL PREPARATIONS$ANTIBACTERIALS FOR SYSTEMIC USE$OPHTHALMOLOGICALS$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIBACTERIALS FOR SYSTEMIC USE$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE$DRUGS FOR ACID RELATED DISORDERS,$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ANTIINFECTIVES FOR SYSTEMIC USE$SENSORY ORGANS$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$SENSORY ORGANS$DERMATOLOGICALS$ALIMENTARY TRACT AND METABOLISM
1351541,46276591,3.32E-28,1.52E-20,adult_children_senior,senior,leuprolide,wrong technique in product usage process,"Injury, poisoning and procedural complications",$Gonadotropin releasing hormone analogues$Gonadotropin releasing hormone analogues,$HORMONES AND RELATED AGENTS$HORMONES AND RELATED AGENTS,$ENDOCRINE THERAPY$ENDOCRINE THERAPY,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1149380,35809293,3.54E-28,1.63E-20,adult_children_senior_youth,adult,fluticasone,product taste abnormal,Product issues,"$Glucocorticoids$Corticosteroids, potent (group III)$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Corticosteroids$Corticosteroids","$OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS$CORTICOSTEROIDS, PLAIN$ADRENERGICS, INHALANTS$ADRENERGICS, INHALANTS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE","$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$NASAL PREPARATIONS$NASAL PREPARATIONS",$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1501700,36617310,3.71E-28,1.70E-20,adult_children_senior_youth,children,levothyroxine,neoplasm recurrence,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Thyroid hormones,THYROID PREPARATIONS,THYROID THERAPY,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
19010482,35607320,3.94E-28,1.81E-20,adult_children_senior_youth,senior,cyclosporine,photophobia,Nervous system disorders,$Calcineurin inhibitors$Other ophthalmologicals,$IMMUNOSUPPRESSANTS$OTHER OPHTHALMOLOGICALS,$IMMUNOSUPPRESSANTS$OPHTHALMOLOGICALS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$SENSORY ORGANS
937368,35809361,4.04E-28,1.85E-20,adult_children_senior_youth,senior,infliximab,treatment failure,General disorders and administration site conditions,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1305058,36313524,4.24E-28,1.95E-20,adult_children_senior_youth,children,methotrexate,alanine aminotransferase increased,Investigations,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1366310,35809059,4.26E-28,1.96E-20,adult_senior,senior,goserelin,death,General disorders and administration site conditions,Gonadotropin releasing hormone analogues,HORMONES AND RELATED AGENTS,ENDOCRINE THERAPY,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1500211,36617164,4.52E-28,2.07E-20,adult_senior,senior,medroxyprogesterone,breast cancer in situ,Reproductive system and breast disorders,0,0,0,0
1151789,36211297,5.33E-28,2.45E-20,adult_children_senior_youth,senior,etanercept,fall,"Injury, poisoning and procedural complications",Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
766529,36718265,5.57E-28,2.56E-20,adult_children_senior_youth,children,haloperidol,tremor,Nervous system disorders,Butyrophenone derivatives,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
735979,37219820,5.81E-28,2.67E-20,adult_children_senior_youth,senior,risperidone,pneumonia aspiration,"Respiratory, thoracic and mediastinal disorders",Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
735979,36416535,6.10E-28,2.80E-20,adult_children_senior_youth,children,risperidone,overweight,Metabolism and nutrition disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1103314,37219894,6.17E-28,2.83E-20,adult_children_senior_youth,children,tramadol,respiratory depression,Nervous system disorders,$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Other opioids,$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1124957,36211484,6.40E-28,2.94E-20,adult_children_senior_youth,children,oxycodone,accidental exposure,"Injury, poisoning and procedural complications
",$Natural opium alkaloids$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1311078,35104341,6.95E-28,3.19E-20,adult_children_senior_youth,youth,cytarabine,acute lymphocytic leukaemia recurrent,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",$Pyrimidine analogues$Combinations of antineoplastic agents,$ANTIMETABOLITES$OTHER ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AGENTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1305058,36009833,7.98E-28,3.66E-20,adult_children_senior_youth,adult,methotrexate,rheumatoid arthritis,Immune system disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1133201,36211504,8.87E-28,4.07E-20,adult_senior_youth,senior,buprenorphine,inadequate analgesia,General disorders and administration site conditions,$Drugs used in opioid dependence$Drugs used in opioid dependence$Oripavine derivatives,$DRUGS USED IN ADDICTIVE DISORDERS$DRUGS USED IN ADDICTIVE DISORDERS$OPIOIDS,$OTHER NERVOUS SYSTEM DRUGS$OTHER NERVOUS SYSTEM DRUGS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1760616,42889647,9.13E-28,4.19E-20,adult_senior_youth,youth,quinine,toxicity to various agents,"Injury, poisoning and procedural complications",$Quinine and derivatives$Methanolquinolines,$OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM$ANTIMALARIALS,$OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM$ANTIPROTOZOALS,"$MUSCULO-SKELETAL SYSTEM$ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS"
956874,35205164,9.46E-28,4.34E-20,adult_children_senior,adult,furosemide,coronary artery disease,Vascular disorders,"$High-ceiling diuretics and potassium-sparing agents$Sulfonamides, plain$Sulfonamides$Sulfonamides and potassium in combination","$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$HIGH-CEILING DIURETICS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$HIGH-CEILING DIURETICS",$DIURETICS$DIURETICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$DIURETICS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
996416,36918858,9.97E-28,4.58E-20,adult_children_senior_youth,youth,finasteride,anxiety,Psychiatric disorders,$Other dermatologicals$Alpha-adrenoreceptor antagonists$Testosterone-5-alpha reductase inhibitors,$OTHER DERMATOLOGICAL PREPARATIONS$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,$OTHER DERMATOLOGICAL PREPARATIONS$UROLOGICALS$UROLOGICALS,$DERMATOLOGICALS$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
19010482,36009891,1.03E-27,4.72E-20,adult_children_senior_youth,children,cyclosporine,acute graft versus host disease,"Injury, poisoning and procedural complications",$Calcineurin inhibitors$Other ophthalmologicals,$IMMUNOSUPPRESSANTS$OTHER OPHTHALMOLOGICALS,$IMMUNOSUPPRESSANTS$OPHTHALMOLOGICALS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$SENSORY ORGANS
19041843,36919098,1.05E-27,4.84E-20,adult_children_senior_youth,children_youth,carbocisteine,abnormal behaviour,Psychiatric disorders,Mucolytics,"EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",COUGH AND COLD PREPARATIONS,RESPIRATORY SYSTEM
766814,35809131,1.14E-27,5.22E-20,adult_children_senior_youth,senior,quetiapine,general physical health deterioration,General disorders and administration site conditions,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1305058,35205230,1.33E-27,6.08E-20,adult_children_senior_youth,children,methotrexate,ascites,Gastrointestinal disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
937368,36617945,1.33E-27,6.08E-20,adult_children_senior_youth,senior,infliximab,skin cancer,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1154343,37622465,1.37E-27,6.31E-20,adult_children_senior_youth,youth,albuterol,deep vein thrombosis,Vascular disorders,0,0,0,0
722031,35205094,1.39E-27,6.39E-20,adult_children_senior_youth,children,paroxetine,mitral valve incompetence,Cardiac disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
956874,37019321,1.39E-27,6.38E-20,adult_children_senior_youth,youth,furosemide,renal impairment,Renal and urinary disorders,"$High-ceiling diuretics and potassium-sparing agents$Sulfonamides, plain$Sulfonamides$Sulfonamides and potassium in combination","$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$HIGH-CEILING DIURETICS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$HIGH-CEILING DIURETICS",$DIURETICS$DIURETICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$DIURETICS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
956874,36516765,1.52E-27,6.96E-20,adult_children_senior_youth,youth,furosemide,pain in jaw,Musculoskeletal and connective tissue disorders,"$High-ceiling diuretics and potassium-sparing agents$Sulfonamides, plain$Sulfonamides$Sulfonamides and potassium in combination","$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$HIGH-CEILING DIURETICS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$HIGH-CEILING DIURETICS",$DIURETICS$DIURETICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$DIURETICS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
956874,37219867,1.52E-27,6.97E-20,adult_children_senior_youth,youth,furosemide,pulmonary arterial hypertension,Vascular disorders,"$High-ceiling diuretics and potassium-sparing agents$Sulfonamides, plain$Sulfonamides$Sulfonamides and potassium in combination","$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$HIGH-CEILING DIURETICS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$HIGH-CEILING DIURETICS",$DIURETICS$DIURETICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$DIURETICS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
1192710,35909625,1.56E-27,7.17E-20,adult_children_senior_youth,youth,chlorpheniramine,hepatotoxicity,"Injury, poisoning and procedural complications",$Substituted alkylamines$Substituted alkylamines,$ANTIHISTAMINES FOR SYSTEMIC USE$ANTIHISTAMINES FOR SYSTEMIC USE,$ANTIHISTAMINES FOR SYSTEMIC USE$ANTIHISTAMINES FOR SYSTEMIC USE,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1119119,37622529,1.59E-27,7.29E-20,adult_children_senior_youth,senior,adalimumab,hypertension,Vascular disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
40228152,37219871,1.64E-27,7.53E-20,adult_children_senior_youth,adult_children,dabigatran etexilate,pulmonary embolism,"$Respiratory, thoracic and mediastinal disorders$Vascular disorders",Direct thrombin inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1177480,36009711,1.74E-27,7.98E-20,adult_children_senior_youth,children,ibuprofen,hypersensitivity,Immune system disorders,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
1786621,37219871,1.74E-27,7.99E-20,adult_senior_youth,youth,cefalexin,pulmonary embolism,"$Respiratory, thoracic and mediastinal disorders$Vascular disorders",0,0,0,0
956874,36416501,1.74E-27,8.00E-20,adult_children_senior_youth,children,furosemide,respiratory failure,Metabolism and nutrition disorders,"$High-ceiling diuretics and potassium-sparing agents$Sulfonamides, plain$Sulfonamides$Sulfonamides and potassium in combination","$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$HIGH-CEILING DIURETICS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$HIGH-CEILING DIURETICS",$DIURETICS$DIURETICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$DIURETICS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
753626,36918869,1.75E-27,8.02E-20,adult_children_senior_youth,senior,propofol,fear,Psychiatric disorders,Other general anesthetics,"ANESTHETICS, GENERAL",ANESTHETICS,NERVOUS SYSTEM
1704183,36416574,1.75E-27,8.04E-20,adult_children_senior_youth,senior,lamivudine,hypophosphataemia,Metabolism and nutrition disorders,"$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Nucleoside and nucleotide reverse transcriptase inhibitors",$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS,$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
1336539,36617295,1.80E-27,8.25E-20,adult_senior_youth,youth,sunitinib,malignant neoplasm progression,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Protein kinase inhibitors,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1734104,35809243,1.87E-27,8.57E-20,adult_children_senior_youth,youth,azithromycin,pain,General disorders and administration site conditions,$Combinations of antibacterials$Antibiotics$Macrolides,"$COMBINATIONS OF ANTIBACTERIALS$ANTIINFECTIVES$MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",$ANTIBACTERIALS FOR SYSTEMIC USE$OPHTHALMOLOGICALS$ANTIBACTERIALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$SENSORY ORGANS$ANTIINFECTIVES FOR SYSTEMIC USE
1332418,35205189,2.14E-27,9.82E-20,adult_children_senior_youth,adult,amlodipine,myocardial infarction,Vascular disorders,"$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$Beta blocking agents and calcium channel blockers$Dihydropyridine derivatives$ACE inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$Calcium channel blockers and diuretics$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs), other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers","$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS$ACE INHIBITORS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$CALCIUM CHANNEL BLOCKERS AND DIURETICS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$BETA BLOCKING AGENTS$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1305058,35708154,2.30E-27,1.05E-19,adult_children_senior_youth,children_youth,methotrexate,abdominal pain,Gastrointestinal disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
937368,35708154,2.32E-27,1.06E-19,adult_children_senior_youth,youth,infliximab,abdominal pain,Gastrointestinal disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1310149,35205240,2.53E-27,1.16E-19,adult_children_senior_youth,children_youth,warfarin,cardiac failure,Cardiac disorders,Vitamin K antagonists,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
964339,36110649,2.75E-27,1.26E-19,adult_children_senior_youth,children,sulfasalazine,septic shock,Infections and infestations,$Sulfonamides$Aminosalicylic acid and similar agents,"$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$INTESTINAL ANTIINFLAMMATORY AGENTS","$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",$GENITO URINARY SYSTEM AND SEX HORMONES$ALIMENTARY TRACT AND METABOLISM
43013024,36211297,2.95E-27,1.35E-19,adult_children_senior,children,apixaban,fall,"Injury, poisoning and procedural complications",Direct factor Xa inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1503297,36919236,3.00E-27,1.37E-19,adult_children_senior_youth,youth,metformin,suicide attempt,Psychiatric disorders,$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Biguanides$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
19011440,37219959,3.04E-27,1.39E-19,adult_children_senior_youth,children,everolimus,rhinorrhoea,"Respiratory, thoracic and mediastinal disorders",$Protein kinase inhibitors$Selective immunosuppressants,$OTHER ANTINEOPLASTIC AGENTS$IMMUNOSUPPRESSANTS,$ANTINEOPLASTIC AGENTS$IMMUNOSUPPRESSANTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1119510,36211496,3.13E-27,1.43E-19,adult_children_senior_youth,children,dextromethorphan,overdose,"Injury, poisoning and procedural complications",$Opium alkaloids and derivatives$Other nervous system drugs,"$COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS$OTHER NERVOUS SYSTEM DRUGS",$COUGH AND COLD PREPARATIONS$OTHER NERVOUS SYSTEM DRUGS,$RESPIRATORY SYSTEM$NERVOUS SYSTEM
735979,35506628,3.25E-27,1.49E-19,adult_children_senior_youth,adult,risperidone,hyperglycaemia,Endocrine disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1125315,36919046,3.26E-27,1.50E-19,adult_children_senior_youth,youth,acetaminophen,emotional distress,Psychiatric disorders,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1110410,36211491,3.28E-27,1.51E-19,adult_children_senior_youth,children_youth,morphine,accidental overdose,"Injury, poisoning and procedural complications",$Antipropulsives$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with antispasmodics,$ANTIPROPULSIVES$OPIOIDS$OPIOIDS$OPIOIDS,"$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$ANALGESICS$ANALGESICS$ANALGESICS",$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1350504,35909571,3.47E-27,1.59E-19,adult_children_senior_youth,children,etoposide,venoocclusive liver disease,Hepatobiliary disorders,Podophyllotoxin derivatives,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1539403,35205164,3.92E-27,1.80E-19,adult_children_senior_youth,adult,simvastatin,coronary artery disease,Vascular disorders,"$Dipeptidyl peptidase 4 (DPP-4) inhibitors$HMG CoA reductase inhibitors$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents","$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS",$DRUGS USED IN DIABETES$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS,$ALIMENTARY TRACT AND METABOLISM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1115008,35809071,3.95E-27,1.81E-19,adult_children_senior_youth,children,naproxen,no adverse event,General disorders and administration site conditions,"$Antiinflammatory products for vaginal administration$Antiinflammatory preparations, non-steroids for topical use$Propionic acid derivatives$Propionic acid derivatives$Propionic acid derivatives","$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
750982,36211492,4.19E-27,1.92E-19,adult_children_senior_youth,children,bupropion,intentional overdose,"Injury, poisoning and procedural complications",$Centrally acting antiobesity products$Other antidepressants,"$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$ANTIDEPRESSANTS","$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$PSYCHOANALEPTICS",$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM
1154161,35809139,4.21E-27,1.93E-19,adult_children_senior_youth,children,montelukast,irritability,$General disorders and administration site conditions$Psychiatric disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1124957,36919132,4.27E-27,1.96E-19,adult_children_senior_youth,youth,oxycodone,substance abuse,Psychiatric disorders,$Natural opium alkaloids$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
729855,35809059,4.30E-27,1.97E-19,adult_children_senior_youth,children,botulinum toxin type A,death,General disorders and administration site conditions,0,0,0,0
1353766,35809092,4.30E-27,1.98E-19,adult_children_senior_youth,children,propranolol,peripheral coldness,General disorders and administration site conditions,"$Beta blocking agents, other combinations$Beta blocking agents, non-selective$Beta blocking agents, non-selective, and thiazides","$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS AND THIAZIDES",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1337068,35205029,4.36E-27,2.00E-19,adult_children_senior_youth,youth,ambrisentan,haemoptysis,Cardiac disorders,$Antihypertensives for pulmonary arterial hypertension$Antihypertensives for pulmonary arterial hypertension,$OTHER ANTIHYPERTENSIVES$OTHER ANTIHYPERTENSIVES,$ANTIHYPERTENSIVES$ANTIHYPERTENSIVES,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1151789,36516896,4.78E-27,2.19E-19,adult_children_senior_youth,senior,etanercept,hand deformity,Musculoskeletal and connective tissue disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1518254,35809170,5.28E-27,2.42E-19,adult_children_senior_youth,senior,dexamethasone,unevaluable event,General disorders and administration site conditions,"$Corticosteroids$Corticosteroids, moderately potent, other combinations$Corticosteroids$Corticosteroids, combinations for treatment of acne$Corticosteroids/antiinfectives/mydriatics in combination$Corticosteroids and antiinfectives in combination$Corticosteroids and antiinfectives in combination$Corticosteroids$Corticosteroids and antiinfectives in combination$Corticosteroids, moderately potent, combinations with antibiotics$Glucocorticoids$Corticosteroids, plain$Corticosteroids for local oral treatment$Corticosteroids$Corticosteroids, moderately potent (group II)$Corticosteroids","$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$CORTICOSTEROIDS, OTHER COMBINATIONS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$ANTIINFLAMMATORY AGENTS$STOMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS$CORTICOSTEROIDS, PLAIN$CORTICOSTEROIDS","$NASAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$NASAL PREPARATIONS$ANTI-ACNE PREPARATIONS$OPHTHALMOLOGICALS$OTOLOGICALS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$VASOPROTECTIVES$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS FOR SYSTEMIC USE$OPHTHALMOLOGICALS$STOMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OTOLOGICALS","$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$DERMATOLOGICALS$SENSORY ORGANS$SENSORY ORGANS$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS$DERMATOLOGICALS$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$SENSORY ORGANS$DERMATOLOGICALS$SENSORY ORGANS"
1518254,37622465,5.36E-27,2.46E-19,adult_children_senior_youth,senior,dexamethasone,deep vein thrombosis,Vascular disorders,"$Corticosteroids$Corticosteroids, moderately potent, other combinations$Corticosteroids$Corticosteroids, combinations for treatment of acne$Corticosteroids/antiinfectives/mydriatics in combination$Corticosteroids and antiinfectives in combination$Corticosteroids and antiinfectives in combination$Corticosteroids$Corticosteroids and antiinfectives in combination$Corticosteroids, moderately potent, combinations with antibiotics$Glucocorticoids$Corticosteroids, plain$Corticosteroids for local oral treatment$Corticosteroids$Corticosteroids, moderately potent (group II)$Corticosteroids","$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$CORTICOSTEROIDS, OTHER COMBINATIONS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$ANTIINFLAMMATORY AGENTS$STOMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS$CORTICOSTEROIDS, PLAIN$CORTICOSTEROIDS","$NASAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$NASAL PREPARATIONS$ANTI-ACNE PREPARATIONS$OPHTHALMOLOGICALS$OTOLOGICALS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$VASOPROTECTIVES$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS FOR SYSTEMIC USE$OPHTHALMOLOGICALS$STOMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OTOLOGICALS","$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$DERMATOLOGICALS$SENSORY ORGANS$SENSORY ORGANS$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS$DERMATOLOGICALS$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$SENSORY ORGANS$DERMATOLOGICALS$SENSORY ORGANS"
749910,35204966,5.62E-27,2.58E-19,adult_children_senior_youth,children,carisoprodol,cardiac arrest,Cardiac disorders,$Carbamic acid esters$Carbamic acid esters$Carbamic acid esters,"$MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS$MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS$MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",$MUSCLE RELAXANTS$MUSCLE RELAXANTS$MUSCLE RELAXANTS,$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
1762711,35909517,6.03E-27,2.77E-19,adult_children_senior,senior,ribavirin,hepatic encephalopathy,$Hepatobiliary disorders$Nervous system disorders,Antivirals for treatment of HCV infections,DIRECT ACTING ANTIVIRALS,ANTIVIRALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
1704183,35306159,6.30E-27,2.89E-19,adult_children_senior_youth,senior,lamivudine,fanconi syndrome,Renal and urinary disorders,"$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Nucleoside and nucleotide reverse transcriptase inhibitors",$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS,$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
1524674,35809120,6.44E-27,2.96E-19,adult_children_senior_youth,adult,zoledronic acid,disease progression,General disorders and administration site conditions,"$Bisphosphonates, combinations$Bisphosphonates",$DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION$DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,$DRUGS FOR TREATMENT OF BONE DISEASES$DRUGS FOR TREATMENT OF BONE DISEASES,$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
705944,36718180,6.71E-27,3.08E-19,adult_children_senior_youth,children,methylphenidate,disturbance in attention,Nervous system disorders,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
1119510,36211491,7.01E-27,3.22E-19,adult_children_senior_youth,children,dextromethorphan,accidental overdose,"Injury, poisoning and procedural complications",$Opium alkaloids and derivatives$Other nervous system drugs,"$COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS$OTHER NERVOUS SYSTEM DRUGS",$COUGH AND COLD PREPARATIONS$OTHER NERVOUS SYSTEM DRUGS,$RESPIRATORY SYSTEM$NERVOUS SYSTEM
766814,35809310,8.13E-27,3.73E-19,adult_children_senior_youth,senior,quetiapine,drug interaction,General disorders and administration site conditions,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1717704,36211496,8.71E-27,4.00E-19,adult_children_senior_youth,senior_youth,valacyclovir,overdose,"Injury, poisoning and procedural complications",0,0,0,0
937368,35708124,9.26E-27,4.25E-19,adult_children_senior_youth,youth,infliximab,frequent bowel movements,Gastrointestinal disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1186087,36110649,9.29E-27,4.27E-19,adult_children_senior_youth,children,abatacept,septic shock,Infections and infestations,Selective immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1151789,35808999,9.30E-27,4.27E-19,adult_children_senior_youth,children_youth,etanercept,injection site mass,General disorders and administration site conditions,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
735979,36718500,1.03E-26,4.73E-19,adult_senior_youth,adult,risperidone,neuropathy peripheral,Nervous system disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
785788,35707713,1.03E-26,4.71E-19,adult_children_senior_youth,adult,olanzapine,pancreatitis,Gastrointestinal disorders,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
722031,35205315,1.10E-26,5.04E-19,adult_children_senior,children,paroxetine,cardiomegaly,Cardiac disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1346823,35204953,1.15E-26,5.28E-19,adult_children_senior_youth,senior,carvedilol,atrial fibrillation,Cardiac disorders,"$Alpha and beta blocking agents$Beta blocking agents, other combinations","$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS, OTHER COMBINATIONS",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1114375,35205025,1.20E-26,5.53E-19,adult_children_senior_youth,children,anakinra,dizziness,Cardiac disorders,Interleukin inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1151789,35809054,1.32E-26,6.07E-19,adult_children_senior_youth,children,etanercept,pyrexia,General disorders and administration site conditions,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1710612,35809310,1.33E-26,6.09E-19,adult_children_senior_youth,senior,zidovudine,drug interaction,General disorders and administration site conditions,"$Antivirals for treatment of HIV infections, combinations$Nucleoside and nucleotide reverse transcriptase inhibitors$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations",$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS,$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
1589505,35708187,1.37E-26,6.28E-19,adult_children_senior_youth,children_youth,levonorgestrel,pelvic pain,Gastrointestinal disorders,"$Progestogens and estrogens, sequential preparations$Emergency contraceptives$Progestogens$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations",$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1305058,35809120,1.38E-26,6.33E-19,adult_children_senior_youth,children_youth,methotrexate,disease progression,General disorders and administration site conditions,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1311078,37622529,1.42E-26,6.51E-19,adult_children_senior_youth,children_youth,cytarabine,hypertension,Vascular disorders,$Pyrimidine analogues$Combinations of antineoplastic agents,$ANTIMETABOLITES$OTHER ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AGENTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
950637,42890355,1.61E-26,7.40E-19,adult_children_senior_youth,children,tacrolimus,posterior reversible encephalopathy syndrome,Nervous system disorders,"$Agents for dermatitis, excluding corticosteroids$Calcineurin inhibitors",$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$DERMATOLOGICALS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1312706,35809207,1.72E-26,7.90E-19,adult_children_senior_youth,children,alemtuzumab,mucosal inflammation,General disorders and administration site conditions,Selective immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1112807,35909517,1.77E-26,8.13E-19,adult_senior_youth,youth,aspirin,hepatic encephalopathy,$Hepatobiliary disorders$Nervous system disorders,0,0,0,0
937368,35708073,1.78E-26,8.18E-19,adult_children_senior_youth,children,infliximab,inflammatory bowel disease,Gastrointestinal disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
19003999,37622529,1.80E-26,8.27E-19,adult_children_senior_youth,children,mycophenolate mofetil,hypertension,Vascular disorders,0,0,0,0
1762711,35104306,1.80E-26,8.27E-19,adult_children_senior_youth,children,ribavirin,jaundice,Hepatobiliary disorders,Antivirals for treatment of HCV infections,DIRECT ACTING ANTIVIRALS,ANTIVIRALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
1354860,42889647,1.82E-26,8.34E-19,adult_children_senior_youth,children,flecainide,toxicity to various agents,"Injury, poisoning and procedural complications","Antiarrhythmics, class Ic","ANTIARRHYTHMICS, CLASS I AND III",CARDIAC THERAPY,CARDIOVASCULAR SYSTEM
1786055,35708154,1.83E-26,8.41E-19,adult_children_senior_youth,children,deferasirox,abdominal pain,Gastrointestinal disorders,Iron chelating agents,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,VARIOUS
1308290,36110978,1.99E-26,9.15E-19,adult_children_senior_youth,senior,vincristine,progressive multifocal leukoencephalopathy,Infections and infestations,Vinca alkaloids and analogues,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
915542,37320214,2.06E-26,9.47E-19,adult_senior_youth,youth,brimonidine,rash macular,Skin and subcutaneous tissue disorders,$Other dermatologicals$Sympathomimetics in glaucoma therapy,$OTHER DERMATOLOGICAL PREPARATIONS$ANTIGLAUCOMA PREPARATIONS AND MIOTICS,$OTHER DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS,$DERMATOLOGICALS$SENSORY ORGANS
1548195,36517125,2.17E-26,9.97E-19,adult_senior,senior,estradiol,synovitis,Musculoskeletal and connective tissue disorders,"$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations$Natural and semisynthetic estrogens, plain$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Androgens and estrogens$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, sequential preparations$Androgens and estrogens$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, sequential preparations$Androgens and estrogens$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations$Antiandrogens and estrogens$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Intravaginal contraceptives$Natural and semisynthetic estrogens, plain$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, sequential preparations",$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$ESTROGENS$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$ANTIANDROGENS$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$CONTRACEPTIVES FOR TOPICAL USE$ESTROGENS$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$OTHER GYNECOLOGICALS$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1396131,35708063,2.48E-26,1.14E-18,adult_children_senior_youth,youth,ferrous sulfate,crohn's disease,$Gastrointestinal disorders$Immune system disorders,0,0,0,0
1322184,35205182,2.51E-26,1.15E-18,adult_senior,adult,clopidogrel,angina unstable,Vascular disorders,Platelet aggregation inhibitors excl. heparin,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
40222444,36617295,2.55E-26,1.17E-18,adult_senior_youth,adult,denosumab,malignant neoplasm progression,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Other drugs affecting bone structure and mineralization,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,DRUGS FOR TREATMENT OF BONE DISEASES,MUSCULO-SKELETAL SYSTEM
711584,36919059,2.56E-26,1.17E-18,adult_children_senior_youth,children_youth,levetiracetam,aggression,Psychiatric disorders,Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
1710612,35809068,2.76E-26,1.27E-18,adult_children_youth,youth,zidovudine,stillbirth,General disorders and administration site conditions,"$Antivirals for treatment of HIV infections, combinations$Nucleoside and nucleotide reverse transcriptase inhibitors$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations",$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS,$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
1118084,35205189,2.80E-26,1.29E-18,adult_children_senior_youth,adult,celecoxib,myocardial infarction,Vascular disorders,$Coxibs$Sulfonamides$Other antineoplastic agents,"$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$OTHER ANTINEOPLASTIC AGENTS",$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$ANTINEOPLASTIC AGENTS,$MUSCULO-SKELETAL SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
904525,37320316,3.32E-26,1.52E-18,adult_children_senior_youth,adult,bimatoprost,trichorrhexis,Skin and subcutaneous tissue disorders,Prostaglandin analogues,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,OPHTHALMOLOGICALS,SENSORY ORGANS
1314273,43053923,3.59E-26,1.65E-18,adult_children_senior,children,rituximab,prescribed underdose,"Injury, poisoning and procedural complications",Monoclonal antibodies,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1351541,35809151,3.68E-26,1.69E-18,adult_children_senior_youth,youth,leuprolide,night sweats,Skin and subcutaneous tissue disorders,$Gonadotropin releasing hormone analogues$Gonadotropin releasing hormone analogues,$HORMONES AND RELATED AGENTS$HORMONES AND RELATED AGENTS,$ENDOCRINE THERAPY$ENDOCRINE THERAPY,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
715233,37320197,3.74E-26,1.72E-18,adult_children_senior_youth,youth,baclofen,pruritus,Skin and subcutaneous tissue disorders,Other centrally acting agents,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",MUSCLE RELAXANTS,MUSCULO-SKELETAL SYSTEM
43531966,36009901,4.05E-26,1.86E-18,adult_children_senior_youth,adult_youth,immunoglobulin A,transplant rejection,"Injury, poisoning and procedural complications",0,0,0,0
1314002,35205189,4.32E-26,1.98E-18,adult_children_senior,adult,atenolol,myocardial infarction,Vascular disorders,"$Beta blocking agents, selective, and other diuretics$Beta blocking agents, selective$Beta blocking agents and calcium channel blockers$Beta blocking agents, selective, thiazides and other diuretics$Beta blocking agents, selective, and thiazides$Beta blocking agents, selective, and other diuretics","$BETA BLOCKING AGENTS AND OTHER DIURETICS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS AND OTHER DIURETICS",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
722031,35205025,4.41E-26,2.02E-18,adult_children_senior_youth,youth,paroxetine,dizziness,Cardiac disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1589505,37019401,4.51E-26,2.07E-18,adult_children_youth,youth,levonorgestrel,pollakiuria,Renal and urinary disorders,"$Progestogens and estrogens, sequential preparations$Emergency contraceptives$Progestogens$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations",$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1511646,36211099,4.82E-26,2.21E-18,adult_children_senior_youth,children_youth,pamidronate,femur fracture,"Injury, poisoning and procedural complications",0,0,0,0
753626,36516888,5.19E-26,2.38E-18,adult_children_senior_youth,children_youth,propofol,rhabdomyolysis,Musculoskeletal and connective tissue disorders,Other general anesthetics,"ANESTHETICS, GENERAL",ANESTHETICS,NERVOUS SYSTEM
1125315,42889647,5.65E-26,2.59E-18,adult_children_senior_youth,youth,acetaminophen,toxicity to various agents,"Injury, poisoning and procedural complications",$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
19049105,36416595,5.99E-26,2.75E-18,adult_children_senior_youth,children_youth,potassium chloride,hypokalaemia,Metabolism and nutrition disorders,$Potassium$Electrolyte solutions$Potassium,$POTASSIUM$I.V. SOLUTION ADDITIVES$POTASSIUM,$MINERAL SUPPLEMENTS$BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS$MINERAL SUPPLEMENTS,$ALIMENTARY TRACT AND METABOLISM$BLOOD AND BLOOD FORMING ORGANS$ALIMENTARY TRACT AND METABOLISM
722424,36818729,6.15E-26,2.82E-18,adult_children_youth,children,interferon beta-1a,premature baby,"Pregnancy, puerperium and perinatal conditions",Interferons,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1177480,36009783,6.27E-26,2.88E-18,adult_children_senior_youth,children,ibuprofen,urticaria,Immune system disorders,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
1107830,35809324,6.63E-26,3.04E-18,adult_children_senior_youth,children,loratadine,drug effect delayed,General disorders and administration site conditions,Other antihistamines for systemic use,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,RESPIRATORY SYSTEM
19031397,36009762,6.86E-26,3.15E-18,adult_children_senior_youth,children,dipyrone,angioedema,Immune system disorders,0,0,0,0
1344905,35104877,7.17E-26,3.29E-18,adult_children_senior_youth,youth,carboplatin,febrile neutropenia,General disorders and administration site conditions,Platinum compounds,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
724816,36211297,7.45E-26,3.42E-18,adult_senior,senior,oxazepam,fall,"Injury, poisoning and procedural complications",Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1124957,35104883,7.59E-26,3.48E-18,adult_children_senior_youth,children_senior,oxycodone,neutropenia,Blood and lymphatic system disorders,$Natural opium alkaloids$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1322184,35205179,7.82E-26,3.59E-18,adult_children_senior,adult,clopidogrel,acute coronary syndrome,Vascular disorders,Platelet aggregation inhibitors excl. heparin,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1336926,36312382,7.98E-26,3.66E-18,adult_senior_youth,adult,tadalafil,blood testosterone decreased,Investigations,$Drugs used in erectile dysfunction$Antihypertensives for pulmonary arterial hypertension,$UROLOGICALS$OTHER ANTIHYPERTENSIVES,$UROLOGICALS$ANTIHYPERTENSIVES,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
937368,36617300,8.04E-26,3.69E-18,adult_children_senior_youth,senior,infliximab,neoplasm malignant,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1760616,35809059,8.19E-26,3.76E-18,adult_children_senior_youth,children,quinine,death,General disorders and administration site conditions,$Quinine and derivatives$Methanolquinolines,$OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM$ANTIMALARIALS,$OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM$ANTIPROTOZOALS,"$MUSCULO-SKELETAL SYSTEM$ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS"
1119119,36110597,8.54E-26,3.92E-18,adult_children_senior_youth,senior,adalimumab,pneumonia,Infections and infestations,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
705103,36211492,9.10E-26,4.18E-18,adult_children_senior_youth,youth,lamotrigine,intentional overdose,"Injury, poisoning and procedural complications",Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
923645,36211303,9.81E-26,4.50E-18,adult_children_senior_youth,youth,omeprazole,injury,"Injury, poisoning and procedural complications",$Proton pump inhibitors$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori,$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1307863,37622449,1.05E-25,4.81E-18,adult_children_senior_youth,children_youth,verapamil,hypotension,Vascular disorders,$ACE inhibitors and calcium channel blockers$Phenylalkylamine derivatives$Phenylalkylamine derivatives,"$ACE INHIBITORS, COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$CALCIUM CHANNEL BLOCKERS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1550023,36211465,1.26E-25,5.77E-18,adult_children_senior_youth,children,insulin lispro,incorrect dose administered,"Injury, poisoning and procedural complications","$Insulins and analogues for injection, intermediate-acting$Insulins and analogues for injection, fast-acting$Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting",$INSULINS AND ANALOGUES$INSULINS AND ANALOGUES$INSULINS AND ANALOGUES,$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
948078,36718323,1.30E-25,5.95E-18,adult_children_senior_youth,children_youth,pantoprazole,sopor,Nervous system disorders,$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Proton pump inhibitors,$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1000560,35204985,1.57E-25,7.19E-18,adult_children_senior_youth,children,ondansetron,ventricular tachycardia,Cardiac disorders,Serotonin (5HT3) antagonists,ANTIEMETICS AND ANTINAUSEANTS,ANTIEMETICS AND ANTINAUSEANTS,ALIMENTARY TRACT AND METABOLISM
1119119,36211297,1.59E-25,7.28E-18,adult_children_senior_youth,senior,adalimumab,fall,"Injury, poisoning and procedural complications",Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1351541,35506587,1.59E-25,7.32E-18,adult_children_youth,youth,leuprolide,menstruation irregular,$Endocrine disorders$Reproductive system and breast disorders,$Gonadotropin releasing hormone analogues$Gonadotropin releasing hormone analogues,$HORMONES AND RELATED AGENTS$HORMONES AND RELATED AGENTS,$ENDOCRINE THERAPY$ENDOCRINE THERAPY,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1717704,36718315,1.62E-25,7.42E-18,adult_children_senior_youth,senior,valacyclovir,depressed level of consciousness,Nervous system disorders,0,0,0,0
1000560,35809243,1.83E-25,8.41E-18,adult_children_senior_youth,youth,ondansetron,pain,General disorders and administration site conditions,Serotonin (5HT3) antagonists,ANTIEMETICS AND ANTINAUSEANTS,ANTIEMETICS AND ANTINAUSEANTS,ALIMENTARY TRACT AND METABOLISM
904525,36211465,1.91E-25,8.78E-18,adult_children_senior_youth,youth,bimatoprost,incorrect dose administered,"Injury, poisoning and procedural complications",Prostaglandin analogues,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,OPHTHALMOLOGICALS,SENSORY ORGANS
984232,35809059,1.92E-25,8.79E-18,adult_children_senior_youth,senior,isotretinoin,death,General disorders and administration site conditions,$Retinoids for topical use in acne$Retinoids for topical use in acne$Retinoids for treatment of acne,$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE,$ANTI-ACNE PREPARATIONS$ANTI-ACNE PREPARATIONS$ANTI-ACNE PREPARATIONS,$DERMATOLOGICALS$DERMATOLOGICALS$DERMATOLOGICALS
937368,36110708,1.92E-25,8.79E-18,adult_children_senior_youth,senior,infliximab,sinusitis,Infections and infestations,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
19041065,36516909,2.09E-25,9.59E-18,adult_senior,senior,golimumab,sciatica,$Musculoskeletal and connective tissue disorders$Nervous system disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1307046,35204928,2.35E-25,1.08E-17,adult_children_senior_youth,children_youth,metoprolol,bradycardia,Cardiac disorders,"$Beta blocking agents and calcium channel blockers$Beta blocking agents, other combinations$Beta blocking agents, other combinations$Beta blocking agents and calcium channel blockers$Beta blocking agents, selective$Beta blocking agents, selective, and thiazides$Beta blocking agents, selective, and other diuretics$Beta blocking agents, selective, and thiazides","$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS AND OTHER DIURETICS$BETA BLOCKING AGENTS AND THIAZIDES",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1154161,36211496,2.60E-25,1.19E-17,adult_children_senior_youth,children,montelukast,overdose,"Injury, poisoning and procedural complications",$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
19012585,35104103,2.67E-25,1.22E-17,adult_children_senior_youth,adult,asparaginase,bone marrow failure,Blood and lymphatic system disorders,0,0,0,0
1597756,36315380,2.80E-25,1.28E-17,adult_children_senior_youth,adult,glimepiride,weight decreased,Investigations,$Combinations of oral blood glucose lowering drugs$Sulfonylureas$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1310149,36211603,3.09E-25,1.42E-17,adult_children_senior_youth,youth,warfarin,thrombosis in device,$Vascular disorders$Product issues,Vitamin K antagonists,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1343916,35809170,3.17E-25,1.46E-17,adult_children_senior_youth,senior,epinephrine,unevaluable event,General disorders and administration site conditions,"$Other agents for local oral treatment$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Local hemostatics$Adrenergic and dopaminergic agents$Sympathomimetics in glaucoma therapy$Sympathomimetics, plain$Alpha- and beta-adrenoreceptor agonists$Sympathomimetics in glaucoma therapy","$STOMATOLOGICAL PREPARATIONS$ADRENERGICS, INHALANTS$VITAMIN K AND OTHER HEMOSTATICS$CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES$ANTIGLAUCOMA PREPARATIONS AND MIOTICS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ADRENERGICS, INHALANTS$ANTIGLAUCOMA PREPARATIONS AND MIOTICS",$STOMATOLOGICAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$ANTIHEMORRHAGICS$CARDIAC THERAPY$OPHTHALMOLOGICALS$NASAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OPHTHALMOLOGICALS,$ALIMENTARY TRACT AND METABOLISM$RESPIRATORY SYSTEM$BLOOD AND BLOOD FORMING ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$SENSORY ORGANS
1351541,37119548,3.18E-25,1.46E-17,adult_children_senior_youth,youth,leuprolide,menorrhagia,Reproductive system and breast disorders,$Gonadotropin releasing hormone analogues$Gonadotropin releasing hormone analogues,$HORMONES AND RELATED AGENTS$HORMONES AND RELATED AGENTS,$ENDOCRINE THERAPY$ENDOCRINE THERAPY,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1777806,37019460,3.36E-25,1.54E-17,adult_children_senior_youth,children,ceftriaxone,calculus ureteric,0,$Third-generation cephalosporins$Third-generation cephalosporins,$OTHER BETA-LACTAM ANTIBACTERIALS$OTHER BETA-LACTAM ANTIBACTERIALS,$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIBACTERIALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
1305058,35809059,3.49E-25,1.60E-17,adult_children_senior_youth,senior,methotrexate,death,General disorders and administration site conditions,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1518254,35104877,3.53E-25,1.62E-17,adult_children_senior_youth,children,dexamethasone,febrile neutropenia,General disorders and administration site conditions,"$Corticosteroids$Corticosteroids, moderately potent, other combinations$Corticosteroids$Corticosteroids, combinations for treatment of acne$Corticosteroids/antiinfectives/mydriatics in combination$Corticosteroids and antiinfectives in combination$Corticosteroids and antiinfectives in combination$Corticosteroids$Corticosteroids and antiinfectives in combination$Corticosteroids, moderately potent, combinations with antibiotics$Glucocorticoids$Corticosteroids, plain$Corticosteroids for local oral treatment$Corticosteroids$Corticosteroids, moderately potent (group II)$Corticosteroids","$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$CORTICOSTEROIDS, OTHER COMBINATIONS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$ANTIINFLAMMATORY AGENTS$STOMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS$CORTICOSTEROIDS, PLAIN$CORTICOSTEROIDS","$NASAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$NASAL PREPARATIONS$ANTI-ACNE PREPARATIONS$OPHTHALMOLOGICALS$OTOLOGICALS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$VASOPROTECTIVES$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS FOR SYSTEMIC USE$OPHTHALMOLOGICALS$STOMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OTOLOGICALS","$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$DERMATOLOGICALS$SENSORY ORGANS$SENSORY ORGANS$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS$DERMATOLOGICALS$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$SENSORY ORGANS$DERMATOLOGICALS$SENSORY ORGANS"
996416,36919197,3.62E-25,1.66E-17,adult_senior_youth,youth,finasteride,loss of libido,Psychiatric disorders,$Other dermatologicals$Alpha-adrenoreceptor antagonists$Testosterone-5-alpha reductase inhibitors,$OTHER DERMATOLOGICAL PREPARATIONS$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,$OTHER DERMATOLOGICAL PREPARATIONS$UROLOGICALS$UROLOGICALS,$DERMATOLOGICALS$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1177480,36919046,3.81E-25,1.75E-17,adult_children_senior_youth,youth,ibuprofen,emotional distress,Psychiatric disorders,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
722031,36211297,4.35E-25,2.00E-17,adult_children_senior_youth,senior,paroxetine,fall,"Injury, poisoning and procedural complications",Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
745466,36919059,4.36E-25,2.00E-17,adult_children_senior_youth,youth,valproate,aggression,Psychiatric disorders,0,0,0,0
991876,36311923,4.70E-25,2.16E-17,adult_children_senior_youth,youth,loperamide,electrocardiogram qt prolonged,Investigations,$Antipropulsives$Antipropulsives,$ANTIPROPULSIVES$ANTIPROPULSIVES,"$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
996416,37119648,4.78E-25,2.20E-17,adult_senior_youth,youth,finasteride,ejaculation failure,Reproductive system and breast disorders,$Other dermatologicals$Alpha-adrenoreceptor antagonists$Testosterone-5-alpha reductase inhibitors,$OTHER DERMATOLOGICAL PREPARATIONS$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,$OTHER DERMATOLOGICAL PREPARATIONS$UROLOGICALS$UROLOGICALS,$DERMATOLOGICALS$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1354118,35506790,5.23E-25,2.40E-17,adult_children_senior_youth,children_youth,epoprostenol,hyperthyroidism,$Endocrine disorders$Metabolism and nutrition disorders,Platelet aggregation inhibitors excl. heparin,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
750982,36919230,5.28E-25,2.42E-17,adult_children_senior_youth,youth,bupropion,completed suicide,General disorders and administration site conditions,$Centrally acting antiobesity products$Other antidepressants,"$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$ANTIDEPRESSANTS","$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$PSYCHOANALEPTICS",$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM
996416,36718180,5.36E-25,2.46E-17,adult_children_senior_youth,youth,finasteride,disturbance in attention,Nervous system disorders,$Other dermatologicals$Alpha-adrenoreceptor antagonists$Testosterone-5-alpha reductase inhibitors,$OTHER DERMATOLOGICAL PREPARATIONS$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,$OTHER DERMATOLOGICAL PREPARATIONS$UROLOGICALS$UROLOGICALS,$DERMATOLOGICALS$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1503297,37622449,5.37E-25,2.47E-17,adult_children_senior_youth,youth,metformin,hypotension,Vascular disorders,$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Biguanides$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1592085,36919230,5.44E-25,2.50E-17,adult_children_senior_youth,children,lovastatin,completed suicide,General disorders and administration site conditions,$HMG CoA reductase inhibitors$HMG CoA reductase inhibitors in combination with other lipid modifying agents,"$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS",$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1305058,36416637,5.92E-25,2.72E-17,adult_children_senior_youth,children,methotrexate,hypertriglyceridaemia,Metabolism and nutrition disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1322184,37522318,6.38E-25,2.93E-17,adult_children_senior,adult,clopidogrel,coronary artery bypass,Surgical and medical procedures,Platelet aggregation inhibitors excl. heparin,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1305058,36315575,6.51E-25,2.99E-17,adult_children_senior_youth,children_youth,methotrexate,blood creatinine increased,Investigations,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1707687,36918869,6.81E-25,3.13E-17,adult_children_senior_youth,senior,vancomycin,fear,Psychiatric disorders,$Glycopeptide antibacterials$Antibiotics,$OTHER ANTIBACTERIALS$INTESTINAL ANTIINFECTIVES,"$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",$ANTIINFECTIVES FOR SYSTEMIC USE$ALIMENTARY TRACT AND METABOLISM
1738521,35708318,7.00E-25,3.21E-17,adult_children_senior_youth,youth,doxycycline,oesophageal ulcer,Gastrointestinal disorders,$Tetracyclines$Antiinfectives and antiseptics for local oral treatment$Tetracyclines,$TETRACYCLINES$STOMATOLOGICAL PREPARATIONS$TETRACYCLINES,$ANTIBACTERIALS FOR SYSTEMIC USE$STOMATOLOGICAL PREPARATIONS$ANTIBACTERIALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ALIMENTARY TRACT AND METABOLISM$ANTIINFECTIVES FOR SYSTEMIC USE
798874,35204970,7.19E-25,3.30E-17,adult_children_senior_youth,youth,clonazepam,cardio-respiratory arrest,Cardiac disorders,Benzodiazepine derivatives,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
1309944,35204963,7.39E-25,3.39E-17,adult_children_senior_youth,children,amiodarone,supraventricular tachycardia,Cardiac disorders,"Antiarrhythmics, class III","ANTIARRHYTHMICS, CLASS I AND III",CARDIAC THERAPY,CARDIOVASCULAR SYSTEM
907879,35809310,7.47E-25,3.43E-17,adult_children_senior_youth,children_senior,miconazole,drug interaction,General disorders and administration site conditions,$Imidazole derivatives$Imidazole derivatives$Imidazole and triazole derivatives$Imidazole derivatives$Antiinfectives and antiseptics for local oral treatment$Imidazole and triazole derivatives$Antiinfectives$Imidazole derivatives,"$INTESTINAL ANTIINFECTIVES$ANTIMYCOTICS FOR SYSTEMIC USE$ANTIFUNGALS FOR TOPICAL USE$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$STOMATOLOGICAL PREPARATIONS$ANTIFUNGALS FOR TOPICAL USE$ANTIINFECTIVES$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS","$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$ANTIMYCOTICS FOR SYSTEMIC USE$ANTIFUNGALS FOR DERMATOLOGICAL USE$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$STOMATOLOGICAL PREPARATIONS$ANTIFUNGALS FOR DERMATOLOGICAL USE$OTOLOGICALS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",$ALIMENTARY TRACT AND METABOLISM$ANTIINFECTIVES FOR SYSTEMIC USE$DERMATOLOGICALS$GENITO URINARY SYSTEM AND SEX HORMONES$ALIMENTARY TRACT AND METABOLISM$DERMATOLOGICALS$SENSORY ORGANS$GENITO URINARY SYSTEM AND SEX HORMONES
1786621,37622465,7.87E-25,3.61E-17,adult_children_senior_youth,youth,cefalexin,deep vein thrombosis,Vascular disorders,0,0,0,0
964407,36211183,8.35E-25,3.83E-17,adult_children_senior_youth,adult_senior,salicylic acid,poisoning,"Injury, poisoning and procedural complications","$Other antifungals for topical use$Salicylic acid and derivatives$Salicylic acid and derivatives$Antiinflammatory agents, non-steroids",$ANTIFUNGALS FOR TOPICAL USE$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$ANTIINFLAMMATORY AGENTS,$ANTIFUNGALS FOR DERMATOLOGICAL USE$ANALGESICS$ANALGESICS$OPHTHALMOLOGICALS,$DERMATOLOGICALS$NERVOUS SYSTEM$NERVOUS SYSTEM$SENSORY ORGANS
1154161,37420486,8.93E-25,4.10E-17,adult_children_youth,children,montelukast,physical assault,Social circumstances,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1125315,35909625,9.04E-25,4.15E-17,adult_children_senior_youth,children_youth,acetaminophen,hepatotoxicity,"Injury, poisoning and procedural complications",$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1154029,35809243,9.24E-25,4.24E-17,adult_children_senior_youth,adult,fentanyl,pain,General disorders and administration site conditions,$Opioid anesthetics$Phenylpiperidine derivatives$Opioid anesthetics,"$ANESTHETICS, GENERAL$OPIOIDS$ANESTHETICS, GENERAL",$ANESTHETICS$ANALGESICS$ANESTHETICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1106776,35708690,9.33E-25,4.28E-17,adult_children_senior,senior,tiotropium,dry mouth,Gastrointestinal disorders,$Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids$Anticholinergics$Anticholinergics,"$ADRENERGICS, INHALANTS$OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS$OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1539403,36516837,9.87E-25,4.53E-17,adult_children_senior_youth,children,simvastatin,myalgia,Musculoskeletal and connective tissue disorders,"$Dipeptidyl peptidase 4 (DPP-4) inhibitors$HMG CoA reductase inhibitors$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents","$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS",$DRUGS USED IN DIABETES$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS,$ALIMENTARY TRACT AND METABOLISM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
735979,36110597,1.03E-24,4.71E-17,adult_children_senior_youth,senior,risperidone,pneumonia,Infections and infestations,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
964407,37320212,1.04E-24,4.79E-17,adult_children_senior_youth,children_youth,salicylic acid,rash,Skin and subcutaneous tissue disorders,"$Other antifungals for topical use$Salicylic acid and derivatives$Salicylic acid and derivatives$Antiinflammatory agents, non-steroids",$ANTIFUNGALS FOR TOPICAL USE$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$ANTIINFLAMMATORY AGENTS,$ANTIFUNGALS FOR DERMATOLOGICAL USE$ANALGESICS$ANALGESICS$OPHTHALMOLOGICALS,$DERMATOLOGICALS$NERVOUS SYSTEM$NERVOUS SYSTEM$SENSORY ORGANS
735979,35809104,1.05E-24,4.81E-17,adult_children_senior_youth,senior,risperidone,gait disturbance,General disorders and administration site conditions,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
19003999,36516909,1.08E-24,4.97E-17,adult_senior,senior,mycophenolate mofetil,sciatica,$Musculoskeletal and connective tissue disorders$Nervous system disorders,0,0,0,0
984232,36818823,1.20E-24,5.49E-17,adult_children_youth,children,isotretinoin,normal newborn,"Pregnancy, puerperium and perinatal conditions",$Retinoids for topical use in acne$Retinoids for topical use in acne$Retinoids for treatment of acne,$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE,$ANTI-ACNE PREPARATIONS$ANTI-ACNE PREPARATIONS$ANTI-ACNE PREPARATIONS,$DERMATOLOGICALS$DERMATOLOGICALS$DERMATOLOGICALS
1547504,35205164,1.24E-24,5.67E-17,adult_senior,adult,rosiglitazone,coronary artery disease,Vascular disorders,$Combinations of oral blood glucose lowering drugs$Thiazolidinediones$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1310317,43562827,1.26E-24,5.78E-17,adult_children_senior_youth,senior,cyclophosphamide,pneumocystis jirovecii pneumonia,Infections and infestations,Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
974166,35204928,1.31E-24,6.00E-17,adult_children_senior_youth,youth,hydrochlorothiazide,bradycardia,Cardiac disorders,"$ACE inhibitors, other combinations$Thiazides, combinations with other drugs$Thiazides and potassium in combination$Angiotensin II receptor blockers (ARBs), other combinations$Low-ceiling diuretics and potassium-sparing agents$Angiotensin II receptor blockers (ARBs), other combinations$Renin-inhibitors$Sulfonamides$Angiotensin II receptor blockers (ARBs), other combinations$Thiazides, plain$Renin-inhibitors","$ACE INHIBITORS, COMBINATIONS$LOW-CEILING DIURETICS, THIAZIDES$LOW-CEILING DIURETICS, THIAZIDES$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LOW-CEILING DIURETICS, THIAZIDES$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$DIURETICS$DIURETICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$DIURETICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$DIURETICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
735979,35809310,1.37E-24,6.28E-17,adult_children_senior_youth,senior,risperidone,drug interaction,General disorders and administration site conditions,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1305058,35104243,1.44E-24,6.59E-17,adult_children_senior_youth,children,methotrexate,epstein-barr virus associated lymphoproliferative disorder,Infections and infestations,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1763204,36718540,1.47E-24,6.73E-17,adult_children_senior_youth,senior,rifampicin,status epilepticus,Nervous system disorders,$Combinations of drugs for treatment of tuberculosis$Antibiotics$Combinations of drugs for treatment of tuberculosis$Combinations of drugs for treatment of tuberculosis$Combinations of drugs for treatment of tuberculosis,$DRUGS FOR TREATMENT OF TUBERCULOSIS$DRUGS FOR TREATMENT OF TUBERCULOSIS$DRUGS FOR TREATMENT OF TUBERCULOSIS$DRUGS FOR TREATMENT OF TUBERCULOSIS$DRUGS FOR TREATMENT OF TUBERCULOSIS,$ANTIMYCOBACTERIALS$ANTIMYCOBACTERIALS$ANTIMYCOBACTERIALS$ANTIMYCOBACTERIALS$ANTIMYCOBACTERIALS,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
1151789,36416551,1.50E-24,6.91E-17,adult_children_senior_youth,senior,etanercept,osteoporosis,$Metabolism and nutrition disorders$Musculoskeletal and connective tissue disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1326303,35205268,1.55E-24,7.12E-17,adult_children_senior_youth,youth,digoxin,right ventricular failure,Cardiac disorders,Digitalis glycosides,CARDIAC GLYCOSIDES,CARDIAC THERAPY,CARDIOVASCULAR SYSTEM
1305058,36211491,1.58E-24,7.25E-17,adult_children_senior_youth,children_senior,methotrexate,accidental overdose,"Injury, poisoning and procedural complications",$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1201620,42889647,1.62E-24,7.45E-17,adult_children_senior_youth,youth,codeine,toxicity to various agents,"Injury, poisoning and procedural complications",$Natural opium alkaloids$Opium alkaloids and derivatives$Natural opium alkaloids$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,"$OPIOIDS$COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS",$ANALGESICS$COUGH AND COLD PREPARATIONS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
40228152,37622465,1.66E-24,7.61E-17,adult_children_senior_youth,adult_children,dabigatran etexilate,deep vein thrombosis,Vascular disorders,Direct thrombin inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
785649,36009757,1.75E-24,8.02E-17,adult_senior_youth,senior,ketamine,anaphylactic shock,Immune system disorders,Other general anesthetics,"ANESTHETICS, GENERAL",ANESTHETICS,NERVOUS SYSTEM
1521987,43053808,1.87E-24,8.60E-17,adult_children_senior_youth,adult,teriparatide,injection site bruising,General disorders and administration site conditions,Parathyroid hormones and analogues,PARATHYROID HORMONES AND ANALOGUES,CALCIUM HOMEOSTASIS,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
1124957,36009738,1.88E-24,8.61E-17,adult_children_senior_youth,senior,oxycodone,drug hypersensitivity,Immune system disorders,$Natural opium alkaloids$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1336926,35205029,1.90E-24,8.72E-17,adult_children_senior_youth,children_youth,tadalafil,haemoptysis,Cardiac disorders,$Drugs used in erectile dysfunction$Antihypertensives for pulmonary arterial hypertension,$UROLOGICALS$OTHER ANTIHYPERTENSIVES,$UROLOGICALS$ANTIHYPERTENSIVES,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
950637,36009740,2.00E-24,9.20E-17,adult_children_youth,children,tacrolimus,food allergy,Immune system disorders,"$Agents for dermatitis, excluding corticosteroids$Calcineurin inhibitors",$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$DERMATOLOGICALS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1303425,36718510,2.02E-24,9.29E-17,adult_senior,senior,tranexamic acid,grand mal convulsion,0,Amino acids,ANTIFIBRINOLYTICS,ANTIHEMORRHAGICS,BLOOD AND BLOOD FORMING ORGANS
970250,37219868,2.03E-24,9.30E-17,adult_children_senior_youth,children_youth,spironolactone,pulmonary hypertension,Vascular disorders,Aldosterone antagonists,POTASSIUM-SPARING AGENTS,DIURETICS,CARDIOVASCULAR SYSTEM
1344905,35607096,2.40E-24,1.10E-16,adult_children_senior,children,carboplatin,eyelid oedema,Immune system disorders,Platinum compounds,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1308290,36110419,2.40E-24,1.10E-16,adult_children_senior_youth,adult,vincristine,pneumocystis jiroveci pneumonia,0,Vinca alkaloids and analogues,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
956874,37019455,3.08E-24,1.41E-16,adult_children_senior_youth,children,furosemide,nephrocalcinosis,Renal and urinary disorders,"$High-ceiling diuretics and potassium-sparing agents$Sulfonamides, plain$Sulfonamides$Sulfonamides and potassium in combination","$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$HIGH-CEILING DIURETICS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$HIGH-CEILING DIURETICS",$DIURETICS$DIURETICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$DIURETICS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
1338512,42890655,3.84E-24,1.76E-16,adult_senior,adult,doxorubicin,psychological trauma,Psychiatric disorders,Anthracyclines and related substances,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
766814,36110736,3.99E-24,1.83E-16,adult_children_senior_youth,senior,quetiapine,urinary tract infection,Infections and infestations,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
19010482,43053920,4.51E-24,2.07E-16,adult_senior,senior,cyclosporine,accidental exposure to product,"Injury, poisoning and procedural complications",$Calcineurin inhibitors$Other ophthalmologicals,$IMMUNOSUPPRESSANTS$OTHER OPHTHALMOLOGICALS,$IMMUNOSUPPRESSANTS$OPHTHALMOLOGICALS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$SENSORY ORGANS
1710612,36818729,4.68E-24,2.15E-16,adult_children_youth,children,zidovudine,premature baby,"Pregnancy, puerperium and perinatal conditions","$Antivirals for treatment of HIV infections, combinations$Nucleoside and nucleotide reverse transcriptase inhibitors$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations",$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS,$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
904453,35809243,4.83E-24,2.22E-16,adult_children_senior_youth,youth,esomeprazole,pain,General disorders and administration site conditions,$Combinations for eradication of Helicobacter pylori$Proton pump inhibitors$Propionic acid derivatives,"$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$MUSCULO-SKELETAL SYSTEM
19010482,36110874,5.10E-24,2.34E-16,adult_children_senior_youth,children_youth,cyclosporine,cytomegalovirus infection,Infections and infestations,$Calcineurin inhibitors$Other ophthalmologicals,$IMMUNOSUPPRESSANTS$OTHER OPHTHALMOLOGICALS,$IMMUNOSUPPRESSANTS$OPHTHALMOLOGICALS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$SENSORY ORGANS
1332418,35205164,5.45E-24,2.50E-16,adult_senior_youth,adult,amlodipine,coronary artery disease,Vascular disorders,"$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$Beta blocking agents and calcium channel blockers$Dihydropyridine derivatives$ACE inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$Calcium channel blockers and diuretics$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs), other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers","$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS$ACE INHIBITORS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$CALCIUM CHANNEL BLOCKERS AND DIURETICS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$BETA BLOCKING AGENTS$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
711584,36818833,5.62E-24,2.58E-16,adult_children_youth,youth,levetiracetam,pregnancy,"Pregnancy, puerperium and perinatal conditions",Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
968426,35708073,6.10E-24,2.80E-16,adult_children_senior_youth,children,mesalamine,inflammatory bowel disease,Gastrointestinal disorders,0,0,0,0
19011440,35406310,6.12E-24,2.81E-16,adult_children_senior_youth,children,everolimus,ear infection,Infections and infestations,$Protein kinase inhibitors$Selective immunosuppressants,$OTHER ANTINEOPLASTIC AGENTS$IMMUNOSUPPRESSANTS,$ANTINEOPLASTIC AGENTS$IMMUNOSUPPRESSANTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
722031,36718458,6.29E-24,2.89E-16,adult_children_senior_youth,senior_youth,paroxetine,serotonin syndrome,"Injury, poisoning and procedural complications",Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
797617,43053904,6.35E-24,2.92E-16,adult_children_youth,children,citalopram,exposure during pregnancy,"Injury, poisoning and procedural complications",Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
750982,36516888,6.39E-24,2.93E-16,adult_children_senior_youth,children,bupropion,rhabdomyolysis,Musculoskeletal and connective tissue disorders,$Centrally acting antiobesity products$Other antidepressants,"$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$ANTIDEPRESSANTS","$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$PSYCHOANALEPTICS",$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM
735979,36416501,6.49E-24,2.98E-16,adult_children_senior_youth,senior,risperidone,respiratory failure,Metabolism and nutrition disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1325363,35809059,6.59E-24,3.03E-16,adult_children_senior_youth,senior,erlotinib,death,General disorders and administration site conditions,Protein kinase inhibitors,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
723013,35204970,6.73E-24,3.09E-16,adult_children_senior_youth,youth,diazepam,cardio-respiratory arrest,Cardiac disorders,Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1154161,37622529,7.68E-24,3.53E-16,adult_children_senior_youth,adult_senior,montelukast,hypertension,Vascular disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
43526465,36110466,7.90E-24,3.63E-16,adult_children_senior,adult,canagliflozin,osteomyelitis,Infections and infestations,$Combinations of oral blood glucose lowering drugs$Sodium-glucose co-transporter 2 (SGLT2) inhibitors,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
991876,35204948,7.97E-24,3.66E-16,adult_children_senior_youth,youth,loperamide,tachycardia,Cardiac disorders,$Antipropulsives$Antipropulsives,$ANTIPROPULSIVES$ANTIPROPULSIVES,"$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1305058,36718404,8.41E-24,3.86E-16,adult_children_senior_youth,children_youth,methotrexate,palmar-plantar erythrodysaesthesia syndrome,Nervous system disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
974166,35205246,8.72E-24,4.00E-16,adult_children_senior_youth,youth,hydrochlorothiazide,cardiogenic shock,Vascular disorders,"$ACE inhibitors, other combinations$Thiazides, combinations with other drugs$Thiazides and potassium in combination$Angiotensin II receptor blockers (ARBs), other combinations$Low-ceiling diuretics and potassium-sparing agents$Angiotensin II receptor blockers (ARBs), other combinations$Renin-inhibitors$Sulfonamides$Angiotensin II receptor blockers (ARBs), other combinations$Thiazides, plain$Renin-inhibitors","$ACE INHIBITORS, COMBINATIONS$LOW-CEILING DIURETICS, THIAZIDES$LOW-CEILING DIURETICS, THIAZIDES$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LOW-CEILING DIURETICS, THIAZIDES$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$DIURETICS$DIURETICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$DIURETICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$DIURETICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1307046,35205181,9.04E-24,4.15E-16,adult_children_senior,adult,metoprolol,angina pectoris,Vascular disorders,"$Beta blocking agents and calcium channel blockers$Beta blocking agents, other combinations$Beta blocking agents, other combinations$Beta blocking agents and calcium channel blockers$Beta blocking agents, selective$Beta blocking agents, selective, and thiazides$Beta blocking agents, selective, and other diuretics$Beta blocking agents, selective, and thiazides","$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS AND OTHER DIURETICS$BETA BLOCKING AGENTS AND THIAZIDES",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
797617,37219893,9.22E-24,4.23E-16,adult_children_senior_youth,youth,citalopram,respiratory arrest,"Respiratory, thoracic and mediastinal disorders",Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
735979,35506622,1.02E-23,4.67E-16,adult_children_senior_youth,adult,risperidone,type 2 diabetes mellitus,Endocrine disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1151789,35506459,1.03E-23,4.75E-16,adult_children_senior,children,etanercept,adrenal insufficiency,$Endocrine disorders$Metabolism and nutrition disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1305058,35708208,1.04E-23,4.79E-16,adult_children_senior_youth,children,methotrexate,vomiting,Gastrointestinal disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
967823,35708663,1.10E-23,5.03E-16,adult_children_senior_youth,adult,sodium chloride,peritonitis,$Gastrointestinal disorders$Infections and infestations,$Electrolyte solutions$Salt solutions$Sodium,$I.V. SOLUTION ADDITIVES$IRRIGATING SOLUTIONS$OTHER MINERAL SUPPLEMENTS,$BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS$BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS$MINERAL SUPPLEMENTS,$BLOOD AND BLOOD FORMING ORGANS$BLOOD AND BLOOD FORMING ORGANS$ALIMENTARY TRACT AND METABOLISM
1167322,35909571,1.13E-23,5.17E-16,adult_children_senior_youth,youth,allopurinol,venoocclusive liver disease,Hepatobiliary disorders,$Preparations inhibiting uric acid production$Preparations inhibiting uric acid production,$ANTIGOUT PREPARATIONS$ANTIGOUT PREPARATIONS,$ANTIGOUT PREPARATIONS$ANTIGOUT PREPARATIONS,$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
766529,36919232,1.20E-23,5.50E-16,adult_children_senior_youth,youth,haloperidol,self injurious behaviour,0,Butyrophenone derivatives,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1310317,36009891,1.30E-23,5.97E-16,adult_children_senior_youth,children_youth,cyclophosphamide,acute graft versus host disease,"Injury, poisoning and procedural complications",Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
956874,36718323,1.34E-23,6.14E-16,adult_children_senior,senior,furosemide,sopor,Nervous system disorders,"$High-ceiling diuretics and potassium-sparing agents$Sulfonamides, plain$Sulfonamides$Sulfonamides and potassium in combination","$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$HIGH-CEILING DIURETICS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$HIGH-CEILING DIURETICS",$DIURETICS$DIURETICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$DIURETICS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
1112807,36718382,1.37E-23,6.31E-16,adult_children_senior_youth,adult,aspirin,skin burning sensation,Nervous system disorders,0,0,0,0
19100985,35708417,1.40E-23,6.44E-16,adult_children_senior,children,panitumumab,colon cancer,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Monoclonal antibodies,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1151789,35406359,1.52E-23,6.97E-16,adult_children_senior_youth,senior,etanercept,deafness,Ear and labyrinth disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
723013,35204966,1.53E-23,7.04E-16,adult_children_senior_youth,youth,diazepam,cardiac arrest,Cardiac disorders,Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1307046,35205305,1.62E-23,7.42E-16,adult_children_senior_youth,children,metoprolol,atrial septal defect,Cardiac disorders,"$Beta blocking agents and calcium channel blockers$Beta blocking agents, other combinations$Beta blocking agents, other combinations$Beta blocking agents and calcium channel blockers$Beta blocking agents, selective$Beta blocking agents, selective, and thiazides$Beta blocking agents, selective, and other diuretics$Beta blocking agents, selective, and thiazides","$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS AND OTHER DIURETICS$BETA BLOCKING AGENTS AND THIAZIDES",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
907879,37119780,1.66E-23,7.62E-16,adult_children_senior_youth,youth,miconazole,vulvovaginal burning sensation,Reproductive system and breast disorders,$Imidazole derivatives$Imidazole derivatives$Imidazole and triazole derivatives$Imidazole derivatives$Antiinfectives and antiseptics for local oral treatment$Imidazole and triazole derivatives$Antiinfectives$Imidazole derivatives,"$INTESTINAL ANTIINFECTIVES$ANTIMYCOTICS FOR SYSTEMIC USE$ANTIFUNGALS FOR TOPICAL USE$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$STOMATOLOGICAL PREPARATIONS$ANTIFUNGALS FOR TOPICAL USE$ANTIINFECTIVES$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS","$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$ANTIMYCOTICS FOR SYSTEMIC USE$ANTIFUNGALS FOR DERMATOLOGICAL USE$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$STOMATOLOGICAL PREPARATIONS$ANTIFUNGALS FOR DERMATOLOGICAL USE$OTOLOGICALS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",$ALIMENTARY TRACT AND METABOLISM$ANTIINFECTIVES FOR SYSTEMIC USE$DERMATOLOGICALS$GENITO URINARY SYSTEM AND SEX HORMONES$ALIMENTARY TRACT AND METABOLISM$DERMATOLOGICALS$SENSORY ORGANS$GENITO URINARY SYSTEM AND SEX HORMONES
1398937,35607305,1.84E-23,8.44E-16,adult_children_senior_youth,children,clonidine,miosis,Nervous system disorders,$Sympathomimetics in glaucoma therapy$Imidazoline receptor agonists in combination with diuretics$Imidazoline receptor agonists$Other antimigraine preparations$Imidazoline receptor agonists in combination with diuretics,"$ANTIGLAUCOMA PREPARATIONS AND MIOTICS$ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION$ANTIADRENERGIC AGENTS, CENTRALLY ACTING$ANTIMIGRAINE PREPARATIONS$ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",$OPHTHALMOLOGICALS$ANTIHYPERTENSIVES$ANTIHYPERTENSIVES$ANALGESICS$ANTIHYPERTENSIVES,$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$NERVOUS SYSTEM$CARDIOVASCULAR SYSTEM
755695,36919230,1.92E-23,8.84E-16,adult_children_senior_youth,youth,fluoxetine,completed suicide,General disorders and administration site conditions,$Antidepressants in combination with psycholeptics$Selective serotonin reuptake inhibitors,$PSYCHOLEPTICS AND PSYCHOANALEPTICS IN COMBINATION$ANTIDEPRESSANTS,$PSYCHOANALEPTICS$PSYCHOANALEPTICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
1124957,35809076,1.96E-23,9.01E-16,adult_children_senior_youth,senior,oxycodone,fatigue,General disorders and administration site conditions,$Natural opium alkaloids$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1354860,35204912,2.26E-23,1.04E-15,adult_children_senior_youth,children_youth,flecainide,bundle branch block right,Cardiac disorders,"Antiarrhythmics, class Ic","ANTIARRHYTHMICS, CLASS I AND III",CARDIAC THERAPY,CARDIOVASCULAR SYSTEM
937368,35204998,2.28E-23,1.05E-15,adult_children_senior_youth,senior,infliximab,cardiovascular disorder,Cardiac disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1103640,35809243,2.28E-23,1.05E-15,adult_children_senior_youth,senior,methadone,pain,General disorders and administration site conditions,$Drugs used in opioid dependence$Diphenylpropylamine derivatives,$DRUGS USED IN ADDICTIVE DISORDERS$OPIOIDS,$OTHER NERVOUS SYSTEM DRUGS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
1151789,36110649,2.34E-23,1.07E-15,adult_children_senior_youth,children,etanercept,septic shock,Infections and infestations,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
996416,37119584,2.45E-23,1.12E-15,adult_senior_youth,youth,finasteride,penile size reduced,Reproductive system and breast disorders,$Other dermatologicals$Alpha-adrenoreceptor antagonists$Testosterone-5-alpha reductase inhibitors,$OTHER DERMATOLOGICAL PREPARATIONS$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,$OTHER DERMATOLOGICAL PREPARATIONS$UROLOGICALS$UROLOGICALS,$DERMATOLOGICALS$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1314273,37019321,2.53E-23,1.16E-15,adult_children_senior_youth,children_youth,rituximab,renal impairment,Renal and urinary disorders,Monoclonal antibodies,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1177480,37320212,2.58E-23,1.18E-15,adult_children_senior_youth,children,ibuprofen,rash,Skin and subcutaneous tissue disorders,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
735979,36416595,2.59E-23,1.19E-15,adult_children_senior_youth,senior,risperidone,hypokalaemia,Metabolism and nutrition disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1310317,35909577,2.63E-23,1.21E-15,adult_children_senior_youth,senior,cyclophosphamide,hepatitis b,Infections and infestations,Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1501700,36919230,2.75E-23,1.26E-15,adult_children_senior_youth,youth,levothyroxine,completed suicide,General disorders and administration site conditions,Thyroid hormones,THYROID PREPARATIONS,THYROID THERAPY,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
1311078,35104691,3.35E-23,1.54E-15,adult_children_senior_youth,senior,cytarabine,thrombocytopenia,Blood and lymphatic system disorders,$Pyrimidine analogues$Combinations of antineoplastic agents,$ANTIMETABOLITES$OTHER ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AGENTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
781039,36211183,3.36E-23,1.54E-15,adult_children_senior_youth,youth,alprazolam,poisoning,"Injury, poisoning and procedural complications",Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1000560,35104883,3.39E-23,1.56E-15,adult_children_senior_youth,children_senior,ondansetron,neutropenia,Blood and lymphatic system disorders,Serotonin (5HT3) antagonists,ANTIEMETICS AND ANTINAUSEANTS,ANTIEMETICS AND ANTINAUSEANTS,ALIMENTARY TRACT AND METABOLISM
1321636,35205029,3.45E-23,1.58E-15,adult_children_senior_youth,youth,bosentan,haemoptysis,Cardiac disorders,$Sulfonamides$Antihypertensives for pulmonary arterial hypertension,"$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$OTHER ANTIHYPERTENSIVES",$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$ANTIHYPERTENSIVES,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
1718054,35909571,4.41E-23,2.03E-15,adult_children_senior_youth,youth,caspofungin,venoocclusive liver disease,Hepatobiliary disorders,Other antimycotics for systemic use,ANTIMYCOTICS FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
1125315,43053920,4.56E-23,2.09E-15,adult_children_senior_youth,children,acetaminophen,accidental exposure to product,"Injury, poisoning and procedural complications",$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1524674,35809190,4.77E-23,2.19E-15,adult_children_senior_youth,children,zoledronic acid,systemic inflammatory response syndrome,Vascular disorders,"$Bisphosphonates, combinations$Bisphosphonates",$DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION$DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,$DRUGS FOR TREATMENT OF BONE DISEASES$DRUGS FOR TREATMENT OF BONE DISEASES,$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
1308290,35104868,4.83E-23,2.22E-15,adult_children_senior_youth,adult_senior,vincristine,leukopenia,Blood and lymphatic system disorders,Vinca alkaloids and analogues,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1154161,36918948,4.87E-23,2.24E-15,adult_children_senior_youth,children,montelukast,decreased interest,Psychiatric disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
797617,36416600,5.15E-23,2.37E-15,adult_children_senior_youth,senior,citalopram,hyponatraemia,Metabolism and nutrition disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
715939,43053904,5.30E-23,2.43E-15,adult_children_senior_youth,children,escitalopram,exposure during pregnancy,"Injury, poisoning and procedural complications",Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1337068,36311887,5.53E-23,2.54E-15,adult_children_senior_youth,children_youth,ambrisentan,catheterisation cardiac,Investigations,$Antihypertensives for pulmonary arterial hypertension$Antihypertensives for pulmonary arterial hypertension,$OTHER ANTIHYPERTENSIVES$OTHER ANTIHYPERTENSIVES,$ANTIHYPERTENSIVES$ANTIHYPERTENSIVES,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
948078,36617948,5.54E-23,2.55E-15,adult_children_senior_youth,children,pantoprazole,squamous cell carcinoma of skin,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Proton pump inhibitors,$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1314924,36516833,5.70E-23,2.61E-15,adult_children_senior_youth,children,gemcitabine,myositis,Musculoskeletal and connective tissue disorders,Pyrimidine analogues,ANTIMETABOLITES,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1119119,37119745,5.74E-23,2.63E-15,adult_children_senior_youth,adult,adalimumab,vaginal haemorrhage,Reproductive system and breast disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1000560,36211303,5.83E-23,2.67E-15,adult_children_senior_youth,youth,ondansetron,injury,"Injury, poisoning and procedural complications",Serotonin (5HT3) antagonists,ANTIEMETICS AND ANTINAUSEANTS,ANTIEMETICS AND ANTINAUSEANTS,ALIMENTARY TRACT AND METABOLISM
1589505,35708156,6.03E-23,2.77E-15,adult_children_senior_youth,children_youth,levonorgestrel,abdominal pain upper,Gastrointestinal disorders,"$Progestogens and estrogens, sequential preparations$Emergency contraceptives$Progestogens$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations",$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
937368,36416606,6.85E-23,3.14E-15,adult_children_senior_youth,children_youth,infliximab,dehydration,Metabolism and nutrition disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
986417,35708124,7.05E-23,3.24E-15,adult_children_senior_youth,senior,polyethylene glycol 3350,frequent bowel movements,Gastrointestinal disorders,0,0,0,0
1307046,36919230,7.06E-23,3.24E-15,adult_children_senior_youth,children_youth,metoprolol,completed suicide,General disorders and administration site conditions,"$Beta blocking agents and calcium channel blockers$Beta blocking agents, other combinations$Beta blocking agents, other combinations$Beta blocking agents and calcium channel blockers$Beta blocking agents, selective$Beta blocking agents, selective, and thiazides$Beta blocking agents, selective, and other diuretics$Beta blocking agents, selective, and thiazides","$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS AND OTHER DIURETICS$BETA BLOCKING AGENTS AND THIAZIDES",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
753626,36918861,7.21E-23,3.31E-15,adult_children_senior_youth,senior,propofol,stress,Psychiatric disorders,Other general anesthetics,"ANESTHETICS, GENERAL",ANESTHETICS,NERVOUS SYSTEM
1354860,35204904,7.31E-23,3.35E-15,adult_children_senior,children,flecainide,atrioventricular block first degree,Cardiac disorders,"Antiarrhythmics, class Ic","ANTIARRHYTHMICS, CLASS I AND III",CARDIAC THERAPY,CARDIOVASCULAR SYSTEM
1734104,35809131,7.70E-23,3.53E-15,adult_children_senior_youth,youth,azithromycin,general physical health deterioration,General disorders and administration site conditions,$Combinations of antibacterials$Antibiotics$Macrolides,"$COMBINATIONS OF ANTIBACTERIALS$ANTIINFECTIVES$MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",$ANTIBACTERIALS FOR SYSTEMIC USE$OPHTHALMOLOGICALS$ANTIBACTERIALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$SENSORY ORGANS$ANTIINFECTIVES FOR SYSTEMIC USE
937368,36516828,7.71E-23,3.54E-15,adult_children_senior_youth,senior,infliximab,psoriatic arthropathy,$Immune system disorders$Musculoskeletal and connective tissue disorders$Skin and subcutaneous tissue disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
703547,35506609,8.30E-23,3.81E-15,adult_children_senior_youth,adult,trazodone,diabetes mellitus,Endocrine disorders,Other antidepressants,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1119119,35205243,8.35E-23,3.83E-15,adult_senior_youth,senior,adalimumab,cardiac failure congestive,Cardiac disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1305058,35809207,8.66E-23,3.98E-15,adult_children_senior_youth,children,methotrexate,mucosal inflammation,General disorders and administration site conditions,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
44814284,36919230,9.36E-23,4.30E-15,adult_children_senior_youth,children,acetaminophen / oxycodone Extended Release Oral Tablet,completed suicide,General disorders and administration site conditions,0,0,0,0
991876,35204913,9.55E-23,4.39E-15,adult_children_senior_youth,children_youth,loperamide,conduction disorder,Cardiac disorders,$Antipropulsives$Antipropulsives,$ANTIPROPULSIVES$ANTIPROPULSIVES,"$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1125315,35205038,1.02E-22,4.68E-15,adult_children_senior_youth,senior,acetaminophen,dyspnoea,"$Cardiac disorders$Respiratory, thoracic and mediastinal disorders",$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
780442,36919059,1.06E-22,4.85E-15,adult_children_senior_youth,youth,varenicline,aggression,Psychiatric disorders,Drugs used in nicotine dependence,DRUGS USED IN ADDICTIVE DISORDERS,OTHER NERVOUS SYSTEM DRUGS,NERVOUS SYSTEM
1103640,42889647,1.19E-22,5.46E-15,adult_children_senior_youth,youth,methadone,toxicity to various agents,"Injury, poisoning and procedural complications",$Drugs used in opioid dependence$Diphenylpropylamine derivatives,$DRUGS USED IN ADDICTIVE DISORDERS$OPIOIDS,$OTHER NERVOUS SYSTEM DRUGS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
915542,36718382,1.21E-22,5.55E-15,adult_senior_youth,youth,brimonidine,skin burning sensation,Nervous system disorders,$Other dermatologicals$Sympathomimetics in glaucoma therapy,$OTHER DERMATOLOGICAL PREPARATIONS$ANTIGLAUCOMA PREPARATIONS AND MIOTICS,$OTHER DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS,$DERMATOLOGICALS$SENSORY ORGANS
1797155,36313550,1.24E-22,5.68E-15,adult_children_senior_youth,senior,peginterferon alfa-2b,blood bilirubin increased,Investigations,$Interferons$Interferons,$IMMUNOSTIMULANTS$IMMUNOSTIMULANTS,$IMMUNOSTIMULANTS$IMMUNOSTIMULANTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
753626,36918947,1.31E-22,5.99E-15,adult_children_senior_youth,senior,propofol,anhedonia,Psychiatric disorders,Other general anesthetics,"ANESTHETICS, GENERAL",ANESTHETICS,NERVOUS SYSTEM
703547,36718323,1.31E-22,6.00E-15,adult_senior_youth,senior,trazodone,sopor,Nervous system disorders,Other antidepressants,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
956874,36416581,1.34E-22,6.17E-15,adult_children_senior_youth,youth,furosemide,hypochloraemia,Metabolism and nutrition disorders,"$High-ceiling diuretics and potassium-sparing agents$Sulfonamides, plain$Sulfonamides$Sulfonamides and potassium in combination","$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$HIGH-CEILING DIURETICS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$HIGH-CEILING DIURETICS",$DIURETICS$DIURETICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$DIURETICS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
750982,36718288,1.39E-22,6.39E-15,adult_children_senior_youth,children,bupropion,coma,Nervous system disorders,$Centrally acting antiobesity products$Other antidepressants,"$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$ANTIDEPRESSANTS","$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$PSYCHOANALEPTICS",$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM
735979,35809059,1.49E-22,6.82E-15,adult_children_senior_youth,senior,risperidone,death,General disorders and administration site conditions,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1149380,43053848,1.51E-22,6.91E-15,adult_children_senior_youth,adult,fluticasone,drug effect incomplete,General disorders and administration site conditions,"$Glucocorticoids$Corticosteroids, potent (group III)$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Corticosteroids$Corticosteroids","$OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS$CORTICOSTEROIDS, PLAIN$ADRENERGICS, INHALANTS$ADRENERGICS, INHALANTS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE","$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$NASAL PREPARATIONS$NASAL PREPARATIONS",$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1308290,35707713,1.63E-22,7.50E-15,adult_children_senior_youth,youth,vincristine,pancreatitis,Gastrointestinal disorders,Vinca alkaloids and analogues,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1310317,37320313,1.75E-22,8.03E-15,adult_senior,adult,cyclophosphamide,hair texture abnormal,Skin and subcutaneous tissue disorders,Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1715117,45885642,1.77E-22,8.11E-15,adult_children_senior_youth,children_youth,aztreonam,cystic fibrosis respiratory infection suppression,Surgical and medical procedures,Monobactams,OTHER BETA-LACTAM ANTIBACTERIALS,ANTIBACTERIALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
705103,37320212,1.99E-22,9.12E-15,adult_children_senior_youth,youth,lamotrigine,rash,Skin and subcutaneous tissue disorders,Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
785788,36315381,2.04E-22,9.38E-15,adult_children_senior_youth,children_youth,olanzapine,weight increased,Investigations,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
766814,36718301,2.27E-22,1.04E-14,adult_children_senior_youth,senior,quetiapine,confusional state,Nervous system disorders,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
735979,36110642,2.35E-22,1.08E-14,adult_children_senior_youth,senior,risperidone,sepsis,Infections and infestations,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1119119,35809243,2.36E-22,1.08E-14,adult_children_senior_youth,adult,adalimumab,pain,General disorders and administration site conditions,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1358436,35104877,2.41E-22,1.11E-14,adult_children_senior_youth,children,dasatinib,febrile neutropenia,General disorders and administration site conditions,Protein kinase inhibitors,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
729855,36516876,2.41E-22,1.11E-14,adult_children_senior_youth,children_youth,botulinum toxin type A,muscular weakness,Musculoskeletal and connective tissue disorders,0,0,0,0
43013024,37622460,2.43E-22,1.12E-14,adult_children_senior_youth,children,apixaban,thrombosis,Vascular disorders,Direct factor Xa inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
19003999,43053848,2.47E-22,1.13E-14,adult_children_senior_youth,senior,mycophenolate mofetil,drug effect incomplete,General disorders and administration site conditions,0,0,0,0
44507848,35809059,2.53E-22,1.16E-14,adult_children_senior_youth,children,ibrutinib,death,General disorders and administration site conditions,Protein kinase inhibitors,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1177480,35809054,2.67E-22,1.23E-14,adult_children_senior_youth,children,ibuprofen,pyrexia,General disorders and administration site conditions,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
734354,35205025,2.74E-22,1.26E-14,adult_children_senior_youth,children,pregabalin,dizziness,Cardiac disorders,Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
785788,36919236,2.77E-22,1.27E-14,adult_children_senior_youth,youth,olanzapine,suicide attempt,Psychiatric disorders,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
903963,36110649,2.87E-22,1.32E-14,adult_children_senior_youth,children,triamcinolone,septic shock,Infections and infestations,"$Corticosteroids, moderately potent (group II)$Corticosteroids$Glucocorticoids$Corticosteroids, moderately potent, combinations with antiseptics$Corticosteroids for local oral treatment$Glucocorticoids$Corticosteroids, moderately potent, combinations with antibiotics$Corticosteroids, plain$Corticosteroids, moderately potent, other combinations$Corticosteroids and antiinfectives in combination$Corticosteroids","$CORTICOSTEROIDS, PLAIN$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS$CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS$STOMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS, OTHER COMBINATIONS$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE","$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$NASAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$STOMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS FOR SYSTEMIC USE$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OTOLOGICALS$VASOPROTECTIVES","$DERMATOLOGICALS$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$DERMATOLOGICALS$ALIMENTARY TRACT AND METABOLISM$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$DERMATOLOGICALS$SENSORY ORGANS$DERMATOLOGICALS$SENSORY ORGANS$CARDIOVASCULAR SYSTEM"
1332418,37219851,2.91E-22,1.34E-14,adult_senior_youth,youth,amlodipine,non-cardiogenic pulmonary oedema,"Respiratory, thoracic and mediastinal disorders","$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$Beta blocking agents and calcium channel blockers$Dihydropyridine derivatives$ACE inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$Calcium channel blockers and diuretics$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs), other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers","$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS$ACE INHIBITORS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$CALCIUM CHANNEL BLOCKERS AND DIURETICS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$BETA BLOCKING AGENTS$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
735979,35104074,2.92E-22,1.34E-14,adult_children_senior_youth,senior,risperidone,anaemia,Blood and lymphatic system disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1318137,35205255,3.06E-22,1.40E-14,adult_children_senior_youth,youth,nicardipine,acute pulmonary oedema,"Respiratory, thoracic and mediastinal disorders",Dihydropyridine derivatives,SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS,CALCIUM CHANNEL BLOCKERS,CARDIOVASCULAR SYSTEM
1119119,37219804,3.32E-22,1.52E-14,adult_senior,senior,adalimumab,chronic obstructive pulmonary disease,"Respiratory, thoracic and mediastinal disorders",Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1704183,36416549,3.42E-22,1.57E-14,adult_children_senior,senior,lamivudine,osteomalacia,Renal and urinary disorders,"$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations$Nucleoside and nucleotide reverse transcriptase inhibitors",$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS,$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
782043,36211303,3.76E-22,1.73E-14,adult_children_senior_youth,senior,isoflurane,injury,"Injury, poisoning and procedural complications",Halogenated hydrocarbons,"ANESTHETICS, GENERAL",ANESTHETICS,NERVOUS SYSTEM
766529,36211484,3.87E-22,1.78E-14,adult_children_senior_youth,children,haloperidol,accidental exposure,"Injury, poisoning and procedural complications
",Butyrophenone derivatives,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1154161,36919005,3.97E-22,1.82E-14,adult_children,children,montelukast,morbid thoughts,Psychiatric disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
766814,36315381,3.97E-22,1.82E-14,adult_children_senior_youth,children_youth,quetiapine,weight increased,Investigations,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1717704,36718338,4.01E-22,1.84E-14,adult_children_senior_youth,senior,valacyclovir,nervous system disorder,Nervous system disorders,0,0,0,0
974166,36311918,4.25E-22,1.95E-14,adult_senior_youth,youth,hydrochlorothiazide,electrocardiogram qrs complex prolonged,Investigations,"$ACE inhibitors, other combinations$Thiazides, combinations with other drugs$Thiazides and potassium in combination$Angiotensin II receptor blockers (ARBs), other combinations$Low-ceiling diuretics and potassium-sparing agents$Angiotensin II receptor blockers (ARBs), other combinations$Renin-inhibitors$Sulfonamides$Angiotensin II receptor blockers (ARBs), other combinations$Thiazides, plain$Renin-inhibitors","$ACE INHIBITORS, COMBINATIONS$LOW-CEILING DIURETICS, THIAZIDES$LOW-CEILING DIURETICS, THIAZIDES$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LOW-CEILING DIURETICS, THIAZIDES$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$DIURETICS$DIURETICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$DIURETICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$DIURETICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1322184,35204953,4.82E-22,2.21E-14,adult_senior_youth,senior,clopidogrel,atrial fibrillation,Cardiac disorders,Platelet aggregation inhibitors excl. heparin,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1584910,36516930,4.89E-22,2.24E-14,adult_children_senior_youth,youth,somatropin,scoliosis,"Respiratory, thoracic and mediastinal disorders",0,0,0,0
42900250,36617702,5.15E-22,2.37E-14,adult_children_senior,children,enzalutamide,prostate cancer,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Anti-androgens,HORMONE ANTAGONISTS AND RELATED AGENTS,ENDOCRINE THERAPY,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1310317,36009894,5.95E-22,2.73E-14,adult_children_senior_youth,children_youth,cyclophosphamide,chronic graft versus host disease,"Injury, poisoning and procedural complications",Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1149196,35708156,6.01E-22,2.76E-14,adult_children_senior_youth,children,cetirizine,abdominal pain upper,Gastrointestinal disorders,Piperazine derivatives,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,RESPIRATORY SYSTEM
1397599,36416606,6.25E-22,2.87E-14,adult_children_senior_youth,senior,cisplatin,dehydration,Metabolism and nutrition disorders,Platinum compounds,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
785788,36311923,6.56E-22,3.01E-14,adult_children_senior_youth,senior,olanzapine,electrocardiogram qt prolonged,Investigations,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1154161,36919085,6.71E-22,3.08E-14,adult_children_senior_youth,children,montelukast,self esteem decreased,Psychiatric disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1557272,36516751,6.85E-22,3.15E-14,adult_children_senior_youth,children,alendronate,osteosclerosis,Musculoskeletal and connective tissue disorders,0,0,0,0
743670,43053904,7.02E-22,3.22E-14,adult_children_youth,children,venlafaxine,exposure during pregnancy,"Injury, poisoning and procedural complications",Other antidepressants,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
996416,36516840,7.45E-22,3.42E-14,adult_senior_youth,youth,finasteride,muscle atrophy,Musculoskeletal and connective tissue disorders,$Other dermatologicals$Alpha-adrenoreceptor antagonists$Testosterone-5-alpha reductase inhibitors,$OTHER DERMATOLOGICAL PREPARATIONS$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,$OTHER DERMATOLOGICAL PREPARATIONS$UROLOGICALS$UROLOGICALS,$DERMATOLOGICALS$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
970250,37219867,7.55E-22,3.47E-14,adult_children_senior_youth,youth,spironolactone,pulmonary arterial hypertension,Vascular disorders,Aldosterone antagonists,POTASSIUM-SPARING AGENTS,DIURETICS,CARDIOVASCULAR SYSTEM
996416,36312382,8.02E-22,3.68E-14,adult_senior_youth,youth,finasteride,blood testosterone decreased,Investigations,$Other dermatologicals$Alpha-adrenoreceptor antagonists$Testosterone-5-alpha reductase inhibitors,$OTHER DERMATOLOGICAL PREPARATIONS$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,$OTHER DERMATOLOGICAL PREPARATIONS$UROLOGICALS$UROLOGICALS,$DERMATOLOGICALS$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
797617,35204966,9.02E-22,4.14E-14,adult_children_senior_youth,youth,citalopram,cardiac arrest,Cardiac disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1154029,35204928,9.05E-22,4.16E-14,adult_children_senior_youth,children,fentanyl,bradycardia,Cardiac disorders,$Opioid anesthetics$Phenylpiperidine derivatives$Opioid anesthetics,"$ANESTHETICS, GENERAL$OPIOIDS$ANESTHETICS, GENERAL",$ANESTHETICS$ANALGESICS$ANESTHETICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
750982,35809039,9.25E-22,4.25E-14,adult_children_senior_youth,children,bupropion,hyperthermia,General disorders and administration site conditions,$Centrally acting antiobesity products$Other antidepressants,"$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$ANTIDEPRESSANTS","$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$PSYCHOANALEPTICS",$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM
1557272,36211297,9.37E-22,4.30E-14,adult_children_senior_youth,children_senior,alendronate,fall,"Injury, poisoning and procedural complications",0,0,0,0
19010482,35809148,9.42E-22,4.32E-14,adult_children_senior_youth,children_youth,cyclosporine,multi-organ failure,0,$Calcineurin inhibitors$Other ophthalmologicals,$IMMUNOSUPPRESSANTS$OTHER OPHTHALMOLOGICALS,$IMMUNOSUPPRESSANTS$OPHTHALMOLOGICALS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$SENSORY ORGANS
40228152,35204987,9.48E-22,4.35E-14,adult_children_senior,adult_children,dabigatran etexilate,atrial thrombosis,Cardiac disorders,Direct thrombin inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1177480,36918858,9.77E-22,4.48E-14,adult_children_senior_youth,youth,ibuprofen,anxiety,Psychiatric disorders,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
715233,36211297,9.86E-22,4.52E-14,adult_children_senior_youth,senior,baclofen,fall,"Injury, poisoning and procedural complications",Other centrally acting agents,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",MUSCLE RELAXANTS,MUSCULO-SKELETAL SYSTEM
717607,36718458,9.86E-22,4.53E-14,adult_senior_youth,youth,desvenlafaxine,serotonin syndrome,"Injury, poisoning and procedural complications",Other antidepressants,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1322184,36255528,1.00E-21,4.60E-14,adult_children_senior_youth,youth,clopidogrel,vascular stent thrombosis,$General disorders and administration site conditions$Vascular disorders,Platelet aggregation inhibitors excl. heparin,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
19010482,35606946,1.01E-21,4.65E-14,adult_children_senior_youth,senior,cyclosporine,dry eye,Eye disorders,$Calcineurin inhibitors$Other ophthalmologicals,$IMMUNOSUPPRESSANTS$OTHER OPHTHALMOLOGICALS,$IMMUNOSUPPRESSANTS$OPHTHALMOLOGICALS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$SENSORY ORGANS
1115008,36516888,1.05E-21,4.84E-14,adult_children_senior_youth,children,naproxen,rhabdomyolysis,Musculoskeletal and connective tissue disorders,"$Antiinflammatory products for vaginal administration$Antiinflammatory preparations, non-steroids for topical use$Propionic acid derivatives$Propionic acid derivatives$Propionic acid derivatives","$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
1112921,36009700,1.07E-21,4.90E-14,adult_children_senior_youth,youth,ipratropium,asthma,"Respiratory, thoracic and mediastinal disorders",$Anticholinergics$Other nasal preparations$Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids$Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids,"$OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ADRENERGICS, INHALANTS$ADRENERGICS, INHALANTS",$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$NASAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
964407,36718382,1.08E-21,4.94E-14,adult_children_senior_youth,children_youth,salicylic acid,skin burning sensation,Nervous system disorders,"$Other antifungals for topical use$Salicylic acid and derivatives$Salicylic acid and derivatives$Antiinflammatory agents, non-steroids",$ANTIFUNGALS FOR TOPICAL USE$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$ANTIINFLAMMATORY AGENTS,$ANTIFUNGALS FOR DERMATOLOGICAL USE$ANALGESICS$ANALGESICS$OPHTHALMOLOGICALS,$DERMATOLOGICALS$NERVOUS SYSTEM$NERVOUS SYSTEM$SENSORY ORGANS
1328165,35204966,1.12E-21,5.13E-14,adult_children_senior_youth,youth,diltiazem,cardiac arrest,Cardiac disorders,$Benzothiazepine derivatives$Muscle relaxants,$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,$CALCIUM CHANNEL BLOCKERS$VASOPROTECTIVES,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
739138,35205113,1.12E-21,5.13E-14,adult_children_senior,children,sertraline,tricuspid valve incompetence,Cardiac disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
705944,35708093,1.16E-21,5.34E-14,adult_children_senior_youth,senior,methylphenidate,diarrhoea,Gastrointestinal disorders,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
702865,42889647,1.20E-21,5.51E-14,adult_senior_youth,youth,meprobamate,toxicity to various agents,"Injury, poisoning and procedural complications","$Carbamates$Hypnotics and sedatives in combination, excl. barbiturates$Carbamates",$ANXIOLYTICS$HYPNOTICS AND SEDATIVES$ANXIOLYTICS,$PSYCHOLEPTICS$PSYCHOLEPTICS$PSYCHOLEPTICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1167322,43053854,1.28E-21,5.88E-14,adult_children_senior_youth,youth,allopurinol,drug reaction with eosinophilia and systemic symptoms,Immune system disorders,$Preparations inhibiting uric acid production$Preparations inhibiting uric acid production,$ANTIGOUT PREPARATIONS$ANTIGOUT PREPARATIONS,$ANTIGOUT PREPARATIONS$ANTIGOUT PREPARATIONS,$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
1307863,36919230,1.31E-21,5.99E-14,adult_children_senior_youth,children_youth,verapamil,completed suicide,General disorders and administration site conditions,$ACE inhibitors and calcium channel blockers$Phenylalkylamine derivatives$Phenylalkylamine derivatives,"$ACE INHIBITORS, COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$CALCIUM CHANNEL BLOCKERS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1799139,35708208,1.35E-21,6.21E-14,adult_children_senior_youth,children,oseltamivir,vomiting,Gastrointestinal disorders,Neuraminidase inhibitors,DIRECT ACTING ANTIVIRALS,ANTIVIRALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
1397599,35406359,1.42E-21,6.50E-14,adult_children_senior_youth,children,cisplatin,deafness,Ear and labyrinth disorders,Platinum compounds,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1124957,36919047,1.44E-21,6.61E-14,adult_children_senior_youth,youth,oxycodone,euphoric mood,Psychiatric disorders,$Natural opium alkaloids$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1322184,35205190,1.45E-21,6.65E-14,adult_senior,adult,clopidogrel,myocardial ischaemia,Vascular disorders,Platelet aggregation inhibitors excl. heparin,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
766814,36211496,1.47E-21,6.77E-14,adult_children_senior_youth,youth,quetiapine,overdose,"Injury, poisoning and procedural complications","Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
904453,36211303,1.48E-21,6.79E-14,adult_children_senior_youth,youth,esomeprazole,injury,"Injury, poisoning and procedural complications",$Combinations for eradication of Helicobacter pylori$Proton pump inhibitors$Propionic acid derivatives,"$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$MUSCULO-SKELETAL SYSTEM
1307046,37522318,1.49E-21,6.84E-14,adult_children_senior,adult,metoprolol,coronary artery bypass,Surgical and medical procedures,"$Beta blocking agents and calcium channel blockers$Beta blocking agents, other combinations$Beta blocking agents, other combinations$Beta blocking agents and calcium channel blockers$Beta blocking agents, selective$Beta blocking agents, selective, and thiazides$Beta blocking agents, selective, and other diuretics$Beta blocking agents, selective, and thiazides","$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS AND OTHER DIURETICS$BETA BLOCKING AGENTS AND THIAZIDES",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
734354,42889640,1.56E-21,7.18E-14,adult_children_youth,children,pregabalin,maternal exposure during pregnancy,"Injury, poisoning and procedural complications",Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
735979,35506494,1.63E-21,7.49E-14,adult_children_senior_youth,adult,risperidone,diabetic ketoacidosis,$Endocrine disorders$Metabolism and nutrition disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
705944,35809323,1.67E-21,7.68E-14,adult_children_senior_youth,children,methylphenidate,drug effect decreased,General disorders and administration site conditions,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
1114220,43562865,1.74E-21,8.00E-14,adult_senior_youth,adult_youth,naloxone,intentional underdose,"Injury, poisoning and procedural complications",$Peripheral opioid receptor antagonists$Natural opium alkaloids$Antidotes$Natural opium alkaloids,$DRUGS FOR CONSTIPATION$OPIOIDS$ALL OTHER THERAPEUTIC PRODUCTS$OPIOIDS,$DRUGS FOR CONSTIPATION$ANALGESICS$ALL OTHER THERAPEUTIC PRODUCTS$ANALGESICS,$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM$VARIOUS$NERVOUS SYSTEM
1125315,36919098,1.79E-21,8.20E-14,adult_children_senior_youth,children,acetaminophen,abnormal behaviour,Psychiatric disorders,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
40222444,35809120,1.81E-21,8.30E-14,adult_children_senior_youth,adult,denosumab,disease progression,General disorders and administration site conditions,Other drugs affecting bone structure and mineralization,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,DRUGS FOR TREATMENT OF BONE DISEASES,MUSCULO-SKELETAL SYSTEM
1305058,35204970,1.87E-21,8.59E-14,adult_children_senior_youth,children,methotrexate,cardio-respiratory arrest,Cardiac disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1351541,36110597,1.89E-21,8.65E-14,adult_children_senior_youth,senior,leuprolide,pneumonia,Infections and infestations,$Gonadotropin releasing hormone analogues$Gonadotropin releasing hormone analogues,$HORMONES AND RELATED AGENTS$HORMONES AND RELATED AGENTS,$ENDOCRINE THERAPY$ENDOCRINE THERAPY,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1338512,36110978,2.01E-21,9.24E-14,adult_children_senior_youth,senior,doxorubicin,progressive multifocal leukoencephalopathy,Infections and infestations,Anthracyclines and related substances,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1112807,35809086,2.13E-21,9.80E-14,adult_children_senior_youth,adult,aspirin,feeling hot,General disorders and administration site conditions,0,0,0,0
1304643,36313965,2.16E-21,9.92E-14,adult_children_senior_youth,senior,darbepoetin alfa,investigation,Investigations,Other antianemic preparations,OTHER ANTIANEMIC PREPARATIONS,ANTIANEMIC PREPARATIONS,BLOOD AND BLOOD FORMING ORGANS
970250,36110597,2.22E-21,1.02E-13,adult_children_senior_youth,children,spironolactone,pneumonia,Infections and infestations,Aldosterone antagonists,POTASSIUM-SPARING AGENTS,DIURETICS,CARDIOVASCULAR SYSTEM
19035704,36416551,2.25E-21,1.03E-13,adult_children_senior_youth,adult,calcium carbonate,osteoporosis,$Metabolism and nutrition disorders$Musculoskeletal and connective tissue disorders,"$Calcium compounds$Calcium$Ascorbic acid (vitamin C), combinations","$ANTACIDS$CALCIUM$ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS",$DRUGS FOR ACID RELATED DISORDERS$MINERAL SUPPLEMENTS$VITAMINS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
19003999,36009895,2.33E-21,1.07E-13,adult_children_senior_youth,children,mycophenolate mofetil,graft versus host disease,"Injury, poisoning and procedural complications",0,0,0,0
1312706,36110874,2.35E-21,1.08E-13,adult_children_senior_youth,children,alemtuzumab,cytomegalovirus infection,Infections and infestations,Selective immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1338512,36918858,2.64E-21,1.21E-13,adult_children_senior_youth,adult,doxorubicin,anxiety,Psychiatric disorders,Anthracyclines and related substances,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
40239330,35607430,2.75E-21,1.26E-13,adult_senior,senior,telaprevir,retinopathy,Eye disorders,Antivirals for treatment of HCV infections,DIRECT ACTING ANTIVIRALS,ANTIVIRALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
705944,35808828,2.76E-21,1.27E-13,adult_children_youth,children,methylphenidate,application site swelling,General disorders and administration site conditions,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
1133201,35808822,2.83E-21,1.30E-13,adult_children_senior_youth,adult,buprenorphine,application site pruritus,General disorders and administration site conditions,$Drugs used in opioid dependence$Drugs used in opioid dependence$Oripavine derivatives,$DRUGS USED IN ADDICTIVE DISORDERS$DRUGS USED IN ADDICTIVE DISORDERS$OPIOIDS,$OTHER NERVOUS SYSTEM DRUGS$OTHER NERVOUS SYSTEM DRUGS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
19012598,36211303,2.83E-21,1.30E-13,adult_children_senior_youth,senior,vecuronium,injury,"Injury, poisoning and procedural complications",Other quaternary ammonium compounds,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",MUSCLE RELAXANTS,MUSCULO-SKELETAL SYSTEM
1151789,35809013,2.91E-21,1.34E-13,adult_children_senior_youth,youth,etanercept,injection site rash,General disorders and administration site conditions,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
729855,35708171,3.21E-21,1.48E-13,adult_children_senior_youth,children_youth,botulinum toxin type A,dysphagia,Gastrointestinal disorders,0,0,0,0
1503297,36919118,3.25E-21,1.49E-13,adult_children_senior_youth,youth,metformin,mental status changes,Psychiatric disorders,$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Biguanides$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1154029,35205259,3.26E-21,1.50E-13,adult_children_senior_youth,children_youth,fentanyl,pulmonary oedema,"Respiratory, thoracic and mediastinal disorders",$Opioid anesthetics$Phenylpiperidine derivatives$Opioid anesthetics,"$ANESTHETICS, GENERAL$OPIOIDS$ANESTHETICS, GENERAL",$ANESTHETICS$ANALGESICS$ANESTHETICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1151789,36516824,3.32E-21,1.52E-13,adult_children_senior_youth,senior,etanercept,osteoarthritis,Musculoskeletal and connective tissue disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
739138,36919230,3.33E-21,1.53E-13,adult_children_senior_youth,youth,sertraline,completed suicide,General disorders and administration site conditions,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1589505,43053904,3.41E-21,1.57E-13,adult_children_youth,children,levonorgestrel,exposure during pregnancy,"Injury, poisoning and procedural complications","$Progestogens and estrogens, sequential preparations$Emergency contraceptives$Progestogens$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations",$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1589505,35406392,3.46E-21,1.59E-13,adult_children_senior_youth,adult,levonorgestrel,vertigo,$Ear and labyrinth disorders$Nervous system disorders,"$Progestogens and estrogens, sequential preparations$Emergency contraceptives$Progestogens$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations",$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
705103,35607287,3.63E-21,1.66E-13,adult_children_senior_youth,children,lamotrigine,oculogyric crisis,Eye disorders,Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
19014878,36009833,3.77E-21,1.73E-13,adult_children_senior_youth,senior,azathioprine,rheumatoid arthritis,Immune system disorders,Other immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1777087,35606985,4.16E-21,1.91E-13,adult_senior,senior,hydroxychloroquine,glaucoma,Eye disorders,Aminoquinolines,ANTIMALARIALS,ANTIPROTOZOALS,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS"
1154161,36919048,4.18E-21,1.92E-13,adult_children_senior_youth,children,montelukast,frustration,0,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1177480,35809115,4.23E-21,1.94E-13,adult_children_senior_youth,children,ibuprofen,condition aggravated,General disorders and administration site conditions,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
19026972,35809120,4.67E-21,2.14E-13,adult_children_senior_youth,children_youth,lenalidomide,disease progression,General disorders and administration site conditions,Other immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
735979,37019321,4.89E-21,2.24E-13,adult_children_senior_youth,senior,risperidone,renal impairment,Renal and urinary disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1508439,36818833,5.00E-21,2.29E-13,adult_children_youth,youth,mifepristone,pregnancy,"Pregnancy, puerperium and perinatal conditions",$Progesterone receptor modulators$Progesterone receptor modulators,$OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
44507700,36718563,5.05E-21,2.32E-13,adult_senior_youth,youth,vortioxetine,hypersomnia,$Nervous system disorders$Psychiatric disorders,Other antidepressants,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
715233,35809134,5.06E-21,2.32E-13,adult_children_senior_youth,youth,baclofen,hyperhidrosis,Skin and subcutaneous tissue disorders,Other centrally acting agents,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",MUSCLE RELAXANTS,MUSCULO-SKELETAL SYSTEM
750982,35204960,5.30E-21,2.43E-13,adult_children_senior_youth,children,bupropion,sinus tachycardia,Cardiac disorders,$Centrally acting antiobesity products$Other antidepressants,"$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$ANTIDEPRESSANTS","$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$PSYCHOANALEPTICS",$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM
924566,37019456,5.62E-21,2.58E-13,adult_senior_youth,youth,tamsulosin,nephrolithiasis,Renal and urinary disorders,$Alpha-adrenoreceptor antagonists$Alpha-adrenoreceptor antagonists$Sulfonamides$Alpha-adrenoreceptor antagonists,"$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",$UROLOGICALS$UROLOGICALS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$UROLOGICALS,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
705944,42889647,5.75E-21,2.64E-13,adult_children_senior_youth,youth,methylphenidate,toxicity to various agents,"Injury, poisoning and procedural complications",Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
44785094,43053853,5.96E-21,2.74E-13,adult_children_senior,senior,sofosbuvir,hepatocellular carcinoma,Hepatobiliary disorders,$Antivirals for treatment of HCV infections$Antivirals for treatment of HCV infections$Antivirals for treatment of HCV infections$Antivirals for treatment of HCV infections,$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS,$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
1344905,37019321,6.07E-21,2.78E-13,adult_children_senior_youth,youth,carboplatin,renal impairment,Renal and urinary disorders,Platinum compounds,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
902427,35809077,6.16E-21,2.83E-13,adult_children_senior,children,timolol,lethargy,Nervous system disorders,"$Beta blocking agents, non-selective$Beta blocking agents$Beta blocking agents, non-selective, and thiazides$Beta blocking agents, non-selective, thiazides and other diuretics$Beta blocking agents","$BETA BLOCKING AGENTS$ANTIGLAUCOMA PREPARATIONS AND MIOTICS$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS$ANTIGLAUCOMA PREPARATIONS AND MIOTICS",$BETA BLOCKING AGENTS$OPHTHALMOLOGICALS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$OPHTHALMOLOGICALS,$CARDIOVASCULAR SYSTEM$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$SENSORY ORGANS
42904205,35809059,6.27E-21,2.88E-13,adult_children_senior_youth,senior,tofacitinib,death,General disorders and administration site conditions,Selective immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
739138,36110597,6.31E-21,2.90E-13,adult_children_senior_youth,senior,sertraline,pneumonia,Infections and infestations,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
40222444,35104883,6.57E-21,3.01E-13,adult_children_senior,adult,denosumab,neutropenia,Blood and lymphatic system disorders,Other drugs affecting bone structure and mineralization,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,DRUGS FOR TREATMENT OF BONE DISEASES,MUSCULO-SKELETAL SYSTEM
1119119,36313985,6.63E-21,3.04E-13,adult_senior_youth,senior,adalimumab,blood cholesterol increased,Investigations,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
703244,36919045,6.91E-21,3.17E-13,adult_children_youth,children_youth,paliperidone,emotional disorder,Psychiatric disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1309068,35809357,7.11E-21,3.26E-13,adult_children_senior_youth,children,minoxidil,therapeutic response unexpected,General disorders and administration site conditions,$Other dermatologicals$Pyrimidine derivatives,"$OTHER DERMATOLOGICAL PREPARATIONS$ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON",$OTHER DERMATOLOGICAL PREPARATIONS$ANTIHYPERTENSIVES,$DERMATOLOGICALS$CARDIOVASCULAR SYSTEM
1154029,36211484,7.29E-21,3.34E-13,adult_children_senior_youth,children,fentanyl,accidental exposure,"Injury, poisoning and procedural complications",$Opioid anesthetics$Phenylpiperidine derivatives$Opioid anesthetics,"$ANESTHETICS, GENERAL$OPIOIDS$ANESTHETICS, GENERAL",$ANESTHETICS$ANALGESICS$ANESTHETICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
735979,37019318,7.30E-21,3.35E-13,adult_children_senior_youth,senior,risperidone,renal failure,Renal and urinary disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
19014878,35708044,7.40E-21,3.40E-13,adult_children_senior_youth,children_youth,azathioprine,colitis ulcerative,Gastrointestinal disorders,Other immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1310317,36110852,7.49E-21,3.44E-13,adult_children_senior_youth,children,cyclophosphamide,adenovirus infection,Infections and infestations,Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1551099,35809059,8.02E-21,3.68E-13,adult_children_senior_youth,senior,prednisone,death,General disorders and administration site conditions,$Corticosteroids acting locally$Glucocorticoids,"$INTESTINAL ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN","$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE","$ALIMENTARY TRACT AND METABOLISM$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
1103640,35708202,8.10E-21,3.72E-13,adult_children_senior_youth,senior,methadone,nausea,Gastrointestinal disorders,$Drugs used in opioid dependence$Diphenylpropylamine derivatives,$DRUGS USED IN ADDICTIVE DISORDERS$OPIOIDS,$OTHER NERVOUS SYSTEM DRUGS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
1734104,37622465,8.34E-21,3.83E-13,adult_children_senior_youth,youth,azithromycin,deep vein thrombosis,Vascular disorders,$Combinations of antibacterials$Antibiotics$Macrolides,"$COMBINATIONS OF ANTIBACTERIALS$ANTIINFECTIVES$MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",$ANTIBACTERIALS FOR SYSTEMIC USE$OPHTHALMOLOGICALS$ANTIBACTERIALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$SENSORY ORGANS$ANTIINFECTIVES FOR SYSTEMIC USE
1151789,37622529,8.59E-21,3.94E-13,adult_children_senior_youth,senior,etanercept,hypertension,Vascular disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1151789,35607074,8.64E-21,3.97E-13,adult_children_senior_youth,children,etanercept,iridocyclitis,Eye disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1119119,43053808,8.71E-21,4.00E-13,adult_children_senior_youth,youth,adalimumab,injection site bruising,General disorders and administration site conditions,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1521369,36617162,8.95E-21,4.11E-13,adult_senior,senior,norethindrone,breast cancer,Reproductive system and breast disorders,0,0,0,0
40171288,36009833,9.28E-21,4.26E-13,adult_children_senior_youth,youth,tocilizumab,rheumatoid arthritis,Immune system disorders,Interleukin inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1367571,35607096,9.41E-21,4.32E-13,adult_children_senior_youth,children,heparin,eyelid oedema,Immune system disorders,$Heparin group$Heparins or heparinoids for topical use$Other ophthalmologicals$Heparins or heparinoids for topical use$Heparin group,$ANTITHROMBOTIC AGENTS$ANTIVARICOSE THERAPY$OTHER OPHTHALMOLOGICALS$ANTIVARICOSE THERAPY$ANTITHROMBOTIC AGENTS,$ANTITHROMBOTIC AGENTS$VASOPROTECTIVES$OPHTHALMOLOGICALS$VASOPROTECTIVES$ANTITHROMBOTIC AGENTS,$BLOOD AND BLOOD FORMING ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$BLOOD AND BLOOD FORMING ORGANS
1125315,35809243,9.72E-21,4.46E-13,adult_children_senior_youth,youth,acetaminophen,pain,General disorders and administration site conditions,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
836208,36211303,9.88E-21,4.54E-13,adult_children_senior_youth,senior,succinylcholine,injury,"Injury, poisoning and procedural complications",Choline derivatives,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",MUSCLE RELAXANTS,MUSCULO-SKELETAL SYSTEM
1308290,36110552,1.03E-20,4.72E-13,adult_children_senior_youth,senior,vincristine,infection,Infections and infestations,Vinca alkaloids and analogues,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1351541,35809104,1.06E-20,4.85E-13,adult_children_senior_youth,children,leuprolide,gait disturbance,General disorders and administration site conditions,$Gonadotropin releasing hormone analogues$Gonadotropin releasing hormone analogues,$HORMONES AND RELATED AGENTS$HORMONES AND RELATED AGENTS,$ENDOCRINE THERAPY$ENDOCRINE THERAPY,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1119119,35205168,1.08E-20,4.98E-13,adult_senior_youth,senior,adalimumab,coronary artery occlusion,Vascular disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1636780,36211484,1.09E-20,5.00E-13,adult_children_senior_youth,children,testosterone,accidental exposure,"Injury, poisoning and procedural complications",$3-oxoandrosten (4) derivatives$Androgens and estrogens,$ANDROGENS$ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1322184,36718229,1.13E-20,5.18E-13,adult_children_senior_youth,youth,clopidogrel,hemiparesis,Nervous system disorders,Platelet aggregation inhibitors excl. heparin,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1154343,36009700,1.14E-20,5.21E-13,adult_children_senior_youth,children,albuterol,asthma,"Respiratory, thoracic and mediastinal disorders",0,0,0,0
1797513,36009738,1.14E-20,5.22E-13,adult_children_senior_youth,senior,ciprofloxacin,drug hypersensitivity,Immune system disorders,$Combinations of antibacterials$Antiinfectives$Fluoroquinolones$Antiinfectives$Combinations of antibacterials$Combinations of antibacterials$Fluoroquinolones,$COMBINATIONS OF ANTIBACTERIALS$ANTIINFECTIVES$QUINOLONE ANTIBACTERIALS$ANTIINFECTIVES$COMBINATIONS OF ANTIBACTERIALS$COMBINATIONS OF ANTIBACTERIALS$ANTIINFECTIVES,$ANTIBACTERIALS FOR SYSTEMIC USE$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$ANTIBACTERIALS FOR SYSTEMIC USE$OTOLOGICALS$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIBACTERIALS FOR SYSTEMIC USE$OPHTHALMOLOGICALS,$ANTIINFECTIVES FOR SYSTEMIC USE$SENSORY ORGANS$ANTIINFECTIVES FOR SYSTEMIC USE$SENSORY ORGANS$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$SENSORY ORGANS
1549080,37119780,1.21E-20,5.54E-13,adult_children_senior,children,conjugated estrogens,vulvovaginal burning sensation,Reproductive system and breast disorders,"$Natural and semisynthetic estrogens, plain$Estrogens, combinations with other drugs",$ESTROGENS$ESTROGENS,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1724869,35104883,1.33E-20,6.11E-13,adult_children_youth,children,didanosine,neutropenia,Blood and lymphatic system disorders,Nucleoside and nucleotide reverse transcriptase inhibitors,DIRECT ACTING ANTIVIRALS,ANTIVIRALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
1305058,35205232,1.36E-20,6.24E-13,adult_children_senior_youth,children_youth,methotrexate,fluid overload,$Cardiac disorders$Metabolism and nutrition disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
703244,36416534,1.38E-20,6.36E-13,adult_children_senior_youth,children,paliperidone,obesity,Metabolism and nutrition disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
19007737,42889647,1.39E-20,6.40E-13,adult_children_senior_youth,youth,mianserin,toxicity to various agents,"Injury, poisoning and procedural complications",Other antidepressants,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1308290,43562827,1.43E-20,6.58E-13,adult_children_senior_youth,senior,vincristine,pneumocystis jirovecii pneumonia,Infections and infestations,Vinca alkaloids and analogues,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
19031397,36009756,1.49E-20,6.82E-13,adult_children_senior_youth,children,dipyrone,anaphylactic reaction,Immune system disorders,0,0,0,0
797617,36211297,1.50E-20,6.87E-13,adult_children_senior_youth,senior,citalopram,fall,"Injury, poisoning and procedural complications",Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1154161,36919045,1.54E-20,7.05E-13,adult_children_senior_youth,children,montelukast,emotional disorder,Psychiatric disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
735979,36416518,1.60E-20,7.35E-13,adult_children_senior_youth,children,risperidone,increased appetite,General disorders and administration site conditions,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
19087090,36918984,1.62E-20,7.42E-13,adult_children_senior_youth,senior,amantadine,hallucination,Psychiatric disorders,Adamantane derivatives,DOPAMINERGIC AGENTS,ANTI-PARKINSON DRUGS,NERVOUS SYSTEM
1114220,37219831,1.63E-20,7.49E-13,adult_children_senior_youth,senior,naloxone,interstitial lung disease,"$Immune system disorders$Respiratory, thoracic and mediastinal disorders",$Peripheral opioid receptor antagonists$Natural opium alkaloids$Antidotes$Natural opium alkaloids,$DRUGS FOR CONSTIPATION$OPIOIDS$ALL OTHER THERAPEUTIC PRODUCTS$OPIOIDS,$DRUGS FOR CONSTIPATION$ANALGESICS$ALL OTHER THERAPEUTIC PRODUCTS$ANALGESICS,$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM$VARIOUS$NERVOUS SYSTEM
1119119,43053904,1.66E-20,7.60E-13,adult_youth,youth,adalimumab,exposure during pregnancy,"Injury, poisoning and procedural complications",Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
797617,36311918,1.71E-20,7.84E-13,adult_children_senior_youth,youth,citalopram,electrocardiogram qrs complex prolonged,Investigations,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1550557,42890501,1.82E-20,8.35E-13,adult_children_senior,senior,prednisolone,osteonecrosis of jaw,Vascular disorders,"$Corticosteroids, weak (group I)$Corticosteroids and antiinfectives in combination$Corticosteroids, weak, other combinations$Corticosteroids for local oral treatment$Corticosteroids$Corticosteroids and mydriatics in combination$Corticosteroids$Corticosteroids/antiinfectives/mydriatics in combination$Antidotes$Corticosteroids$Corticosteroids, weak, combinations with antiseptics$Corticosteroids, weak, combinations with antibiotics$Corticosteroids, plain$Corticosteroids$Corticosteroids acting locally$Glucocorticoids$Corticosteroids and antiinfectives in combination$Corticosteroids$Corticosteroids and antiinfectives in combination","$CORTICOSTEROIDS, PLAIN$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS, OTHER COMBINATIONS$STOMATOLOGICAL PREPARATIONS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$ALL OTHER THERAPEUTIC PRODUCTS$CORTICOSTEROIDS$CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS$INTESTINAL ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION","$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$STOMATOLOGICAL PREPARATIONS$NASAL PREPARATIONS$OPHTHALMOLOGICALS$NASAL PREPARATIONS$OPHTHALMOLOGICALS$ALL OTHER THERAPEUTIC PRODUCTS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS$OTOLOGICALS$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE$OTOLOGICALS$VASOPROTECTIVES$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS","$DERMATOLOGICALS$SENSORY ORGANS$DERMATOLOGICALS$ALIMENTARY TRACT AND METABOLISM$RESPIRATORY SYSTEM$SENSORY ORGANS$RESPIRATORY SYSTEM$SENSORY ORGANS$VARIOUS$SENSORY ORGANS$DERMATOLOGICALS$DERMATOLOGICALS$SENSORY ORGANS$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS"
1305058,36009700,1.85E-20,8.49E-13,adult_children_senior_youth,adult,methotrexate,asthma,"Respiratory, thoracic and mediastinal disorders",$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1378382,36516888,1.89E-20,8.67E-13,adult_children_senior_youth,youth,paclitaxel,rhabdomyolysis,Musculoskeletal and connective tissue disorders,Taxanes,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1125315,35104877,1.90E-20,8.73E-13,adult_children_senior_youth,children,acetaminophen,febrile neutropenia,General disorders and administration site conditions,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1154029,35204966,1.97E-20,9.06E-13,adult_children_senior_youth,children_youth,fentanyl,cardiac arrest,Cardiac disorders,$Opioid anesthetics$Phenylpiperidine derivatives$Opioid anesthetics,"$ANESTHETICS, GENERAL$OPIOIDS$ANESTHETICS, GENERAL",$ANESTHETICS$ANALGESICS$ANESTHETICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
950637,35909571,2.07E-20,9.49E-13,adult_children_senior_youth,children,tacrolimus,venoocclusive liver disease,Hepatobiliary disorders,"$Agents for dermatitis, excluding corticosteroids$Calcineurin inhibitors",$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$DERMATOLOGICALS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
718122,36416600,2.08E-20,9.57E-13,adult_children_senior_youth,senior,oxcarbazepine,hyponatraemia,Metabolism and nutrition disorders,Carboxamide derivatives,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
1717704,36718119,2.26E-20,1.04E-12,adult_children_senior_youth,children_senior,valacyclovir,encephalopathy,Nervous system disorders,0,0,0,0
1167322,35104877,2.37E-20,1.09E-12,adult_children_senior_youth,children_youth,allopurinol,febrile neutropenia,General disorders and administration site conditions,$Preparations inhibiting uric acid production$Preparations inhibiting uric acid production,$ANTIGOUT PREPARATIONS$ANTIGOUT PREPARATIONS,$ANTIGOUT PREPARATIONS$ANTIGOUT PREPARATIONS,$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
44817909,36919230,2.50E-20,1.15E-12,adult_senior_youth,youth,acetaminophen / codeine Effervescent Oral Tablet,completed suicide,General disorders and administration site conditions,0,0,0,0
996416,36919054,2.51E-20,1.15E-12,adult_senior_youth,youth,finasteride,apathy,Psychiatric disorders,$Other dermatologicals$Alpha-adrenoreceptor antagonists$Testosterone-5-alpha reductase inhibitors,$OTHER DERMATOLOGICAL PREPARATIONS$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,$OTHER DERMATOLOGICAL PREPARATIONS$UROLOGICALS$UROLOGICALS,$DERMATOLOGICALS$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1125315,36416600,2.68E-20,1.23E-12,adult_children_senior_youth,senior,acetaminophen,hyponatraemia,Metabolism and nutrition disorders,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1114220,46276711,2.85E-20,1.31E-12,adult_senior_youth,adult_youth,naloxone,product preparation error,"Injury, poisoning and procedural complications",$Peripheral opioid receptor antagonists$Natural opium alkaloids$Antidotes$Natural opium alkaloids,$DRUGS FOR CONSTIPATION$OPIOIDS$ALL OTHER THERAPEUTIC PRODUCTS$OPIOIDS,$DRUGS FOR CONSTIPATION$ANALGESICS$ALL OTHER THERAPEUTIC PRODUCTS$ANALGESICS,$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM$VARIOUS$NERVOUS SYSTEM
718583,35808800,2.89E-20,1.32E-12,adult_children_senior_youth,senior_youth,nicotine,application site erythema,General disorders and administration site conditions,Drugs used in nicotine dependence,DRUGS USED IN ADDICTIVE DISORDERS,OTHER NERVOUS SYSTEM DRUGS,NERVOUS SYSTEM
19044883,36416600,2.97E-20,1.36E-12,adult_senior,senior,zopiclone,hyponatraemia,Metabolism and nutrition disorders,Benzodiazepine related drugs,HYPNOTICS AND SEDATIVES,PSYCHOLEPTICS,NERVOUS SYSTEM
1517824,37320158,2.99E-20,1.37E-12,adult_senior_youth,adult_youth,niacin,erythema,Skin and subcutaneous tissue disorders,$Nicotinic acid and derivatives$Nicotinic acid and derivatives$HMG CoA reductase inhibitors in combination with other lipid modifying agents$Nicotinic acid and derivatives,"$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS$PERIPHERAL VASODILATORS",$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$PERIPHERAL VASODILATORS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1151789,37520652,3.03E-20,1.39E-12,adult_senior,senior,etanercept,knee arthroplasty,Surgical and medical procedures,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
996416,36718175,3.20E-20,1.47E-12,adult_children_senior_youth,youth,finasteride,memory impairment,$Nervous system disorders$Psychiatric disorders,$Other dermatologicals$Alpha-adrenoreceptor antagonists$Testosterone-5-alpha reductase inhibitors,$OTHER DERMATOLOGICAL PREPARATIONS$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,$OTHER DERMATOLOGICAL PREPARATIONS$UROLOGICALS$UROLOGICALS,$DERMATOLOGICALS$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
44507700,35809076,3.26E-20,1.50E-12,adult_children_senior_youth,youth,vortioxetine,fatigue,General disorders and administration site conditions,Other antidepressants,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
956874,35205230,3.34E-20,1.53E-12,adult_children_senior_youth,children_youth,furosemide,ascites,Gastrointestinal disorders,"$High-ceiling diuretics and potassium-sparing agents$Sulfonamides, plain$Sulfonamides$Sulfonamides and potassium in combination","$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$HIGH-CEILING DIURETICS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$HIGH-CEILING DIURETICS",$DIURETICS$DIURETICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$DIURETICS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
1518254,35708642,3.61E-20,1.66E-12,adult_children_senior_youth,youth,dexamethasone,stomatitis,Gastrointestinal disorders,"$Corticosteroids$Corticosteroids, moderately potent, other combinations$Corticosteroids$Corticosteroids, combinations for treatment of acne$Corticosteroids/antiinfectives/mydriatics in combination$Corticosteroids and antiinfectives in combination$Corticosteroids and antiinfectives in combination$Corticosteroids$Corticosteroids and antiinfectives in combination$Corticosteroids, moderately potent, combinations with antibiotics$Glucocorticoids$Corticosteroids, plain$Corticosteroids for local oral treatment$Corticosteroids$Corticosteroids, moderately potent (group II)$Corticosteroids","$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$CORTICOSTEROIDS, OTHER COMBINATIONS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$ANTIINFLAMMATORY AGENTS$STOMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS$CORTICOSTEROIDS, PLAIN$CORTICOSTEROIDS","$NASAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$NASAL PREPARATIONS$ANTI-ACNE PREPARATIONS$OPHTHALMOLOGICALS$OTOLOGICALS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$VASOPROTECTIVES$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS FOR SYSTEMIC USE$OPHTHALMOLOGICALS$STOMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OTOLOGICALS","$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$DERMATOLOGICALS$SENSORY ORGANS$SENSORY ORGANS$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS$DERMATOLOGICALS$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$SENSORY ORGANS$DERMATOLOGICALS$SENSORY ORGANS"
1151789,36617300,3.62E-20,1.66E-12,adult_children_senior,senior,etanercept,neoplasm malignant,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
912263,35809361,3.62E-20,1.66E-12,adult_senior_youth,senior,certolizumab pegol,treatment failure,General disorders and administration site conditions,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
713196,35809059,3.65E-20,1.68E-12,adult_children_senior_youth,senior,interferon beta-1b,death,General disorders and administration site conditions,Interferons,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
766814,36718500,3.68E-20,1.69E-12,adult_children_senior_youth,adult,quetiapine,neuropathy peripheral,Nervous system disorders,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1343916,35808987,3.79E-20,1.74E-12,adult_children_senior_youth,children,epinephrine,injection site injury,General disorders and administration site conditions,"$Other agents for local oral treatment$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Local hemostatics$Adrenergic and dopaminergic agents$Sympathomimetics in glaucoma therapy$Sympathomimetics, plain$Alpha- and beta-adrenoreceptor agonists$Sympathomimetics in glaucoma therapy","$STOMATOLOGICAL PREPARATIONS$ADRENERGICS, INHALANTS$VITAMIN K AND OTHER HEMOSTATICS$CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES$ANTIGLAUCOMA PREPARATIONS AND MIOTICS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ADRENERGICS, INHALANTS$ANTIGLAUCOMA PREPARATIONS AND MIOTICS",$STOMATOLOGICAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$ANTIHEMORRHAGICS$CARDIAC THERAPY$OPHTHALMOLOGICALS$NASAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OPHTHALMOLOGICALS,$ALIMENTARY TRACT AND METABOLISM$RESPIRATORY SYSTEM$BLOOD AND BLOOD FORMING ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$SENSORY ORGANS
1124957,36718371,3.90E-20,1.79E-12,adult_children_senior_youth,children,oxycodone,unresponsive to stimuli,Nervous system disorders,$Natural opium alkaloids$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1151789,35809146,3.91E-20,1.79E-12,adult_children_senior_youth,senior,etanercept,mobility decreased,Nervous system disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1125315,36315381,3.93E-20,1.80E-12,adult_children_senior_youth,adult,acetaminophen,weight increased,Investigations,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1186087,36516909,3.96E-20,1.82E-12,adult_senior,senior,abatacept,sciatica,$Musculoskeletal and connective tissue disorders$Nervous system disorders,Selective immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
19014878,35809361,4.09E-20,1.88E-12,adult_children_senior_youth,senior,azathioprine,treatment failure,General disorders and administration site conditions,Other immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
19025274,35204928,4.16E-20,1.91E-12,adult_children_senior_youth,children_youth,oxygen,bradycardia,Cardiac disorders,Medical gases,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,VARIOUS
1506270,36110874,4.16E-20,1.91E-12,adult_children_senior_youth,children_youth,methylprednisolone,cytomegalovirus infection,Infections and infestations,"$Corticosteroids, combinations for treatment of acne$Glucocorticoids$Corticosteroids for systemic use, combinations$Corticosteroids, weak, combinations with antibiotics$Corticosteroids and antiinfectives in combination$Corticosteroids, weak (group I)","$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS, PLAIN","$ANTI-ACNE PREPARATIONS$CORTICOSTEROIDS FOR SYSTEMIC USE$CORTICOSTEROIDS FOR SYSTEMIC USE$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS","$DERMATOLOGICALS$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$DERMATOLOGICALS$SENSORY ORGANS$DERMATOLOGICALS"
964339,36516909,4.26E-20,1.95E-12,adult_senior,senior,sulfasalazine,sciatica,$Musculoskeletal and connective tissue disorders$Nervous system disorders,$Sulfonamides$Aminosalicylic acid and similar agents,"$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$INTESTINAL ANTIINFLAMMATORY AGENTS","$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",$GENITO URINARY SYSTEM AND SEX HORMONES$ALIMENTARY TRACT AND METABOLISM
970250,35205029,4.32E-20,1.98E-12,adult_children_senior_youth,youth,spironolactone,haemoptysis,Cardiac disorders,Aldosterone antagonists,POTASSIUM-SPARING AGENTS,DIURETICS,CARDIOVASCULAR SYSTEM
1310149,35205185,4.48E-20,2.05E-12,adult_children_senior_youth,youth,warfarin,chest pain,"Respiratory, thoracic and mediastinal disorders",Vitamin K antagonists,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
745466,35306159,4.55E-20,2.09E-12,adult_children_youth,children,valproate,fanconi syndrome,Renal and urinary disorders,0,0,0,0
1154343,36919046,4.93E-20,2.26E-12,adult_children_senior_youth,youth,albuterol,emotional distress,Psychiatric disorders,0,0,0,0
745466,36919236,4.95E-20,2.27E-12,adult_children_senior_youth,youth,valproate,suicide attempt,Psychiatric disorders,0,0,0,0
1503297,35809005,5.04E-20,2.31E-12,adult_children_senior_youth,adult,metformin,injection site pain,General disorders and administration site conditions,$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Biguanides$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
19026972,36312856,5.09E-20,2.34E-12,adult_senior_youth,senior,lenalidomide,full blood count decreased,Investigations,Other immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
40239330,36416698,5.09E-20,2.33E-12,adult_children_senior_youth,senior,telaprevir,hyperuricaemia,Metabolism and nutrition disorders,Antivirals for treatment of HCV infections,DIRECT ACTING ANTIVIRALS,ANTIVIRALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
1503297,36311923,5.49E-20,2.52E-12,adult_children_senior_youth,youth,metformin,electrocardiogram qt prolonged,Investigations,$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Biguanides$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
40239330,37019321,6.12E-20,2.81E-12,adult_senior,senior,telaprevir,renal impairment,Renal and urinary disorders,Antivirals for treatment of HCV infections,DIRECT ACTING ANTIVIRALS,ANTIVIRALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
766529,35506609,6.52E-20,2.99E-12,adult_children_senior_youth,adult,haloperidol,diabetes mellitus,Endocrine disorders,Butyrophenone derivatives,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
19010482,46276591,6.68E-20,3.07E-12,adult_children_senior_youth,senior,cyclosporine,wrong technique in product usage process,"Injury, poisoning and procedural complications",$Calcineurin inhibitors$Other ophthalmologicals,$IMMUNOSUPPRESSANTS$OTHER OPHTHALMOLOGICALS,$IMMUNOSUPPRESSANTS$OPHTHALMOLOGICALS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$SENSORY ORGANS
734354,37219961,6.74E-20,3.09E-12,adult_children_senior_youth,youth,pregabalin,snoring,"Respiratory, thoracic and mediastinal disorders",Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
1551860,35205189,6.81E-20,3.13E-12,adult_children_senior_youth,adult,pravastatin,myocardial infarction,Vascular disorders,"$HMG CoA reductase inhibitors$HMG CoA reductase inhibitors in combination with other lipid modifying agents$HMG CoA reductase inhibitors, other combinations","$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS",$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
749910,35204970,6.98E-20,3.21E-12,adult_children_senior_youth,youth,carisoprodol,cardio-respiratory arrest,Cardiac disorders,$Carbamic acid esters$Carbamic acid esters$Carbamic acid esters,"$MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS$MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS$MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",$MUSCLE RELAXANTS$MUSCLE RELAXANTS$MUSCLE RELAXANTS,$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
40239330,37019308,7.12E-20,3.27E-12,adult_children_senior,senior,telaprevir,renal disorder,Renal and urinary disorders,Antivirals for treatment of HCV infections,DIRECT ACTING ANTIVIRALS,ANTIVIRALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
703244,35506663,8.28E-20,3.80E-12,adult_children_youth,children_youth,paliperidone,galactorrhoea,$Endocrine disorders$Reproductive system and breast disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1351541,36718141,8.38E-20,3.85E-12,adult_children_senior_youth,youth,leuprolide,migraine,Vascular disorders,$Gonadotropin releasing hormone analogues$Gonadotropin releasing hormone analogues,$HORMONES AND RELATED AGENTS$HORMONES AND RELATED AGENTS,$ENDOCRINE THERAPY$ENDOCRINE THERAPY,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1315942,35809120,8.40E-20,3.85E-12,adult_children_senior_youth,children_youth,docetaxel,disease progression,General disorders and administration site conditions,Taxanes,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
743670,36919230,8.42E-20,3.87E-12,adult_children_senior_youth,youth,venlafaxine,completed suicide,General disorders and administration site conditions,Other antidepressants,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1110410,35104266,8.62E-20,3.96E-12,adult_children_youth,children,morphine,acute chest syndrome,Vascular disorders,$Antipropulsives$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with antispasmodics,$ANTIPROPULSIVES$OPIOIDS$OPIOIDS$OPIOIDS,"$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$ANALGESICS$ANALGESICS$ANALGESICS",$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
904525,35607096,8.80E-20,4.04E-12,adult_children_senior_youth,children,bimatoprost,eyelid oedema,Immune system disorders,Prostaglandin analogues,ANTIGLAUCOMA PREPARATIONS AND MIOTICS,OPHTHALMOLOGICALS,SENSORY ORGANS
1738521,36818629,8.86E-20,4.07E-12,adult_children_youth,youth,doxycycline,abortion incomplete,"Pregnancy, puerperium and perinatal conditions",$Tetracyclines$Antiinfectives and antiseptics for local oral treatment$Tetracyclines,$TETRACYCLINES$STOMATOLOGICAL PREPARATIONS$TETRACYCLINES,$ANTIBACTERIALS FOR SYSTEMIC USE$STOMATOLOGICAL PREPARATIONS$ANTIBACTERIALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ALIMENTARY TRACT AND METABOLISM$ANTIINFECTIVES FOR SYSTEMIC USE
1545958,35205246,9.25E-20,4.25E-12,adult_children_senior_youth,youth,atorvastatin,cardiogenic shock,Vascular disorders,"$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations","$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS",$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1151789,36110918,9.31E-20,4.27E-12,adult_children_senior_youth,senior,etanercept,herpes zoster,Infections and infestations,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
19003999,36009833,9.44E-20,4.33E-12,adult_senior,senior,mycophenolate mofetil,rheumatoid arthritis,Immune system disorders,0,0,0,0
705103,36919059,9.57E-20,4.39E-12,adult_children_senior_youth,children,lamotrigine,aggression,Psychiatric disorders,Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
45775396,36617295,9.63E-20,4.42E-12,adult_children_senior,adult,nintedanib,malignant neoplasm progression,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Protein kinase inhibitors,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1140643,35808816,1.03E-19,4.73E-12,adult_children_senior_youth,youth,sumatriptan,application site pain,General disorders and administration site conditions,$Selective serotonin (5HT1) agonists$Sulfonamides,"$ANTIMIGRAINE PREPARATIONS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",$ANALGESICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,$NERVOUS SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES
1119119,36516828,1.03E-19,4.74E-12,adult_children_senior_youth,adult,adalimumab,psoriatic arthropathy,$Immune system disorders$Musculoskeletal and connective tissue disorders$Skin and subcutaneous tissue disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1545958,36311918,1.05E-19,4.83E-12,adult_senior_youth,youth,atorvastatin,electrocardiogram qrs complex prolonged,Investigations,"$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations","$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS",$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
735979,35506663,1.09E-19,5.00E-12,adult_children_senior_youth,children_youth,risperidone,galactorrhoea,$Endocrine disorders$Reproductive system and breast disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1305058,35809329,1.10E-19,5.03E-12,adult_children_senior_youth,senior,methotrexate,drug intolerance,General disorders and administration site conditions,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1332418,35809221,1.10E-19,5.06E-12,adult_children_senior_youth,children,amlodipine,generalised oedema,$General disorders and administration site conditions$Metabolism and nutrition disorders,"$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$Beta blocking agents and calcium channel blockers$Dihydropyridine derivatives$ACE inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$Calcium channel blockers and diuretics$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs), other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers","$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS$ACE INHIBITORS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$CALCIUM CHANNEL BLOCKERS AND DIURETICS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$BETA BLOCKING AGENTS$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
797617,42889647,1.10E-19,5.07E-12,adult_children_senior_youth,youth,citalopram,toxicity to various agents,"Injury, poisoning and procedural complications",Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
743670,35205246,1.14E-19,5.22E-12,adult_senior_youth,youth,venlafaxine,cardiogenic shock,Vascular disorders,Other antidepressants,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1504620,35104874,1.16E-19,5.32E-12,adult_children_senior_youth,youth,methimazole,agranulocytosis,Blood and lymphatic system disorders,$Sulfur-containing imidazole derivatives$Sulfur-containing imidazole derivatives,$ANTITHYROID PREPARATIONS$ANTITHYROID PREPARATIONS,$THYROID THERAPY$THYROID THERAPY,"$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
1742253,37219871,1.18E-19,5.42E-12,adult_children_senior_youth,youth,levofloxacin,pulmonary embolism,"$Respiratory, thoracic and mediastinal disorders$Vascular disorders",$Fluoroquinolones$Combinations for eradication of Helicobacter pylori$Combinations of antibacterials$Fluoroquinolones,$QUINOLONE ANTIBACTERIALS$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$COMBINATIONS OF ANTIBACTERIALS$ANTIINFECTIVES,$ANTIBACTERIALS FOR SYSTEMIC USE$DRUGS FOR ACID RELATED DISORDERS$ANTIBACTERIALS FOR SYSTEMIC USE$OPHTHALMOLOGICALS,$ANTIINFECTIVES FOR SYSTEMIC USE$ALIMENTARY TRACT AND METABOLISM$ANTIINFECTIVES FOR SYSTEMIC USE$SENSORY ORGANS
19010482,35205025,1.25E-19,5.73E-12,adult_children_senior_youth,senior,cyclosporine,dizziness,Cardiac disorders,$Calcineurin inhibitors$Other ophthalmologicals,$IMMUNOSUPPRESSANTS$OTHER OPHTHALMOLOGICALS,$IMMUNOSUPPRESSANTS$OPHTHALMOLOGICALS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$SENSORY ORGANS
1332418,35204966,1.26E-19,5.77E-12,adult_children_senior_youth,youth,amlodipine,cardiac arrest,Cardiac disorders,"$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$Beta blocking agents and calcium channel blockers$Dihydropyridine derivatives$ACE inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$Calcium channel blockers and diuretics$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs), other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers","$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS$ACE INHIBITORS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$CALCIUM CHANNEL BLOCKERS AND DIURETICS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$BETA BLOCKING AGENTS$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
45776944,35809120,1.26E-19,5.78E-12,adult_senior_youth,adult,idelalisib,disease progression,General disorders and administration site conditions,Other antineoplastic agents,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
745466,36416600,1.39E-19,6.37E-12,adult_children_senior_youth,senior,valproate,hyponatraemia,Metabolism and nutrition disorders,0,0,0,0
1328165,36314160,1.47E-19,6.73E-12,adult_children_senior_youth,youth,diltiazem,blood glucose increased,Investigations,$Benzothiazepine derivatives$Muscle relaxants,$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,$CALCIUM CHANNEL BLOCKERS$VASOPROTECTIVES,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1154343,36919098,1.49E-19,6.86E-12,adult_children_senior_youth,children,albuterol,abnormal behaviour,Psychiatric disorders,0,0,0,0
43013024,37622465,1.49E-19,6.84E-12,adult_children_senior_youth,children,apixaban,deep vein thrombosis,Vascular disorders,Direct factor Xa inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1124957,42889647,1.49E-19,6.82E-12,adult_children_senior_youth,children_youth,oxycodone,toxicity to various agents,"Injury, poisoning and procedural complications",$Natural opium alkaloids$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1551860,35205164,1.56E-19,7.16E-12,adult_senior_youth,adult,pravastatin,coronary artery disease,Vascular disorders,"$HMG CoA reductase inhibitors$HMG CoA reductase inhibitors in combination with other lipid modifying agents$HMG CoA reductase inhibitors, other combinations","$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS",$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1125315,37219871,1.56E-19,7.14E-12,adult_children_senior_youth,youth,acetaminophen,pulmonary embolism,"$Respiratory, thoracic and mediastinal disorders$Vascular disorders",$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
40171288,35606985,1.58E-19,7.24E-12,adult_senior,senior,tocilizumab,glaucoma,Eye disorders,Interleukin inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
766814,36110597,1.58E-19,7.24E-12,adult_children_senior_youth,senior,quetiapine,pneumonia,Infections and infestations,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1153013,35909445,1.60E-19,7.33E-12,adult_children_senior_youth,youth,promethazine,cholelithiasis,Hepatobiliary disorders,$Phenothiazine derivatives$Antihistamines for topical use$Antidotes$Phenothiazine derivatives,"$ANTIHISTAMINES FOR SYSTEMIC USE$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ALL OTHER THERAPEUTIC PRODUCTS$ANTIHISTAMINES FOR SYSTEMIC USE","$ANTIHISTAMINES FOR SYSTEMIC USE$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ALL OTHER THERAPEUTIC PRODUCTS$ANTIHISTAMINES FOR SYSTEMIC USE",$RESPIRATORY SYSTEM$DERMATOLOGICALS$VARIOUS$RESPIRATORY SYSTEM
1778162,36211491,1.65E-19,7.56E-12,adult_children_senior,senior,cefuroxime,accidental overdose,"Injury, poisoning and procedural complications",$Antibiotics$Second-generation cephalosporins$Combinations of antibacterials,$ANTIINFECTIVES$OTHER BETA-LACTAM ANTIBACTERIALS$COMBINATIONS OF ANTIBACTERIALS,$OPHTHALMOLOGICALS$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIBACTERIALS FOR SYSTEMIC USE,$SENSORY ORGANS$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
797399,36211297,1.69E-19,7.76E-12,adult_children_senior_youth,senior,gabapentin,fall,"Injury, poisoning and procedural complications",Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
996416,35506603,1.70E-19,7.78E-12,adult_senior_youth,youth,finasteride,testicular atrophy,Endocrine disorders,$Other dermatologicals$Alpha-adrenoreceptor antagonists$Testosterone-5-alpha reductase inhibitors,$OTHER DERMATOLOGICAL PREPARATIONS$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,$OTHER DERMATOLOGICAL PREPARATIONS$UROLOGICALS$UROLOGICALS,$DERMATOLOGICALS$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1518254,36110597,1.79E-19,8.21E-12,adult_children_senior_youth,senior,dexamethasone,pneumonia,Infections and infestations,"$Corticosteroids$Corticosteroids, moderately potent, other combinations$Corticosteroids$Corticosteroids, combinations for treatment of acne$Corticosteroids/antiinfectives/mydriatics in combination$Corticosteroids and antiinfectives in combination$Corticosteroids and antiinfectives in combination$Corticosteroids$Corticosteroids and antiinfectives in combination$Corticosteroids, moderately potent, combinations with antibiotics$Glucocorticoids$Corticosteroids, plain$Corticosteroids for local oral treatment$Corticosteroids$Corticosteroids, moderately potent (group II)$Corticosteroids","$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$CORTICOSTEROIDS, OTHER COMBINATIONS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$ANTIINFLAMMATORY AGENTS$STOMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS$CORTICOSTEROIDS, PLAIN$CORTICOSTEROIDS","$NASAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$NASAL PREPARATIONS$ANTI-ACNE PREPARATIONS$OPHTHALMOLOGICALS$OTOLOGICALS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$VASOPROTECTIVES$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS FOR SYSTEMIC USE$OPHTHALMOLOGICALS$STOMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OTOLOGICALS","$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$DERMATOLOGICALS$SENSORY ORGANS$SENSORY ORGANS$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS$DERMATOLOGICALS$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$SENSORY ORGANS$DERMATOLOGICALS$SENSORY ORGANS"
705944,36919066,1.81E-19,8.31E-12,adult_children_senior_youth,children,methylphenidate,disturbance in social behaviour,Psychiatric disorders,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
1786055,35809059,1.88E-19,8.62E-12,adult_children_senior_youth,senior,deferasirox,death,General disorders and administration site conditions,Iron chelating agents,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,VARIOUS
19034726,36416638,1.92E-19,8.82E-12,adult_children_senior_youth,children,sirolimus,hyperlipidaemia,Metabolism and nutrition disorders,$Other ophthalmologicals$Selective immunosuppressants,$OTHER OPHTHALMOLOGICALS$IMMUNOSUPPRESSANTS,$OPHTHALMOLOGICALS$IMMUNOSUPPRESSANTS,$SENSORY ORGANS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1103314,35506459,2.08E-19,9.55E-12,adult_senior_youth,youth,tramadol,adrenal insufficiency,$Endocrine disorders$Metabolism and nutrition disorders,$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Other opioids,$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
735979,35506610,2.09E-19,9.58E-12,adult_children_senior_youth,adult,risperidone,diabetes mellitus inadequate control,Endocrine disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
717607,36211496,2.12E-19,9.74E-12,adult_children_senior_youth,youth,desvenlafaxine,overdose,"Injury, poisoning and procedural complications",Other antidepressants,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
44814284,35204966,2.21E-19,1.02E-11,adult_children_senior_youth,children,acetaminophen / oxycodone Extended Release Oral Tablet,cardiac arrest,Cardiac disorders,0,0,0,0
785649,36110716,2.26E-19,1.04E-11,adult_senior_youth,youth,ketamine,cystitis,Infections and infestations,Other general anesthetics,"ANESTHETICS, GENERAL",ANESTHETICS,NERVOUS SYSTEM
715939,36416600,2.27E-19,1.04E-11,adult_children_senior_youth,senior,escitalopram,hyponatraemia,Metabolism and nutrition disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
722424,36718005,2.28E-19,1.05E-11,adult_senior_youth,senior,interferon beta-1a,cerebrovascular accident,Vascular disorders,Interferons,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1000560,35809076,2.28E-19,1.05E-11,adult_children_senior_youth,senior,ondansetron,fatigue,General disorders and administration site conditions,Serotonin (5HT3) antagonists,ANTIEMETICS AND ANTINAUSEANTS,ANTIEMETICS AND ANTINAUSEANTS,ALIMENTARY TRACT AND METABOLISM
1309944,37622442,2.37E-19,1.09E-11,adult_children_senior_youth,children,amiodarone,circulatory collapse,Vascular disorders,"Antiarrhythmics, class III","ANTIARRHYTHMICS, CLASS I AND III",CARDIAC THERAPY,CARDIOVASCULAR SYSTEM
723013,36211492,2.37E-19,1.09E-11,adult_children_senior_youth,youth,diazepam,intentional overdose,"Injury, poisoning and procedural complications",Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1315942,35205230,2.39E-19,1.10E-11,adult_children_senior_youth,youth,docetaxel,ascites,Gastrointestinal disorders,Taxanes,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1151789,43562827,2.40E-19,1.10E-11,adult_children_senior_youth,children,etanercept,pneumocystis jirovecii pneumonia,Infections and infestations,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1310317,35708642,2.42E-19,1.11E-11,adult_children_senior_youth,youth,cyclophosphamide,stomatitis,Gastrointestinal disorders,Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1373928,35809221,2.44E-19,1.12E-11,adult_children_senior_youth,children,hydralazine,generalised oedema,$General disorders and administration site conditions$Metabolism and nutrition disorders,$Hydrazinophthalazine derivatives$Hydrazinophthalazine derivatives and diuretics,"$ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON$ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",$ANTIHYPERTENSIVES$ANTIHYPERTENSIVES,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1742253,35809310,2.51E-19,1.15E-11,adult_children_senior_youth,senior,levofloxacin,drug interaction,General disorders and administration site conditions,$Fluoroquinolones$Combinations for eradication of Helicobacter pylori$Combinations of antibacterials$Fluoroquinolones,$QUINOLONE ANTIBACTERIALS$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$COMBINATIONS OF ANTIBACTERIALS$ANTIINFECTIVES,$ANTIBACTERIALS FOR SYSTEMIC USE$DRUGS FOR ACID RELATED DISORDERS$ANTIBACTERIALS FOR SYSTEMIC USE$OPHTHALMOLOGICALS,$ANTIINFECTIVES FOR SYSTEMIC USE$ALIMENTARY TRACT AND METABOLISM$ANTIINFECTIVES FOR SYSTEMIC USE$SENSORY ORGANS
1036525,37320158,2.51E-19,1.15E-11,adult_children_senior_youth,children,sulfur,erythema,Skin and subcutaneous tissue disorders,0,0,0,0
1112807,37219804,2.58E-19,1.18E-11,adult_children_senior,senior,aspirin,chronic obstructive pulmonary disease,"Respiratory, thoracic and mediastinal disorders",0,0,0,0
1151789,37219959,2.60E-19,1.20E-11,adult_children_senior_youth,children,etanercept,rhinorrhoea,"Respiratory, thoracic and mediastinal disorders",Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1114220,36313176,2.61E-19,1.20E-11,adult_children_senior_youth,senior,naloxone,platelet count decreased,Investigations,$Peripheral opioid receptor antagonists$Natural opium alkaloids$Antidotes$Natural opium alkaloids,$DRUGS FOR CONSTIPATION$OPIOIDS$ALL OTHER THERAPEUTIC PRODUCTS$OPIOIDS,$DRUGS FOR CONSTIPATION$ANALGESICS$ALL OTHER THERAPEUTIC PRODUCTS$ANALGESICS,$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM$VARIOUS$NERVOUS SYSTEM
1502905,36718175,2.78E-19,1.27E-11,adult_children_senior_youth,senior,insulin glargine,memory impairment,$Nervous system disorders$Psychiatric disorders,"$Insulins and analogues for injection, long-acting$Insulins and analogues for injection, long-acting",$INSULINS AND ANALOGUES$INSULINS AND ANALOGUES,$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
19010482,36009892,2.80E-19,1.29E-11,adult_children_senior_youth,children,cyclosporine,acute graft versus host disease in skin,"Injury, poisoning and procedural complications",$Calcineurin inhibitors$Other ophthalmologicals,$IMMUNOSUPPRESSANTS$OTHER OPHTHALMOLOGICALS,$IMMUNOSUPPRESSANTS$OPHTHALMOLOGICALS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$SENSORY ORGANS
1597756,35506636,2.85E-19,1.31E-11,adult_children_senior_youth,children,glimepiride,hypoglycaemia,Endocrine disorders,$Combinations of oral blood glucose lowering drugs$Sulfonylureas$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
766814,36416638,3.00E-19,1.38E-11,adult_children_senior_youth,adult,quetiapine,hyperlipidaemia,Metabolism and nutrition disorders,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
40241331,37119745,3.06E-19,1.40E-11,adult_children_senior_youth,youth,rivaroxaban,vaginal haemorrhage,Reproductive system and breast disorders,Direct factor Xa inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1343916,35809148,3.14E-19,1.44E-11,adult_children_senior_youth,senior,epinephrine,multi-organ failure,0,"$Other agents for local oral treatment$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Local hemostatics$Adrenergic and dopaminergic agents$Sympathomimetics in glaucoma therapy$Sympathomimetics, plain$Alpha- and beta-adrenoreceptor agonists$Sympathomimetics in glaucoma therapy","$STOMATOLOGICAL PREPARATIONS$ADRENERGICS, INHALANTS$VITAMIN K AND OTHER HEMOSTATICS$CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES$ANTIGLAUCOMA PREPARATIONS AND MIOTICS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ADRENERGICS, INHALANTS$ANTIGLAUCOMA PREPARATIONS AND MIOTICS",$STOMATOLOGICAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$ANTIHEMORRHAGICS$CARDIAC THERAPY$OPHTHALMOLOGICALS$NASAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OPHTHALMOLOGICALS,$ALIMENTARY TRACT AND METABOLISM$RESPIRATORY SYSTEM$BLOOD AND BLOOD FORMING ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$SENSORY ORGANS
1762711,35607430,3.15E-19,1.44E-11,adult_children_senior,senior,ribavirin,retinopathy,Eye disorders,Antivirals for treatment of HCV infections,DIRECT ACTING ANTIVIRALS,ANTIVIRALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
40171288,35809120,3.18E-19,1.46E-11,adult_children_senior_youth,children_youth,tocilizumab,disease progression,General disorders and administration site conditions,Interleukin inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1305058,36316186,3.22E-19,1.48E-11,adult_children_senior_youth,youth,methotrexate,drug level increased,Investigations,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1395557,35104397,3.41E-19,1.56E-11,adult_children_senior_youth,senior,fludarabine,myelodysplastic syndrome,Blood and lymphatic system disorders,Purine analogues,ANTIMETABOLITES,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
743670,35205305,3.49E-19,1.60E-11,adult_children_senior,children,venlafaxine,atrial septal defect,Cardiac disorders,Other antidepressants,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
19011440,35809059,3.59E-19,1.65E-11,adult_children_senior_youth,senior,everolimus,death,General disorders and administration site conditions,$Protein kinase inhibitors$Selective immunosuppressants,$OTHER ANTINEOPLASTIC AGENTS$IMMUNOSUPPRESSANTS,$ANTINEOPLASTIC AGENTS$IMMUNOSUPPRESSANTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1107830,45885695,3.92E-19,1.80E-11,adult_children_senior_youth,children,loratadine,expired product administered,"Injury, poisoning and procedural complications",Other antihistamines for systemic use,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,RESPIRATORY SYSTEM
749910,37219893,3.94E-19,1.81E-11,adult_children_senior_youth,youth,carisoprodol,respiratory arrest,"Respiratory, thoracic and mediastinal disorders",$Carbamic acid esters$Carbamic acid esters$Carbamic acid esters,"$MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS$MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS$MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",$MUSCLE RELAXANTS$MUSCLE RELAXANTS$MUSCLE RELAXANTS,$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
1314002,36416485,3.99E-19,1.83E-11,adult_children_senior_youth,children,atenolol,lactic acidosis,Metabolism and nutrition disorders,"$Beta blocking agents, selective, and other diuretics$Beta blocking agents, selective$Beta blocking agents and calcium channel blockers$Beta blocking agents, selective, thiazides and other diuretics$Beta blocking agents, selective, and thiazides$Beta blocking agents, selective, and other diuretics","$BETA BLOCKING AGENTS AND OTHER DIURETICS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS AND OTHER DIURETICS",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1101898,36009738,4.15E-19,1.90E-11,adult_senior_youth,youth,leflunomide,drug hypersensitivity,Immune system disorders,Selective immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1510813,36919230,4.35E-19,2.00E-11,adult_senior_youth,youth,rosuvastatin,completed suicide,General disorders and administration site conditions,"$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors$Dipeptidyl peptidase 4 (DPP-4) inhibitors$Sulfonamides$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents","$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, PLAIN$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS",$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$DRUGS USED IN DIABETES$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$ALIMENTARY TRACT AND METABOLISM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
981709,36315155,4.46E-19,2.05E-11,adult_children_senior_youth,youth,dorzolamide,intraocular pressure increased,Investigations,$Sulfonamides$Carbonic anhydrase inhibitors,"$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$ANTIGLAUCOMA PREPARATIONS AND MIOTICS",$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$OPHTHALMOLOGICALS,$GENITO URINARY SYSTEM AND SEX HORMONES$SENSORY ORGANS
740275,36416600,4.65E-19,2.13E-11,adult_children_senior_youth,senior,carbamazepine,hyponatraemia,Metabolism and nutrition disorders,Carboxamide derivatives,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
1305058,36718526,4.72E-19,2.17E-11,adult_children_senior_youth,children,methotrexate,convulsion,0,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
19078219,36211303,4.73E-19,2.17E-11,adult_senior,senior,sufentanil,injury,"Injury, poisoning and procedural complications",Opioid anesthetics,"ANESTHETICS, GENERAL",ANESTHETICS,NERVOUS SYSTEM
1501700,35205305,4.81E-19,2.21E-11,adult_children_senior_youth,children,levothyroxine,atrial septal defect,Cardiac disorders,Thyroid hormones,THYROID PREPARATIONS,THYROID THERAPY,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
1315942,36617295,5.00E-19,2.29E-11,adult_children_senior_youth,youth,docetaxel,malignant neoplasm progression,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Taxanes,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1125315,35909611,5.41E-19,2.48E-11,adult_children_senior_youth,children_youth,acetaminophen,hepatic necrosis,Hepatobiliary disorders,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1524674,35506742,5.42E-19,2.49E-11,adult_children_senior_youth,youth,zoledronic acid,hypercalcaemia,Metabolism and nutrition disorders,"$Bisphosphonates, combinations$Bisphosphonates",$DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION$DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,$DRUGS FOR TREATMENT OF BONE DISEASES$DRUGS FOR TREATMENT OF BONE DISEASES,$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
703244,36312331,5.45E-19,2.50E-11,adult_children_senior_youth,children_youth,paliperidone,blood prolactin increased,Investigations,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1129625,35204970,5.47E-19,2.51E-11,adult_children_senior_youth,youth,diphenhydramine,cardio-respiratory arrest,Cardiac disorders,$Antihistamines for topical use$Aminoalkyl ethers$Antihistamines for topical use$Aminoalkyl ethers,"$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ANTIHISTAMINES FOR SYSTEMIC USE$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ANTIHISTAMINES FOR SYSTEMIC USE","$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ANTIHISTAMINES FOR SYSTEMIC USE$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ANTIHISTAMINES FOR SYSTEMIC USE",$DERMATOLOGICALS$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM
1153428,37219871,5.63E-19,2.59E-11,adult_senior_youth,youth,fexofenadine,pulmonary embolism,"$Respiratory, thoracic and mediastinal disorders$Vascular disorders",Other antihistamines for systemic use,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,RESPIRATORY SYSTEM
778711,36416487,5.68E-19,2.61E-11,adult_senior_youth,youth,cyclobenzaprine,metabolic acidosis,Metabolism and nutrition disorders,Other centrally acting agents,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",MUSCLE RELAXANTS,MUSCULO-SKELETAL SYSTEM
1167322,36416589,5.69E-19,2.61E-11,adult_children_senior_youth,children_youth,allopurinol,tumour lysis syndrome,"$Metabolism and nutrition disorders$Neoplasms benign, malignant and unspecified (incl cysts and polyps)",$Preparations inhibiting uric acid production$Preparations inhibiting uric acid production,$ANTIGOUT PREPARATIONS$ANTIGOUT PREPARATIONS,$ANTIGOUT PREPARATIONS$ANTIGOUT PREPARATIONS,$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
722031,35809310,5.88E-19,2.70E-11,adult_children_senior_youth,senior,paroxetine,drug interaction,General disorders and administration site conditions,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
701322,36718119,5.94E-19,2.73E-11,adult_children_senior,children,memantine,encephalopathy,Nervous system disorders,$Anticholinesterases$Other anti-dementia drugs$Anticholinesterases,$ANTI-DEMENTIA DRUGS$ANTI-DEMENTIA DRUGS$ANTI-DEMENTIA DRUGS,$PSYCHOANALEPTICS$PSYCHOANALEPTICS$PSYCHOANALEPTICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
800878,35104883,6.03E-19,2.77E-11,adult_children_senior_youth,children,clozapine,neutropenia,Blood and lymphatic system disorders,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1309944,35707864,6.12E-19,2.81E-11,adult_children_senior_youth,senior,amiodarone,gastrointestinal haemorrhage,Gastrointestinal disorders,"Antiarrhythmics, class III","ANTIARRHYTHMICS, CLASS I AND III",CARDIAC THERAPY,CARDIOVASCULAR SYSTEM
1103314,36718321,6.21E-19,2.85E-11,adult_children_senior_youth,children,tramadol,somnolence,Nervous system disorders,$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Other opioids,$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1125315,36918984,6.41E-19,2.94E-11,adult_children_senior_youth,children,acetaminophen,hallucination,Psychiatric disorders,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1337068,35708208,6.52E-19,2.99E-11,adult_children_senior_youth,children_youth,ambrisentan,vomiting,Gastrointestinal disorders,$Antihypertensives for pulmonary arterial hypertension$Antihypertensives for pulmonary arterial hypertension,$OTHER ANTIHYPERTENSIVES$OTHER ANTIHYPERTENSIVES,$ANTIHYPERTENSIVES$ANTIHYPERTENSIVES,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1334456,37622446,6.77E-19,3.11E-11,adult_senior_youth,youth,ramipril,shock,Vascular disorders,"$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and diuretics$ACE inhibitors, plain","$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, PLAIN",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1337068,35809166,6.79E-19,3.12E-11,adult_children_senior_youth,senior,ambrisentan,swelling,General disorders and administration site conditions,$Antihypertensives for pulmonary arterial hypertension$Antihypertensives for pulmonary arterial hypertension,$OTHER ANTIHYPERTENSIVES$OTHER ANTIHYPERTENSIVES,$ANTIHYPERTENSIVES$ANTIHYPERTENSIVES,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1149196,43053920,6.86E-19,3.15E-11,adult_children_senior_youth,children,cetirizine,accidental exposure to product,"Injury, poisoning and procedural complications",Piperazine derivatives,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,RESPIRATORY SYSTEM
745466,36718526,6.90E-19,3.17E-11,adult_children_senior_youth,children_youth,valproate,convulsion,0,0,0,0,0
735979,36919236,7.02E-19,3.22E-11,adult_children_senior_youth,youth,risperidone,suicide attempt,Psychiatric disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
715458,36919230,7.08E-19,3.25E-11,adult_senior_youth,senior_youth,tiagabine,completed suicide,General disorders and administration site conditions,Fatty acid derivatives,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
1124957,36718317,7.19E-19,3.30E-11,adult_children_senior_youth,children_youth,oxycodone,loss of consciousness,Nervous system disorders,$Natural opium alkaloids$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
19010482,36516888,7.19E-19,3.30E-11,adult_children_senior_youth,senior,cyclosporine,rhabdomyolysis,Musculoskeletal and connective tissue disorders,$Calcineurin inhibitors$Other ophthalmologicals,$IMMUNOSUPPRESSANTS$OTHER OPHTHALMOLOGICALS,$IMMUNOSUPPRESSANTS$OPHTHALMOLOGICALS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$SENSORY ORGANS
1354118,35506786,7.96E-19,3.65E-11,adult_children_senior_youth,children_youth,epoprostenol,basedow's disease,$Endocrine disorders$Eye disorders$Immune system disorders,Platelet aggregation inhibitors excl. heparin,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
953076,36211491,8.15E-19,3.74E-11,adult_children_senior_youth,children,famotidine,accidental overdose,"Injury, poisoning and procedural complications",$H2-receptor antagonists$H2-receptor antagonists,$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
711584,36718510,8.32E-19,3.82E-11,adult_children_senior_youth,youth,levetiracetam,grand mal convulsion,0,Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
1334456,36211496,8.43E-19,3.87E-11,adult_children_senior_youth,youth,ramipril,overdose,"Injury, poisoning and procedural complications","$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and diuretics$ACE inhibitors, plain","$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, PLAIN",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1151789,36416534,8.52E-19,3.91E-11,adult_children_senior_youth,children,etanercept,obesity,Metabolism and nutrition disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
755695,36416600,8.58E-19,3.94E-11,adult_children_senior_youth,senior,fluoxetine,hyponatraemia,Metabolism and nutrition disorders,$Antidepressants in combination with psycholeptics$Selective serotonin reuptake inhibitors,$PSYCHOLEPTICS AND PSYCHOANALEPTICS IN COMBINATION$ANTIDEPRESSANTS,$PSYCHOANALEPTICS$PSYCHOANALEPTICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
43013024,37622518,8.86E-19,4.07E-11,adult_children_senior_youth,children,apixaban,haemorrhage,Vascular disorders,Direct factor Xa inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
40239330,35809076,9.07E-19,4.17E-11,adult_children_senior_youth,youth,telaprevir,fatigue,General disorders and administration site conditions,Antivirals for treatment of HCV infections,DIRECT ACTING ANTIVIRALS,ANTIVIRALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
1305058,35809323,9.35E-19,4.29E-11,adult_children_senior_youth,adult,methotrexate,drug effect decreased,General disorders and administration site conditions,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1322184,35205172,9.57E-19,4.39E-11,adult_children_senior,adult,clopidogrel,coronary artery stenosis,Vascular disorders,Platelet aggregation inhibitors excl. heparin,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1518254,35205038,9.68E-19,4.44E-11,adult_children_senior_youth,adult_senior,dexamethasone,dyspnoea,"$Cardiac disorders$Respiratory, thoracic and mediastinal disorders","$Corticosteroids$Corticosteroids, moderately potent, other combinations$Corticosteroids$Corticosteroids, combinations for treatment of acne$Corticosteroids/antiinfectives/mydriatics in combination$Corticosteroids and antiinfectives in combination$Corticosteroids and antiinfectives in combination$Corticosteroids$Corticosteroids and antiinfectives in combination$Corticosteroids, moderately potent, combinations with antibiotics$Glucocorticoids$Corticosteroids, plain$Corticosteroids for local oral treatment$Corticosteroids$Corticosteroids, moderately potent (group II)$Corticosteroids","$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$CORTICOSTEROIDS, OTHER COMBINATIONS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$ANTIINFLAMMATORY AGENTS$STOMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS$CORTICOSTEROIDS, PLAIN$CORTICOSTEROIDS","$NASAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$NASAL PREPARATIONS$ANTI-ACNE PREPARATIONS$OPHTHALMOLOGICALS$OTOLOGICALS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$VASOPROTECTIVES$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS FOR SYSTEMIC USE$OPHTHALMOLOGICALS$STOMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OTOLOGICALS","$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$DERMATOLOGICALS$SENSORY ORGANS$SENSORY ORGANS$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS$DERMATOLOGICALS$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$SENSORY ORGANS$DERMATOLOGICALS$SENSORY ORGANS"
912263,35809059,9.89E-19,4.54E-11,adult_children_senior,senior,certolizumab pegol,death,General disorders and administration site conditions,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1310317,36516851,9.94E-19,4.56E-11,adult_children_senior,senior,cyclophosphamide,muscle twitching,Musculoskeletal and connective tissue disorders,Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
19026972,35104669,9.99E-19,4.59E-11,adult_children_senior,adult,lenalidomide,plasmacytoma,"$Blood and lymphatic system disorders$Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Other immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1119510,42889647,1.01E-18,4.66E-11,adult_children_senior_youth,youth,dextromethorphan,toxicity to various agents,"Injury, poisoning and procedural complications",$Opium alkaloids and derivatives$Other nervous system drugs,"$COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS$OTHER NERVOUS SYSTEM DRUGS",$COUGH AND COLD PREPARATIONS$OTHER NERVOUS SYSTEM DRUGS,$RESPIRATORY SYSTEM$NERVOUS SYSTEM
735979,35506577,1.02E-18,4.69E-11,adult_children_youth,adult_youth,risperidone,amenorrhoea,$Endocrine disorders$Reproductive system and breast disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1636780,36312388,1.02E-18,4.68E-11,adult_children_senior_youth,children,testosterone,blood testosterone increased,Investigations,$3-oxoandrosten (4) derivatives$Androgens and estrogens,$ANDROGENS$ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
19111620,35104877,1.03E-18,4.73E-11,adult_children_senior_youth,senior,folic acid,febrile neutropenia,General disorders and administration site conditions,$Iron in other combinations$Folic acid and derivatives$Iron in other combinations$Folic acid and derivatives,$IRON PREPARATIONS$VITAMIN B12 AND FOLIC ACID$IRON PREPARATIONS$VITAMIN B12 AND FOLIC ACID,$ANTIANEMIC PREPARATIONS$ANTIANEMIC PREPARATIONS$ANTIANEMIC PREPARATIONS$ANTIANEMIC PREPARATIONS,$BLOOD AND BLOOD FORMING ORGANS$BLOOD AND BLOOD FORMING ORGANS$BLOOD AND BLOOD FORMING ORGANS$BLOOD AND BLOOD FORMING ORGANS
1154161,36919068,1.03E-18,4.74E-11,adult_children_senior_youth,children,montelukast,homicidal ideation,Psychiatric disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
734275,36919230,1.05E-18,4.81E-11,adult_senior_youth,adult,phenobarbital,completed suicide,General disorders and administration site conditions,"$Barbiturates, combinations$Barbiturates and derivatives",$HYPNOTICS AND SEDATIVES$ANTIEPILEPTICS,$PSYCHOLEPTICS$ANTIEPILEPTICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
40241331,35305425,1.05E-18,4.82E-11,adult_senior,senior,rivaroxaban,haemorrhagic arteriovenous malformation,"Congenital, familial and genetic disorders",Direct factor Xa inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
40222444,36517076,1.06E-18,4.84E-11,adult_children_senior,adult,denosumab,metastases to bone,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Other drugs affecting bone structure and mineralization,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,DRUGS FOR TREATMENT OF BONE DISEASES,MUSCULO-SKELETAL SYSTEM
708298,37019321,1.07E-18,4.93E-11,adult_children_senior_youth,senior,midazolam,renal impairment,Renal and urinary disorders,Benzodiazepine derivatives,HYPNOTICS AND SEDATIVES,PSYCHOLEPTICS,NERVOUS SYSTEM
1301267,36009892,1.13E-18,5.20E-11,adult_children_senior_youth,children_youth,melphalan,acute graft versus host disease in skin,"Injury, poisoning and procedural complications",Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1110410,35204966,1.18E-18,5.41E-11,adult_children_senior_youth,youth,morphine,cardiac arrest,Cardiac disorders,$Antipropulsives$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with antispasmodics,$ANTIPROPULSIVES$OPIOIDS$OPIOIDS$OPIOIDS,"$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$ANALGESICS$ANALGESICS$ANALGESICS",$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1305058,36918942,1.19E-18,5.45E-11,adult_children_senior_youth,adult,methotrexate,depression,Psychiatric disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
19080458,37019321,1.19E-18,5.45E-11,adult_children_senior_youth,children_youth,eculizumab,renal impairment,Renal and urinary disorders,Selective immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1305058,35707714,1.20E-18,5.50E-11,adult_children_senior_youth,children,methotrexate,pancreatitis acute,Gastrointestinal disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
923645,35809243,1.21E-18,5.54E-11,adult_children_senior_youth,youth,omeprazole,pain,General disorders and administration site conditions,$Proton pump inhibitors$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori,$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
753626,35809243,1.30E-18,5.96E-11,adult_children_senior_youth,senior,propofol,pain,General disorders and administration site conditions,Other general anesthetics,"ANESTHETICS, GENERAL",ANESTHETICS,NERVOUS SYSTEM
961047,36211496,1.32E-18,6.04E-11,adult_children_senior_youth,children,ranitidine,overdose,"Injury, poisoning and procedural complications",$H2-receptor antagonists$H2-receptor antagonists,$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1551099,35707866,1.33E-18,6.10E-11,adult_children_senior_youth,youth,prednisone,haematochezia,Gastrointestinal disorders,$Corticosteroids acting locally$Glucocorticoids,"$INTESTINAL ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN","$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE","$ALIMENTARY TRACT AND METABOLISM$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
1177480,35909452,1.41E-18,6.47E-11,adult_children_senior_youth,youth,ibuprofen,gallbladder disorder,Hepatobiliary disorders,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
1115008,36211303,1.43E-18,6.55E-11,adult_children_senior_youth,youth,naproxen,injury,"Injury, poisoning and procedural complications","$Antiinflammatory products for vaginal administration$Antiinflammatory preparations, non-steroids for topical use$Propionic acid derivatives$Propionic acid derivatives$Propionic acid derivatives","$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
975125,35808914,1.44E-18,6.63E-11,adult_children_senior_youth,youth,hydrocortisone,infusion related reaction,Immune system disorders,"$Corticosteroids/antiinfectives/mydriatics in combination$Corticosteroids for local oral treatment$Corticosteroids, plain$Corticosteroids and antiinfectives in combination$Corticosteroids, weak (group I)$Corticosteroids and mydriatics in combination$Corticosteroids, weak, other combinations$Corticosteroids, weak, combinations with antiseptics$Corticosteroids and antiinfectives in combination$Corticosteroids acting locally$Corticosteroids$Corticosteroids$Glucocorticoids$Corticosteroids, weak, combinations with antibiotics$Corticosteroids and antiinfectives in combination$Corticosteroids","$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$STOMATOLOGICAL PREPARATIONS$ANTIINFLAMMATORY AGENTS$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS, PLAIN$ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS, OTHER COMBINATIONS$CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$INTESTINAL ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE","$OPHTHALMOLOGICALS$STOMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OTOLOGICALS$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$OTOLOGICALS$NASAL PREPARATIONS$CORTICOSTEROIDS FOR SYSTEMIC USE$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$VASOPROTECTIVES","$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$SENSORY ORGANS$SENSORY ORGANS$DERMATOLOGICALS$SENSORY ORGANS$DERMATOLOGICALS$DERMATOLOGICALS$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$SENSORY ORGANS$RESPIRATORY SYSTEM$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$DERMATOLOGICALS$SENSORY ORGANS$CARDIOVASCULAR SYSTEM"
722424,36211197,1.45E-18,6.68E-11,adult_children_youth,children,interferon beta-1a,maternal drugs affecting foetus,"Injury, poisoning and procedural complications",Interferons,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
40228152,37622460,1.45E-18,6.66E-11,adult_children_senior_youth,adult_children,dabigatran etexilate,thrombosis,Vascular disorders,Direct thrombin inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1502905,35406369,1.46E-18,6.72E-11,adult_senior_youth,senior,insulin glargine,hypoacusis,Ear and labyrinth disorders,"$Insulins and analogues for injection, long-acting$Insulins and analogues for injection, long-acting",$INSULINS AND ANALOGUES$INSULINS AND ANALOGUES,$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
800878,36718323,1.48E-18,6.82E-11,adult_children_senior_youth,senior,clozapine,sopor,Nervous system disorders,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1115008,36314856,1.49E-18,6.84E-11,adult_children_senior,children,naproxen,bone density decreased,Investigations,"$Antiinflammatory products for vaginal administration$Antiinflammatory preparations, non-steroids for topical use$Propionic acid derivatives$Propionic acid derivatives$Propionic acid derivatives","$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
1151789,37522270,1.49E-18,6.83E-11,adult_children_senior_youth,senior,etanercept,surgery,Surgical and medical procedures,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
703547,36718458,1.51E-18,6.95E-11,adult_children_senior_youth,youth,trazodone,serotonin syndrome,"Injury, poisoning and procedural complications",Other antidepressants,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
964339,36516779,1.52E-18,6.97E-11,adult_children_senior_youth,children,sulfasalazine,arthritis,Musculoskeletal and connective tissue disorders,$Sulfonamides$Aminosalicylic acid and similar agents,"$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$INTESTINAL ANTIINFLAMMATORY AGENTS","$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",$GENITO URINARY SYSTEM AND SEX HORMONES$ALIMENTARY TRACT AND METABOLISM
912263,35707700,1.62E-18,7.45E-11,adult_senior,senior,certolizumab pegol,diverticulitis,Gastrointestinal disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1781406,35104883,1.67E-18,7.68E-11,adult_children_senior_youth,children,stavudine,neutropenia,Blood and lymphatic system disorders,"$Nucleoside and nucleotide reverse transcriptase inhibitors$Antivirals for treatment of HIV infections, combinations",$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS,$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
1154343,35708156,1.70E-18,7.82E-11,adult_children_senior_youth,youth,albuterol,abdominal pain upper,Gastrointestinal disorders,0,0,0,0
1326303,36416610,1.73E-18,7.92E-11,adult_children_senior_youth,adult,digoxin,fluid retention,Renal and urinary disorders,Digitalis glycosides,CARDIAC GLYCOSIDES,CARDIAC THERAPY,CARDIOVASCULAR SYSTEM
1129625,35104877,1.76E-18,8.08E-11,adult_children_senior_youth,children,diphenhydramine,febrile neutropenia,General disorders and administration site conditions,$Antihistamines for topical use$Aminoalkyl ethers$Antihistamines for topical use$Aminoalkyl ethers,"$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ANTIHISTAMINES FOR SYSTEMIC USE$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ANTIHISTAMINES FOR SYSTEMIC USE","$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ANTIHISTAMINES FOR SYSTEMIC USE$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ANTIHISTAMINES FOR SYSTEMIC USE",$DERMATOLOGICALS$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM
1786055,35104351,1.78E-18,8.19E-11,adult_children_senior_youth,senior,deferasirox,acute myeloid leukaemia,Blood and lymphatic system disorders,Iron chelating agents,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,VARIOUS
766814,36718256,1.79E-18,8.21E-11,adult_senior,senior,quetiapine,parkinson's disease,Nervous system disorders,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1308290,36313476,1.79E-18,8.22E-11,adult_children_senior_youth,senior,vincristine,white blood cell count decreased,Investigations,Vinca alkaloids and analogues,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
722031,37219942,1.80E-18,8.26E-11,adult_children_senior_youth,children,paroxetine,lung disorder,"Respiratory, thoracic and mediastinal disorders",Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1177480,36211491,1.85E-18,8.48E-11,adult_children_senior_youth,children,ibuprofen,accidental overdose,"Injury, poisoning and procedural complications","$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
1636780,37320312,1.85E-18,8.50E-11,adult_children_senior_youth,children,testosterone,hair growth abnormal,Skin and subcutaneous tissue disorders,$3-oxoandrosten (4) derivatives$Androgens and estrogens,$ANDROGENS$ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1550557,36516749,1.88E-18,8.64E-11,adult_children_senior_youth,youth,prednisolone,osteonecrosis,Vascular disorders,"$Corticosteroids, weak (group I)$Corticosteroids and antiinfectives in combination$Corticosteroids, weak, other combinations$Corticosteroids for local oral treatment$Corticosteroids$Corticosteroids and mydriatics in combination$Corticosteroids$Corticosteroids/antiinfectives/mydriatics in combination$Antidotes$Corticosteroids$Corticosteroids, weak, combinations with antiseptics$Corticosteroids, weak, combinations with antibiotics$Corticosteroids, plain$Corticosteroids$Corticosteroids acting locally$Glucocorticoids$Corticosteroids and antiinfectives in combination$Corticosteroids$Corticosteroids and antiinfectives in combination","$CORTICOSTEROIDS, PLAIN$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS, OTHER COMBINATIONS$STOMATOLOGICAL PREPARATIONS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$ALL OTHER THERAPEUTIC PRODUCTS$CORTICOSTEROIDS$CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS$INTESTINAL ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION","$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$STOMATOLOGICAL PREPARATIONS$NASAL PREPARATIONS$OPHTHALMOLOGICALS$NASAL PREPARATIONS$OPHTHALMOLOGICALS$ALL OTHER THERAPEUTIC PRODUCTS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS$OTOLOGICALS$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE$OTOLOGICALS$VASOPROTECTIVES$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS","$DERMATOLOGICALS$SENSORY ORGANS$DERMATOLOGICALS$ALIMENTARY TRACT AND METABOLISM$RESPIRATORY SYSTEM$SENSORY ORGANS$RESPIRATORY SYSTEM$SENSORY ORGANS$VARIOUS$SENSORY ORGANS$DERMATOLOGICALS$DERMATOLOGICALS$SENSORY ORGANS$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS"
735979,36918985,1.90E-18,8.72E-11,adult_children_senior_youth,youth,risperidone,"hallucination, auditory",Psychiatric disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1559684,35506636,1.90E-18,8.71E-11,adult_children_senior_youth,children_youth,glibenclamide,hypoglycaemia,Endocrine disorders,0,0,0,0
1331235,35205189,1.91E-18,8.76E-11,adult_senior,adult,quinapril,myocardial infarction,Vascular disorders,"$ACE inhibitors, plain$ACE inhibitors and diuretics","$ACE INHIBITORS, PLAIN$ACE INHIBITORS, COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1134439,36211491,1.92E-18,8.83E-11,adult_children_youth,youth,caffeine,accidental overdose,"Injury, poisoning and procedural complications",$Xanthines$Tests for gastric secretion$Xanthine derivatives,"$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER DIAGNOSTIC AGENTS$PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DIAGNOSTIC AGENTS$PSYCHOANALEPTICS,$RESPIRATORY SYSTEM$VARIOUS$NERVOUS SYSTEM
40241331,37219874,1.94E-18,8.90E-11,adult_children_senior,adult,rivaroxaban,pulmonary thrombosis,"$Respiratory, thoracic and mediastinal disorders$Vascular disorders",Direct factor Xa inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1115008,35909445,1.95E-18,8.94E-11,adult_children_senior_youth,youth,naproxen,cholelithiasis,Hepatobiliary disorders,"$Antiinflammatory products for vaginal administration$Antiinflammatory preparations, non-steroids for topical use$Propionic acid derivatives$Propionic acid derivatives$Propionic acid derivatives","$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
44507580,36516765,1.95E-18,8.95E-11,adult_children_senior_youth,adult_youth,macitentan,pain in jaw,Musculoskeletal and connective tissue disorders,Antihypertensives for pulmonary arterial hypertension,OTHER ANTIHYPERTENSIVES,ANTIHYPERTENSIVES,CARDIOVASCULAR SYSTEM
1351541,35809014,2.03E-18,9.32E-11,adult_children_senior,children,leuprolide,injection site reaction,General disorders and administration site conditions,$Gonadotropin releasing hormone analogues$Gonadotropin releasing hormone analogues,$HORMONES AND RELATED AGENTS$HORMONES AND RELATED AGENTS,$ENDOCRINE THERAPY$ENDOCRINE THERAPY,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1347450,36009762,2.07E-18,9.50E-11,adult_children_senior,senior,alteplase,angioedema,Immune system disorders,$Enzymes$Other ophthalmologicals,$ANTITHROMBOTIC AGENTS$OTHER OPHTHALMOLOGICALS,$ANTITHROMBOTIC AGENTS$OPHTHALMOLOGICALS,$BLOOD AND BLOOD FORMING ORGANS$SENSORY ORGANS
1154332,42889647,2.07E-18,9.49E-11,adult_children_senior_youth,children,pseudoephedrine,toxicity to various agents,"Injury, poisoning and procedural complications",$Sympathomimetics$Sympathomimetics,$NASAL DECONGESTANTS FOR SYSTEMIC USE$NASAL DECONGESTANTS FOR SYSTEMIC USE,$NASAL PREPARATIONS$NASAL PREPARATIONS,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
720810,35809043,2.10E-18,9.65E-11,adult_children_senior_youth,children,pramipexole,neuroleptic malignant syndrome,General disorders and administration site conditions,Dopamine agonists,DOPAMINERGIC AGENTS,ANTI-PARKINSON DRUGS,NERVOUS SYSTEM
1174888,35809131,2.12E-18,9.73E-11,adult_senior_youth,youth,hydrocodone,general physical health deterioration,General disorders and administration site conditions,Opium alkaloids and derivatives,"COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",COUGH AND COLD PREPARATIONS,RESPIRATORY SYSTEM
19078219,36919046,2.32E-18,1.07E-10,adult_senior,senior,sufentanil,emotional distress,Psychiatric disorders,Opioid anesthetics,"ANESTHETICS, GENERAL",ANESTHETICS,NERVOUS SYSTEM
956874,35809148,2.33E-18,1.07E-10,adult_children_senior_youth,children_youth,furosemide,multi-organ failure,0,"$High-ceiling diuretics and potassium-sparing agents$Sulfonamides, plain$Sulfonamides$Sulfonamides and potassium in combination","$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$HIGH-CEILING DIURETICS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$HIGH-CEILING DIURETICS",$DIURETICS$DIURETICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$DIURETICS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
766814,43053904,2.37E-18,1.09E-10,adult_children_youth,children,quetiapine,exposure during pregnancy,"Injury, poisoning and procedural complications","Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
705944,36110642,2.37E-18,1.09E-10,adult_children_senior_youth,senior,methylphenidate,sepsis,Infections and infestations,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
735979,36416599,2.44E-18,1.12E-10,adult_children_senior,senior,risperidone,hypernatraemia,Metabolism and nutrition disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
931973,35205029,2.51E-18,1.15E-10,adult_children_senior_youth,youth,protease,haemoptysis,Cardiac disorders,0,0,0,0
722031,36718353,2.69E-18,1.24E-10,adult_children_senior_youth,youth,paroxetine,crying,"Injury, poisoning and procedural complications",Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1351541,37320268,2.79E-18,1.28E-10,adult_children_senior_youth,youth,leuprolide,alopecia,Skin and subcutaneous tissue disorders,$Gonadotropin releasing hormone analogues$Gonadotropin releasing hormone analogues,$HORMONES AND RELATED AGENTS$HORMONES AND RELATED AGENTS,$ENDOCRINE THERAPY$ENDOCRINE THERAPY,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
937368,36416534,2.84E-18,1.30E-10,adult_children,children,infliximab,obesity,Metabolism and nutrition disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
766814,36918912,2.92E-18,1.34E-10,adult_children_senior_youth,children,quetiapine,catatonia,Psychiatric disorders,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
19111620,36211465,3.10E-18,1.42E-10,adult_children_senior_youth,youth,folic acid,incorrect dose administered,"Injury, poisoning and procedural complications",$Iron in other combinations$Folic acid and derivatives$Iron in other combinations$Folic acid and derivatives,$IRON PREPARATIONS$VITAMIN B12 AND FOLIC ACID$IRON PREPARATIONS$VITAMIN B12 AND FOLIC ACID,$ANTIANEMIC PREPARATIONS$ANTIANEMIC PREPARATIONS$ANTIANEMIC PREPARATIONS$ANTIANEMIC PREPARATIONS,$BLOOD AND BLOOD FORMING ORGANS$BLOOD AND BLOOD FORMING ORGANS$BLOOD AND BLOOD FORMING ORGANS$BLOOD AND BLOOD FORMING ORGANS
735979,36416680,3.15E-18,1.45E-10,adult_children_senior_youth,adult,risperidone,metabolic disorder,Metabolism and nutrition disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
750982,35204970,3.34E-18,1.53E-10,adult_children_senior_youth,youth,bupropion,cardio-respiratory arrest,Cardiac disorders,$Centrally acting antiobesity products$Other antidepressants,"$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$ANTIDEPRESSANTS","$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$PSYCHOANALEPTICS",$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM
19012598,36918858,3.40E-18,1.56E-10,adult_children_senior_youth,senior,vecuronium,anxiety,Psychiatric disorders,Other quaternary ammonium compounds,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",MUSCLE RELAXANTS,MUSCULO-SKELETAL SYSTEM
1397599,37219844,3.46E-18,1.59E-10,adult_children_senior_youth,youth,cisplatin,pulmonary fibrosis,"Respiratory, thoracic and mediastinal disorders",Platinum compounds,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1110942,36009700,3.49E-18,1.60E-10,adult_children_senior_youth,children,omalizumab,asthma,"Respiratory, thoracic and mediastinal disorders",Other systemic drugs for obstructive airway diseases,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,RESPIRATORY SYSTEM
715233,36211219,3.74E-18,1.72E-10,adult_children_senior_youth,children,baclofen,intracranial hypotension,Nervous system disorders,Other centrally acting agents,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",MUSCLE RELAXANTS,MUSCULO-SKELETAL SYSTEM
1119119,36516972,3.86E-18,1.77E-10,adult_senior_youth,senior,adalimumab,musculoskeletal disorder,Musculoskeletal and connective tissue disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
991876,36211491,3.92E-18,1.80E-10,adult_children_senior_youth,youth,loperamide,accidental overdose,"Injury, poisoning and procedural complications",$Antipropulsives$Antipropulsives,$ANTIPROPULSIVES$ANTIPROPULSIVES,"$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1167322,35204953,4.17E-18,1.91E-10,adult_children_senior_youth,senior,allopurinol,atrial fibrillation,Cardiac disorders,$Preparations inhibiting uric acid production$Preparations inhibiting uric acid production,$ANTIGOUT PREPARATIONS$ANTIGOUT PREPARATIONS,$ANTIGOUT PREPARATIONS$ANTIGOUT PREPARATIONS,$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
1310317,37320310,4.19E-18,1.92E-10,adult_senior,adult,cyclophosphamide,hair colour changes,Skin and subcutaneous tissue disorders,Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
723013,36416500,4.20E-18,1.93E-10,adult_children_senior_youth,children,diazepam,respiratory acidosis,Metabolism and nutrition disorders,Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
19003999,36009891,4.30E-18,1.97E-10,adult_children_senior_youth,children,mycophenolate mofetil,acute graft versus host disease,"Injury, poisoning and procedural complications",0,0,0,0
1328165,36919230,4.31E-18,1.98E-10,adult_children_senior_youth,youth,diltiazem,completed suicide,General disorders and administration site conditions,$Benzothiazepine derivatives$Muscle relaxants,$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,$CALCIUM CHANNEL BLOCKERS$VASOPROTECTIVES,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1125315,36009783,4.43E-18,2.03E-10,adult_children_senior_youth,children,acetaminophen,urticaria,Immune system disorders,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
800878,43053920,4.50E-18,2.07E-10,adult_children_senior_youth,senior,clozapine,accidental exposure to product,"Injury, poisoning and procedural complications","Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1344905,35104691,4.57E-18,2.10E-10,adult_children_senior_youth,youth,carboplatin,thrombocytopenia,Blood and lymphatic system disorders,Platinum compounds,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1703687,35809076,4.58E-18,2.10E-10,adult_children_senior_youth,senior,acyclovir,fatigue,General disorders and administration site conditions,$Nucleosides and nucleotides excl. reverse transcriptase inhibitors$Antivirals$Antivirals$Antivirals,$DIRECT ACTING ANTIVIRALS$CHEMOTHERAPEUTICS FOR TOPICAL USE$ANTIINFECTIVES$CHEMOTHERAPEUTICS FOR TOPICAL USE,$ANTIVIRALS FOR SYSTEMIC USE$ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE$OPHTHALMOLOGICALS$ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,$ANTIINFECTIVES FOR SYSTEMIC USE$DERMATOLOGICALS$SENSORY ORGANS$DERMATOLOGICALS
1154161,36919122,4.66E-18,2.14E-10,adult_children_senior_youth,children,montelukast,enuresis,Psychiatric disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
735979,35205240,4.75E-18,2.18E-10,adult_children_senior_youth,senior,risperidone,cardiac failure,Cardiac disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1307046,35204966,4.76E-18,2.19E-10,adult_children_senior_youth,children_youth,metoprolol,cardiac arrest,Cardiac disorders,"$Beta blocking agents and calcium channel blockers$Beta blocking agents, other combinations$Beta blocking agents, other combinations$Beta blocking agents and calcium channel blockers$Beta blocking agents, selective$Beta blocking agents, selective, and thiazides$Beta blocking agents, selective, and other diuretics$Beta blocking agents, selective, and thiazides","$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS AND OTHER DIURETICS$BETA BLOCKING AGENTS AND THIAZIDES",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1125315,36918937,4.76E-18,2.19E-10,adult_children_senior_youth,children,acetaminophen,delirium,Psychiatric disorders,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
904453,35909443,4.79E-18,2.20E-10,adult_children_senior_youth,youth,esomeprazole,cholecystitis chronic,Hepatobiliary disorders,$Combinations for eradication of Helicobacter pylori$Proton pump inhibitors$Propionic acid derivatives,"$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$MUSCULO-SKELETAL SYSTEM
1177480,35909442,5.00E-18,2.30E-10,adult_senior_youth,youth,ibuprofen,cholecystitis acute,Hepatobiliary disorders,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
1115008,36211481,5.01E-18,2.30E-10,adult_children_senior_youth,senior,naproxen,medication error,"Injury, poisoning and procedural complications","$Antiinflammatory products for vaginal administration$Antiinflammatory preparations, non-steroids for topical use$Propionic acid derivatives$Propionic acid derivatives$Propionic acid derivatives","$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
19003999,36110817,5.11E-18,2.35E-10,adult_children_senior_youth,senior,mycophenolate mofetil,cerebral toxoplasmosis,$Infections and infestations$Nervous system disorders,0,0,0,0
705944,36416501,5.15E-18,2.37E-10,adult_children_senior_youth,senior,methylphenidate,respiratory failure,Metabolism and nutrition disorders,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
1524674,36517076,5.16E-18,2.37E-10,adult_children_senior_youth,adult,zoledronic acid,metastases to bone,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","$Bisphosphonates, combinations$Bisphosphonates",$DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION$DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,$DRUGS FOR TREATMENT OF BONE DISEASES$DRUGS FOR TREATMENT OF BONE DISEASES,$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
1308290,35104405,5.50E-18,2.52E-10,adult_children_senior_youth,adult,vincristine,hodgkin's disease,"$Blood and lymphatic system disorders$Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Vinca alkaloids and analogues,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1777087,35606961,5.60E-18,2.57E-10,adult_children_senior_youth,senior,hydroxychloroquine,eye disorder,Eye disorders,Aminoquinolines,ANTIMALARIALS,ANTIPROTOZOALS,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS"
750982,35607306,5.80E-18,2.66E-10,adult_children_senior_youth,children,bupropion,mydriasis,Nervous system disorders,$Centrally acting antiobesity products$Other antidepressants,"$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$ANTIDEPRESSANTS","$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$PSYCHOANALEPTICS",$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM
1149380,37219871,5.89E-18,2.70E-10,adult_children_senior_youth,youth,fluticasone,pulmonary embolism,"$Respiratory, thoracic and mediastinal disorders$Vascular disorders","$Glucocorticoids$Corticosteroids, potent (group III)$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Corticosteroids$Corticosteroids","$OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS$CORTICOSTEROIDS, PLAIN$ADRENERGICS, INHALANTS$ADRENERGICS, INHALANTS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE","$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$NASAL PREPARATIONS$NASAL PREPARATIONS",$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1150871,35205025,5.96E-18,2.73E-10,adult_senior_youth,youth,misoprostol,dizziness,Cardiac disorders,$Prostaglandins$Prostaglandins$Propionic acid derivatives,"$UTEROTONICS$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$DRUGS FOR ACID RELATED DISORDERS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$ALIMENTARY TRACT AND METABOLISM$MUSCULO-SKELETAL SYSTEM
1115008,36110649,6.16E-18,2.83E-10,adult_children_senior_youth,children,naproxen,septic shock,Infections and infestations,"$Antiinflammatory products for vaginal administration$Antiinflammatory preparations, non-steroids for topical use$Propionic acid derivatives$Propionic acid derivatives$Propionic acid derivatives","$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
40241331,35205185,6.23E-18,2.86E-10,adult_children_senior_youth,youth,rivaroxaban,chest pain,"Respiratory, thoracic and mediastinal disorders",Direct factor Xa inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1305058,35708259,6.56E-18,3.01E-10,adult_children_senior_youth,children,methotrexate,oesophageal stenosis,Gastrointestinal disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
19078219,36918858,6.61E-18,3.03E-10,adult_senior_youth,senior,sufentanil,anxiety,Psychiatric disorders,Opioid anesthetics,"ANESTHETICS, GENERAL",ANESTHETICS,NERVOUS SYSTEM
1703687,36718500,6.62E-18,3.04E-10,adult_children_senior_youth,senior,acyclovir,neuropathy peripheral,Nervous system disorders,$Nucleosides and nucleotides excl. reverse transcriptase inhibitors$Antivirals$Antivirals$Antivirals,$DIRECT ACTING ANTIVIRALS$CHEMOTHERAPEUTICS FOR TOPICAL USE$ANTIINFECTIVES$CHEMOTHERAPEUTICS FOR TOPICAL USE,$ANTIVIRALS FOR SYSTEMIC USE$ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE$OPHTHALMOLOGICALS$ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,$ANTIINFECTIVES FOR SYSTEMIC USE$DERMATOLOGICALS$SENSORY ORGANS$DERMATOLOGICALS
923645,35708063,6.68E-18,3.06E-10,adult_children_senior_youth,children_youth,omeprazole,crohn's disease,$Gastrointestinal disorders$Immune system disorders,$Proton pump inhibitors$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori,$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1500211,35205025,6.68E-18,3.07E-10,adult_children_senior_youth,children_youth,medroxyprogesterone,dizziness,Cardiac disorders,0,0,0,0
722031,36919059,6.92E-18,3.17E-10,adult_children_senior_youth,youth,paroxetine,aggression,Psychiatric disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
718583,35708609,6.93E-18,3.18E-10,adult_senior_youth,youth,nicotine,throat irritation,"Respiratory, thoracic and mediastinal disorders",Drugs used in nicotine dependence,DRUGS USED IN ADDICTIVE DISORDERS,OTHER NERVOUS SYSTEM DRUGS,NERVOUS SYSTEM
1547504,35205182,7.19E-18,3.30E-10,adult_senior,adult,rosiglitazone,angina unstable,Vascular disorders,$Combinations of oral blood glucose lowering drugs$Thiazolidinediones$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1125315,36211491,7.28E-18,3.34E-10,adult_children_senior_youth,children,acetaminophen,accidental overdose,"Injury, poisoning and procedural complications",$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1310317,36009895,7.37E-18,3.38E-10,adult_children_senior_youth,children_youth,cyclophosphamide,graft versus host disease,"Injury, poisoning and procedural complications",Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
714785,42889647,7.41E-18,3.40E-10,adult_children_senior_youth,youth,amphetamine,toxicity to various agents,"Injury, poisoning and procedural complications",Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
964339,36516824,7.53E-18,3.46E-10,adult_children_senior,senior,sulfasalazine,osteoarthritis,Musculoskeletal and connective tissue disorders,$Sulfonamides$Aminosalicylic acid and similar agents,"$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$INTESTINAL ANTIINFLAMMATORY AGENTS","$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",$GENITO URINARY SYSTEM AND SEX HORMONES$ALIMENTARY TRACT AND METABOLISM
739138,35205315,8.16E-18,3.74E-10,adult_children_senior_youth,children,sertraline,cardiomegaly,Cardiac disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1526475,35205189,8.29E-18,3.81E-10,adult_children_senior_youth,adult,ezetimibe,myocardial infarction,Vascular disorders,$HMG CoA reductase inhibitors in combination with other lipid modifying agents$HMG CoA reductase inhibitors in combination with other lipid modifying agents$Other lipid modifying agents$HMG CoA reductase inhibitors in combination with other lipid modifying agents,"$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS",$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1545958,35506622,8.40E-18,3.86E-10,adult_children_senior_youth,children,atorvastatin,type 2 diabetes mellitus,Endocrine disorders,"$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations","$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS",$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1154161,36718214,8.45E-18,3.88E-10,adult_children_senior_youth,children,montelukast,psychomotor hyperactivity,Nervous system disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
964407,35809059,8.71E-18,4.00E-10,adult_children_senior_youth,senior,salicylic acid,death,General disorders and administration site conditions,"$Other antifungals for topical use$Salicylic acid and derivatives$Salicylic acid and derivatives$Antiinflammatory agents, non-steroids",$ANTIFUNGALS FOR TOPICAL USE$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$ANTIINFLAMMATORY AGENTS,$ANTIFUNGALS FOR DERMATOLOGICAL USE$ANALGESICS$ANALGESICS$OPHTHALMOLOGICALS,$DERMATOLOGICALS$NERVOUS SYSTEM$NERVOUS SYSTEM$SENSORY ORGANS
740275,36718098,8.72E-18,4.00E-10,adult_senior_youth,senior,carbamazepine,trigeminal neuralgia,Nervous system disorders,Carboxamide derivatives,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
778711,37219871,8.85E-18,4.06E-10,adult_children_senior_youth,youth,cyclobenzaprine,pulmonary embolism,"$Respiratory, thoracic and mediastinal disorders$Vascular disorders",Other centrally acting agents,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",MUSCLE RELAXANTS,MUSCULO-SKELETAL SYSTEM
1386957,36416593,9.02E-18,4.14E-10,adult_children_senior_youth,youth,labetalol,hyperkalaemia,Metabolism and nutrition disorders,$Alpha and beta blocking agents and thiazides$Alpha and beta blocking agents and other diuretics$Alpha and beta blocking agents,$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS AND OTHER DIURETICS$BETA BLOCKING AGENTS,$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
40002705,36211303,9.05E-18,4.15E-10,adult_senior_youth,youth,acetaminophen / hydrocodone Oral Solution,injury,"Injury, poisoning and procedural complications",0,0,0,0
800878,36313437,9.21E-18,4.23E-10,adult_children_senior_youth,adult_senior,clozapine,neutrophil count increased,Investigations,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1347384,35506636,9.41E-18,4.32E-10,adult_senior_youth,youth,irbesartan,hypoglycaemia,Endocrine disorders,"$Angiotensin II receptor blockers (ARBs), plain$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and diuretics","$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1550023,35607485,9.49E-18,4.36E-10,adult_senior_youth,senior,insulin lispro,visual impairment,Eye disorders,"$Insulins and analogues for injection, intermediate-acting$Insulins and analogues for injection, fast-acting$Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting",$INSULINS AND ANALOGUES$INSULINS AND ANALOGUES$INSULINS AND ANALOGUES,$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1154332,36211165,9.58E-18,4.40E-10,adult_children_senior_youth,children,pseudoephedrine,drug toxicity,"Surgical and medical procedures
",$Sympathomimetics$Sympathomimetics,$NASAL DECONGESTANTS FOR SYSTEMIC USE$NASAL DECONGESTANTS FOR SYSTEMIC USE,$NASAL PREPARATIONS$NASAL PREPARATIONS,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1112807,35205172,9.83E-18,4.51E-10,adult_children_senior_youth,adult,aspirin,coronary artery stenosis,Vascular disorders,0,0,0,0
1516976,35506494,9.97E-18,4.58E-10,adult_children_senior_youth,children_youth,insulin detemir,diabetic ketoacidosis,$Endocrine disorders$Metabolism and nutrition disorders,"Insulins and analogues for injection, long-acting",INSULINS AND ANALOGUES,DRUGS USED IN DIABETES,ALIMENTARY TRACT AND METABOLISM
732893,36516957,1.01E-17,4.65E-10,adult_senior_youth,youth,bupivacaine,musculoskeletal pain,Musculoskeletal and connective tissue disorders,$Amides$Amides,"$ANESTHETICS, LOCAL$ANESTHETICS, LOCAL",$ANESTHETICS$ANESTHETICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
1545958,36617948,1.01E-17,4.63E-10,adult_senior_youth,youth,atorvastatin,squamous cell carcinoma of skin,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations","$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS",$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1309944,35809170,1.01E-17,4.62E-10,adult_children_senior_youth,adult,amiodarone,unevaluable event,General disorders and administration site conditions,"Antiarrhythmics, class III","ANTIARRHYTHMICS, CLASS I AND III",CARDIAC THERAPY,CARDIOVASCULAR SYSTEM
705944,35809324,1.04E-17,4.76E-10,adult_children_senior_youth,children,methylphenidate,drug effect delayed,General disorders and administration site conditions,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
718583,35808822,1.05E-17,4.80E-10,adult_senior_youth,senior_youth,nicotine,application site pruritus,General disorders and administration site conditions,Drugs used in nicotine dependence,DRUGS USED IN ADDICTIVE DISORDERS,OTHER NERVOUS SYSTEM DRUGS,NERVOUS SYSTEM
1118084,35104883,1.06E-17,4.87E-10,adult_children_senior_youth,children,celecoxib,neutropenia,Blood and lymphatic system disorders,$Coxibs$Sulfonamides$Other antineoplastic agents,"$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$OTHER ANTINEOPLASTIC AGENTS",$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$ANTINEOPLASTIC AGENTS,$MUSCULO-SKELETAL SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1326303,35205189,1.11E-17,5.10E-10,adult_children_senior_youth,adult,digoxin,myocardial infarction,Vascular disorders,Digitalis glycosides,CARDIAC GLYCOSIDES,CARDIAC THERAPY,CARDIOVASCULAR SYSTEM
766814,36110642,1.11E-17,5.12E-10,adult_children_senior_youth,senior,quetiapine,sepsis,Infections and infestations,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1119510,35204970,1.12E-17,5.16E-10,adult_children_senior_youth,adult_youth,dextromethorphan,cardio-respiratory arrest,Cardiac disorders,$Opium alkaloids and derivatives$Other nervous system drugs,"$COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS$OTHER NERVOUS SYSTEM DRUGS",$COUGH AND COLD PREPARATIONS$OTHER NERVOUS SYSTEM DRUGS,$RESPIRATORY SYSTEM$NERVOUS SYSTEM
766814,42889647,1.15E-17,5.29E-10,adult_children_senior_youth,youth,quetiapine,toxicity to various agents,"Injury, poisoning and procedural complications","Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1110410,35205259,1.18E-17,5.42E-10,adult_children_senior_youth,youth,morphine,pulmonary oedema,"Respiratory, thoracic and mediastinal disorders",$Antipropulsives$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with antispasmodics,$ANTIPROPULSIVES$OPIOIDS$OPIOIDS$OPIOIDS,"$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$ANALGESICS$ANALGESICS$ANALGESICS",$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1301025,35707864,1.21E-17,5.57E-10,adult_children_senior_youth,senior,enoxaparin,gastrointestinal haemorrhage,Gastrointestinal disorders,Heparin group,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
915542,37320318,1.21E-17,5.55E-10,adult_senior_youth,adult_youth,brimonidine,rosacea,Skin and subcutaneous tissue disorders,$Other dermatologicals$Sympathomimetics in glaucoma therapy,$OTHER DERMATOLOGICAL PREPARATIONS$ANTIGLAUCOMA PREPARATIONS AND MIOTICS,$OTHER DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS,$DERMATOLOGICALS$SENSORY ORGANS
1799139,36211465,1.27E-17,5.83E-10,adult_children_senior_youth,children_youth,oseltamivir,incorrect dose administered,"Injury, poisoning and procedural complications",Neuraminidase inhibitors,DIRECT ACTING ANTIVIRALS,ANTIVIRALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
1110942,36009756,1.30E-17,5.96E-10,adult_children_senior_youth,children_youth,omalizumab,anaphylactic reaction,Immune system disorders,Other systemic drugs for obstructive airway diseases,OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,RESPIRATORY SYSTEM
1353766,36311982,1.36E-17,6.25E-10,adult_children_senior_youth,children,propranolol,heart rate decreased,Investigations,"$Beta blocking agents, other combinations$Beta blocking agents, non-selective$Beta blocking agents, non-selective, and thiazides","$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS AND THIAZIDES",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
912263,35708042,1.40E-17,6.43E-10,adult_senior,senior,certolizumab pegol,colitis microscopic,Gastrointestinal disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
785788,36919230,1.42E-17,6.54E-10,adult_children_senior_youth,youth,olanzapine,completed suicide,General disorders and administration site conditions,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
43526465,35205025,1.45E-17,6.65E-10,adult_children_senior_youth,children,canagliflozin,dizziness,Cardiac disorders,$Combinations of oral blood glucose lowering drugs$Sodium-glucose co-transporter 2 (SGLT2) inhibitors,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
40171288,35606961,1.46E-17,6.71E-10,adult_children_senior_youth,senior,tocilizumab,eye disorder,Eye disorders,Interleukin inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
19010482,35104177,1.47E-17,6.76E-10,adult_children_senior_youth,children_youth,cyclosporine,thrombotic microangiopathy,Blood and lymphatic system disorders,$Calcineurin inhibitors$Other ophthalmologicals,$IMMUNOSUPPRESSANTS$OTHER OPHTHALMOLOGICALS,$IMMUNOSUPPRESSANTS$OPHTHALMOLOGICALS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$SENSORY ORGANS
1310317,35606938,1.53E-17,7.00E-10,adult_senior,adult,cyclophosphamide,madarosis,Eye disorders,Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
745466,36919230,1.55E-17,7.11E-10,adult_children_senior_youth,adult_youth,valproate,completed suicide,General disorders and administration site conditions,0,0,0,0
780442,35708164,1.59E-17,7.30E-10,adult_senior_youth,senior,varenicline,abdominal discomfort,Gastrointestinal disorders,Drugs used in nicotine dependence,DRUGS USED IN ADDICTIVE DISORDERS,OTHER NERVOUS SYSTEM DRUGS,NERVOUS SYSTEM
43526465,37520692,1.59E-17,7.28E-10,adult_children_senior,adult,canagliflozin,toe amputation,Surgical and medical procedures,$Combinations of oral blood glucose lowering drugs$Sodium-glucose co-transporter 2 (SGLT2) inhibitors,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1119119,35607078,1.62E-17,7.45E-10,adult_children_senior_youth,children,adalimumab,uveitis,Eye disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1119119,36516907,1.65E-17,7.60E-10,adult_children_senior_youth,adult_senior,adalimumab,intervertebral disc protrusion,Musculoskeletal and connective tissue disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1307046,35205182,1.68E-17,7.71E-10,adult_senior,adult,metoprolol,angina unstable,Vascular disorders,"$Beta blocking agents and calcium channel blockers$Beta blocking agents, other combinations$Beta blocking agents, other combinations$Beta blocking agents and calcium channel blockers$Beta blocking agents, selective$Beta blocking agents, selective, and thiazides$Beta blocking agents, selective, and other diuretics$Beta blocking agents, selective, and thiazides","$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS AND OTHER DIURETICS$BETA BLOCKING AGENTS AND THIAZIDES",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1328165,35205189,1.79E-17,8.22E-10,adult_children_senior,adult,diltiazem,myocardial infarction,Vascular disorders,$Benzothiazepine derivatives$Muscle relaxants,$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,$CALCIUM CHANNEL BLOCKERS$VASOPROTECTIVES,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
709567,36718428,1.92E-17,8.81E-10,adult_children_senior_youth,children,lisdexamfetamine,logorrhoea,Nervous system disorders,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
1149380,36919235,1.95E-17,8.94E-10,adult_children_senior_youth,children,fluticasone,suicidal ideation,Psychiatric disorders,"$Glucocorticoids$Corticosteroids, potent (group III)$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Corticosteroids$Corticosteroids","$OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS$CORTICOSTEROIDS, PLAIN$ADRENERGICS, INHALANTS$ADRENERGICS, INHALANTS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE","$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$NASAL PREPARATIONS$NASAL PREPARATIONS",$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1149196,36919098,1.97E-17,9.03E-10,adult_children_senior_youth,children,cetirizine,abnormal behaviour,Psychiatric disorders,Piperazine derivatives,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,RESPIRATORY SYSTEM
1551099,36717998,2.05E-17,9.43E-10,adult_children_senior_youth,children_youth,prednisone,cerebral haemorrhage,Vascular disorders,$Corticosteroids acting locally$Glucocorticoids,"$INTESTINAL ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN","$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE","$ALIMENTARY TRACT AND METABOLISM$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
923645,35909571,2.06E-17,9.46E-10,adult_children_senior_youth,youth,omeprazole,venoocclusive liver disease,Hepatobiliary disorders,$Proton pump inhibitors$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori,$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1133201,36211297,2.09E-17,9.59E-10,adult_children_senior_youth,senior,buprenorphine,fall,"Injury, poisoning and procedural complications",$Drugs used in opioid dependence$Drugs used in opioid dependence$Oripavine derivatives,$DRUGS USED IN ADDICTIVE DISORDERS$DRUGS USED IN ADDICTIVE DISORDERS$OPIOIDS,$OTHER NERVOUS SYSTEM DRUGS$OTHER NERVOUS SYSTEM DRUGS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1177480,37019295,2.10E-17,9.65E-10,adult_children_senior_youth,children,ibuprofen,tubulointerstitial nephritis,Renal and urinary disorders,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
956874,36315580,2.11E-17,9.67E-10,adult_children_senior_youth,children_youth,furosemide,blood urea increased,Investigations,"$High-ceiling diuretics and potassium-sparing agents$Sulfonamides, plain$Sulfonamides$Sulfonamides and potassium in combination","$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$HIGH-CEILING DIURETICS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$HIGH-CEILING DIURETICS",$DIURETICS$DIURETICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$DIURETICS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
1309944,35204966,2.12E-17,9.71E-10,adult_children_senior_youth,children_youth,amiodarone,cardiac arrest,Cardiac disorders,"Antiarrhythmics, class III","ANTIARRHYTHMICS, CLASS I AND III",CARDIAC THERAPY,CARDIOVASCULAR SYSTEM
1308216,37622449,2.23E-17,1.02E-09,adult_children_senior_youth,children,lisinopril,hypotension,Vascular disorders,"$ACE inhibitors and diuretics$HMG CoA reductase inhibitors, other combinations$ACE inhibitors, plain$ACE inhibitors and calcium channel blockers","$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, PLAIN$ACE INHIBITORS, COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
931973,36110591,2.27E-17,1.04E-09,adult_children_senior_youth,children_youth,protease,lung infection,Infections and infestations,0,0,0,0
800878,35104879,2.32E-17,1.07E-09,adult_children_senior_youth,children,clozapine,granulocytopenia,Blood and lymphatic system disorders,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
19010482,35809054,2.34E-17,1.07E-09,adult_children_senior_youth,children_youth,cyclosporine,pyrexia,General disorders and administration site conditions,$Calcineurin inhibitors$Other ophthalmologicals,$IMMUNOSUPPRESSANTS$OTHER OPHTHALMOLOGICALS,$IMMUNOSUPPRESSANTS$OPHTHALMOLOGICALS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$SENSORY ORGANS
1589505,37320285,2.42E-17,1.11E-09,adult_youth,adult,levonorgestrel,hypertrichosis,Skin and subcutaneous tissue disorders,"$Progestogens and estrogens, sequential preparations$Emergency contraceptives$Progestogens$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations",$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1314002,37622449,2.49E-17,1.15E-09,adult_children_senior_youth,children_youth,atenolol,hypotension,Vascular disorders,"$Beta blocking agents, selective, and other diuretics$Beta blocking agents, selective$Beta blocking agents and calcium channel blockers$Beta blocking agents, selective, thiazides and other diuretics$Beta blocking agents, selective, and thiazides$Beta blocking agents, selective, and other diuretics","$BETA BLOCKING AGENTS AND OTHER DIURETICS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS AND OTHER DIURETICS",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1703687,35909625,2.52E-17,1.15E-09,adult_children_senior_youth,youth,acyclovir,hepatotoxicity,"Injury, poisoning and procedural complications",$Nucleosides and nucleotides excl. reverse transcriptase inhibitors$Antivirals$Antivirals$Antivirals,$DIRECT ACTING ANTIVIRALS$CHEMOTHERAPEUTICS FOR TOPICAL USE$ANTIINFECTIVES$CHEMOTHERAPEUTICS FOR TOPICAL USE,$ANTIVIRALS FOR SYSTEMIC USE$ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE$OPHTHALMOLOGICALS$ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,$ANTIINFECTIVES FOR SYSTEMIC USE$DERMATOLOGICALS$SENSORY ORGANS$DERMATOLOGICALS
1589505,37521618,2.53E-17,1.16E-09,adult_children_youth,children,levonorgestrel,caesarean section,Surgical and medical procedures,"$Progestogens and estrogens, sequential preparations$Emergency contraceptives$Progestogens$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations",$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1036525,36718382,2.54E-17,1.16E-09,adult_children_senior_youth,children_youth,sulfur,skin burning sensation,Nervous system disorders,0,0,0,0
40171288,36516909,2.63E-17,1.21E-09,adult_senior,senior,tocilizumab,sciatica,$Musculoskeletal and connective tissue disorders$Nervous system disorders,Interleukin inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
19080458,37019416,2.65E-17,1.22E-09,adult_children_senior_youth,adult,eculizumab,chromaturia,Renal and urinary disorders,Selective immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
797617,35205305,2.72E-17,1.25E-09,adult_children_youth,children,citalopram,atrial septal defect,Cardiac disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
939259,36919059,2.73E-17,1.25E-09,adult_children_senior_youth,children,budesonide,aggression,Psychiatric disorders,"$Corticosteroids, potent (group III)$Corticosteroids$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Corticosteroids acting locally$Glucocorticoids$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics","$CORTICOSTEROIDS, PLAIN$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ADRENERGICS, INHALANTS$INTESTINAL ANTIINFLAMMATORY AGENTS$OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS$ADRENERGICS, INHALANTS","$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$NASAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",$DERMATOLOGICALS$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$ALIMENTARY TRACT AND METABOLISM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1124300,36416606,2.75E-17,1.26E-09,adult_children_senior_youth,children,diclofenac,dehydration,Metabolism and nutrition disorders,"$Antiinflammatory agents, non-steroids and antiinfectives in combination$Antiinflammatory agents, non-steroids$Acetic acid derivatives and related substances$Antiinflammatory preparations, non-steroids for topical use$Acetic acid derivatives and related substances$Other dermatologicals","$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$ANTIINFLAMMATORY AGENTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$OTHER DERMATOLOGICAL PREPARATIONS",$OPHTHALMOLOGICALS$OPHTHALMOLOGICALS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$OTHER DERMATOLOGICAL PREPARATIONS,$SENSORY ORGANS$SENSORY ORGANS$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$DERMATOLOGICALS
1149380,35909613,2.78E-17,1.28E-09,adult_senior_youth,senior,fluticasone,hepatitis,Hepatobiliary disorders,"$Glucocorticoids$Corticosteroids, potent (group III)$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Corticosteroids$Corticosteroids","$OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS$CORTICOSTEROIDS, PLAIN$ADRENERGICS, INHALANTS$ADRENERGICS, INHALANTS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE","$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$NASAL PREPARATIONS$NASAL PREPARATIONS",$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
19010482,36110888,2.90E-17,1.33E-09,adult_children_senior_youth,children_youth,cyclosporine,epstein-barr virus infection,Infections and infestations,$Calcineurin inhibitors$Other ophthalmologicals,$IMMUNOSUPPRESSANTS$OTHER OPHTHALMOLOGICALS,$IMMUNOSUPPRESSANTS$OPHTHALMOLOGICALS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$SENSORY ORGANS
753626,35809170,3.17E-17,1.46E-09,adult_children_senior_youth,senior,propofol,unevaluable event,General disorders and administration site conditions,Other general anesthetics,"ANESTHETICS, GENERAL",ANESTHETICS,NERVOUS SYSTEM
734354,36211297,3.34E-17,1.53E-09,adult_children_senior_youth,children,pregabalin,fall,"Injury, poisoning and procedural complications",Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
1307046,36416593,3.37E-17,1.55E-09,adult_children_senior_youth,youth,metoprolol,hyperkalaemia,Metabolism and nutrition disorders,"$Beta blocking agents and calcium channel blockers$Beta blocking agents, other combinations$Beta blocking agents, other combinations$Beta blocking agents and calcium channel blockers$Beta blocking agents, selective$Beta blocking agents, selective, and thiazides$Beta blocking agents, selective, and other diuretics$Beta blocking agents, selective, and thiazides","$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS AND OTHER DIURETICS$BETA BLOCKING AGENTS AND THIAZIDES",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
715233,35204928,3.39E-17,1.56E-09,adult_children_senior_youth,children,baclofen,bradycardia,Cardiac disorders,Other centrally acting agents,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",MUSCLE RELAXANTS,MUSCULO-SKELETAL SYSTEM
1125315,36009754,3.40E-17,1.56E-09,adult_children_senior_youth,children,acetaminophen,toxic epidermal necrolysis,Immune system disorders,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
715259,36919231,3.41E-17,1.56E-09,adult_senior_youth,youth,duloxetine,intentional self-injury,"$Injury, poisoning and procedural complications$Psychiatric disorders",Other antidepressants,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1114220,37019321,3.46E-17,1.59E-09,adult_children_senior_youth,senior,naloxone,renal impairment,Renal and urinary disorders,$Peripheral opioid receptor antagonists$Natural opium alkaloids$Antidotes$Natural opium alkaloids,$DRUGS FOR CONSTIPATION$OPIOIDS$ALL OTHER THERAPEUTIC PRODUCTS$OPIOIDS,$DRUGS FOR CONSTIPATION$ANALGESICS$ALL OTHER THERAPEUTIC PRODUCTS$ANALGESICS,$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM$VARIOUS$NERVOUS SYSTEM
1337620,36617219,3.50E-17,1.61E-09,adult_children_senior_youth,children,capecitabine,metastases to central nervous system,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Pyrimidine analogues,ANTIMETABOLITES,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1154029,43053920,3.54E-17,1.62E-09,adult_children_senior_youth,children,fentanyl,accidental exposure to product,"Injury, poisoning and procedural complications",$Opioid anesthetics$Phenylpiperidine derivatives$Opioid anesthetics,"$ANESTHETICS, GENERAL$OPIOIDS$ANESTHETICS, GENERAL",$ANESTHETICS$ANALGESICS$ANESTHETICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1589505,35205034,3.61E-17,1.66E-09,adult_children_youth,adult,levonorgestrel,palpitations,Cardiac disorders,"$Progestogens and estrogens, sequential preparations$Emergency contraceptives$Progestogens$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations",$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1305058,35607078,3.64E-17,1.67E-09,adult_children_senior_youth,children,methotrexate,uveitis,Eye disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1707687,35607161,3.70E-17,1.70E-09,adult_senior,senior,vancomycin,retinal vasculitis,Immune system disorders,$Glycopeptide antibacterials$Antibiotics,$OTHER ANTIBACTERIALS$INTESTINAL ANTIINFECTIVES,"$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",$ANTIINFECTIVES FOR SYSTEMIC USE$ALIMENTARY TRACT AND METABOLISM
1351541,35708151,3.75E-17,1.72E-09,adult_children_senior_youth,youth,leuprolide,abdominal distension,Gastrointestinal disorders,$Gonadotropin releasing hormone analogues$Gonadotropin releasing hormone analogues,$HORMONES AND RELATED AGENTS$HORMONES AND RELATED AGENTS,$ENDOCRINE THERAPY$ENDOCRINE THERAPY,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
956874,37522318,3.82E-17,1.75E-09,adult_children_senior,adult,furosemide,coronary artery bypass,Surgical and medical procedures,"$High-ceiling diuretics and potassium-sparing agents$Sulfonamides, plain$Sulfonamides$Sulfonamides and potassium in combination","$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$HIGH-CEILING DIURETICS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$HIGH-CEILING DIURETICS",$DIURETICS$DIURETICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$DIURETICS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
1174888,35909445,3.83E-17,1.76E-09,adult_children_senior_youth,youth,hydrocodone,cholelithiasis,Hepatobiliary disorders,Opium alkaloids and derivatives,"COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",COUGH AND COLD PREPARATIONS,RESPIRATORY SYSTEM
1125315,35809054,3.94E-17,1.81E-09,adult_children_senior_youth,children,acetaminophen,pyrexia,General disorders and administration site conditions,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1154343,36918947,3.97E-17,1.82E-09,adult_children_senior_youth,youth,albuterol,anhedonia,Psychiatric disorders,0,0,0,0
1301267,36009895,3.97E-17,1.82E-09,adult_children_senior_youth,youth,melphalan,graft versus host disease,"Injury, poisoning and procedural complications",Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1350504,35406368,3.99E-17,1.83E-09,adult_children_youth,children,etoposide,hearing impaired,0,Podophyllotoxin derivatives,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1500211,36818844,4.05E-17,1.86E-09,adult_children_youth,youth,medroxyprogesterone,unintended pregnancy,"Pregnancy, puerperium and perinatal conditions",0,0,0,0
989878,42889647,4.18E-17,1.92E-09,adult_children_senior_youth,children_youth,lidocaine,toxicity to various agents,"Injury, poisoning and procedural complications","$Local anesthetics$Anesthetics for topical use$Anesthetics, local$Antiarrhythmics, class Ib$Analgesics and anesthetics$Amides$Local anesthetics$Amides","$LOCAL ANESTHETICS$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$THROAT PREPARATIONS$ANTIARRHYTHMICS, CLASS I AND III$OTHER OTOLOGICALS$ANESTHETICS, LOCAL$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE$ANESTHETICS, LOCAL","$OPHTHALMOLOGICALS$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$THROAT PREPARATIONS$CARDIAC THERAPY$OTOLOGICALS$ANESTHETICS$VASOPROTECTIVES$ANESTHETICS",$SENSORY ORGANS$DERMATOLOGICALS$RESPIRATORY SYSTEM$CARDIOVASCULAR SYSTEM$SENSORY ORGANS$NERVOUS SYSTEM$CARDIOVASCULAR SYSTEM$NERVOUS SYSTEM
1177480,36315381,4.33E-17,1.99E-09,adult_children_senior_youth,adult,ibuprofen,weight increased,Investigations,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
1149380,36211303,4.38E-17,2.01E-09,adult_children_senior_youth,youth,fluticasone,injury,"Injury, poisoning and procedural complications","$Glucocorticoids$Corticosteroids, potent (group III)$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Corticosteroids$Corticosteroids","$OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS$CORTICOSTEROIDS, PLAIN$ADRENERGICS, INHALANTS$ADRENERGICS, INHALANTS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE","$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$NASAL PREPARATIONS$NASAL PREPARATIONS",$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1174888,36211491,4.39E-17,2.02E-09,adult_children_senior_youth,children,hydrocodone,accidental overdose,"Injury, poisoning and procedural complications",Opium alkaloids and derivatives,"COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",COUGH AND COLD PREPARATIONS,RESPIRATORY SYSTEM
1346823,35205272,4.43E-17,2.03E-09,adult_children_senior_youth,children_youth,carvedilol,cardiomyopathy,Cardiac disorders,"$Alpha and beta blocking agents$Beta blocking agents, other combinations","$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS, OTHER COMBINATIONS",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1338512,37320313,4.47E-17,2.05E-09,adult_senior,adult,doxorubicin,hair texture abnormal,Skin and subcutaneous tissue disorders,Anthracyclines and related substances,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1710612,36312538,4.63E-17,2.12E-09,adult_children_senior_youth,children_senior,zidovudine,blood creatine phosphokinase increased,Investigations,"$Antivirals for treatment of HIV infections, combinations$Nucleoside and nucleotide reverse transcriptase inhibitors$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations",$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS,$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
19011440,36316184,4.63E-17,2.12E-09,adult_children_senior_youth,children_youth,everolimus,drug level decreased,Investigations,$Protein kinase inhibitors$Selective immunosuppressants,$OTHER ANTINEOPLASTIC AGENTS$IMMUNOSUPPRESSANTS,$ANTINEOPLASTIC AGENTS$IMMUNOSUPPRESSANTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1517824,42889647,4.66E-17,2.14E-09,adult_senior_youth,youth,niacin,toxicity to various agents,"Injury, poisoning and procedural complications",$Nicotinic acid and derivatives$Nicotinic acid and derivatives$HMG CoA reductase inhibitors in combination with other lipid modifying agents$Nicotinic acid and derivatives,"$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS$PERIPHERAL VASODILATORS",$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$PERIPHERAL VASODILATORS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1334456,36718235,5.02E-17,2.31E-09,adult_senior_youth,youth,ramipril,paralysis,Nervous system disorders,"$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and diuretics$ACE inhibitors, plain","$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, PLAIN",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1310149,37622518,5.09E-17,2.34E-09,adult_children_senior_youth,children,warfarin,haemorrhage,Vascular disorders,Vitamin K antagonists,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
19011773,36211303,5.15E-17,2.36E-09,adult_children_senior_youth,youth,ascorbic acid,injury,"Injury, poisoning and procedural complications","$Organic acids$Ascorbic acid (vitamin C), plain$Ascorbic acid (vitamin C), combinations$Other ophthalmologicals","$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS$ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS$OTHER OPHTHALMOLOGICALS",$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$VITAMINS$VITAMINS$OPHTHALMOLOGICALS,$GENITO URINARY SYSTEM AND SEX HORMONES$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$SENSORY ORGANS
19025274,35809310,5.39E-17,2.47E-09,adult_children_senior_youth,children_youth,oxygen,drug interaction,General disorders and administration site conditions,Medical gases,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,VARIOUS
1112807,36255528,5.44E-17,2.50E-09,adult_children_senior_youth,youth,aspirin,vascular stent thrombosis,$General disorders and administration site conditions$Vascular disorders,0,0,0,0
1314273,35708609,5.46E-17,2.51E-09,adult_children_senior_youth,youth,rituximab,throat irritation,"Respiratory, thoracic and mediastinal disorders",Monoclonal antibodies,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1547504,35205185,5.69E-17,2.61E-09,adult_children_senior_youth,adult,rosiglitazone,chest pain,"Respiratory, thoracic and mediastinal disorders",$Combinations of oral blood glucose lowering drugs$Thiazolidinediones$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1101898,35809329,5.86E-17,2.69E-09,adult_senior_youth,youth,leflunomide,drug intolerance,General disorders and administration site conditions,Selective immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1154029,42889647,5.86E-17,2.69E-09,adult_children_senior_youth,youth,fentanyl,toxicity to various agents,"Injury, poisoning and procedural complications",$Opioid anesthetics$Phenylpiperidine derivatives$Opioid anesthetics,"$ANESTHETICS, GENERAL$OPIOIDS$ANESTHETICS, GENERAL",$ANESTHETICS$ANALGESICS$ANESTHETICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
705944,43053848,5.88E-17,2.70E-09,adult_children_senior_youth,children,methylphenidate,drug effect incomplete,General disorders and administration site conditions,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
19015523,35809120,5.89E-17,2.70E-09,adult_children_senior_youth,adult,bendamustine,disease progression,General disorders and administration site conditions,Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1517824,35205240,5.97E-17,2.74E-09,adult_senior_youth,youth,niacin,cardiac failure,Cardiac disorders,$Nicotinic acid and derivatives$Nicotinic acid and derivatives$HMG CoA reductase inhibitors in combination with other lipid modifying agents$Nicotinic acid and derivatives,"$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS$PERIPHERAL VASODILATORS",$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$PERIPHERAL VASODILATORS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1114375,35809361,6.08E-17,2.79E-09,adult_children_senior,senior,anakinra,treatment failure,General disorders and administration site conditions,Interleukin inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1521987,36516761,6.19E-17,2.84E-09,adult_senior_youth,adult,teriparatide,bone pain,Musculoskeletal and connective tissue disorders,Parathyroid hormones and analogues,PARATHYROID HORMONES AND ANALOGUES,CALCIUM HOMEOSTASIS,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
722031,36919207,6.22E-17,2.85E-09,adult_children_senior_youth,youth,paroxetine,nightmare,Psychiatric disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1305058,36776613,6.42E-17,2.95E-09,adult_children_senior_youth,children,methotrexate,seizure,Nervous system disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
725131,36919236,6.46E-17,2.96E-09,adult_children_senior_youth,children_youth,mirtazapine,suicide attempt,Psychiatric disorders,Other antidepressants,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
722031,37019318,6.47E-17,2.97E-09,adult_children_senior_youth,senior,paroxetine,renal failure,Renal and urinary disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1112921,36416485,6.48E-17,2.97E-09,adult_children_senior_youth,children_youth,ipratropium,lactic acidosis,Metabolism and nutrition disorders,$Anticholinergics$Other nasal preparations$Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids$Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids,"$OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ADRENERGICS, INHALANTS$ADRENERGICS, INHALANTS",$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$NASAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1322184,35707871,6.52E-17,2.99E-09,adult_children_senior,senior,clopidogrel,upper gastrointestinal haemorrhage,Gastrointestinal disorders,Platelet aggregation inhibitors excl. heparin,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1129625,36918984,6.59E-17,3.03E-09,adult_children_senior_youth,children,diphenhydramine,hallucination,Psychiatric disorders,$Antihistamines for topical use$Aminoalkyl ethers$Antihistamines for topical use$Aminoalkyl ethers,"$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ANTIHISTAMINES FOR SYSTEMIC USE$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ANTIHISTAMINES FOR SYSTEMIC USE","$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ANTIHISTAMINES FOR SYSTEMIC USE$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ANTIHISTAMINES FOR SYSTEMIC USE",$DERMATOLOGICALS$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM
924724,35809243,6.81E-17,3.13E-09,adult_children_senior_youth,youth,dicyclomine,pain,General disorders and administration site conditions,"Synthetic anticholinergics, esters with tertiary amino group",DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,ALIMENTARY TRACT AND METABOLISM
1307046,35204981,6.93E-17,3.18E-09,adult_senior_youth,youth,metoprolol,ventricular fibrillation,Cardiac disorders,"$Beta blocking agents and calcium channel blockers$Beta blocking agents, other combinations$Beta blocking agents, other combinations$Beta blocking agents and calcium channel blockers$Beta blocking agents, selective$Beta blocking agents, selective, and thiazides$Beta blocking agents, selective, and other diuretics$Beta blocking agents, selective, and thiazides","$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS AND OTHER DIURETICS$BETA BLOCKING AGENTS AND THIAZIDES",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
757688,46276591,7.12E-17,3.27E-09,adult_children_senior_youth,children,aripiprazole,wrong technique in product usage process,"Injury, poisoning and procedural complications",Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
708298,35809369,7.23E-17,3.32E-09,adult_children_senior,children,midazolam,drug withdrawal syndrome,General disorders and administration site conditions,Benzodiazepine derivatives,HYPNOTICS AND SEDATIVES,PSYCHOLEPTICS,NERVOUS SYSTEM
1584910,35506682,7.26E-17,3.33E-09,adult_children_senior_youth,adult_senior,somatropin,pituitary tumour benign,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",0,0,0,0
745466,37622449,7.38E-17,3.39E-09,adult_children_senior_youth,senior,valproate,hypotension,Vascular disorders,0,0,0,0
19003999,35809361,7.44E-17,3.41E-09,adult_children_senior_youth,senior,mycophenolate mofetil,treatment failure,General disorders and administration site conditions,0,0,0,0
1307046,35205246,7.52E-17,3.45E-09,adult_children_senior_youth,children_youth,metoprolol,cardiogenic shock,Vascular disorders,"$Beta blocking agents and calcium channel blockers$Beta blocking agents, other combinations$Beta blocking agents, other combinations$Beta blocking agents and calcium channel blockers$Beta blocking agents, selective$Beta blocking agents, selective, and thiazides$Beta blocking agents, selective, and other diuretics$Beta blocking agents, selective, and thiazides","$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS AND OTHER DIURETICS$BETA BLOCKING AGENTS AND THIAZIDES",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
996416,37119589,7.52E-17,3.45E-09,adult_children_senior_youth,youth,finasteride,penis disorder,Reproductive system and breast disorders,$Other dermatologicals$Alpha-adrenoreceptor antagonists$Testosterone-5-alpha reductase inhibitors,$OTHER DERMATOLOGICAL PREPARATIONS$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,$OTHER DERMATOLOGICAL PREPARATIONS$UROLOGICALS$UROLOGICALS,$DERMATOLOGICALS$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1305058,36009738,7.61E-17,3.49E-09,adult_children_senior_youth,senior,methotrexate,drug hypersensitivity,Immune system disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1154029,36718323,7.93E-17,3.64E-09,adult_senior,senior,fentanyl,sopor,Nervous system disorders,$Opioid anesthetics$Phenylpiperidine derivatives$Opioid anesthetics,"$ANESTHETICS, GENERAL$OPIOIDS$ANESTHETICS, GENERAL",$ANESTHETICS$ANALGESICS$ANESTHETICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1036525,36009738,8.10E-17,3.72E-09,adult_children_senior_youth,senior,sulfur,drug hypersensitivity,Immune system disorders,0,0,0,0
778711,37622465,8.34E-17,3.83E-09,adult_senior_youth,youth,cyclobenzaprine,deep vein thrombosis,Vascular disorders,Other centrally acting agents,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",MUSCLE RELAXANTS,MUSCULO-SKELETAL SYSTEM
722031,35205001,8.47E-17,3.89E-09,adult_children_senior_youth,children,paroxetine,heart disease congenital,Cardiac disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1327256,35205232,8.80E-17,4.04E-09,adult_children_senior_youth,adult_senior,treprostinil,fluid overload,$Cardiac disorders$Metabolism and nutrition disorders,Platelet aggregation inhibitors excl. heparin,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
745466,36718540,9.00E-17,4.13E-09,adult_children_senior_youth,children,valproate,status epilepticus,Nervous system disorders,0,0,0,0
1103640,36211491,9.29E-17,4.27E-09,adult_children_senior_youth,youth,methadone,accidental overdose,"Injury, poisoning and procedural complications",$Drugs used in opioid dependence$Diphenylpropylamine derivatives,$DRUGS USED IN ADDICTIVE DISORDERS$OPIOIDS,$OTHER NERVOUS SYSTEM DRUGS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
1762711,36416698,9.34E-17,4.29E-09,adult_children_senior_youth,senior,ribavirin,hyperuricaemia,Metabolism and nutrition disorders,Antivirals for treatment of HCV infections,DIRECT ACTING ANTIVIRALS,ANTIVIRALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
722031,36918918,9.66E-17,4.44E-09,adult_children_senior_youth,children,paroxetine,attention deficit/hyperactivity disorder,Psychiatric disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1344905,35104074,9.71E-17,4.46E-09,adult_children_senior_youth,senior_youth,carboplatin,anaemia,Blood and lymphatic system disorders,Platinum compounds,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1305058,36110584,9.72E-17,4.46E-09,adult_children_senior_youth,senior,methotrexate,bronchitis,Infections and infestations,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1305058,36718123,1.02E-16,4.69E-09,adult_children_senior_youth,children,methotrexate,leukoencephalopathy,Nervous system disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1112807,37320197,1.02E-16,4.70E-09,adult_children_senior_youth,adult,aspirin,pruritus,Skin and subcutaneous tissue disorders,0,0,0,0
1343346,35205230,1.03E-16,4.71E-09,adult_senior_youth,youth,vinorelbine,ascites,Gastrointestinal disorders,Vinca alkaloids and analogues,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1521987,35809005,1.03E-16,4.71E-09,adult_senior_youth,adult,teriparatide,injection site pain,General disorders and administration site conditions,Parathyroid hormones and analogues,PARATHYROID HORMONES AND ANALOGUES,CALCIUM HOMEOSTASIS,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
1518254,36516749,1.03E-16,4.74E-09,adult_children_senior_youth,youth,dexamethasone,osteonecrosis,Vascular disorders,"$Corticosteroids$Corticosteroids, moderately potent, other combinations$Corticosteroids$Corticosteroids, combinations for treatment of acne$Corticosteroids/antiinfectives/mydriatics in combination$Corticosteroids and antiinfectives in combination$Corticosteroids and antiinfectives in combination$Corticosteroids$Corticosteroids and antiinfectives in combination$Corticosteroids, moderately potent, combinations with antibiotics$Glucocorticoids$Corticosteroids, plain$Corticosteroids for local oral treatment$Corticosteroids$Corticosteroids, moderately potent (group II)$Corticosteroids","$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$CORTICOSTEROIDS, OTHER COMBINATIONS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$ANTIINFLAMMATORY AGENTS$STOMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS$CORTICOSTEROIDS, PLAIN$CORTICOSTEROIDS","$NASAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$NASAL PREPARATIONS$ANTI-ACNE PREPARATIONS$OPHTHALMOLOGICALS$OTOLOGICALS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$VASOPROTECTIVES$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS FOR SYSTEMIC USE$OPHTHALMOLOGICALS$STOMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OTOLOGICALS","$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$DERMATOLOGICALS$SENSORY ORGANS$SENSORY ORGANS$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS$DERMATOLOGICALS$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$SENSORY ORGANS$DERMATOLOGICALS$SENSORY ORGANS"
996416,35809083,1.08E-16,4.94E-09,adult_children_senior_youth,youth,finasteride,feeling abnormal,General disorders and administration site conditions,$Other dermatologicals$Alpha-adrenoreceptor antagonists$Testosterone-5-alpha reductase inhibitors,$OTHER DERMATOLOGICAL PREPARATIONS$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,$OTHER DERMATOLOGICAL PREPARATIONS$UROLOGICALS$UROLOGICALS,$DERMATOLOGICALS$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1338512,35909577,1.10E-16,5.07E-09,adult_children_senior_youth,senior,doxorubicin,hepatitis b,Infections and infestations,Anthracyclines and related substances,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1341927,35205189,1.11E-16,5.08E-09,adult_children_senior_youth,adult,enalapril,myocardial infarction,Vascular disorders,"$ACE inhibitors and diuretics$ACE inhibitors and calcium channel blockers$ACE inhibitors and calcium channel blockers$ACE inhibitors, plain","$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, PLAIN",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1332418,35204903,1.13E-16,5.19E-09,adult_children_senior_youth,youth,amlodipine,atrioventricular block complete,Cardiac disorders,"$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$Beta blocking agents and calcium channel blockers$Dihydropyridine derivatives$ACE inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$Calcium channel blockers and diuretics$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs), other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers","$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS$ACE INHIBITORS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$CALCIUM CHANNEL BLOCKERS AND DIURETICS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$BETA BLOCKING AGENTS$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
798874,35204966,1.15E-16,5.26E-09,adult_children_senior_youth,youth,clonazepam,cardiac arrest,Cardiac disorders,Benzodiazepine derivatives,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
1154343,35909445,1.17E-16,5.37E-09,adult_children_senior_youth,youth,albuterol,cholelithiasis,Hepatobiliary disorders,0,0,0,0
35605744,35809059,1.18E-16,5.43E-09,adult_children_senior,children,daratumumab,death,General disorders and administration site conditions,Monoclonal antibodies,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1551099,35708154,1.19E-16,5.47E-09,adult_children_senior_youth,youth,prednisone,abdominal pain,Gastrointestinal disorders,$Corticosteroids acting locally$Glucocorticoids,"$INTESTINAL ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN","$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE","$ALIMENTARY TRACT AND METABOLISM$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
740275,36718526,1.23E-16,5.66E-09,adult_children_senior_youth,children_youth,carbamazepine,convulsion,0,Carboxamide derivatives,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
903963,36416534,1.25E-16,5.73E-09,adult_children_senior,children,triamcinolone,obesity,Metabolism and nutrition disorders,"$Corticosteroids, moderately potent (group II)$Corticosteroids$Glucocorticoids$Corticosteroids, moderately potent, combinations with antiseptics$Corticosteroids for local oral treatment$Glucocorticoids$Corticosteroids, moderately potent, combinations with antibiotics$Corticosteroids, plain$Corticosteroids, moderately potent, other combinations$Corticosteroids and antiinfectives in combination$Corticosteroids","$CORTICOSTEROIDS, PLAIN$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS$CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS$STOMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS, OTHER COMBINATIONS$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE","$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$NASAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$STOMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS FOR SYSTEMIC USE$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OTOLOGICALS$VASOPROTECTIVES","$DERMATOLOGICALS$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$DERMATOLOGICALS$ALIMENTARY TRACT AND METABOLISM$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$DERMATOLOGICALS$SENSORY ORGANS$DERMATOLOGICALS$SENSORY ORGANS$CARDIOVASCULAR SYSTEM"
781039,36919132,1.27E-16,5.82E-09,adult_children_senior_youth,youth,alprazolam,substance abuse,Psychiatric disorders,Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
797617,35204985,1.28E-16,5.86E-09,adult_children_senior_youth,youth,citalopram,ventricular tachycardia,Cardiac disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1308216,35205164,1.30E-16,5.97E-09,adult_children_senior_youth,adult,lisinopril,coronary artery disease,Vascular disorders,"$ACE inhibitors and diuretics$HMG CoA reductase inhibitors, other combinations$ACE inhibitors, plain$ACE inhibitors and calcium channel blockers","$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, PLAIN$ACE INHIBITORS, COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
974166,37019315,1.35E-16,6.20E-09,adult_senior_youth,youth,hydrochlorothiazide,anuria,Renal and urinary disorders,"$ACE inhibitors, other combinations$Thiazides, combinations with other drugs$Thiazides and potassium in combination$Angiotensin II receptor blockers (ARBs), other combinations$Low-ceiling diuretics and potassium-sparing agents$Angiotensin II receptor blockers (ARBs), other combinations$Renin-inhibitors$Sulfonamides$Angiotensin II receptor blockers (ARBs), other combinations$Thiazides, plain$Renin-inhibitors","$ACE INHIBITORS, COMBINATIONS$LOW-CEILING DIURETICS, THIAZIDES$LOW-CEILING DIURETICS, THIAZIDES$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LOW-CEILING DIURETICS, THIAZIDES$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$DIURETICS$DIURETICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$DIURETICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$DIURETICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
937368,35809059,1.36E-16,6.25E-09,adult_children_senior_youth,senior,infliximab,death,General disorders and administration site conditions,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
19012585,35909625,1.36E-16,6.26E-09,adult_children_senior_youth,adult,asparaginase,hepatotoxicity,"Injury, poisoning and procedural complications",0,0,0,0
1518254,36110697,1.36E-16,6.24E-09,adult_children_senior_youth,senior,dexamethasone,nasopharyngitis,Infections and infestations,"$Corticosteroids$Corticosteroids, moderately potent, other combinations$Corticosteroids$Corticosteroids, combinations for treatment of acne$Corticosteroids/antiinfectives/mydriatics in combination$Corticosteroids and antiinfectives in combination$Corticosteroids and antiinfectives in combination$Corticosteroids$Corticosteroids and antiinfectives in combination$Corticosteroids, moderately potent, combinations with antibiotics$Glucocorticoids$Corticosteroids, plain$Corticosteroids for local oral treatment$Corticosteroids$Corticosteroids, moderately potent (group II)$Corticosteroids","$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$CORTICOSTEROIDS, OTHER COMBINATIONS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$ANTIINFLAMMATORY AGENTS$STOMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS$CORTICOSTEROIDS, PLAIN$CORTICOSTEROIDS","$NASAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$NASAL PREPARATIONS$ANTI-ACNE PREPARATIONS$OPHTHALMOLOGICALS$OTOLOGICALS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$VASOPROTECTIVES$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS FOR SYSTEMIC USE$OPHTHALMOLOGICALS$STOMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OTOLOGICALS","$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$DERMATOLOGICALS$SENSORY ORGANS$SENSORY ORGANS$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS$DERMATOLOGICALS$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$SENSORY ORGANS$DERMATOLOGICALS$SENSORY ORGANS"
715939,36211297,1.38E-16,6.34E-09,adult_children_senior_youth,senior,escitalopram,fall,"Injury, poisoning and procedural complications",Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1500211,35506577,1.44E-16,6.60E-09,adult_children_youth,children_youth,medroxyprogesterone,amenorrhoea,$Endocrine disorders$Reproductive system and breast disorders,0,0,0,0
974166,35204902,1.52E-16,6.97E-09,adult_senior_youth,youth,hydrochlorothiazide,atrioventricular block,Cardiac disorders,"$ACE inhibitors, other combinations$Thiazides, combinations with other drugs$Thiazides and potassium in combination$Angiotensin II receptor blockers (ARBs), other combinations$Low-ceiling diuretics and potassium-sparing agents$Angiotensin II receptor blockers (ARBs), other combinations$Renin-inhibitors$Sulfonamides$Angiotensin II receptor blockers (ARBs), other combinations$Thiazides, plain$Renin-inhibitors","$ACE INHIBITORS, COMBINATIONS$LOW-CEILING DIURETICS, THIAZIDES$LOW-CEILING DIURETICS, THIAZIDES$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LOW-CEILING DIURETICS, THIAZIDES$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$DIURETICS$DIURETICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$DIURETICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$DIURETICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1301267,37622529,1.52E-16,6.99E-09,adult_children_senior_youth,children_youth,melphalan,hypertension,Vascular disorders,Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
937368,35909501,1.53E-16,7.03E-09,adult_children_senior_youth,senior,infliximab,liver disorder,Hepatobiliary disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
708298,35809310,1.61E-16,7.38E-09,adult_children_senior_youth,youth,midazolam,drug interaction,General disorders and administration site conditions,Benzodiazepine derivatives,HYPNOTICS AND SEDATIVES,PSYCHOLEPTICS,NERVOUS SYSTEM
1000560,35909625,1.67E-16,7.67E-09,adult_children_senior_youth,youth,ondansetron,hepatotoxicity,"Injury, poisoning and procedural complications",Serotonin (5HT3) antagonists,ANTIEMETICS AND ANTINAUSEANTS,ANTIEMETICS AND ANTINAUSEANTS,ALIMENTARY TRACT AND METABOLISM
942799,36718321,1.74E-16,7.99E-09,adult_senior,senior,trimethobenzamide,somnolence,Nervous system disorders,Aminoalkyl ethers,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,RESPIRATORY SYSTEM
918906,35808800,1.75E-16,8.03E-09,adult_children_senior_youth,senior,oxybutynin,application site erythema,General disorders and administration site conditions,Drugs for urinary frequency and incontinence,UROLOGICALS,UROLOGICALS,GENITO URINARY SYSTEM AND SEX HORMONES
1124957,37219871,1.78E-16,8.18E-09,adult_children_senior_youth,youth,oxycodone,pulmonary embolism,"$Respiratory, thoracic and mediastinal disorders$Vascular disorders",$Natural opium alkaloids$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1539403,35809086,1.80E-16,8.26E-09,adult_children_senior,adult,simvastatin,feeling hot,General disorders and administration site conditions,"$Dipeptidyl peptidase 4 (DPP-4) inhibitors$HMG CoA reductase inhibitors$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents","$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS",$DRUGS USED IN DIABETES$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS,$ALIMENTARY TRACT AND METABOLISM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1545958,36416638,1.80E-16,8.24E-09,adult_senior_youth,youth,atorvastatin,hyperlipidaemia,Metabolism and nutrition disorders,"$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations","$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS",$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1124957,36718288,1.81E-16,8.30E-09,adult_children_senior_youth,children_youth,oxycodone,coma,Nervous system disorders,$Natural opium alkaloids$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1305058,36110642,1.83E-16,8.38E-09,adult_children_senior_youth,children,methotrexate,sepsis,Infections and infestations,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1154161,36919232,1.97E-16,9.02E-09,adult_children_senior_youth,children_youth,montelukast,self injurious behaviour,0,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1310317,35104341,2.01E-16,9.22E-09,adult_children_senior_youth,youth,cyclophosphamide,acute lymphocytic leukaemia recurrent,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
735979,36315575,2.04E-16,9.36E-09,adult_children_senior_youth,senior,risperidone,blood creatinine increased,Investigations,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
720810,36918984,2.11E-16,9.67E-09,adult_children_senior,senior,pramipexole,hallucination,Psychiatric disorders,Dopamine agonists,DOPAMINERGIC AGENTS,ANTI-PARKINSON DRUGS,NERVOUS SYSTEM
1707687,36918861,2.12E-16,9.74E-09,adult_children_senior_youth,senior,vancomycin,stress,Psychiatric disorders,$Glycopeptide antibacterials$Antibiotics,$OTHER ANTIBACTERIALS$INTESTINAL ANTIINFECTIVES,"$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",$ANTIINFECTIVES FOR SYSTEMIC USE$ALIMENTARY TRACT AND METABOLISM
1310317,35104397,2.13E-16,9.76E-09,adult_children_senior_youth,senior,cyclophosphamide,myelodysplastic syndrome,Blood and lymphatic system disorders,Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1378382,37019321,2.13E-16,9.79E-09,adult_children_senior_youth,youth,paclitaxel,renal impairment,Renal and urinary disorders,Taxanes,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1112807,35205305,2.15E-16,9.86E-09,adult_children_senior_youth,children,aspirin,atrial septal defect,Cardiac disorders,0,0,0,0
1119119,36110534,2.23E-16,1.02E-08,adult_children_senior_youth,children_youth,adalimumab,abscess,Infections and infestations,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
723013,36211491,2.26E-16,1.04E-08,adult_children_senior_youth,youth,diazepam,accidental overdose,"Injury, poisoning and procedural complications",Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1150345,35809005,2.34E-16,1.07E-08,adult_children_senior_youth,children,meloxicam,injection site pain,General disorders and administration site conditions,$Oxicams$Oxicams,"$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
750982,36718362,2.38E-16,1.09E-08,adult_children_senior_youth,children,bupropion,myoclonus,Nervous system disorders,$Centrally acting antiobesity products$Other antidepressants,"$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$ANTIDEPRESSANTS","$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$PSYCHOANALEPTICS",$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM
1353766,37622449,2.41E-16,0.000000011,adult_children_senior_youth,children,propranolol,hypotension,Vascular disorders,"$Beta blocking agents, other combinations$Beta blocking agents, non-selective$Beta blocking agents, non-selective, and thiazides","$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS AND THIAZIDES",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
792263,42889647,2.44E-16,1.12E-08,adult_children_senior_youth,children,loxapine,toxicity to various agents,"Injury, poisoning and procedural complications","Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1308290,37622499,2.51E-16,1.15E-08,adult_children_youth,children,vincristine,venoocclusive disease,Vascular disorders,Vinca alkaloids and analogues,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
40167554,37320310,2.54E-16,1.17E-08,adult_children_senior_youth,youth,pazopanib,hair colour changes,Skin and subcutaneous tissue disorders,Protein kinase inhibitors,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1545958,35204953,2.56E-16,1.17E-08,adult_children_senior_youth,senior,atorvastatin,atrial fibrillation,Cardiac disorders,"$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations","$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS",$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
777221,42889647,2.56E-16,1.18E-08,adult_children_senior_youth,youth,hydroxyzine,toxicity to various agents,"Injury, poisoning and procedural complications",$Diphenylmethane derivatives$Diphenylmethane derivatives,$ANXIOLYTICS$ANXIOLYTICS,$PSYCHOLEPTICS$PSYCHOLEPTICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
1301065,35909508,2.68E-16,1.23E-08,adult_children_senior_youth,children,dalteparin,hepatic function abnormal,Hepatobiliary disorders,Heparin group,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
974166,35204911,2.69E-16,1.23E-08,adult_senior_youth,youth,hydrochlorothiazide,bundle branch block left,Cardiac disorders,"$ACE inhibitors, other combinations$Thiazides, combinations with other drugs$Thiazides and potassium in combination$Angiotensin II receptor blockers (ARBs), other combinations$Low-ceiling diuretics and potassium-sparing agents$Angiotensin II receptor blockers (ARBs), other combinations$Renin-inhibitors$Sulfonamides$Angiotensin II receptor blockers (ARBs), other combinations$Thiazides, plain$Renin-inhibitors","$ACE INHIBITORS, COMBINATIONS$LOW-CEILING DIURETICS, THIAZIDES$LOW-CEILING DIURETICS, THIAZIDES$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LOW-CEILING DIURETICS, THIAZIDES$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$DIURETICS$DIURETICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$DIURETICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$DIURETICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1305058,37219905,2.70E-16,1.24E-08,adult_children_senior_youth,children,methotrexate,hypoxia,"Respiratory, thoracic and mediastinal disorders",$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1310317,37219871,2.70E-16,1.24E-08,adult_children_senior_youth,senior,cyclophosphamide,pulmonary embolism,"$Respiratory, thoracic and mediastinal disorders$Vascular disorders",Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1119119,36110716,2.82E-16,0.000000013,adult_children_senior_youth,senior,adalimumab,cystitis,Infections and infestations,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
915542,35809155,2.90E-16,1.33E-08,adult_children_senior_youth,children_youth,brimonidine,pallor,Vascular disorders,$Other dermatologicals$Sympathomimetics in glaucoma therapy,$OTHER DERMATOLOGICAL PREPARATIONS$ANTIGLAUCOMA PREPARATIONS AND MIOTICS,$OTHER DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS,$DERMATOLOGICALS$SENSORY ORGANS
1524674,35909682,2.93E-16,1.35E-08,adult_senior,adult,zoledronic acid,metastases to liver,Hepatobiliary disorders,"$Bisphosphonates, combinations$Bisphosphonates",$DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION$DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,$DRUGS FOR TREATMENT OF BONE DISEASES$DRUGS FOR TREATMENT OF BONE DISEASES,$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
1551099,35104199,2.95E-16,1.36E-08,adult_children_senior_youth,youth,prednisone,haematotoxicity,"Injury, poisoning and procedural complications",$Corticosteroids acting locally$Glucocorticoids,"$INTESTINAL ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN","$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE","$ALIMENTARY TRACT AND METABOLISM$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
1154343,35909452,3.08E-16,1.41E-08,adult_children_senior_youth,youth,albuterol,gallbladder disorder,Hepatobiliary disorders,0,0,0,0
991876,36416584,3.13E-16,1.43E-08,adult_children_senior_youth,youth,loperamide,electrolyte imbalance,Metabolism and nutrition disorders,$Antipropulsives$Antipropulsives,$ANTIPROPULSIVES$ANTIPROPULSIVES,"$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
19080458,36313240,3.39E-16,1.56E-08,adult_children_senior_youth,senior,eculizumab,haemoglobin decreased,Investigations,Selective immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
705103,36211496,3.43E-16,1.58E-08,adult_children_senior_youth,youth,lamotrigine,overdose,"Injury, poisoning and procedural complications",Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
42904205,36516729,3.46E-16,1.59E-08,adult_senior_youth,youth,tofacitinib,bone erosion,Musculoskeletal and connective tissue disorders,Selective immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1316262,35809054,3.67E-16,1.68E-08,adult_children_senior_youth,children,sildenafil,pyrexia,General disorders and administration site conditions,$Sulfonamides$Drugs used in erectile dysfunction,"$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$UROLOGICALS",$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$UROLOGICALS,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1307046,43053904,3.68E-16,1.69E-08,adult_children_youth,children_youth,metoprolol,exposure during pregnancy,"Injury, poisoning and procedural complications","$Beta blocking agents and calcium channel blockers$Beta blocking agents, other combinations$Beta blocking agents, other combinations$Beta blocking agents and calcium channel blockers$Beta blocking agents, selective$Beta blocking agents, selective, and thiazides$Beta blocking agents, selective, and other diuretics$Beta blocking agents, selective, and thiazides","$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS AND OTHER DIURETICS$BETA BLOCKING AGENTS AND THIAZIDES",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1118084,37019321,3.72E-16,1.71E-08,adult_children_senior,children,celecoxib,renal impairment,Renal and urinary disorders,$Coxibs$Sulfonamides$Other antineoplastic agents,"$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$OTHER ANTINEOPLASTIC AGENTS",$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$ANTINEOPLASTIC AGENTS,$MUSCULO-SKELETAL SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
988095,35909571,3.81E-16,1.75E-08,adult_children_senior_youth,children_youth,ursodeoxycholate,venoocclusive liver disease,Hepatobiliary disorders,0,0,0,0
1125315,35809310,3.95E-16,1.81E-08,adult_children_senior_youth,senior,acetaminophen,drug interaction,General disorders and administration site conditions,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
44814284,35204970,3.96E-16,1.82E-08,adult_children_senior_youth,youth,acetaminophen / oxycodone Extended Release Oral Tablet,cardio-respiratory arrest,Cardiac disorders,0,0,0,0
1125315,35104161,3.96E-16,1.82E-08,adult_children_senior_youth,children,acetaminophen,coagulopathy,Blood and lymphatic system disorders,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1718054,35909625,4.06E-16,1.86E-08,adult_children_senior_youth,youth,caspofungin,hepatotoxicity,"Injury, poisoning and procedural complications",Other antimycotics for systemic use,ANTIMYCOTICS FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
757688,35809041,4.21E-16,1.93E-08,adult_children_senior_youth,senior,aripiprazole,hypothermia,General disorders and administration site conditions,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1154029,36918942,4.23E-16,1.94E-08,adult_children_senior_youth,adult,fentanyl,depression,Psychiatric disorders,$Opioid anesthetics$Phenylpiperidine derivatives$Opioid anesthetics,"$ANESTHETICS, GENERAL$OPIOIDS$ANESTHETICS, GENERAL",$ANESTHETICS$ANALGESICS$ANESTHETICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1326303,36516765,4.35E-16,0.00000002,adult_children_senior_youth,adult,digoxin,pain in jaw,Musculoskeletal and connective tissue disorders,Digitalis glycosides,CARDIAC GLYCOSIDES,CARDIAC THERAPY,CARDIOVASCULAR SYSTEM
1305058,36110649,4.39E-16,2.02E-08,adult_children_senior_youth,children_youth,methotrexate,septic shock,Infections and infestations,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
723013,36718526,4.43E-16,2.04E-08,adult_children_senior_youth,children,diazepam,convulsion,0,Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1177480,35708302,4.48E-16,2.06E-08,adult_children_senior_youth,children,ibuprofen,intestinal perforation,Gastrointestinal disorders,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
1304044,35809076,4.50E-16,2.06E-08,adult_children_senior,senior,fulvestrant,fatigue,General disorders and administration site conditions,Anti-estrogens,HORMONE ANTAGONISTS AND RELATED AGENTS,ENDOCRINE THERAPY,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1154161,36918902,4.57E-16,0.000000021,adult_children_senior_youth,children,montelukast,obsessive-compulsive disorder,Psychiatric disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
937368,35205184,4.62E-16,2.12E-08,adult_children_senior_youth,youth,infliximab,chest discomfort,"Respiratory, thoracic and mediastinal disorders",Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1762711,35104281,4.62E-16,2.12E-08,adult_senior_youth,senior,ribavirin,haemolytic anaemia,Blood and lymphatic system disorders,Antivirals for treatment of HCV infections,DIRECT ACTING ANTIVIRALS,ANTIVIRALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
1503297,35205164,4.83E-16,2.22E-08,adult_children_senior_youth,adult,metformin,coronary artery disease,Vascular disorders,$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Biguanides$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1119119,36211071,4.87E-16,2.24E-08,adult_children_senior_youth,senior,adalimumab,joint dislocation,"Injury, poisoning and procedural complications",Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
19026972,43053717,4.87E-16,2.23E-08,adult_senior,adult,lenalidomide,plasma cell myeloma recurrent,"$Blood and lymphatic system disorders$Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Other immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1305058,35809005,4.89E-16,2.25E-08,adult_children_senior_youth,adult,methotrexate,injection site pain,General disorders and administration site conditions,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1119119,36516779,4.95E-16,2.27E-08,adult_children_senior_youth,children,adalimumab,arthritis,Musculoskeletal and connective tissue disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
723013,36919235,5.12E-16,2.35E-08,adult_children_senior_youth,youth,diazepam,suicidal ideation,Psychiatric disorders,Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1762711,35809079,5.20E-16,2.39E-08,adult_children_senior_youth,senior,ribavirin,malaise,General disorders and administration site conditions,Antivirals for treatment of HCV infections,DIRECT ACTING ANTIVIRALS,ANTIVIRALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
40241331,36313240,5.25E-16,2.41E-08,adult_children_senior_youth,children,rivaroxaban,haemoglobin decreased,Investigations,Direct factor Xa inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
19037038,35808981,5.25E-16,2.41E-08,adult_senior,senior,calcium gluconate,injection site haemorrhage,General disorders and administration site conditions,$Calcium$Other dermatologicals,$CALCIUM$OTHER DERMATOLOGICAL PREPARATIONS,$MINERAL SUPPLEMENTS$OTHER DERMATOLOGICAL PREPARATIONS,$ALIMENTARY TRACT AND METABOLISM$DERMATOLOGICALS
800878,35809131,5.28E-16,2.42E-08,adult_children_senior_youth,senior,clozapine,general physical health deterioration,General disorders and administration site conditions,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1351541,35808999,5.34E-16,2.45E-08,adult_children_senior_youth,children,leuprolide,injection site mass,General disorders and administration site conditions,$Gonadotropin releasing hormone analogues$Gonadotropin releasing hormone analogues,$HORMONES AND RELATED AGENTS$HORMONES AND RELATED AGENTS,$ENDOCRINE THERAPY$ENDOCRINE THERAPY,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1308290,35104236,5.41E-16,2.48E-08,adult_children_senior_youth,children,vincristine,histiocytosis haematophagic,0,Vinca alkaloids and analogues,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1305058,35708642,5.54E-16,2.54E-08,adult_children_senior_youth,children_youth,methotrexate,stomatitis,Gastrointestinal disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1154161,36919117,5.59E-16,2.56E-08,adult_children_senior_youth,children_youth,montelukast,mental disorder,Psychiatric disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
941258,36211303,5.66E-16,0.000000026,adult_children_senior_youth,youth,docusate,injury,"Injury, poisoning and procedural complications",0,0,0,0
912263,36315486,5.84E-16,2.68E-08,adult_children_senior_youth,senior,certolizumab pegol,c-reactive protein increased,Investigations,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1301267,36009703,5.85E-16,2.68E-08,adult_children_senior,children,melphalan,bronchospasm,"Respiratory, thoracic and mediastinal disorders",Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1186087,35708164,6.06E-16,2.78E-08,adult_senior_youth,youth,abatacept,abdominal discomfort,Gastrointestinal disorders,Selective immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1308290,36718132,6.12E-16,2.81E-08,adult_children_senior_youth,youth,vincristine,headache,Nervous system disorders,Vinca alkaloids and analogues,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
722031,36416485,6.24E-16,2.86E-08,adult_senior_youth,youth,paroxetine,lactic acidosis,Metabolism and nutrition disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1714277,35909571,6.51E-16,2.99E-08,adult_children_senior_youth,youth,voriconazole,venoocclusive liver disease,Hepatobiliary disorders,Triazole derivatives,ANTIMYCOTICS FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
1717704,37019319,6.55E-16,0.00000003,adult_children_senior_youth,senior,valacyclovir,renal failure acute,0,0,0,0,0
40228152,37622518,6.62E-16,3.04E-08,adult_children_senior,children,dabigatran etexilate,haemorrhage,Vascular disorders,Direct thrombin inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
755695,36311779,6.68E-16,3.07E-08,adult_children_senior_youth,children,fluoxetine,cardiac murmur,Investigations,$Antidepressants in combination with psycholeptics$Selective serotonin reuptake inhibitors,$PSYCHOLEPTICS AND PSYCHOANALEPTICS IN COMBINATION$ANTIDEPRESSANTS,$PSYCHOANALEPTICS$PSYCHOANALEPTICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
942350,36919236,6.69E-16,3.07E-08,adult_children_senior_youth,youth,torasemide,suicide attempt,Psychiatric disorders,"$Sulfonamides, plain$Sulfonamides","$HIGH-CEILING DIURETICS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",$DIURETICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES
956874,36110986,6.92E-16,3.18E-08,adult_children_senior_youth,children,furosemide,respiratory syncytial virus infection,Infections and infestations,"$High-ceiling diuretics and potassium-sparing agents$Sulfonamides, plain$Sulfonamides$Sulfonamides and potassium in combination","$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$HIGH-CEILING DIURETICS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$HIGH-CEILING DIURETICS",$DIURETICS$DIURETICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$DIURETICS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
766814,36919098,6.99E-16,3.21E-08,adult_children_senior_youth,children,quetiapine,abnormal behaviour,Psychiatric disorders,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1777806,35707991,7.22E-16,3.31E-08,adult_children_senior_youth,senior,ceftriaxone,clostridium difficile colitis,Gastrointestinal disorders,$Third-generation cephalosporins$Third-generation cephalosporins,$OTHER BETA-LACTAM ANTIBACTERIALS$OTHER BETA-LACTAM ANTIBACTERIALS,$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIBACTERIALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
1344905,37320313,7.24E-16,3.32E-08,adult_senior_youth,adult,carboplatin,hair texture abnormal,Skin and subcutaneous tissue disorders,Platinum compounds,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1710612,36416652,7.26E-16,3.33E-08,adult_children_senior_youth,senior,zidovudine,lipodystrophy acquired,$Metabolism and nutrition disorders$Skin and subcutaneous tissue disorders,"$Antivirals for treatment of HIV infections, combinations$Nucleoside and nucleotide reverse transcriptase inhibitors$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations",$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS,$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
1174888,35204966,7.27E-16,3.34E-08,adult_children_senior_youth,children_youth,hydrocodone,cardiac arrest,Cardiac disorders,Opium alkaloids and derivatives,"COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",COUGH AND COLD PREPARATIONS,RESPIRATORY SYSTEM
1521369,36617163,7.29E-16,3.35E-08,adult_senior,senior,norethindrone,breast cancer female,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",0,0,0,0
1789276,35506628,7.36E-16,3.38E-08,adult_children_senior_youth,youth,gatifloxacin,hyperglycaemia,Endocrine disorders,$Fluoroquinolones$Fluoroquinolones,$ANTIINFECTIVES$QUINOLONE ANTIBACTERIALS,$OPHTHALMOLOGICALS$ANTIBACTERIALS FOR SYSTEMIC USE,$SENSORY ORGANS$ANTIINFECTIVES FOR SYSTEMIC USE
705944,37622449,7.65E-16,3.51E-08,adult_children_senior_youth,senior,methylphenidate,hypotension,Vascular disorders,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
42709324,36211297,8.08E-16,3.71E-08,adult_children_senior_youth,senior,vitamin D3,fall,"Injury, poisoning and procedural complications",0,0,0,0
745466,35809043,8.19E-16,3.76E-08,adult_children_senior_youth,youth,valproate,neuroleptic malignant syndrome,General disorders and administration site conditions,0,0,0,0
19080458,37622529,8.24E-16,3.78E-08,adult_children_senior_youth,children,eculizumab,hypertension,Vascular disorders,Selective immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
723013,36211496,8.37E-16,3.84E-08,adult_children_senior_youth,youth,diazepam,overdose,"Injury, poisoning and procedural complications",Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1301267,36009894,8.38E-16,3.85E-08,adult_children_senior_youth,youth,melphalan,chronic graft versus host disease,"Injury, poisoning and procedural complications",Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1500211,36315381,8.39E-16,3.85E-08,adult_children_senior_youth,children_youth,medroxyprogesterone,weight increased,Investigations,0,0,0,0
1503297,37521163,8.49E-16,0.000000039,adult_children_senior_youth,children_youth,metformin,haemodialysis,Surgical and medical procedures,$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Biguanides$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
798874,36718132,8.77E-16,4.03E-08,adult_children_senior_youth,adult,clonazepam,headache,Nervous system disorders,Benzodiazepine derivatives,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
703244,36315381,9.33E-16,4.28E-08,adult_children_senior_youth,children,paliperidone,weight increased,Investigations,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1125315,36009724,9.36E-16,0.000000043,adult_children_senior_youth,children,acetaminophen,stevens-johnson syndrome,Infections and infestations,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
836715,36919230,9.37E-16,0.000000043,adult_children_senior_youth,children,temazepam,completed suicide,General disorders and administration site conditions,Benzodiazepine derivatives,HYPNOTICS AND SEDATIVES,PSYCHOLEPTICS,NERVOUS SYSTEM
1149380,36516729,9.38E-16,4.31E-08,adult_senior,senior,fluticasone,bone erosion,Musculoskeletal and connective tissue disorders,"$Glucocorticoids$Corticosteroids, potent (group III)$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Corticosteroids$Corticosteroids","$OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS$CORTICOSTEROIDS, PLAIN$ADRENERGICS, INHALANTS$ADRENERGICS, INHALANTS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE","$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$NASAL PREPARATIONS$NASAL PREPARATIONS",$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
981774,37320158,9.47E-16,4.34E-08,adult_children_senior_youth,children_senior,adapalene,erythema,Skin and subcutaneous tissue disorders,$Retinoids for topical use in acne$Retinoids for topical use in acne,$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR TOPICAL USE,$ANTI-ACNE PREPARATIONS$ANTI-ACNE PREPARATIONS,$DERMATOLOGICALS$DERMATOLOGICALS
744740,35204970,9.76E-16,4.48E-08,adult_children_senior_youth,children_youth,zolpidem,cardio-respiratory arrest,Cardiac disorders,Benzodiazepine related drugs,HYPNOTICS AND SEDATIVES,PSYCHOLEPTICS,NERVOUS SYSTEM
1119119,36416551,1.01E-15,4.63E-08,adult_children_senior_youth,senior,adalimumab,osteoporosis,$Metabolism and nutrition disorders$Musculoskeletal and connective tissue disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
970250,36110986,1.02E-15,4.68E-08,adult_children_senior_youth,children,spironolactone,respiratory syncytial virus infection,Infections and infestations,Aldosterone antagonists,POTASSIUM-SPARING AGENTS,DIURETICS,CARDIOVASCULAR SYSTEM
1327256,36009735,1.04E-15,4.75E-08,adult_children_senior_youth,children_youth,treprostinil,dermatitis contact,Immune system disorders,Platelet aggregation inhibitors excl. heparin,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1560171,36718526,1.05E-15,4.81E-08,adult_children_senior_youth,children,glipizide,convulsion,0,Sulfonylureas,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",DRUGS USED IN DIABETES,ALIMENTARY TRACT AND METABOLISM
1762711,35909518,1.05E-15,4.84E-08,adult_children_senior_youth,children,ribavirin,hepatic failure,Hepatobiliary disorders,Antivirals for treatment of HCV infections,DIRECT ACTING ANTIVIRALS,ANTIVIRALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
1344905,36919046,1.06E-15,4.88E-08,adult_senior_youth,adult,carboplatin,emotional distress,Psychiatric disorders,Platinum compounds,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1351541,36211473,1.06E-15,4.85E-08,adult_children_senior,senior,leuprolide,underdose,"Injury, poisoning and procedural complications",$Gonadotropin releasing hormone analogues$Gonadotropin releasing hormone analogues,$HORMONES AND RELATED AGENTS$HORMONES AND RELATED AGENTS,$ENDOCRINE THERAPY$ENDOCRINE THERAPY,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1799139,36919207,1.08E-15,4.95E-08,adult_children_senior_youth,children,oseltamivir,nightmare,Psychiatric disorders,Neuraminidase inhibitors,DIRECT ACTING ANTIVIRALS,ANTIVIRALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
991876,36718288,1.09E-15,4.99E-08,adult_children_senior_youth,children_youth,loperamide,coma,Nervous system disorders,$Antipropulsives$Antipropulsives,$ANTIPROPULSIVES$ANTIPROPULSIVES,"$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1777087,36516909,1.10E-15,5.04E-08,adult_senior,senior,hydroxychloroquine,sciatica,$Musculoskeletal and connective tissue disorders$Nervous system disorders,Aminoquinolines,ANTIMALARIALS,ANTIPROTOZOALS,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS"
1310317,35104199,1.13E-15,5.18E-08,adult_children_senior_youth,children_youth,cyclophosphamide,haematotoxicity,"Injury, poisoning and procedural complications",Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
735979,37080784,1.14E-15,5.23E-08,adult_children_senior_youth,senior,risperidone,acute kidney injury,Renal and urinary disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1305058,36313534,1.16E-15,5.31E-08,adult_children_senior_youth,children,methotrexate,aspartate aminotransferase increased,Investigations,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
19015768,35205038,1.17E-15,5.37E-08,adult_children_senior_youth,youth,methoxy polyethylene glycol-epoetin beta,dyspnoea,"$Cardiac disorders$Respiratory, thoracic and mediastinal disorders",Other antianemic preparations,OTHER ANTIANEMIC PREPARATIONS,ANTIANEMIC PREPARATIONS,BLOOD AND BLOOD FORMING ORGANS
1103314,35809101,1.18E-15,5.42E-08,adult_children_senior_youth,children,tramadol,ataxia,Nervous system disorders,$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Other opioids,$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1305058,35909624,1.20E-15,0.000000055,adult_children_senior_youth,children,methotrexate,hepatocellular injury,Hepatobiliary disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1518254,35909624,1.21E-15,5.56E-08,adult_children_senior_youth,children,dexamethasone,hepatocellular injury,Hepatobiliary disorders,"$Corticosteroids$Corticosteroids, moderately potent, other combinations$Corticosteroids$Corticosteroids, combinations for treatment of acne$Corticosteroids/antiinfectives/mydriatics in combination$Corticosteroids and antiinfectives in combination$Corticosteroids and antiinfectives in combination$Corticosteroids$Corticosteroids and antiinfectives in combination$Corticosteroids, moderately potent, combinations with antibiotics$Glucocorticoids$Corticosteroids, plain$Corticosteroids for local oral treatment$Corticosteroids$Corticosteroids, moderately potent (group II)$Corticosteroids","$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$CORTICOSTEROIDS, OTHER COMBINATIONS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$ANTIINFLAMMATORY AGENTS$STOMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS$CORTICOSTEROIDS, PLAIN$CORTICOSTEROIDS","$NASAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$NASAL PREPARATIONS$ANTI-ACNE PREPARATIONS$OPHTHALMOLOGICALS$OTOLOGICALS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$VASOPROTECTIVES$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS FOR SYSTEMIC USE$OPHTHALMOLOGICALS$STOMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OTOLOGICALS","$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$DERMATOLOGICALS$SENSORY ORGANS$SENSORY ORGANS$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS$DERMATOLOGICALS$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$SENSORY ORGANS$DERMATOLOGICALS$SENSORY ORGANS"
1149196,36211491,1.24E-15,5.69E-08,adult_children_senior_youth,children,cetirizine,accidental overdose,"Injury, poisoning and procedural complications",Piperazine derivatives,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,RESPIRATORY SYSTEM
1186087,36516779,1.24E-15,5.69E-08,adult_children_senior_youth,children,abatacept,arthritis,Musculoskeletal and connective tissue disorders,Selective immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
715997,36718119,1.24E-15,5.69E-08,adult_children_senior,children,donepezil,encephalopathy,Nervous system disorders,$Anticholinesterases$Anticholinesterases$Anticholinesterases,$ANTI-DEMENTIA DRUGS$ANTI-DEMENTIA DRUGS$ANTI-DEMENTIA DRUGS,$PSYCHOANALEPTICS$PSYCHOANALEPTICS$PSYCHOANALEPTICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1153428,35809293,1.25E-15,5.75E-08,adult_children_senior_youth,children,fexofenadine,product taste abnormal,Product issues,Other antihistamines for systemic use,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,RESPIRATORY SYSTEM
750982,36718526,1.26E-15,0.000000058,adult_children_senior_youth,children_youth,bupropion,convulsion,0,$Centrally acting antiobesity products$Other antidepressants,"$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$ANTIDEPRESSANTS","$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$PSYCHOANALEPTICS",$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM
1305058,37219863,1.28E-15,5.89E-08,adult_children_senior_youth,children_youth,methotrexate,pleural effusion,"Respiratory, thoracic and mediastinal disorders",$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1125315,36918947,1.31E-15,6.02E-08,adult_children_senior_youth,youth,acetaminophen,anhedonia,Psychiatric disorders,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
937368,36516909,1.32E-15,6.06E-08,adult_senior,senior,infliximab,sciatica,$Musculoskeletal and connective tissue disorders$Nervous system disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1334456,42889647,1.33E-15,0.000000061,adult_senior_youth,youth,ramipril,toxicity to various agents,"Injury, poisoning and procedural complications","$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and diuretics$ACE inhibitors, plain","$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, PLAIN",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1315942,35909682,1.34E-15,6.15E-08,adult_senior_youth,youth,docetaxel,metastases to liver,Hepatobiliary disorders,Taxanes,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1501700,35204966,1.35E-15,6.21E-08,adult_children_senior_youth,children_youth,levothyroxine,cardiac arrest,Cardiac disorders,Thyroid hormones,THYROID PREPARATIONS,THYROID THERAPY,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
1703687,37622465,1.42E-15,6.53E-08,adult_children_senior_youth,senior,acyclovir,deep vein thrombosis,Vascular disorders,$Nucleosides and nucleotides excl. reverse transcriptase inhibitors$Antivirals$Antivirals$Antivirals,$DIRECT ACTING ANTIVIRALS$CHEMOTHERAPEUTICS FOR TOPICAL USE$ANTIINFECTIVES$CHEMOTHERAPEUTICS FOR TOPICAL USE,$ANTIVIRALS FOR SYSTEMIC USE$ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE$OPHTHALMOLOGICALS$ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,$ANTIINFECTIVES FOR SYSTEMIC USE$DERMATOLOGICALS$SENSORY ORGANS$DERMATOLOGICALS
1327256,35809059,1.43E-15,6.58E-08,adult_children_senior_youth,senior,treprostinil,death,General disorders and administration site conditions,Platelet aggregation inhibitors excl. heparin,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1154161,36009762,1.44E-15,6.62E-08,adult_children_senior_youth,youth,montelukast,angioedema,Immune system disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
19051649,37320268,1.46E-15,6.72E-08,adult_children_senior,adult,doxorubicin liposome,alopecia,Skin and subcutaneous tissue disorders,0,0,0,0
1557272,36516824,1.49E-15,6.82E-08,adult_children_senior_youth,adult,alendronate,osteoarthritis,Musculoskeletal and connective tissue disorders,0,0,0,0
40045116,36919230,1.50E-15,6.89E-08,adult_senior_youth,youth,hydrochlorothiazide / triamterene Oral Tablet,completed suicide,General disorders and administration site conditions,0,0,0,0
1344905,35909571,1.50E-15,0.000000069,adult_children,children,carboplatin,venoocclusive liver disease,Hepatobiliary disorders,Platinum compounds,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1713332,37622465,1.51E-15,6.95E-08,adult_children_senior_youth,youth,amoxicillin,deep vein thrombosis,Vascular disorders,"$Combinations for eradication of Helicobacter pylori$Combinations of penicillins, incl. beta-lactamase inhibitors$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Penicillins with extended spectrum","$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$BETA-LACTAM ANTIBACTERIALS, PENICILLINS$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$BETA-LACTAM ANTIBACTERIALS, PENICILLINS",$DRUGS FOR ACID RELATED DISORDERS$ANTIBACTERIALS FOR SYSTEMIC USE$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$ANTIBACTERIALS FOR SYSTEMIC USE,$ALIMENTARY TRACT AND METABOLISM$ANTIINFECTIVES FOR SYSTEMIC USE$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ANTIINFECTIVES FOR SYSTEMIC USE
797617,36919202,1.52E-15,6.97E-08,adult_children_senior_youth,youth,citalopram,sexual dysfunction,$Psychiatric disorders$Reproductive system and breast disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1328165,35205246,1.53E-15,7.04E-08,adult_children_senior_youth,children,diltiazem,cardiogenic shock,Vascular disorders,$Benzothiazepine derivatives$Muscle relaxants,$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE,$CALCIUM CHANNEL BLOCKERS$VASOPROTECTIVES,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1201620,36211491,1.58E-15,7.23E-08,adult_children_senior_youth,youth,codeine,accidental overdose,"Injury, poisoning and procedural complications",$Natural opium alkaloids$Opium alkaloids and derivatives$Natural opium alkaloids$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,"$OPIOIDS$COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS",$ANALGESICS$COUGH AND COLD PREPARATIONS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1112807,36211496,1.59E-15,7.31E-08,adult_children_senior_youth,youth,aspirin,overdose,"Injury, poisoning and procedural complications",0,0,0,0
40222444,37219831,1.62E-15,7.45E-08,adult_children_senior,children,denosumab,interstitial lung disease,"$Immune system disorders$Respiratory, thoracic and mediastinal disorders",Other drugs affecting bone structure and mineralization,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,DRUGS FOR TREATMENT OF BONE DISEASES,MUSCULO-SKELETAL SYSTEM
798874,37219893,1.62E-15,7.44E-08,adult_children_senior_youth,youth,clonazepam,respiratory arrest,"Respiratory, thoracic and mediastinal disorders",Benzodiazepine derivatives,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
920293,35809243,1.69E-15,7.76E-08,adult_children_senior_youth,youth,nitrofurantoin,pain,General disorders and administration site conditions,$Nitrofuran derivatives$Nitrofuran derivatives,$OTHER ANTIBACTERIALS$OTHER ANTIBACTERIALS,$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIBACTERIALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
740275,36776613,1.69E-15,7.74E-08,adult_children_senior_youth,children_youth,carbamazepine,seizure,Nervous system disorders,Carboxamide derivatives,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
44814542,35708208,1.72E-15,0.000000079,adult_children_senior_youth,adult_youth,droxidopa,vomiting,Gastrointestinal disorders,Adrenergic and dopaminergic agents,CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,CARDIAC THERAPY,CARDIOVASCULAR SYSTEM
1115008,35506459,1.74E-15,7.99E-08,adult_children_senior_youth,children,naproxen,adrenal insufficiency,$Endocrine disorders$Metabolism and nutrition disorders,"$Antiinflammatory products for vaginal administration$Antiinflammatory preparations, non-steroids for topical use$Propionic acid derivatives$Propionic acid derivatives$Propionic acid derivatives","$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
1769389,36211179,1.76E-15,8.07E-08,adult_senior_youth,senior,nevirapine,nephropathy toxic,"Injury, poisoning and procedural complications","$Non-nucleoside reverse transcriptase inhibitors$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations",$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS,$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
1784444,35607130,1.77E-15,8.12E-08,adult_senior_youth,youth,ivermectin,ocular hyperaemia,Eye disorders,$Avermectines$Other dermatologicals,$ANTINEMATODAL AGENTS$OTHER DERMATOLOGICAL PREPARATIONS,$ANTHELMINTICS$OTHER DERMATOLOGICAL PREPARATIONS,"$ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS$DERMATOLOGICALS"
1311078,36110597,1.77E-15,0.000000081,adult_children_senior_youth,senior,cytarabine,pneumonia,Infections and infestations,$Pyrimidine analogues$Combinations of antineoplastic agents,$ANTIMETABOLITES$OTHER ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AGENTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
723013,35809243,1.89E-15,8.66E-08,adult_children_senior_youth,adult_senior,diazepam,pain,General disorders and administration site conditions,Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1315942,36919046,1.96E-15,8.99E-08,adult_senior_youth,adult,docetaxel,emotional distress,Psychiatric disorders,Taxanes,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
904453,35909452,1.97E-15,9.04E-08,adult_children_senior_youth,youth,esomeprazole,gallbladder disorder,Hepatobiliary disorders,$Combinations for eradication of Helicobacter pylori$Proton pump inhibitors$Propionic acid derivatives,"$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$MUSCULO-SKELETAL SYSTEM
1154343,36919235,1.98E-15,0.000000091,adult_children_senior_youth,children,albuterol,suicidal ideation,Psychiatric disorders,0,0,0,0
42709322,36617495,2.00E-15,9.19E-08,adult_children_senior_youth,children,axitinib,renal cell carcinoma,"$Neoplasms benign, malignant and unspecified (incl cysts and polyps)$Renal and urinary disorders",Protein kinase inhibitors,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
987366,35205038,2.02E-15,9.25E-08,adult_children_senior_youth,youth,lubiprostone,dyspnoea,"$Cardiac disorders$Respiratory, thoracic and mediastinal disorders",Other drugs for constipation,DRUGS FOR CONSTIPATION,DRUGS FOR CONSTIPATION,ALIMENTARY TRACT AND METABOLISM
1501700,36516837,2.05E-15,9.39E-08,adult_children_senior_youth,adult,levothyroxine,myalgia,Musculoskeletal and connective tissue disorders,Thyroid hormones,THYROID PREPARATIONS,THYROID THERAPY,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
766814,36919230,2.16E-15,0.000000099,adult_children_senior_youth,youth,quetiapine,completed suicide,General disorders and administration site conditions,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1119119,37219942,2.19E-15,0.0000001,adult_children_senior_youth,senior,adalimumab,lung disorder,"Respiratory, thoracic and mediastinal disorders",Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1154343,36211496,2.19E-15,0.0000001,adult_children_senior_youth,children,albuterol,overdose,"Injury, poisoning and procedural complications",0,0,0,0
1305058,36516973,2.25E-15,0.000000103,adult_children_senior_youth,adult,methotrexate,musculoskeletal stiffness,Musculoskeletal and connective tissue disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1797155,36313176,2.25E-15,0.000000103,adult_children_senior_youth,senior,peginterferon alfa-2b,platelet count decreased,Investigations,$Interferons$Interferons,$IMMUNOSTIMULANTS$IMMUNOSTIMULANTS,$IMMUNOSTIMULANTS$IMMUNOSTIMULANTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1524674,36718404,2.35E-15,0.000000108,adult_senior_youth,adult,zoledronic acid,palmar-plantar erythrodysaesthesia syndrome,Nervous system disorders,"$Bisphosphonates, combinations$Bisphosphonates",$DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION$DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,$DRUGS FOR TREATMENT OF BONE DISEASES$DRUGS FOR TREATMENT OF BONE DISEASES,$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
923645,36919046,2.36E-15,0.000000108,adult_children_senior_youth,youth,omeprazole,emotional distress,Psychiatric disorders,$Proton pump inhibitors$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori,$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1398937,35204928,2.37E-15,0.000000109,adult_children_senior_youth,youth,clonidine,bradycardia,Cardiac disorders,$Sympathomimetics in glaucoma therapy$Imidazoline receptor agonists in combination with diuretics$Imidazoline receptor agonists$Other antimigraine preparations$Imidazoline receptor agonists in combination with diuretics,"$ANTIGLAUCOMA PREPARATIONS AND MIOTICS$ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION$ANTIADRENERGIC AGENTS, CENTRALLY ACTING$ANTIMIGRAINE PREPARATIONS$ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",$OPHTHALMOLOGICALS$ANTIHYPERTENSIVES$ANTIHYPERTENSIVES$ANALGESICS$ANTIHYPERTENSIVES,$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$NERVOUS SYSTEM$CARDIOVASCULAR SYSTEM
1503297,36211303,2.38E-15,0.000000109,adult_children_senior_youth,youth,metformin,injury,"Injury, poisoning and procedural complications",$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Biguanides$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1316262,36009735,2.39E-15,0.00000011,adult_children_senior_youth,children_youth,sildenafil,dermatitis contact,Immune system disorders,$Sulfonamides$Drugs used in erectile dysfunction,"$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$UROLOGICALS",$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$UROLOGICALS,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1119119,36918858,2.45E-15,0.000000112,adult_children_senior_youth,children_youth,adalimumab,anxiety,Psychiatric disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
742185,35708171,2.46E-15,0.000000113,adult_children_youth,children,atomoxetine,dysphagia,Gastrointestinal disorders,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
19010482,35809083,2.54E-15,0.000000116,adult_children_senior,senior,cyclosporine,feeling abnormal,General disorders and administration site conditions,$Calcineurin inhibitors$Other ophthalmologicals,$IMMUNOSUPPRESSANTS$OTHER OPHTHALMOLOGICALS,$IMMUNOSUPPRESSANTS$OPHTHALMOLOGICALS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$SENSORY ORGANS
1154161,36919053,2.59E-15,0.000000119,adult_children_senior_youth,children_youth,montelukast,affective disorder,Psychiatric disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
735843,35809059,2.59E-15,0.000000119,adult_senior_youth,senior,natalizumab,death,General disorders and administration site conditions,Selective immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1551099,35104877,2.63E-15,0.000000121,adult_children_senior_youth,children_youth,prednisone,febrile neutropenia,General disorders and administration site conditions,$Corticosteroids acting locally$Glucocorticoids,"$INTESTINAL ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN","$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE","$ALIMENTARY TRACT AND METABOLISM$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
1315942,35104768,2.65E-15,0.000000122,adult_senior_youth,youth,docetaxel,metastases to lymph nodes,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Taxanes,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1136980,37219871,2.69E-15,0.000000124,adult_children_senior_youth,youth,ketorolac,pulmonary embolism,"$Respiratory, thoracic and mediastinal disorders$Vascular disorders","$Acetic acid derivatives and related substances$Sympathomimetics excl. antiglaucoma preparations$Antiinflammatory agents, non-steroids","$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$MYDRIATICS AND CYCLOPLEGICS$ANTIINFLAMMATORY AGENTS",$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$OPHTHALMOLOGICALS$OPHTHALMOLOGICALS,$MUSCULO-SKELETAL SYSTEM$SENSORY ORGANS$SENSORY ORGANS
1119119,36111036,2.74E-15,0.000000126,adult_senior,senior,adalimumab,pneumonia viral,"$Infections and infestations$Respiratory, thoracic and mediastinal disorders",Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1305058,36617309,2.80E-15,0.000000129,adult_children_senior_youth,youth,methotrexate,neoplasm progression,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1713332,37219871,2.82E-15,0.000000129,adult_children_senior_youth,youth,amoxicillin,pulmonary embolism,"$Respiratory, thoracic and mediastinal disorders$Vascular disorders","$Combinations for eradication of Helicobacter pylori$Combinations of penicillins, incl. beta-lactamase inhibitors$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Penicillins with extended spectrum","$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$BETA-LACTAM ANTIBACTERIALS, PENICILLINS$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$BETA-LACTAM ANTIBACTERIALS, PENICILLINS",$DRUGS FOR ACID RELATED DISORDERS$ANTIBACTERIALS FOR SYSTEMIC USE$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$ANTIBACTERIALS FOR SYSTEMIC USE,$ALIMENTARY TRACT AND METABOLISM$ANTIINFECTIVES FOR SYSTEMIC USE$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ANTIINFECTIVES FOR SYSTEMIC USE
1539403,36718365,2.88E-15,0.000000132,adult_children_senior,children,simvastatin,personality change,Nervous system disorders,"$Dipeptidyl peptidase 4 (DPP-4) inhibitors$HMG CoA reductase inhibitors$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents","$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS",$DRUGS USED IN DIABETES$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS,$ALIMENTARY TRACT AND METABOLISM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1338512,43562827,2.93E-15,0.000000134,adult_children_senior_youth,senior,doxorubicin,pneumocystis jirovecii pneumonia,Infections and infestations,Anthracyclines and related substances,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
735979,36516888,2.99E-15,0.000000137,adult_children_senior_youth,senior,risperidone,rhabdomyolysis,Musculoskeletal and connective tissue disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1154161,36918985,3.00E-15,0.000000138,adult_children_senior_youth,children,montelukast,"hallucination, auditory",Psychiatric disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
735979,36110736,3.00E-15,0.000000138,adult_children_senior_youth,senior,risperidone,urinary tract infection,Infections and infestations,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
722031,35809139,3.07E-15,0.000000141,adult_children_senior_youth,youth,paroxetine,irritability,$General disorders and administration site conditions$Psychiatric disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1305058,36110933,3.12E-15,0.000000143,adult_children_senior_youth,adult,methotrexate,influenza,Infections and infestations,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1326303,35205164,3.15E-15,0.000000144,adult_children_senior,adult,digoxin,coronary artery disease,Vascular disorders,Digitalis glycosides,CARDIAC GLYCOSIDES,CARDIAC THERAPY,CARDIOVASCULAR SYSTEM
991876,36919236,3.15E-15,0.000000145,adult_children_senior_youth,children_youth,loperamide,suicide attempt,Psychiatric disorders,$Antipropulsives$Antipropulsives,$ANTIPROPULSIVES$ANTIPROPULSIVES,"$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
743670,36416600,3.16E-15,0.000000145,adult_children_senior_youth,senior,venlafaxine,hyponatraemia,Metabolism and nutrition disorders,Other antidepressants,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1301267,35909571,3.16E-15,0.000000145,adult_children_senior_youth,children_youth,melphalan,venoocclusive liver disease,Hepatobiliary disorders,Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1550557,36009895,3.29E-15,0.000000151,adult_children_senior_youth,children_youth,prednisolone,graft versus host disease,"Injury, poisoning and procedural complications","$Corticosteroids, weak (group I)$Corticosteroids and antiinfectives in combination$Corticosteroids, weak, other combinations$Corticosteroids for local oral treatment$Corticosteroids$Corticosteroids and mydriatics in combination$Corticosteroids$Corticosteroids/antiinfectives/mydriatics in combination$Antidotes$Corticosteroids$Corticosteroids, weak, combinations with antiseptics$Corticosteroids, weak, combinations with antibiotics$Corticosteroids, plain$Corticosteroids$Corticosteroids acting locally$Glucocorticoids$Corticosteroids and antiinfectives in combination$Corticosteroids$Corticosteroids and antiinfectives in combination","$CORTICOSTEROIDS, PLAIN$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS, OTHER COMBINATIONS$STOMATOLOGICAL PREPARATIONS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$ALL OTHER THERAPEUTIC PRODUCTS$CORTICOSTEROIDS$CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS$INTESTINAL ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION","$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$STOMATOLOGICAL PREPARATIONS$NASAL PREPARATIONS$OPHTHALMOLOGICALS$NASAL PREPARATIONS$OPHTHALMOLOGICALS$ALL OTHER THERAPEUTIC PRODUCTS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS$OTOLOGICALS$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE$OTOLOGICALS$VASOPROTECTIVES$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS","$DERMATOLOGICALS$SENSORY ORGANS$DERMATOLOGICALS$ALIMENTARY TRACT AND METABOLISM$RESPIRATORY SYSTEM$SENSORY ORGANS$RESPIRATORY SYSTEM$SENSORY ORGANS$VARIOUS$SENSORY ORGANS$DERMATOLOGICALS$DERMATOLOGICALS$SENSORY ORGANS$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS"
1597756,35205189,3.35E-15,0.000000154,adult_children_senior,adult,glimepiride,myocardial infarction,Vascular disorders,$Combinations of oral blood glucose lowering drugs$Sulfonylureas$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
745466,36718530,3.38E-15,0.000000155,adult_children_senior_youth,children,valproate,epilepsy,Nervous system disorders,0,0,0,0
798874,36919230,3.39E-15,0.000000156,adult_children_senior_youth,youth,clonazepam,completed suicide,General disorders and administration site conditions,Benzodiazepine derivatives,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
19113013,36313050,3.40E-15,0.000000156,adult_children_senior,senior,fluindione,international normalised ratio increased,Investigations,Vitamin K antagonists,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1343916,36009703,3.52E-15,0.000000161,adult_children_senior_youth,children,epinephrine,bronchospasm,"Respiratory, thoracic and mediastinal disorders","$Other agents for local oral treatment$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Local hemostatics$Adrenergic and dopaminergic agents$Sympathomimetics in glaucoma therapy$Sympathomimetics, plain$Alpha- and beta-adrenoreceptor agonists$Sympathomimetics in glaucoma therapy","$STOMATOLOGICAL PREPARATIONS$ADRENERGICS, INHALANTS$VITAMIN K AND OTHER HEMOSTATICS$CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES$ANTIGLAUCOMA PREPARATIONS AND MIOTICS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ADRENERGICS, INHALANTS$ANTIGLAUCOMA PREPARATIONS AND MIOTICS",$STOMATOLOGICAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$ANTIHEMORRHAGICS$CARDIAC THERAPY$OPHTHALMOLOGICALS$NASAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OPHTHALMOLOGICALS,$ALIMENTARY TRACT AND METABOLISM$RESPIRATORY SYSTEM$BLOOD AND BLOOD FORMING ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$SENSORY ORGANS
996416,37119647,3.56E-15,0.000000163,adult_senior_youth,youth,finasteride,ejaculation disorder,Reproductive system and breast disorders,$Other dermatologicals$Alpha-adrenoreceptor antagonists$Testosterone-5-alpha reductase inhibitors,$OTHER DERMATOLOGICAL PREPARATIONS$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,$OTHER DERMATOLOGICAL PREPARATIONS$UROLOGICALS$UROLOGICALS,$DERMATOLOGICALS$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1177480,35909441,3.60E-15,0.000000165,adult_children_senior_youth,youth,ibuprofen,cholecystitis,Hepatobiliary disorders,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
1154161,36312077,3.65E-15,0.000000168,adult_children_senior_youth,adult,montelukast,blood pressure increased,Investigations,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
785788,35809084,3.72E-15,0.000000171,adult_children_senior_youth,children_senior,olanzapine,feeling cold,General disorders and administration site conditions,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1151789,43562826,3.74E-15,0.000000172,adult_children_senior_youth,children_youth,etanercept,fear of injection,Psychiatric disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1398937,36315381,3.74E-15,0.000000172,adult_children_senior_youth,children_youth,clonidine,weight increased,Investigations,$Sympathomimetics in glaucoma therapy$Imidazoline receptor agonists in combination with diuretics$Imidazoline receptor agonists$Other antimigraine preparations$Imidazoline receptor agonists in combination with diuretics,"$ANTIGLAUCOMA PREPARATIONS AND MIOTICS$ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION$ANTIADRENERGIC AGENTS, CENTRALLY ACTING$ANTIMIGRAINE PREPARATIONS$ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",$OPHTHALMOLOGICALS$ANTIHYPERTENSIVES$ANTIHYPERTENSIVES$ANALGESICS$ANTIHYPERTENSIVES,$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$NERVOUS SYSTEM$CARDIOVASCULAR SYSTEM
722031,37219868,3.82E-15,0.000000175,adult_children_senior_youth,children,paroxetine,pulmonary hypertension,Vascular disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1353011,35104883,3.87E-15,0.000000178,adult_children_senior_youth,youth,dexrazoxane,neutropenia,Blood and lymphatic system disorders,Detoxifying agents for antineoplastic treatment,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,VARIOUS
1545958,37320098,3.94E-15,0.000000181,adult_senior_youth,youth,atorvastatin,actinic keratosis,Skin and subcutaneous tissue disorders,"$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations","$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS",$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1398937,36718220,4.18E-15,0.000000192,adult_children_senior_youth,children,clonidine,dystonia,Nervous system disorders,$Sympathomimetics in glaucoma therapy$Imidazoline receptor agonists in combination with diuretics$Imidazoline receptor agonists$Other antimigraine preparations$Imidazoline receptor agonists in combination with diuretics,"$ANTIGLAUCOMA PREPARATIONS AND MIOTICS$ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION$ANTIADRENERGIC AGENTS, CENTRALLY ACTING$ANTIMIGRAINE PREPARATIONS$ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",$OPHTHALMOLOGICALS$ANTIHYPERTENSIVES$ANTIHYPERTENSIVES$ANALGESICS$ANTIHYPERTENSIVES,$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$NERVOUS SYSTEM$CARDIOVASCULAR SYSTEM
1500211,36718132,4.20E-15,0.000000193,adult_children_senior_youth,children,medroxyprogesterone,headache,Nervous system disorders,0,0,0,0
705944,36919230,4.21E-15,0.000000193,adult_children_senior_youth,senior_youth,methylphenidate,completed suicide,General disorders and administration site conditions,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
781039,36211496,4.27E-15,0.000000196,adult_children_senior_youth,youth,alprazolam,overdose,"Injury, poisoning and procedural complications",Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1341149,35909682,4.28E-15,0.000000196,adult_children_senior_youth,youth,temozolomide,metastases to liver,Hepatobiliary disorders,Other alkylating agents,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
778268,36211496,4.37E-15,0.000000201,adult_children_senior_youth,youth,imipramine,overdose,"Injury, poisoning and procedural complications",Non-selective monoamine reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
42904205,36009833,4.50E-15,0.000000207,adult_senior_youth,youth,tofacitinib,rheumatoid arthritis,Immune system disorders,Selective immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1119119,35708073,4.58E-15,0.00000021,adult_children_senior_youth,children,adalimumab,inflammatory bowel disease,Gastrointestinal disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
40244266,35809059,4.59E-15,0.000000211,adult_children_senior,senior,aflibercept,death,General disorders and administration site conditions,$Antineovascularisation agents$Other antineoplastic agents,$OCULAR VASCULAR DISORDER AGENTS$OTHER ANTINEOPLASTIC AGENTS,$OPHTHALMOLOGICALS$ANTINEOPLASTIC AGENTS,$SENSORY ORGANS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1316262,36311887,4.74E-15,0.000000218,adult_children_senior_youth,children,sildenafil,catheterisation cardiac,Investigations,$Sulfonamides$Drugs used in erectile dysfunction,"$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$UROLOGICALS",$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$UROLOGICALS,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
766814,36919046,4.84E-15,0.000000222,adult_children_senior_youth,children,quetiapine,emotional distress,Psychiatric disorders,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1734104,42889536,5.06E-15,0.000000232,adult_children_youth,youth,azithromycin,infective pulmonary exacerbation of cystic fibrosis,"Respiratory, thoracic and mediastinal disorders",$Combinations of antibacterials$Antibiotics$Macrolides,"$COMBINATIONS OF ANTIBACTERIALS$ANTIINFECTIVES$MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",$ANTIBACTERIALS FOR SYSTEMIC USE$OPHTHALMOLOGICALS$ANTIBACTERIALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$SENSORY ORGANS$ANTIINFECTIVES FOR SYSTEMIC USE
937368,36009756,5.08E-15,0.000000233,adult_children_senior_youth,children,infliximab,anaphylactic reaction,Immune system disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
705944,35808830,5.09E-15,0.000000234,adult_children_youth,children,methylphenidate,application site urticaria,General disorders and administration site conditions,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
1304107,35104883,5.16E-15,0.000000237,adult_children_senior_youth,children_youth,imatinib,neutropenia,Blood and lymphatic system disorders,Protein kinase inhibitors,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1353766,35205246,5.26E-15,0.000000242,adult_children_senior_youth,youth,propranolol,cardiogenic shock,Vascular disorders,"$Beta blocking agents, other combinations$Beta blocking agents, non-selective$Beta blocking agents, non-selective, and thiazides","$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS AND THIAZIDES",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1103640,36918858,5.37E-15,0.000000247,adult_senior_youth,adult_senior,methadone,anxiety,Psychiatric disorders,$Drugs used in opioid dependence$Diphenylpropylamine derivatives,$DRUGS USED IN ADDICTIVE DISORDERS$OPIOIDS,$OTHER NERVOUS SYSTEM DRUGS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
1192710,36416487,5.50E-15,0.000000252,adult_children_senior_youth,youth,chlorpheniramine,metabolic acidosis,Metabolism and nutrition disorders,$Substituted alkylamines$Substituted alkylamines,$ANTIHISTAMINES FOR SYSTEMIC USE$ANTIHISTAMINES FOR SYSTEMIC USE,$ANTIHISTAMINES FOR SYSTEMIC USE$ANTIHISTAMINES FOR SYSTEMIC USE,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1503297,36919230,5.52E-15,0.000000253,adult_children_senior_youth,youth,metformin,completed suicide,General disorders and administration site conditions,$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Biguanides$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1305058,36718555,5.53E-15,0.000000254,adult_children_senior_youth,adult,methotrexate,insomnia,$Nervous system disorders$Psychiatric disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1149380,37622465,5.63E-15,0.000000258,adult_children_senior_youth,youth,fluticasone,deep vein thrombosis,Vascular disorders,"$Glucocorticoids$Corticosteroids, potent (group III)$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Corticosteroids$Corticosteroids","$OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS$CORTICOSTEROIDS, PLAIN$ADRENERGICS, INHALANTS$ADRENERGICS, INHALANTS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE","$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$NASAL PREPARATIONS$NASAL PREPARATIONS",$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
750982,36718510,5.68E-15,0.000000261,adult_children_senior_youth,children_youth,bupropion,grand mal convulsion,0,$Centrally acting antiobesity products$Other antidepressants,"$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$ANTIDEPRESSANTS","$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$PSYCHOANALEPTICS",$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM
19010482,35809207,5.72E-15,0.000000262,adult_children_senior_youth,children,cyclosporine,mucosal inflammation,General disorders and administration site conditions,$Calcineurin inhibitors$Other ophthalmologicals,$IMMUNOSUPPRESSANTS$OTHER OPHTHALMOLOGICALS,$IMMUNOSUPPRESSANTS$OPHTHALMOLOGICALS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$SENSORY ORGANS
1518254,36718008,5.75E-15,0.000000264,adult_children_senior_youth,children,dexamethasone,haemorrhage intracranial,Vascular disorders,"$Corticosteroids$Corticosteroids, moderately potent, other combinations$Corticosteroids$Corticosteroids, combinations for treatment of acne$Corticosteroids/antiinfectives/mydriatics in combination$Corticosteroids and antiinfectives in combination$Corticosteroids and antiinfectives in combination$Corticosteroids$Corticosteroids and antiinfectives in combination$Corticosteroids, moderately potent, combinations with antibiotics$Glucocorticoids$Corticosteroids, plain$Corticosteroids for local oral treatment$Corticosteroids$Corticosteroids, moderately potent (group II)$Corticosteroids","$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$CORTICOSTEROIDS, OTHER COMBINATIONS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$ANTIINFLAMMATORY AGENTS$STOMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS$CORTICOSTEROIDS, PLAIN$CORTICOSTEROIDS","$NASAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$NASAL PREPARATIONS$ANTI-ACNE PREPARATIONS$OPHTHALMOLOGICALS$OTOLOGICALS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$VASOPROTECTIVES$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS FOR SYSTEMIC USE$OPHTHALMOLOGICALS$STOMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OTOLOGICALS","$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$DERMATOLOGICALS$SENSORY ORGANS$SENSORY ORGANS$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS$DERMATOLOGICALS$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$SENSORY ORGANS$DERMATOLOGICALS$SENSORY ORGANS"
1797513,36517150,6.02E-15,0.000000276,adult_children_senior_youth,adult,ciprofloxacin,tendon pain,Musculoskeletal and connective tissue disorders,$Combinations of antibacterials$Antiinfectives$Fluoroquinolones$Antiinfectives$Combinations of antibacterials$Combinations of antibacterials$Fluoroquinolones,$COMBINATIONS OF ANTIBACTERIALS$ANTIINFECTIVES$QUINOLONE ANTIBACTERIALS$ANTIINFECTIVES$COMBINATIONS OF ANTIBACTERIALS$COMBINATIONS OF ANTIBACTERIALS$ANTIINFECTIVES,$ANTIBACTERIALS FOR SYSTEMIC USE$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$ANTIBACTERIALS FOR SYSTEMIC USE$OTOLOGICALS$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIBACTERIALS FOR SYSTEMIC USE$OPHTHALMOLOGICALS,$ANTIINFECTIVES FOR SYSTEMIC USE$SENSORY ORGANS$ANTIINFECTIVES FOR SYSTEMIC USE$SENSORY ORGANS$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$SENSORY ORGANS
1151789,36718132,6.25E-15,0.000000287,adult_children_senior_youth,children_youth,etanercept,headache,Nervous system disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
778711,36919236,6.28E-15,0.000000288,adult_children_senior_youth,children,cyclobenzaprine,suicide attempt,Psychiatric disorders,Other centrally acting agents,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",MUSCLE RELAXANTS,MUSCULO-SKELETAL SYSTEM
1762711,35909513,6.46E-15,0.000000297,adult_children_senior,senior,ribavirin,acute hepatic failure,Hepatobiliary disorders,Antivirals for treatment of HCV infections,DIRECT ACTING ANTIVIRALS,ANTIVIRALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
757688,36919098,6.72E-15,0.000000308,adult_children_senior_youth,children,aripiprazole,abnormal behaviour,Psychiatric disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
797617,36919183,6.72E-15,0.000000308,adult_children_senior_youth,youth,citalopram,erectile dysfunction,$Psychiatric disorders$Reproductive system and breast disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1115008,35809243,6.80E-15,0.000000312,adult_children_senior_youth,youth,naproxen,pain,General disorders and administration site conditions,"$Antiinflammatory products for vaginal administration$Antiinflammatory preparations, non-steroids for topical use$Propionic acid derivatives$Propionic acid derivatives$Propionic acid derivatives","$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
916005,35708690,7.09E-15,0.000000326,adult_children_senior_youth,children,solifenacin,dry mouth,Gastrointestinal disorders,$Drugs for urinary frequency and incontinence$Alpha-adrenoreceptor antagonists,$UROLOGICALS$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,$UROLOGICALS$UROLOGICALS,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1539403,36919230,7.11E-15,0.000000326,adult_children_senior_youth,children_youth,simvastatin,completed suicide,General disorders and administration site conditions,"$Dipeptidyl peptidase 4 (DPP-4) inhibitors$HMG CoA reductase inhibitors$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents","$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS",$DRUGS USED IN DIABETES$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS,$ALIMENTARY TRACT AND METABOLISM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
19054936,36416487,7.27E-15,0.000000334,adult_children_senior_youth,senior,floxacillin,metabolic acidosis,Metabolism and nutrition disorders,0,0,0,0
1314924,43053848,7.28E-15,0.000000334,adult_senior_youth,youth,gemcitabine,drug effect incomplete,General disorders and administration site conditions,Pyrimidine analogues,ANTIMETABOLITES,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1308290,36110597,7.29E-15,0.000000335,adult_children_senior_youth,senior,vincristine,pneumonia,Infections and infestations,Vinca alkaloids and analogues,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1151789,36516973,7.44E-15,0.000000341,adult_children_senior_youth,adult,etanercept,musculoskeletal stiffness,Musculoskeletal and connective tissue disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
929887,37522181,7.49E-15,0.000000344,adult_children_senior_youth,children,lansoprazole,hospitalisation,Surgical and medical procedures,$Proton pump inhibitors$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Proton pump inhibitors,$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1177480,36918984,7.57E-15,0.000000348,adult_children_senior_youth,children,ibuprofen,hallucination,Psychiatric disorders,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
723013,35708202,7.61E-15,0.000000349,adult_children_senior_youth,senior,diazepam,nausea,Gastrointestinal disorders,Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
744740,35204966,7.69E-15,0.000000353,adult_children_senior_youth,children_youth,zolpidem,cardiac arrest,Cardiac disorders,Benzodiazepine related drugs,HYPNOTICS AND SEDATIVES,PSYCHOLEPTICS,NERVOUS SYSTEM
1124957,36919046,7.71E-15,0.000000354,adult_children_senior_youth,youth,oxycodone,emotional distress,Psychiatric disorders,$Natural opium alkaloids$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1124300,37019425,7.84E-15,0.00000036,adult_children_senior_youth,children_youth,diclofenac,haematuria,Reproductive system and breast disorders,"$Antiinflammatory agents, non-steroids and antiinfectives in combination$Antiinflammatory agents, non-steroids$Acetic acid derivatives and related substances$Antiinflammatory preparations, non-steroids for topical use$Acetic acid derivatives and related substances$Other dermatologicals","$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$ANTIINFLAMMATORY AGENTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$OTHER DERMATOLOGICAL PREPARATIONS",$OPHTHALMOLOGICALS$OPHTHALMOLOGICALS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$OTHER DERMATOLOGICAL PREPARATIONS,$SENSORY ORGANS$SENSORY ORGANS$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$DERMATOLOGICALS
1524674,36718005,7.87E-15,0.000000361,adult_senior_youth,senior,zoledronic acid,cerebrovascular accident,Vascular disorders,"$Bisphosphonates, combinations$Bisphosphonates",$DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION$DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,$DRUGS FOR TREATMENT OF BONE DISEASES$DRUGS FOR TREATMENT OF BONE DISEASES,$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
46287466,35809138,7.97E-15,0.000000366,adult_children_senior,adult,evolocumab,influenza like illness,General disorders and administration site conditions,Other lipid modifying agents,"LIPID MODIFYING AGENTS, PLAIN",LIPID MODIFYING AGENTS,CARDIOVASCULAR SYSTEM
1119510,35708093,8.04E-15,0.000000369,adult_children_senior_youth,senior,dextromethorphan,diarrhoea,Gastrointestinal disorders,$Opium alkaloids and derivatives$Other nervous system drugs,"$COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS$OTHER NERVOUS SYSTEM DRUGS",$COUGH AND COLD PREPARATIONS$OTHER NERVOUS SYSTEM DRUGS,$RESPIRATORY SYSTEM$NERVOUS SYSTEM
1119119,36516909,8.21E-15,0.000000377,adult_senior_youth,senior,adalimumab,sciatica,$Musculoskeletal and connective tissue disorders$Nervous system disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
750982,35204966,8.34E-15,0.000000383,adult_children_senior_youth,children_youth,bupropion,cardiac arrest,Cardiac disorders,$Centrally acting antiobesity products$Other antidepressants,"$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$ANTIDEPRESSANTS","$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$PSYCHOANALEPTICS",$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM
1539403,35204953,8.36E-15,0.000000384,adult_children_senior_youth,senior,simvastatin,atrial fibrillation,Cardiac disorders,"$Dipeptidyl peptidase 4 (DPP-4) inhibitors$HMG CoA reductase inhibitors$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents","$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS",$DRUGS USED IN DIABETES$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS,$ALIMENTARY TRACT AND METABOLISM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1103640,35205259,8.49E-15,0.00000039,adult_children_senior_youth,youth,methadone,pulmonary oedema,"Respiratory, thoracic and mediastinal disorders",$Drugs used in opioid dependence$Diphenylpropylamine derivatives,$DRUGS USED IN ADDICTIVE DISORDERS$OPIOIDS,$OTHER NERVOUS SYSTEM DRUGS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
1334456,36312077,8.55E-15,0.000000393,adult_children_senior_youth,adult,ramipril,blood pressure increased,Investigations,"$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and diuretics$ACE inhibitors, plain","$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, PLAIN",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
40044817,37019318,8.63E-15,0.000000396,adult_senior_youth,youth,hydrochlorothiazide / lisinopril Oral Tablet,renal failure,Renal and urinary disorders,0,0,0,0
40161532,36617304,8.63E-15,0.000000396,adult_children_senior,senior,ustekinumab,squamous cell carcinoma,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Interleukin inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
991876,37219894,8.70E-15,0.0000004,adult_children_senior_youth,youth,loperamide,respiratory depression,Nervous system disorders,$Antipropulsives$Antipropulsives,$ANTIPROPULSIVES$ANTIPROPULSIVES,"$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1778162,35843604,8.82E-15,0.000000405,adult_children_senior_youth,children,cefuroxime,pharmaceutical product complaint,0,$Antibiotics$Second-generation cephalosporins$Combinations of antibacterials,$ANTIINFECTIVES$OTHER BETA-LACTAM ANTIBACTERIALS$COMBINATIONS OF ANTIBACTERIALS,$OPHTHALMOLOGICALS$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIBACTERIALS FOR SYSTEMIC USE,$SENSORY ORGANS$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
1762711,43053904,8.83E-15,0.000000406,adult_senior_youth,youth,ribavirin,exposure during pregnancy,"Injury, poisoning and procedural complications",Antivirals for treatment of HCV infections,DIRECT ACTING ANTIVIRALS,ANTIVIRALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
19010482,37219959,8.86E-15,0.000000407,adult_children_senior_youth,senior,cyclosporine,rhinorrhoea,"Respiratory, thoracic and mediastinal disorders",$Calcineurin inhibitors$Other ophthalmologicals,$IMMUNOSUPPRESSANTS$OTHER OPHTHALMOLOGICALS,$IMMUNOSUPPRESSANTS$OPHTHALMOLOGICALS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$SENSORY ORGANS
40241331,37080784,9.07E-15,0.000000416,adult_children_senior_youth,senior,rivaroxaban,acute kidney injury,Renal and urinary disorders,Direct factor Xa inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1151789,36617894,9.07E-15,0.000000416,adult_children_senior,senior,etanercept,lung neoplasm malignant,"$Neoplasms benign, malignant and unspecified (incl cysts and polyps)$Respiratory, thoracic and mediastinal disorders",Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1551099,37019440,9.15E-15,0.00000042,adult_children_senior_youth,children_youth,prednisone,proteinuria,Renal and urinary disorders,$Corticosteroids acting locally$Glucocorticoids,"$INTESTINAL ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN","$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE","$ALIMENTARY TRACT AND METABOLISM$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
715259,36718379,9.35E-15,0.000000429,adult_children_senior_youth,youth,duloxetine,paraesthesia,Nervous system disorders,Other antidepressants,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1346823,35205164,9.38E-15,0.00000043,adult_children_senior_youth,adult,carvedilol,coronary artery disease,Vascular disorders,"$Alpha and beta blocking agents$Beta blocking agents, other combinations","$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS, OTHER COMBINATIONS",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
715259,36818729,9.69E-15,0.000000445,adult_children,children,duloxetine,premature baby,"Pregnancy, puerperium and perinatal conditions",Other antidepressants,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1762711,36818634,9.77E-15,0.000000449,adult_youth,youth,ribavirin,abortion spontaneous,"Pregnancy, puerperium and perinatal conditions",Antivirals for treatment of HCV infections,DIRECT ACTING ANTIVIRALS,ANTIVIRALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
1178663,37019319,9.78E-15,0.000000449,adult_children_senior,children,indometacin,renal failure acute,0,0,0,0,0
1309068,35607122,9.85E-15,0.000000452,adult_children_senior_youth,youth,minoxidil,eye irritation,Eye disorders,$Other dermatologicals$Pyrimidine derivatives,"$OTHER DERMATOLOGICAL PREPARATIONS$ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON",$OTHER DERMATOLOGICAL PREPARATIONS$ANTIHYPERTENSIVES,$DERMATOLOGICALS$CARDIOVASCULAR SYSTEM
750982,35809104,1.05E-14,0.000000482,adult_children_senior_youth,senior,bupropion,gait disturbance,General disorders and administration site conditions,$Centrally acting antiobesity products$Other antidepressants,"$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$ANTIDEPRESSANTS","$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$PSYCHOANALEPTICS",$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM
715233,35809139,1.05E-14,0.000000481,adult_children_senior_youth,children,baclofen,irritability,$General disorders and administration site conditions$Psychiatric disorders,Other centrally acting agents,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",MUSCLE RELAXANTS,MUSCULO-SKELETAL SYSTEM
44816294,35809059,1.09E-14,0.000000499,adult_senior_youth,senior,apremilast,death,General disorders and administration site conditions,Selective immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1308290,37219871,1.09E-14,0.000000502,adult_children_senior_youth,senior,vincristine,pulmonary embolism,"$Respiratory, thoracic and mediastinal disorders$Vascular disorders",Vinca alkaloids and analogues,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
723013,36776613,1.11E-14,0.00000051,adult_children_senior_youth,children,diazepam,seizure,Nervous system disorders,Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1119119,35205164,1.16E-14,0.000000533,adult_senior,senior,adalimumab,coronary artery disease,Vascular disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1174888,35204970,1.17E-14,0.000000537,adult_children_senior_youth,children,hydrocodone,cardio-respiratory arrest,Cardiac disorders,Opium alkaloids and derivatives,"COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",COUGH AND COLD PREPARATIONS,RESPIRATORY SYSTEM
739138,35205319,1.18E-14,0.000000541,adult_children_senior_youth,children,sertraline,dilatation ventricular,Cardiac disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
44507700,36919054,1.19E-14,0.000000548,adult_children_senior_youth,youth,vortioxetine,apathy,Psychiatric disorders,Other antidepressants,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
836715,42889647,1.22E-14,0.000000559,adult_children_senior_youth,children_youth,temazepam,toxicity to various agents,"Injury, poisoning and procedural complications",Benzodiazepine derivatives,HYPNOTICS AND SEDATIVES,PSYCHOLEPTICS,NERVOUS SYSTEM
1177480,36919230,1.23E-14,0.000000565,adult_children_senior_youth,youth,ibuprofen,completed suicide,General disorders and administration site conditions,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
1151789,36818729,1.24E-14,0.000000567,adult_children_youth,children,etanercept,premature baby,"Pregnancy, puerperium and perinatal conditions",Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1539403,37320158,1.29E-14,0.000000594,adult_children_senior_youth,adult,simvastatin,erythema,Skin and subcutaneous tissue disorders,"$Dipeptidyl peptidase 4 (DPP-4) inhibitors$HMG CoA reductase inhibitors$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents","$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS",$DRUGS USED IN DIABETES$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS,$ALIMENTARY TRACT AND METABOLISM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
722031,36919230,1.30E-14,0.000000596,adult_children_senior_youth,youth,paroxetine,completed suicide,General disorders and administration site conditions,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
964407,37320257,1.31E-14,0.000000603,adult_children_senior_youth,children_youth,salicylic acid,acne,Skin and subcutaneous tissue disorders,"$Other antifungals for topical use$Salicylic acid and derivatives$Salicylic acid and derivatives$Antiinflammatory agents, non-steroids",$ANTIFUNGALS FOR TOPICAL USE$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$ANTIINFLAMMATORY AGENTS,$ANTIFUNGALS FOR DERMATOLOGICAL USE$ANALGESICS$ANALGESICS$OPHTHALMOLOGICALS,$DERMATOLOGICALS$NERVOUS SYSTEM$NERVOUS SYSTEM$SENSORY ORGANS
766814,36718323,1.31E-14,0.0000006,adult_children_senior_youth,senior,quetiapine,sopor,Nervous system disorders,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
19137385,35104691,1.31E-14,0.000000601,adult_children_senior_youth,adult,thiotepa,thrombocytopenia,Blood and lymphatic system disorders,Ethylene imines,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
780442,36919098,1.32E-14,0.000000605,adult_children_senior_youth,children,varenicline,abnormal behaviour,Psychiatric disorders,Drugs used in nicotine dependence,DRUGS USED IN ADDICTIVE DISORDERS,OTHER NERVOUS SYSTEM DRUGS,NERVOUS SYSTEM
1707687,35104236,1.37E-14,0.00000063,adult_children_senior_youth,children_youth,vancomycin,histiocytosis haematophagic,0,$Glycopeptide antibacterials$Antibiotics,$OTHER ANTIBACTERIALS$INTESTINAL ANTIINFECTIVES,"$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",$ANTIINFECTIVES FOR SYSTEMIC USE$ALIMENTARY TRACT AND METABOLISM
1557272,36211102,1.38E-14,0.000000633,adult_senior_youth,senior,alendronate,hip fracture,"Injury, poisoning and procedural complications",0,0,0,0
1350504,35708642,1.38E-14,0.000000635,adult_children_senior_youth,youth,etoposide,stomatitis,Gastrointestinal disorders,Podophyllotoxin derivatives,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1589505,37019396,1.43E-14,0.000000658,adult_youth,youth,levonorgestrel,dysuria,Renal and urinary disorders,"$Progestogens and estrogens, sequential preparations$Emergency contraceptives$Progestogens$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations",$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
766814,36919231,1.43E-14,0.000000657,adult_children_senior_youth,youth,quetiapine,intentional self-injury,"$Injury, poisoning and procedural complications$Psychiatric disorders","Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1301125,35708663,1.43E-14,0.000000658,adult_children_senior_youth,children_youth,epoetin alfa,peritonitis,$Gastrointestinal disorders$Infections and infestations,0,0,0,0
723013,36919059,1.44E-14,0.00000066,adult_children_senior_youth,youth,diazepam,aggression,Psychiatric disorders,Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
722424,36718132,1.44E-14,0.00000066,adult_children_senior_youth,children_youth,interferon beta-1a,headache,Nervous system disorders,Interferons,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
766529,36718201,1.45E-14,0.000000667,adult_children_senior_youth,children,haloperidol,extrapyramidal disorder,Nervous system disorders,Butyrophenone derivatives,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1151789,36516909,1.47E-14,0.000000677,adult_senior_youth,senior,etanercept,sciatica,$Musculoskeletal and connective tissue disorders$Nervous system disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1314273,37019440,1.48E-14,0.000000678,adult_children_senior_youth,children_youth,rituximab,proteinuria,Renal and urinary disorders,Monoclonal antibodies,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1501700,36312334,1.50E-14,0.000000688,adult_children_senior_youth,adult_youth,levothyroxine,blood thyroid stimulating hormone abnormal,Investigations,Thyroid hormones,THYROID PREPARATIONS,THYROID THERAPY,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
1338512,37320310,1.50E-14,0.000000689,adult_senior,adult,doxorubicin,hair colour changes,Skin and subcutaneous tissue disorders,Anthracyclines and related substances,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1103640,35607485,1.53E-14,0.000000704,adult_children_senior,children,methadone,visual impairment,Eye disorders,$Drugs used in opioid dependence$Diphenylpropylamine derivatives,$DRUGS USED IN ADDICTIVE DISORDERS$OPIOIDS,$OTHER NERVOUS SYSTEM DRUGS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
1361711,36919230,1.57E-14,0.000000719,adult_children_senior_youth,children,glyceryl trinitrate,completed suicide,General disorders and administration site conditions,0,0,0,0
1112807,35909513,1.63E-14,0.000000749,adult_children_senior_youth,youth,aspirin,acute hepatic failure,Hepatobiliary disorders,0,0,0,0
19044883,36718218,1.63E-14,0.000000748,adult_senior_youth,youth,zopiclone,tardive dyskinesia,Nervous system disorders,Benzodiazepine related drugs,HYPNOTICS AND SEDATIVES,PSYCHOLEPTICS,NERVOUS SYSTEM
722031,35205348,1.69E-14,0.000000774,adult_children_senior,children,paroxetine,ventricular hypertrophy,Cardiac disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
40241331,36718001,1.73E-14,0.000000796,adult_children_senior,children,rivaroxaban,cerebral infarction,$Nervous system disorders$Vascular disorders,Direct factor Xa inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1549080,36617166,1.74E-14,0.0000008,adult_children_senior,adult,conjugated estrogens,breast cancer metastatic,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","$Natural and semisynthetic estrogens, plain$Estrogens, combinations with other drugs",$ESTROGENS$ESTROGENS,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
42904205,35809329,1.76E-14,0.000000809,adult_senior_youth,youth,tofacitinib,drug intolerance,General disorders and administration site conditions,Selective immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
711584,35809115,1.77E-14,0.000000814,adult_children_senior_youth,children_youth,levetiracetam,condition aggravated,General disorders and administration site conditions,Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
950637,42889498,1.84E-14,0.000000846,adult_children_senior_youth,children,tacrolimus,graft versus host disease in skin,"Injury, poisoning and procedural complications","$Agents for dermatitis, excluding corticosteroids$Calcineurin inhibitors",$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$DERMATOLOGICALS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1589505,36919194,1.85E-14,0.000000849,adult_youth,adult,levonorgestrel,libido decreased,$Psychiatric disorders$Reproductive system and breast disorders,"$Progestogens and estrogens, sequential preparations$Emergency contraceptives$Progestogens$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations",$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
956874,36516837,1.86E-14,0.000000852,adult_children_senior_youth,adult_youth,furosemide,myalgia,Musculoskeletal and connective tissue disorders,"$High-ceiling diuretics and potassium-sparing agents$Sulfonamides, plain$Sulfonamides$Sulfonamides and potassium in combination","$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$HIGH-CEILING DIURETICS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$HIGH-CEILING DIURETICS",$DIURETICS$DIURETICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$DIURETICS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
1154343,36516729,1.89E-14,0.000000866,adult_senior,senior,albuterol,bone erosion,Musculoskeletal and connective tissue disorders,0,0,0,0
19044883,36211297,1.91E-14,0.000000879,adult_children_senior_youth,senior,zopiclone,fall,"Injury, poisoning and procedural complications",Benzodiazepine related drugs,HYPNOTICS AND SEDATIVES,PSYCHOLEPTICS,NERVOUS SYSTEM
1103314,36416500,1.91E-14,0.000000878,adult_children_senior_youth,children,tramadol,respiratory acidosis,Metabolism and nutrition disorders,$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Other opioids,$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1519936,35808898,1.92E-14,0.000000882,adult_children_youth,children,etonogestrel,implant site pain,General disorders and administration site conditions,Progestogens,HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE,SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,GENITO URINARY SYSTEM AND SEX HORMONES
1797513,36516851,1.95E-14,0.000000897,adult_children_senior_youth,adult_youth,ciprofloxacin,muscle twitching,Musculoskeletal and connective tissue disorders,$Combinations of antibacterials$Antiinfectives$Fluoroquinolones$Antiinfectives$Combinations of antibacterials$Combinations of antibacterials$Fluoroquinolones,$COMBINATIONS OF ANTIBACTERIALS$ANTIINFECTIVES$QUINOLONE ANTIBACTERIALS$ANTIINFECTIVES$COMBINATIONS OF ANTIBACTERIALS$COMBINATIONS OF ANTIBACTERIALS$ANTIINFECTIVES,$ANTIBACTERIALS FOR SYSTEMIC USE$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$ANTIBACTERIALS FOR SYSTEMIC USE$OTOLOGICALS$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIBACTERIALS FOR SYSTEMIC USE$OPHTHALMOLOGICALS,$ANTIINFECTIVES FOR SYSTEMIC USE$SENSORY ORGANS$ANTIINFECTIVES FOR SYSTEMIC USE$SENSORY ORGANS$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$SENSORY ORGANS
1539403,36313976,1.99E-14,0.000000911,adult_senior,adult,simvastatin,quality of life decreased,Investigations,"$Dipeptidyl peptidase 4 (DPP-4) inhibitors$HMG CoA reductase inhibitors$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents","$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS",$DRUGS USED IN DIABETES$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS,$ALIMENTARY TRACT AND METABOLISM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1544838,35506494,2.06E-14,0.000000948,adult_children_senior_youth,children_youth,insulin glulisine,diabetic ketoacidosis,$Endocrine disorders$Metabolism and nutrition disorders,"Insulins and analogues for injection, fast-acting",INSULINS AND ANALOGUES,DRUGS USED IN DIABETES,ALIMENTARY TRACT AND METABOLISM
1000560,35809059,2.17E-14,0.000000995,adult_children_senior_youth,senior,ondansetron,death,General disorders and administration site conditions,Serotonin (5HT3) antagonists,ANTIEMETICS AND ANTINAUSEANTS,ANTIEMETICS AND ANTINAUSEANTS,ALIMENTARY TRACT AND METABOLISM
766814,36416534,2.18E-14,0.000001,adult_children_senior_youth,adult_children,quetiapine,obesity,Metabolism and nutrition disorders,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
19011355,36211297,2.20E-14,0.00000101,adult_senior_youth,youth,etoricoxib,fall,"Injury, poisoning and procedural complications",Coxibs,"ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,MUSCULO-SKELETAL SYSTEM
1305058,36718061,2.21E-14,0.00000102,adult_children_senior_youth,children,methotrexate,intracranial venous sinus thrombosis,Vascular disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
40171288,36313476,2.23E-14,0.00000103,adult_children_senior_youth,children_youth,tocilizumab,white blood cell count decreased,Investigations,Interleukin inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
735979,36919118,2.25E-14,0.00000103,adult_children_senior_youth,senior,risperidone,mental status changes,Psychiatric disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
931973,36316012,2.26E-14,0.00000104,adult_children_youth,children_youth,protease,pulmonary function test decreased,Investigations,0,0,0,0
1119119,36718280,2.29E-14,0.00000105,adult_children_senior_youth,senior,adalimumab,balance disorder,$General disorders and administration site conditions$Nervous system disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1310317,37019261,2.29E-14,0.00000105,adult_children_senior_youth,children_youth,cyclophosphamide,cystitis haemorrhagic,Renal and urinary disorders,Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1001419,36919132,2.34E-14,0.00000107,adult_children_senior_youth,youth,cocaine,substance abuse,Psychiatric disorders,"$Local anesthetics$Analgesics and anesthetics$Esters of benzoic acid$Anesthetics, local","$LOCAL ANESTHETICS$OTHER OTOLOGICALS$ANESTHETICS, LOCAL$THROAT PREPARATIONS",$OPHTHALMOLOGICALS$OTOLOGICALS$ANESTHETICS$THROAT PREPARATIONS,$SENSORY ORGANS$SENSORY ORGANS$NERVOUS SYSTEM$RESPIRATORY SYSTEM
1518254,35809207,2.36E-14,0.00000108,adult_children_senior_youth,children_youth,dexamethasone,mucosal inflammation,General disorders and administration site conditions,"$Corticosteroids$Corticosteroids, moderately potent, other combinations$Corticosteroids$Corticosteroids, combinations for treatment of acne$Corticosteroids/antiinfectives/mydriatics in combination$Corticosteroids and antiinfectives in combination$Corticosteroids and antiinfectives in combination$Corticosteroids$Corticosteroids and antiinfectives in combination$Corticosteroids, moderately potent, combinations with antibiotics$Glucocorticoids$Corticosteroids, plain$Corticosteroids for local oral treatment$Corticosteroids$Corticosteroids, moderately potent (group II)$Corticosteroids","$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$CORTICOSTEROIDS, OTHER COMBINATIONS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$ANTIINFLAMMATORY AGENTS$STOMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS$CORTICOSTEROIDS, PLAIN$CORTICOSTEROIDS","$NASAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$NASAL PREPARATIONS$ANTI-ACNE PREPARATIONS$OPHTHALMOLOGICALS$OTOLOGICALS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$VASOPROTECTIVES$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS FOR SYSTEMIC USE$OPHTHALMOLOGICALS$STOMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OTOLOGICALS","$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$DERMATOLOGICALS$SENSORY ORGANS$SENSORY ORGANS$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS$DERMATOLOGICALS$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$SENSORY ORGANS$DERMATOLOGICALS$SENSORY ORGANS"
1307046,35205168,2.42E-14,0.00000111,adult_senior,adult,metoprolol,coronary artery occlusion,Vascular disorders,"$Beta blocking agents and calcium channel blockers$Beta blocking agents, other combinations$Beta blocking agents, other combinations$Beta blocking agents and calcium channel blockers$Beta blocking agents, selective$Beta blocking agents, selective, and thiazides$Beta blocking agents, selective, and other diuretics$Beta blocking agents, selective, and thiazides","$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS AND OTHER DIURETICS$BETA BLOCKING AGENTS AND THIAZIDES",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
751246,36316186,2.45E-14,0.00000113,adult_children_senior_youth,senior,lithium carbonate,drug level increased,Investigations,0,0,0,0
1398937,37622449,2.45E-14,0.00000112,adult_children_senior_youth,youth,clonidine,hypotension,Vascular disorders,$Sympathomimetics in glaucoma therapy$Imidazoline receptor agonists in combination with diuretics$Imidazoline receptor agonists$Other antimigraine preparations$Imidazoline receptor agonists in combination with diuretics,"$ANTIGLAUCOMA PREPARATIONS AND MIOTICS$ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION$ANTIADRENERGIC AGENTS, CENTRALLY ACTING$ANTIMIGRAINE PREPARATIONS$ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",$OPHTHALMOLOGICALS$ANTIHYPERTENSIVES$ANTIHYPERTENSIVES$ANALGESICS$ANTIHYPERTENSIVES,$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$NERVOUS SYSTEM$CARDIOVASCULAR SYSTEM
1186087,35809059,2.51E-14,0.00000115,adult_children_senior,children_senior,abatacept,death,General disorders and administration site conditions,Selective immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
40241331,36516765,2.63E-14,0.00000121,adult_senior_youth,youth,rivaroxaban,pain in jaw,Musculoskeletal and connective tissue disorders,Direct factor Xa inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1334456,35204953,2.64E-14,0.00000121,adult_children_senior_youth,senior,ramipril,atrial fibrillation,Cardiac disorders,"$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and diuretics$ACE inhibitors, plain","$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, PLAIN",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
766814,36919236,2.66E-14,0.00000122,adult_children_senior_youth,youth,quetiapine,suicide attempt,Psychiatric disorders,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
40171288,35104871,2.72E-14,0.00000125,adult_children_senior_youth,children_youth,tocilizumab,lymphopenia,Blood and lymphatic system disorders,Interleukin inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1124957,37420529,2.75E-14,0.00000126,adult_senior_youth,youth,oxycodone,impaired driving ability,Social circumstances,$Natural opium alkaloids$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1305058,37219898,2.76E-14,0.00000127,adult_children_senior_youth,children,methotrexate,tachypnoea,"Respiratory, thoracic and mediastinal disorders",$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
19011773,35909445,2.80E-14,0.00000129,adult_children_senior_youth,youth,ascorbic acid,cholelithiasis,Hepatobiliary disorders,"$Organic acids$Ascorbic acid (vitamin C), plain$Ascorbic acid (vitamin C), combinations$Other ophthalmologicals","$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS$ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS$OTHER OPHTHALMOLOGICALS",$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$VITAMINS$VITAMINS$OPHTHALMOLOGICALS,$GENITO URINARY SYSTEM AND SEX HORMONES$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$SENSORY ORGANS
742185,37119688,2.90E-14,0.00000133,adult_children_senior_youth,adult,atomoxetine,testicular pain,Reproductive system and breast disorders,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
1126658,36211303,2.92E-14,0.00000134,adult_children_senior_youth,youth,hydromorphone,injury,"Injury, poisoning and procedural complications",$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with antispasmodics,$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1738521,36919230,2.93E-14,0.00000135,adult_children_senior_youth,youth,doxycycline,completed suicide,General disorders and administration site conditions,$Tetracyclines$Antiinfectives and antiseptics for local oral treatment$Tetracyclines,$TETRACYCLINES$STOMATOLOGICAL PREPARATIONS$TETRACYCLINES,$ANTIBACTERIALS FOR SYSTEMIC USE$STOMATOLOGICAL PREPARATIONS$ANTIBACTERIALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ALIMENTARY TRACT AND METABOLISM$ANTIINFECTIVES FOR SYSTEMIC USE
1304850,36009891,2.94E-14,0.00000135,adult_children_senior_youth,children_youth,filgrastim,acute graft versus host disease,"Injury, poisoning and procedural complications",Colony stimulating factors,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1316262,35205029,2.96E-14,0.00000136,adult_children_senior_youth,youth,sildenafil,haemoptysis,Cardiac disorders,$Sulfonamides$Drugs used in erectile dysfunction,"$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$UROLOGICALS",$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$UROLOGICALS,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1322184,37320136,3.00E-14,0.00000138,adult_children_senior_youth,youth,clopidogrel,swelling face,Immune system disorders,Platelet aggregation inhibitors excl. heparin,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1332418,36718555,3.06E-14,0.0000014,adult_children_senior_youth,adult,amlodipine,insomnia,$Nervous system disorders$Psychiatric disorders,"$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$Beta blocking agents and calcium channel blockers$Dihydropyridine derivatives$ACE inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$Calcium channel blockers and diuretics$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs), other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers","$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS$ACE INHIBITORS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$CALCIUM CHANNEL BLOCKERS AND DIURETICS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$BETA BLOCKING AGENTS$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1310149,35808852,3.10E-14,0.00000142,adult_children_senior_youth,youth,warfarin,catheter site haemorrhage,General disorders and administration site conditions,Vitamin K antagonists,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
711584,36776531,3.12E-14,0.00000143,adult_children_senior_youth,youth,levetiracetam,generalised tonic-clonic seizure,Nervous system disorders,Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
1350504,36009891,3.14E-14,0.00000144,adult_children_youth,children_youth,etoposide,acute graft versus host disease,"Injury, poisoning and procedural complications",Podophyllotoxin derivatives,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1501700,36416599,3.14E-14,0.00000144,adult_children_senior_youth,children,levothyroxine,hypernatraemia,Metabolism and nutrition disorders,Thyroid hormones,THYROID PREPARATIONS,THYROID THERAPY,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
1503297,36315606,3.25E-14,0.00000149,adult_children_senior,children,metformin,glomerular filtration rate decreased,Investigations,$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Biguanides$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1350504,36110419,3.29E-14,0.00000151,adult_children_senior_youth,adult,etoposide,pneumocystis jiroveci pneumonia,0,Podophyllotoxin derivatives,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
798874,36718526,3.30E-14,0.00000151,adult_children_senior_youth,children,clonazepam,convulsion,0,Benzodiazepine derivatives,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
1790868,36718119,3.34E-14,0.00000153,adult_children_senior_youth,senior,amikacin,encephalopathy,Nervous system disorders,$Antibiotics$Other antibiotics for topical use$Other aminoglycosides$Combinations of antibacterials,$ANTIINFECTIVES$ANTIBIOTICS FOR TOPICAL USE$AMINOGLYCOSIDE ANTIBACTERIALS$COMBINATIONS OF ANTIBACTERIALS,$OPHTHALMOLOGICALS$ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIBACTERIALS FOR SYSTEMIC USE,$SENSORY ORGANS$DERMATOLOGICALS$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
1125315,37622465,3.40E-14,0.00000156,adult_children_senior_youth,youth,acetaminophen,deep vein thrombosis,Vascular disorders,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1343916,36211347,3.40E-14,0.00000156,adult_children_senior_youth,senior,epinephrine,renal injury,"$Injury, poisoning and procedural complications$Renal and urinary disorders","$Other agents for local oral treatment$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Local hemostatics$Adrenergic and dopaminergic agents$Sympathomimetics in glaucoma therapy$Sympathomimetics, plain$Alpha- and beta-adrenoreceptor agonists$Sympathomimetics in glaucoma therapy","$STOMATOLOGICAL PREPARATIONS$ADRENERGICS, INHALANTS$VITAMIN K AND OTHER HEMOSTATICS$CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES$ANTIGLAUCOMA PREPARATIONS AND MIOTICS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ADRENERGICS, INHALANTS$ANTIGLAUCOMA PREPARATIONS AND MIOTICS",$STOMATOLOGICAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$ANTIHEMORRHAGICS$CARDIAC THERAPY$OPHTHALMOLOGICALS$NASAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OPHTHALMOLOGICALS,$ALIMENTARY TRACT AND METABOLISM$RESPIRATORY SYSTEM$BLOOD AND BLOOD FORMING ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$SENSORY ORGANS
1174888,37219871,3.41E-14,0.00000156,adult_senior_youth,youth,hydrocodone,pulmonary embolism,"$Respiratory, thoracic and mediastinal disorders$Vascular disorders",Opium alkaloids and derivatives,"COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",COUGH AND COLD PREPARATIONS,RESPIRATORY SYSTEM
1332418,35204902,3.45E-14,0.00000158,adult_children_senior_youth,youth,amlodipine,atrioventricular block,Cardiac disorders,"$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$Beta blocking agents and calcium channel blockers$Dihydropyridine derivatives$ACE inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$Calcium channel blockers and diuretics$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs), other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers","$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS$ACE INHIBITORS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$CALCIUM CHANNEL BLOCKERS AND DIURETICS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$BETA BLOCKING AGENTS$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
735979,36312331,3.48E-14,0.0000016,adult_children_senior_youth,children_youth,risperidone,blood prolactin increased,Investigations,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
742185,43053924,3.51E-14,0.00000161,adult_children_senior_youth,children,atomoxetine,prescribed overdose,"Injury, poisoning and procedural complications",Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
1734104,36009783,3.63E-14,0.00000167,adult_children_senior_youth,children,azithromycin,urticaria,Immune system disorders,$Combinations of antibacterials$Antibiotics$Macrolides,"$COMBINATIONS OF ANTIBACTERIALS$ANTIINFECTIVES$MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",$ANTIBACTERIALS FOR SYSTEMIC USE$OPHTHALMOLOGICALS$ANTIBACTERIALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$SENSORY ORGANS$ANTIINFECTIVES FOR SYSTEMIC USE
1709170,35104236,3.69E-14,0.00000169,adult_children_senior_youth,children_youth,meropenem,histiocytosis haematophagic,0,$Carbapenems$Carbapenems,$OTHER BETA-LACTAM ANTIBACTERIALS$OTHER BETA-LACTAM ANTIBACTERIALS,$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIBACTERIALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
1545958,37622529,3.77E-14,0.00000173,adult_children_senior_youth,youth,atorvastatin,hypertension,Vascular disorders,"$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations","$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS",$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1186087,35606985,3.85E-14,0.00000177,adult_senior,senior,abatacept,glaucoma,Eye disorders,Selective immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
19035344,42889647,3.86E-14,0.00000177,adult_senior_youth,youth,phenprocoumon,toxicity to various agents,"Injury, poisoning and procedural complications",Vitamin K antagonists,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1518254,35205230,3.91E-14,0.00000179,adult_children_senior_youth,children,dexamethasone,ascites,Gastrointestinal disorders,"$Corticosteroids$Corticosteroids, moderately potent, other combinations$Corticosteroids$Corticosteroids, combinations for treatment of acne$Corticosteroids/antiinfectives/mydriatics in combination$Corticosteroids and antiinfectives in combination$Corticosteroids and antiinfectives in combination$Corticosteroids$Corticosteroids and antiinfectives in combination$Corticosteroids, moderately potent, combinations with antibiotics$Glucocorticoids$Corticosteroids, plain$Corticosteroids for local oral treatment$Corticosteroids$Corticosteroids, moderately potent (group II)$Corticosteroids","$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$CORTICOSTEROIDS, OTHER COMBINATIONS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$ANTIINFLAMMATORY AGENTS$STOMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS$CORTICOSTEROIDS, PLAIN$CORTICOSTEROIDS","$NASAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$NASAL PREPARATIONS$ANTI-ACNE PREPARATIONS$OPHTHALMOLOGICALS$OTOLOGICALS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$VASOPROTECTIVES$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS FOR SYSTEMIC USE$OPHTHALMOLOGICALS$STOMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OTOLOGICALS","$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$DERMATOLOGICALS$SENSORY ORGANS$SENSORY ORGANS$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS$DERMATOLOGICALS$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$SENSORY ORGANS$DERMATOLOGICALS$SENSORY ORGANS"
715259,36211491,3.92E-14,0.0000018,adult_children_senior_youth,children,duloxetine,accidental overdose,"Injury, poisoning and procedural complications",Other antidepressants,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
739138,35104877,3.92E-14,0.0000018,adult_children_senior_youth,senior,sertraline,febrile neutropenia,General disorders and administration site conditions,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1149196,36211496,3.93E-14,0.0000018,adult_children_senior_youth,children,cetirizine,overdose,"Injury, poisoning and procedural complications",Piperazine derivatives,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,RESPIRATORY SYSTEM
1551099,35707713,3.94E-14,0.00000181,adult_children_senior_youth,children_youth,prednisone,pancreatitis,Gastrointestinal disorders,$Corticosteroids acting locally$Glucocorticoids,"$INTESTINAL ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN","$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE","$ALIMENTARY TRACT AND METABOLISM$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
750982,36416487,3.99E-14,0.00000183,adult_children_senior_youth,children,bupropion,metabolic acidosis,Metabolism and nutrition disorders,$Centrally acting antiobesity products$Other antidepressants,"$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$ANTIDEPRESSANTS","$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$PSYCHOANALEPTICS",$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM
929887,35708063,4.09E-14,0.00000188,adult_children_senior_youth,children_youth,lansoprazole,crohn's disease,$Gastrointestinal disorders$Immune system disorders,$Proton pump inhibitors$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Proton pump inhibitors,$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1201620,36718418,4.16E-14,0.00000191,adult_senior_youth,youth,codeine,dysarthria,Nervous system disorders,$Natural opium alkaloids$Opium alkaloids and derivatives$Natural opium alkaloids$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,"$OPIOIDS$COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS",$ANALGESICS$COUGH AND COLD PREPARATIONS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
798874,43053854,4.33E-14,0.00000199,adult_children_senior_youth,children,clonazepam,drug reaction with eosinophilia and systemic symptoms,Immune system disorders,Benzodiazepine derivatives,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
1151789,36516895,4.37E-14,0.000002,adult_children_senior_youth,senior,etanercept,foot deformity,Musculoskeletal and connective tissue disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
750982,36718151,4.40E-14,0.00000202,adult_children_senior_youth,children_youth,bupropion,brain oedema,"$Injury, poisoning and procedural complications$Nervous system disorders",$Centrally acting antiobesity products$Other antidepressants,"$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$ANTIDEPRESSANTS","$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$PSYCHOANALEPTICS",$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM
40241331,37119548,4.40E-14,0.00000202,adult_children_senior_youth,youth,rivaroxaban,menorrhagia,Reproductive system and breast disorders,Direct factor Xa inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
735979,35506621,4.40E-14,0.00000202,adult_children_senior_youth,adult,risperidone,type 1 diabetes mellitus,Endocrine disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1710612,35708151,4.53E-14,0.00000208,adult_children_senior_youth,children,zidovudine,abdominal distension,Gastrointestinal disorders,"$Antivirals for treatment of HIV infections, combinations$Nucleoside and nucleotide reverse transcriptase inhibitors$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations",$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS,$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
975125,36718123,4.64E-14,0.00000213,adult_children_youth,children_youth,hydrocortisone,leukoencephalopathy,Nervous system disorders,"$Corticosteroids/antiinfectives/mydriatics in combination$Corticosteroids for local oral treatment$Corticosteroids, plain$Corticosteroids and antiinfectives in combination$Corticosteroids, weak (group I)$Corticosteroids and mydriatics in combination$Corticosteroids, weak, other combinations$Corticosteroids, weak, combinations with antiseptics$Corticosteroids and antiinfectives in combination$Corticosteroids acting locally$Corticosteroids$Corticosteroids$Glucocorticoids$Corticosteroids, weak, combinations with antibiotics$Corticosteroids and antiinfectives in combination$Corticosteroids","$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$STOMATOLOGICAL PREPARATIONS$ANTIINFLAMMATORY AGENTS$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS, PLAIN$ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS, OTHER COMBINATIONS$CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$INTESTINAL ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE","$OPHTHALMOLOGICALS$STOMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OTOLOGICALS$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$OTOLOGICALS$NASAL PREPARATIONS$CORTICOSTEROIDS FOR SYSTEMIC USE$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$VASOPROTECTIVES","$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$SENSORY ORGANS$SENSORY ORGANS$DERMATOLOGICALS$SENSORY ORGANS$DERMATOLOGICALS$DERMATOLOGICALS$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$SENSORY ORGANS$RESPIRATORY SYSTEM$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$DERMATOLOGICALS$SENSORY ORGANS$CARDIOVASCULAR SYSTEM"
19088167,36313371,4.75E-14,0.00000218,adult_children_senior_youth,adult,ambroxol,lymphocyte count decreased,Investigations,$Selective beta-2-adrenoreceptor agonists$Mucolytics,"$ADRENERGICS FOR SYSTEMIC USE$EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$COUGH AND COLD PREPARATIONS,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
937368,35205189,4.76E-14,0.00000218,adult_children_senior_youth,senior,infliximab,myocardial infarction,Vascular disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1777087,35708042,5.06E-14,0.00000232,adult_senior,senior,hydroxychloroquine,colitis microscopic,Gastrointestinal disorders,Aminoquinolines,ANTIMALARIALS,ANTIPROTOZOALS,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS"
1154029,37622449,5.07E-14,0.00000233,adult_children_senior_youth,children_youth,fentanyl,hypotension,Vascular disorders,$Opioid anesthetics$Phenylpiperidine derivatives$Opioid anesthetics,"$ANESTHETICS, GENERAL$OPIOIDS$ANESTHETICS, GENERAL",$ANESTHETICS$ANALGESICS$ANESTHETICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1186087,35708202,5.21E-14,0.00000239,adult_children_senior_youth,children_youth,abatacept,nausea,Gastrointestinal disorders,Selective immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1713332,35809243,5.26E-14,0.00000241,adult_children_senior_youth,youth,amoxicillin,pain,General disorders and administration site conditions,"$Combinations for eradication of Helicobacter pylori$Combinations of penicillins, incl. beta-lactamase inhibitors$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Penicillins with extended spectrum","$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$BETA-LACTAM ANTIBACTERIALS, PENICILLINS$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$BETA-LACTAM ANTIBACTERIALS, PENICILLINS",$DRUGS FOR ACID RELATED DISORDERS$ANTIBACTERIALS FOR SYSTEMIC USE$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$ANTIBACTERIALS FOR SYSTEMIC USE,$ALIMENTARY TRACT AND METABOLISM$ANTIINFECTIVES FOR SYSTEMIC USE$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ANTIINFECTIVES FOR SYSTEMIC USE
1545958,35205182,5.35E-14,0.00000246,adult_senior,adult,atorvastatin,angina unstable,Vascular disorders,"$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations","$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS",$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
705944,36416606,5.40E-14,0.00000248,adult_children_senior_youth,senior,methylphenidate,dehydration,Metabolism and nutrition disorders,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
950637,35104877,5.45E-14,0.0000025,adult_children_senior_youth,youth,tacrolimus,febrile neutropenia,General disorders and administration site conditions,"$Agents for dermatitis, excluding corticosteroids$Calcineurin inhibitors",$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$DERMATOLOGICALS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
757688,36211073,5.47E-14,0.00000251,adult_children_senior,senior,aripiprazole,multiple fractures,"Injury, poisoning and procedural complications",Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
729855,37219820,5.51E-14,0.00000253,adult_children_senior_youth,children,botulinum toxin type A,pneumonia aspiration,"Respiratory, thoracic and mediastinal disorders",0,0,0,0
778711,36718458,5.55E-14,0.00000255,adult_children_senior_youth,children,cyclobenzaprine,serotonin syndrome,"Injury, poisoning and procedural complications",Other centrally acting agents,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",MUSCLE RELAXANTS,MUSCULO-SKELETAL SYSTEM
1760616,37019318,5.63E-14,0.00000259,adult_senior_youth,youth,quinine,renal failure,Renal and urinary disorders,$Quinine and derivatives$Methanolquinolines,$OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM$ANTIMALARIALS,$OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM$ANTIPROTOZOALS,"$MUSCULO-SKELETAL SYSTEM$ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS"
725131,35607122,5.65E-14,0.00000259,adult_senior_youth,youth,mirtazapine,eye irritation,Eye disorders,Other antidepressants,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1707687,36009846,5.83E-14,0.00000267,adult_senior,senior,vancomycin,linear iga disease,Skin and subcutaneous tissue disorders,$Glycopeptide antibacterials$Antibiotics,$OTHER ANTIBACTERIALS$INTESTINAL ANTIINFECTIVES,"$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",$ANTIINFECTIVES FOR SYSTEMIC USE$ALIMENTARY TRACT AND METABOLISM
1714277,37320193,5.86E-14,0.00000269,adult_children_senior_youth,children,voriconazole,photosensitivity reaction,Skin and subcutaneous tissue disorders,Triazole derivatives,ANTIMYCOTICS FOR SYSTEMIC USE,ANTIMYCOTICS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
735979,35104113,5.87E-14,0.0000027,adult_children_senior_youth,senior,risperidone,pancytopenia,Blood and lymphatic system disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
766814,36918942,5.91E-14,0.00000271,adult_children_senior_youth,adult,quetiapine,depression,Psychiatric disorders,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
44507700,36718180,5.92E-14,0.00000272,adult_senior_youth,youth,vortioxetine,disturbance in attention,Nervous system disorders,Other antidepressants,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1762711,37320109,5.95E-14,0.00000273,adult_children_senior_youth,adult_youth,ribavirin,dry skin,Skin and subcutaneous tissue disorders,Antivirals for treatment of HCV infections,DIRECT ACTING ANTIVIRALS,ANTIVIRALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
1150871,36516812,5.96E-14,0.00000274,adult_senior_youth,senior,misoprostol,arthralgia,Musculoskeletal and connective tissue disorders,$Prostaglandins$Prostaglandins$Propionic acid derivatives,"$UTEROTONICS$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$DRUGS FOR ACID RELATED DISORDERS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$ALIMENTARY TRACT AND METABOLISM$MUSCULO-SKELETAL SYSTEM
1119119,35808988,6.13E-14,0.00000282,adult_children_senior_youth,children,adalimumab,injection site irritation,General disorders and administration site conditions,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1110410,36718321,6.35E-14,0.00000292,adult_children_senior_youth,children,morphine,somnolence,Nervous system disorders,$Antipropulsives$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with antispasmodics,$ANTIPROPULSIVES$OPIOIDS$OPIOIDS$OPIOIDS,"$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$ANALGESICS$ANALGESICS$ANALGESICS",$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1583722,37019319,6.39E-14,0.00000293,adult_senior_youth,youth,exenatide,renal failure acute,0,Glucagon-like peptide-1 (GLP-1) analogues,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",DRUGS USED IN DIABETES,ALIMENTARY TRACT AND METABOLISM
1707687,35809054,6.40E-14,0.00000294,adult_children_senior_youth,children_youth,vancomycin,pyrexia,General disorders and administration site conditions,$Glycopeptide antibacterials$Antibiotics,$OTHER ANTIBACTERIALS$INTESTINAL ANTIINFECTIVES,"$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",$ANTIINFECTIVES FOR SYSTEMIC USE$ALIMENTARY TRACT AND METABOLISM
1777806,36009882,6.46E-14,0.00000296,adult_children_senior_youth,adult_youth,ceftriaxone,jarisch-herxheimer reaction,Immune system disorders,$Third-generation cephalosporins$Third-generation cephalosporins,$OTHER BETA-LACTAM ANTIBACTERIALS$OTHER BETA-LACTAM ANTIBACTERIALS,$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIBACTERIALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
1305058,37320268,6.60E-14,0.00000303,adult_children_senior_youth,adult,methotrexate,alopecia,Skin and subcutaneous tissue disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1308290,37219831,6.69E-14,0.00000307,adult_children_senior_youth,senior,vincristine,interstitial lung disease,"$Immune system disorders$Respiratory, thoracic and mediastinal disorders",Vinca alkaloids and analogues,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
939259,36718175,7.12E-14,0.00000327,adult_children_senior_youth,senior,budesonide,memory impairment,$Nervous system disorders$Psychiatric disorders,"$Corticosteroids, potent (group III)$Corticosteroids$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Corticosteroids acting locally$Glucocorticoids$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics","$CORTICOSTEROIDS, PLAIN$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ADRENERGICS, INHALANTS$INTESTINAL ANTIINFLAMMATORY AGENTS$OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS$ADRENERGICS, INHALANTS","$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$NASAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",$DERMATOLOGICALS$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$ALIMENTARY TRACT AND METABOLISM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1786055,35708208,7.13E-14,0.00000327,adult_children_senior_youth,children,deferasirox,vomiting,Gastrointestinal disorders,Iron chelating agents,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,VARIOUS
766529,36718321,7.33E-14,0.00000336,adult_children_senior_youth,children,haloperidol,somnolence,Nervous system disorders,Butyrophenone derivatives,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
948078,35909445,7.35E-14,0.00000337,adult_children_senior_youth,youth,pantoprazole,cholelithiasis,Hepatobiliary disorders,$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Proton pump inhibitors,$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1338005,37622529,7.35E-14,0.00000337,adult_senior_youth,youth,bisoprolol,hypertension,Vascular disorders,"$Beta blocking agents, other combinations$Beta blocking agents, selective, and thiazides$Beta blocking agents, selective$ACE inhibitors, other combinations$Beta blocking agents and calcium channel blockers","$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS$ACE INHIBITORS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
991876,42889647,7.63E-14,0.0000035,adult_children_senior_youth,youth,loperamide,toxicity to various agents,"Injury, poisoning and procedural complications",$Antipropulsives$Antipropulsives,$ANTIPROPULSIVES$ANTIPROPULSIVES,"$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
722031,35708093,7.81E-14,0.00000358,adult_children_senior_youth,senior,paroxetine,diarrhoea,Gastrointestinal disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
40161669,36211465,7.95E-14,0.00000365,adult_children_senior_youth,youth,canakinumab,incorrect dose administered,"Injury, poisoning and procedural complications",Interleukin inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1308290,35809059,7.96E-14,0.00000365,adult_children_senior_youth,adult_senior,vincristine,death,General disorders and administration site conditions,Vinca alkaloids and analogues,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
708298,37019318,8.03E-14,0.00000369,adult_children_senior_youth,senior,midazolam,renal failure,Renal and urinary disorders,Benzodiazepine derivatives,HYPNOTICS AND SEDATIVES,PSYCHOLEPTICS,NERVOUS SYSTEM
986417,36919075,8.14E-14,0.00000374,adult_children_senior,children,polyethylene glycol 3350,paranoia,Psychiatric disorders,0,0,0,0
1103314,36211491,8.26E-14,0.00000379,adult_children_senior_youth,children,tramadol,accidental overdose,"Injury, poisoning and procedural complications",$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Other opioids,$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
705944,35104074,8.37E-14,0.00000384,adult_children_senior_youth,senior,methylphenidate,anaemia,Blood and lymphatic system disorders,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
1307046,37522317,8.40E-14,0.00000386,adult_senior,adult,metoprolol,coronary arterial stent insertion,Surgical and medical procedures,"$Beta blocking agents and calcium channel blockers$Beta blocking agents, other combinations$Beta blocking agents, other combinations$Beta blocking agents and calcium channel blockers$Beta blocking agents, selective$Beta blocking agents, selective, and thiazides$Beta blocking agents, selective, and other diuretics$Beta blocking agents, selective, and thiazides","$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS AND OTHER DIURETICS$BETA BLOCKING AGENTS AND THIAZIDES",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1710612,36314099,8.49E-14,0.0000039,adult_children_youth,children,zidovudine,blood lactic acid increased,Investigations,"$Antivirals for treatment of HIV infections, combinations$Nucleoside and nucleotide reverse transcriptase inhibitors$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations",$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS,$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
1125315,35909445,8.53E-14,0.00000391,adult_children_senior_youth,youth,acetaminophen,cholelithiasis,Hepatobiliary disorders,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1125315,36919235,8.91E-14,0.00000409,adult_children_senior_youth,youth,acetaminophen,suicidal ideation,Psychiatric disorders,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
705103,36718526,8.99E-14,0.00000413,adult_children_senior_youth,children_youth,lamotrigine,convulsion,0,Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
1351541,35205189,9.03E-14,0.00000415,adult_children_senior_youth,senior,leuprolide,myocardial infarction,Vascular disorders,$Gonadotropin releasing hormone analogues$Gonadotropin releasing hormone analogues,$HORMONES AND RELATED AGENTS$HORMONES AND RELATED AGENTS,$ENDOCRINE THERAPY$ENDOCRINE THERAPY,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1336926,36919194,9.08E-14,0.00000417,adult_senior_youth,adult,tadalafil,libido decreased,$Psychiatric disorders$Reproductive system and breast disorders,$Drugs used in erectile dysfunction$Antihypertensives for pulmonary arterial hypertension,$UROLOGICALS$OTHER ANTIHYPERTENSIVES,$UROLOGICALS$ANTIHYPERTENSIVES,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
705944,37219863,9.11E-14,0.00000418,adult_children_senior_youth,senior,methylphenidate,pleural effusion,"Respiratory, thoracic and mediastinal disorders",Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
1314924,35708066,9.16E-14,0.0000042,adult_children_senior,children,gemcitabine,enteritis,Gastrointestinal disorders,Pyrimidine analogues,ANTIMETABOLITES,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1782521,35909508,9.18E-14,0.00000421,adult_children_senior_youth,senior,isoniazid,hepatic function abnormal,Hepatobiliary disorders,$Combinations of drugs for treatment of tuberculosis$Combinations of drugs for treatment of tuberculosis$Combinations of drugs for treatment of tuberculosis$Combinations of drugs for treatment of tuberculosis$Hydrazides$Combinations of drugs for treatment of tuberculosis$Combinations of drugs for treatment of tuberculosis$Combinations of drugs for treatment of tuberculosis$Combinations of drugs for treatment of tuberculosis$Hydrazides,$DRUGS FOR TREATMENT OF TUBERCULOSIS$DRUGS FOR TREATMENT OF TUBERCULOSIS$DRUGS FOR TREATMENT OF TUBERCULOSIS$DRUGS FOR TREATMENT OF TUBERCULOSIS$DRUGS FOR TREATMENT OF TUBERCULOSIS$DRUGS FOR TREATMENT OF TUBERCULOSIS$DRUGS FOR TREATMENT OF TUBERCULOSIS$DRUGS FOR TREATMENT OF TUBERCULOSIS$DRUGS FOR TREATMENT OF TUBERCULOSIS$DRUGS FOR TREATMENT OF TUBERCULOSIS,$ANTIMYCOBACTERIALS$ANTIMYCOBACTERIALS$ANTIMYCOBACTERIALS$ANTIMYCOBACTERIALS$ANTIMYCOBACTERIALS$ANTIMYCOBACTERIALS$ANTIMYCOBACTERIALS$ANTIMYCOBACTERIALS$ANTIMYCOBACTERIALS$ANTIMYCOBACTERIALS,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
43526424,36718395,9.21E-14,0.00000423,adult_senior_youth,youth,dimethyl fumarate,hypoaesthesia,Nervous system disorders,Other immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1344905,36313436,9.24E-14,0.00000424,adult_children_senior,senior,carboplatin,neutrophil count decreased,Investigations,Platinum compounds,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1307863,35205246,9.42E-14,0.00000432,adult_senior_youth,youth,verapamil,cardiogenic shock,Vascular disorders,$ACE inhibitors and calcium channel blockers$Phenylalkylamine derivatives$Phenylalkylamine derivatives,"$ACE INHIBITORS, COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$CALCIUM CHANNEL BLOCKERS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
974166,36211076,9.51E-14,0.00000437,adult_children_senior,children,hydrochlorothiazide,pathological fracture,"Injury, poisoning and procedural complications","$ACE inhibitors, other combinations$Thiazides, combinations with other drugs$Thiazides and potassium in combination$Angiotensin II receptor blockers (ARBs), other combinations$Low-ceiling diuretics and potassium-sparing agents$Angiotensin II receptor blockers (ARBs), other combinations$Renin-inhibitors$Sulfonamides$Angiotensin II receptor blockers (ARBs), other combinations$Thiazides, plain$Renin-inhibitors","$ACE INHIBITORS, COMBINATIONS$LOW-CEILING DIURETICS, THIAZIDES$LOW-CEILING DIURETICS, THIAZIDES$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LOW-CEILING DIURETICS, THIAZIDES$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$DIURETICS$DIURETICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$DIURETICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$DIURETICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1149380,36918942,9.53E-14,0.00000438,adult_children_senior_youth,children_youth,fluticasone,depression,Psychiatric disorders,"$Glucocorticoids$Corticosteroids, potent (group III)$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Corticosteroids$Corticosteroids","$OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS$CORTICOSTEROIDS, PLAIN$ADRENERGICS, INHALANTS$ADRENERGICS, INHALANTS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE","$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$NASAL PREPARATIONS$NASAL PREPARATIONS",$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
19041065,43053920,9.76E-14,0.00000448,adult_children_senior_youth,youth,golimumab,accidental exposure to product,"Injury, poisoning and procedural complications",Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
722031,35506690,9.97E-14,0.00000458,adult_children_senior_youth,senior,paroxetine,inappropriate antidiuretic hormone secretion,$Endocrine disorders$Metabolism and nutrition disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
40222444,36211099,1.03E-13,0.00000472,adult_children_senior_youth,children,denosumab,femur fracture,"Injury, poisoning and procedural complications",Other drugs affecting bone structure and mineralization,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,DRUGS FOR TREATMENT OF BONE DISEASES,MUSCULO-SKELETAL SYSTEM
19010482,35606973,1.07E-13,0.00000491,adult_children_senior,senior,cyclosporine,ocular discomfort,Eye disorders,$Calcineurin inhibitors$Other ophthalmologicals,$IMMUNOSUPPRESSANTS$OTHER OPHTHALMOLOGICALS,$IMMUNOSUPPRESSANTS$OPHTHALMOLOGICALS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$SENSORY ORGANS
1310317,37622465,1.09E-13,0.00000501,adult_children_senior_youth,senior,cyclophosphamide,deep vein thrombosis,Vascular disorders,Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1314002,35205164,1.10E-13,0.00000503,adult_children_senior_youth,adult,atenolol,coronary artery disease,Vascular disorders,"$Beta blocking agents, selective, and other diuretics$Beta blocking agents, selective$Beta blocking agents and calcium channel blockers$Beta blocking agents, selective, thiazides and other diuretics$Beta blocking agents, selective, and thiazides$Beta blocking agents, selective, and other diuretics","$BETA BLOCKING AGENTS AND OTHER DIURETICS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS AND OTHER DIURETICS",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
745466,36918937,1.11E-13,0.00000509,adult_children_senior_youth,senior,valproate,delirium,Psychiatric disorders,0,0,0,0
997881,37219871,1.11E-13,0.00000511,adult_senior_youth,youth,clindamycin,pulmonary embolism,"$Respiratory, thoracic and mediastinal disorders$Vascular disorders",$Antiinfectives for treatment of acne$Lincosamides$Antiinfectives for treatment of acne$Antibiotics,"$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",$ANTI-ACNE PREPARATIONS$ANTIBACTERIALS FOR SYSTEMIC USE$ANTI-ACNE PREPARATIONS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,$DERMATOLOGICALS$ANTIINFECTIVES FOR SYSTEMIC USE$DERMATOLOGICALS$GENITO URINARY SYSTEM AND SEX HORMONES
1305058,37220008,1.12E-13,0.00000516,adult_children_senior_youth,adult,methotrexate,nasal congestion,"Respiratory, thoracic and mediastinal disorders",$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1177480,36009756,1.14E-13,0.00000523,adult_children_senior_youth,children,ibuprofen,anaphylactic reaction,Immune system disorders,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
1501700,35506636,1.15E-13,0.00000527,adult_children_senior_youth,children_youth,levothyroxine,hypoglycaemia,Endocrine disorders,Thyroid hormones,THYROID PREPARATIONS,THYROID THERAPY,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
742267,36718132,1.17E-13,0.00000538,adult_children_senior_youth,adult_senior,topiramate,headache,Nervous system disorders,Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
1154343,36718214,1.17E-13,0.00000535,adult_children_senior_youth,children,albuterol,psychomotor hyperactivity,Nervous system disorders,0,0,0,0
1103314,36516972,1.23E-13,0.00000565,adult_senior,senior,tramadol,musculoskeletal disorder,Musculoskeletal and connective tissue disorders,$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Other opioids,$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1149196,36718321,1.23E-13,0.00000562,adult_children_senior_youth,children,cetirizine,somnolence,Nervous system disorders,Piperazine derivatives,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,RESPIRATORY SYSTEM
1154029,35809076,1.24E-13,0.00000569,adult_children_senior_youth,senior,fentanyl,fatigue,General disorders and administration site conditions,$Opioid anesthetics$Phenylpiperidine derivatives$Opioid anesthetics,"$ANESTHETICS, GENERAL$OPIOIDS$ANESTHETICS, GENERAL",$ANESTHETICS$ANALGESICS$ANESTHETICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
988095,35909517,1.26E-13,0.0000058,adult_children_senior_youth,senior,ursodeoxycholate,hepatic encephalopathy,$Hepatobiliary disorders$Nervous system disorders,0,0,0,0
1106776,37219810,1.26E-13,0.0000058,adult_children_senior_youth,youth,tiotropium,wheezing,"Respiratory, thoracic and mediastinal disorders",$Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids$Anticholinergics$Anticholinergics,"$ADRENERGICS, INHALANTS$OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS$OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1305058,36110708,1.27E-13,0.00000581,adult_children_senior_youth,adult,methotrexate,sinusitis,Infections and infestations,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1103314,36718526,1.29E-13,0.00000593,adult_children_senior_youth,children_youth,tramadol,convulsion,0,$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Other opioids,$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
797399,35204966,1.32E-13,0.00000607,adult_children_senior_youth,children_youth,gabapentin,cardiac arrest,Cardiac disorders,Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
1703687,35909571,1.32E-13,0.00000605,adult_children_senior_youth,youth,acyclovir,venoocclusive liver disease,Hepatobiliary disorders,$Nucleosides and nucleotides excl. reverse transcriptase inhibitors$Antivirals$Antivirals$Antivirals,$DIRECT ACTING ANTIVIRALS$CHEMOTHERAPEUTICS FOR TOPICAL USE$ANTIINFECTIVES$CHEMOTHERAPEUTICS FOR TOPICAL USE,$ANTIVIRALS FOR SYSTEMIC USE$ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE$OPHTHALMOLOGICALS$ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,$ANTIINFECTIVES FOR SYSTEMIC USE$DERMATOLOGICALS$SENSORY ORGANS$DERMATOLOGICALS
781039,36718317,1.33E-13,0.00000608,adult_children_senior_youth,children_youth,alprazolam,loss of consciousness,Nervous system disorders,Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1308842,35707907,1.34E-13,0.00000614,adult_children_senior_youth,youth,valsartan,gastroenteritis,Gastrointestinal disorders,"$Angiotensin II receptor blockers (ARBs), other combinations$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and diuretics$Angiotensin II receptor blockers (ARBs), plain$Angiotensin II receptor blockers (ARBs), other combinations$Angiotensin II receptor blockers (ARBs), other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations","$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1337068,36516779,1.36E-13,0.00000625,adult_senior_youth,senior,ambrisentan,arthritis,Musculoskeletal and connective tissue disorders,$Antihypertensives for pulmonary arterial hypertension$Antihypertensives for pulmonary arterial hypertension,$OTHER ANTIHYPERTENSIVES$OTHER ANTIHYPERTENSIVES,$ANTIHYPERTENSIVES$ANTIHYPERTENSIVES,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1589505,36718171,1.39E-13,0.00000639,adult_youth,adult,levonorgestrel,amnesia,$Nervous system disorders$Psychiatric disorders,"$Progestogens and estrogens, sequential preparations$Emergency contraceptives$Progestogens$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations",$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
19044883,35809131,1.40E-13,0.00000644,adult_children_senior_youth,senior,zopiclone,general physical health deterioration,General disorders and administration site conditions,Benzodiazepine related drugs,HYPNOTICS AND SEDATIVES,PSYCHOLEPTICS,NERVOUS SYSTEM
1344905,37320310,1.41E-13,0.00000648,adult_senior_youth,adult,carboplatin,hair colour changes,Skin and subcutaneous tissue disorders,Platinum compounds,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1797155,35809076,1.42E-13,0.00000652,adult_children_senior_youth,adult_youth,peginterferon alfa-2b,fatigue,General disorders and administration site conditions,$Interferons$Interferons,$IMMUNOSTIMULANTS$IMMUNOSTIMULANTS,$IMMUNOSTIMULANTS$IMMUNOSTIMULANTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1361711,37522317,1.43E-13,0.00000654,adult_senior,adult,glyceryl trinitrate,coronary arterial stent insertion,Surgical and medical procedures,0,0,0,0
739138,35506690,1.43E-13,0.00000655,adult_senior_youth,senior,sertraline,inappropriate antidiuretic hormone secretion,$Endocrine disorders$Metabolism and nutrition disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1777806,37019315,1.45E-13,0.00000664,adult_children_senior_youth,children,ceftriaxone,anuria,Renal and urinary disorders,$Third-generation cephalosporins$Third-generation cephalosporins,$OTHER BETA-LACTAM ANTIBACTERIALS$OTHER BETA-LACTAM ANTIBACTERIALS,$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIBACTERIALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
1311078,36718132,1.49E-13,0.00000685,adult_children_senior_youth,youth,cytarabine,headache,Nervous system disorders,$Pyrimidine analogues$Combinations of antineoplastic agents,$ANTIMETABOLITES$OTHER ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AGENTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
929887,36617948,1.52E-13,0.00000698,adult_senior_youth,youth,lansoprazole,squamous cell carcinoma of skin,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",$Proton pump inhibitors$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Proton pump inhibitors,$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
912263,36110584,1.53E-13,0.00000704,adult_senior_youth,senior,certolizumab pegol,bronchitis,Infections and infestations,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1115008,36311923,1.57E-13,0.00000723,adult_children_senior,children,naproxen,electrocardiogram qt prolonged,Investigations,"$Antiinflammatory products for vaginal administration$Antiinflammatory preparations, non-steroids for topical use$Propionic acid derivatives$Propionic acid derivatives$Propionic acid derivatives","$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
702865,36211491,1.61E-13,0.00000741,adult_senior_youth,youth,meprobamate,accidental overdose,"Injury, poisoning and procedural complications","$Carbamates$Hypnotics and sedatives in combination, excl. barbiturates$Carbamates",$ANXIOLYTICS$HYPNOTICS AND SEDATIVES$ANXIOLYTICS,$PSYCHOLEPTICS$PSYCHOLEPTICS$PSYCHOLEPTICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1103640,36919230,1.61E-13,0.0000074,adult_children_senior_youth,youth,methadone,completed suicide,General disorders and administration site conditions,$Drugs used in opioid dependence$Diphenylpropylamine derivatives,$DRUGS USED IN ADDICTIVE DISORDERS$OPIOIDS,$OTHER NERVOUS SYSTEM DRUGS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
996416,36718555,1.61E-13,0.0000074,adult_senior_youth,adult_youth,finasteride,insomnia,$Nervous system disorders$Psychiatric disorders,$Other dermatologicals$Alpha-adrenoreceptor antagonists$Testosterone-5-alpha reductase inhibitors,$OTHER DERMATOLOGICAL PREPARATIONS$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,$OTHER DERMATOLOGICAL PREPARATIONS$UROLOGICALS$UROLOGICALS,$DERMATOLOGICALS$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
40222444,35909682,1.61E-13,0.00000737,adult_children_senior_youth,adult,denosumab,metastases to liver,Hepatobiliary disorders,Other drugs affecting bone structure and mineralization,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,DRUGS FOR TREATMENT OF BONE DISEASES,MUSCULO-SKELETAL SYSTEM
1321636,37219921,1.61E-13,0.00000738,adult_children_senior_youth,youth,bosentan,pulmonary haemorrhage,"Respiratory, thoracic and mediastinal disorders",$Sulfonamides$Antihypertensives for pulmonary arterial hypertension,"$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$OTHER ANTIHYPERTENSIVES",$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$ANTIHYPERTENSIVES,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
1125315,35104074,1.64E-13,0.00000752,adult_children_senior_youth,senior,acetaminophen,anaemia,Blood and lymphatic system disorders,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
729855,35809146,1.66E-13,0.00000761,adult_children_senior_youth,children,botulinum toxin type A,mobility decreased,Nervous system disorders,0,0,0,0
778711,35204966,1.67E-13,0.00000766,adult_children_senior_youth,youth,cyclobenzaprine,cardiac arrest,Cardiac disorders,Other centrally acting agents,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",MUSCLE RELAXANTS,MUSCULO-SKELETAL SYSTEM
1103640,36918942,1.68E-13,0.00000769,adult_senior_youth,adult_senior,methadone,depression,Psychiatric disorders,$Drugs used in opioid dependence$Diphenylpropylamine derivatives,$DRUGS USED IN ADDICTIVE DISORDERS$OPIOIDS,$OTHER NERVOUS SYSTEM DRUGS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
1778162,35708208,1.68E-13,0.00000773,adult_children_senior_youth,children,cefuroxime,vomiting,Gastrointestinal disorders,$Antibiotics$Second-generation cephalosporins$Combinations of antibacterials,$ANTIINFECTIVES$OTHER BETA-LACTAM ANTIBACTERIALS$COMBINATIONS OF ANTIBACTERIALS,$OPHTHALMOLOGICALS$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIBACTERIALS FOR SYSTEMIC USE,$SENSORY ORGANS$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
1314002,37219937,1.69E-13,0.00000776,adult_children_senior_youth,youth,atenolol,aspiration,"Respiratory, thoracic and mediastinal disorders","$Beta blocking agents, selective, and other diuretics$Beta blocking agents, selective$Beta blocking agents and calcium channel blockers$Beta blocking agents, selective, thiazides and other diuretics$Beta blocking agents, selective, and thiazides$Beta blocking agents, selective, and other diuretics","$BETA BLOCKING AGENTS AND OTHER DIURETICS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS AND OTHER DIURETICS",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1124957,35707864,1.69E-13,0.00000777,adult_children_senior_youth,senior,oxycodone,gastrointestinal haemorrhage,Gastrointestinal disorders,$Natural opium alkaloids$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1307863,37019315,1.70E-13,0.00000779,adult_children_senior_youth,youth,verapamil,anuria,Renal and urinary disorders,$ACE inhibitors and calcium channel blockers$Phenylalkylamine derivatives$Phenylalkylamine derivatives,"$ACE INHIBITORS, COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$CALCIUM CHANNEL BLOCKERS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1715117,37521795,1.71E-13,0.00000784,adult_children_senior_youth,adult,aztreonam,lung transplant,Surgical and medical procedures,Monobactams,OTHER BETA-LACTAM ANTIBACTERIALS,ANTIBACTERIALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
936748,35809310,1.72E-13,0.00000788,adult_children_senior_youth,youth,aprepitant,drug interaction,General disorders and administration site conditions,Other antiemetics,ANTIEMETICS AND ANTINAUSEANTS,ANTIEMETICS AND ANTINAUSEANTS,ALIMENTARY TRACT AND METABOLISM
742185,35809323,1.73E-13,0.00000794,adult_children_senior_youth,children,atomoxetine,drug effect decreased,General disorders and administration site conditions,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
1503297,36315381,1.76E-13,0.00000808,adult_children_senior_youth,children_youth,metformin,weight increased,Investigations,$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Biguanides$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
750982,42888986,1.79E-13,0.00000822,adult_senior_youth,youth,bupropion,pulseless electrical activity,Cardiac disorders,$Centrally acting antiobesity products$Other antidepressants,"$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$ANTIDEPRESSANTS","$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$PSYCHOANALEPTICS",$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM
1115008,36416534,1.80E-13,0.00000827,adult_children_senior_youth,children,naproxen,obesity,Metabolism and nutrition disorders,"$Antiinflammatory products for vaginal administration$Antiinflammatory preparations, non-steroids for topical use$Propionic acid derivatives$Propionic acid derivatives$Propionic acid derivatives","$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
1304107,35104877,1.84E-13,0.00000845,adult_children_senior_youth,children,imatinib,febrile neutropenia,General disorders and administration site conditions,Protein kinase inhibitors,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
942350,35809310,1.85E-13,0.00000849,adult_children_senior_youth,senior,torasemide,drug interaction,General disorders and administration site conditions,"$Sulfonamides, plain$Sulfonamides","$HIGH-CEILING DIURETICS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",$DIURETICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES
1597756,42889647,1.92E-13,0.00000883,adult_children_senior_youth,children,glimepiride,toxicity to various agents,"Injury, poisoning and procedural complications",$Combinations of oral blood glucose lowering drugs$Sulfonylureas$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1149196,36718214,1.96E-13,0.00000898,adult_children_senior_youth,children,cetirizine,psychomotor hyperactivity,Nervous system disorders,Piperazine derivatives,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,RESPIRATORY SYSTEM
757688,35809310,1.98E-13,0.00000911,adult_children_senior_youth,youth,aripiprazole,drug interaction,General disorders and administration site conditions,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
705944,35204970,1.99E-13,0.00000913,adult_children_senior_youth,senior,methylphenidate,cardio-respiratory arrest,Cardiac disorders,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
35604848,36516765,2.03E-13,0.00000933,adult_children_senior_youth,children_youth,selexipag,pain in jaw,Musculoskeletal and connective tissue disorders,Platelet aggregation inhibitors excl. heparin,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1118084,42889647,2.04E-13,0.00000936,adult_children_senior_youth,children_youth,celecoxib,toxicity to various agents,"Injury, poisoning and procedural complications",$Coxibs$Sulfonamides$Other antineoplastic agents,"$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$OTHER ANTINEOPLASTIC AGENTS",$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$ANTINEOPLASTIC AGENTS,$MUSCULO-SKELETAL SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1321636,36111047,2.06E-13,0.00000945,adult_children_senior_youth,children,bosentan,viral infection,Infections and infestations,$Sulfonamides$Antihypertensives for pulmonary arterial hypertension,"$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$OTHER ANTIHYPERTENSIVES",$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$ANTIHYPERTENSIVES,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
904453,37521342,2.09E-13,0.00000959,adult_children_senior_youth,youth,esomeprazole,cholecystectomy,Surgical and medical procedures,$Combinations for eradication of Helicobacter pylori$Proton pump inhibitors$Propionic acid derivatives,"$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$MUSCULO-SKELETAL SYSTEM
1310317,35205240,2.11E-13,0.00000966,adult_children_senior_youth,senior,cyclophosphamide,cardiac failure,Cardiac disorders,Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
735979,36718259,2.12E-13,0.00000973,adult_children_senior_youth,senior,risperidone,parkinsonism,Nervous system disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1177480,35104074,2.16E-13,0.00000993,adult_children_senior_youth,senior,ibuprofen,anaemia,Blood and lymphatic system disorders,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
1149196,36919230,2.17E-13,0.00000997,adult_senior_youth,youth,cetirizine,completed suicide,General disorders and administration site conditions,Piperazine derivatives,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,RESPIRATORY SYSTEM
987245,37219907,2.25E-13,0.0000103,adult_children_senior_youth,children,lactulose,cough,"Respiratory, thoracic and mediastinal disorders",$Osmotically acting laxatives$Osmotically acting laxatives,$DRUGS FOR CONSTIPATION$DRUGS FOR CONSTIPATION,$DRUGS FOR CONSTIPATION$DRUGS FOR CONSTIPATION,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
705103,35204948,2.26E-13,0.0000104,adult_children_senior_youth,youth,lamotrigine,tachycardia,Cardiac disorders,Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
1395557,36516812,2.29E-13,0.0000105,adult_children_senior_youth,senior,fludarabine,arthralgia,Musculoskeletal and connective tissue disorders,Purine analogues,ANTIMETABOLITES,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
745466,36919231,2.30E-13,0.0000105,adult_children_senior_youth,youth,valproate,intentional self-injury,"$Injury, poisoning and procedural complications$Psychiatric disorders",0,0,0,0
715233,35808844,2.31E-13,0.0000106,adult_children_senior_youth,children_youth,baclofen,catheter related complication,0,Other centrally acting agents,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",MUSCLE RELAXANTS,MUSCULO-SKELETAL SYSTEM
19078219,36918869,2.32E-13,0.0000107,adult_senior,senior,sufentanil,fear,Psychiatric disorders,Opioid anesthetics,"ANESTHETICS, GENERAL",ANESTHETICS,NERVOUS SYSTEM
1115008,36517125,2.33E-13,0.0000107,adult_children_senior_youth,children,naproxen,synovitis,Musculoskeletal and connective tissue disorders,"$Antiinflammatory products for vaginal administration$Antiinflammatory preparations, non-steroids for topical use$Propionic acid derivatives$Propionic acid derivatives$Propionic acid derivatives","$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
1314002,37622446,2.34E-13,0.0000107,adult_children_senior_youth,youth,atenolol,shock,Vascular disorders,"$Beta blocking agents, selective, and other diuretics$Beta blocking agents, selective$Beta blocking agents and calcium channel blockers$Beta blocking agents, selective, thiazides and other diuretics$Beta blocking agents, selective, and thiazides$Beta blocking agents, selective, and other diuretics","$BETA BLOCKING AGENTS AND OTHER DIURETICS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS AND OTHER DIURETICS",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1310317,36718008,2.35E-13,0.0000108,adult_children_senior_youth,children_youth,cyclophosphamide,haemorrhage intracranial,Vascular disorders,Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
19011773,37219871,2.43E-13,0.0000112,adult_senior_youth,youth,ascorbic acid,pulmonary embolism,"$Respiratory, thoracic and mediastinal disorders$Vascular disorders","$Organic acids$Ascorbic acid (vitamin C), plain$Ascorbic acid (vitamin C), combinations$Other ophthalmologicals","$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS$ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS$OTHER OPHTHALMOLOGICALS",$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$VITAMINS$VITAMINS$OPHTHALMOLOGICALS,$GENITO URINARY SYSTEM AND SEX HORMONES$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$SENSORY ORGANS
1353766,35204928,2.46E-13,0.0000113,adult_children_senior_youth,children,propranolol,bradycardia,Cardiac disorders,"$Beta blocking agents, other combinations$Beta blocking agents, non-selective$Beta blocking agents, non-selective, and thiazides","$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS AND THIAZIDES",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
757688,36110597,2.46E-13,0.0000113,adult_children_senior_youth,senior,aripiprazole,pneumonia,Infections and infestations,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1129625,35607306,2.54E-13,0.0000116,adult_children_senior_youth,children,diphenhydramine,mydriasis,Nervous system disorders,$Antihistamines for topical use$Aminoalkyl ethers$Antihistamines for topical use$Aminoalkyl ethers,"$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ANTIHISTAMINES FOR SYSTEMIC USE$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ANTIHISTAMINES FOR SYSTEMIC USE","$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ANTIHISTAMINES FOR SYSTEMIC USE$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ANTIHISTAMINES FOR SYSTEMIC USE",$DERMATOLOGICALS$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM
1000560,36919046,2.60E-13,0.000012,adult_children_senior_youth,youth,ondansetron,emotional distress,Psychiatric disorders,Serotonin (5HT3) antagonists,ANTIEMETICS AND ANTINAUSEANTS,ANTIEMETICS AND ANTINAUSEANTS,ALIMENTARY TRACT AND METABOLISM
1305058,35909682,2.61E-13,0.000012,adult_children_senior_youth,senior,methotrexate,metastases to liver,Hepatobiliary disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1115008,35809005,2.66E-13,0.0000122,adult_children_senior_youth,children,naproxen,injection site pain,General disorders and administration site conditions,"$Antiinflammatory products for vaginal administration$Antiinflammatory preparations, non-steroids for topical use$Propionic acid derivatives$Propionic acid derivatives$Propionic acid derivatives","$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
745466,36315381,2.66E-13,0.0000122,adult_children_senior_youth,youth,valproate,weight increased,Investigations,0,0,0,0
1114220,36718555,2.70E-13,0.0000124,adult_senior_youth,adult_youth,naloxone,insomnia,$Nervous system disorders$Psychiatric disorders,$Peripheral opioid receptor antagonists$Natural opium alkaloids$Antidotes$Natural opium alkaloids,$DRUGS FOR CONSTIPATION$OPIOIDS$ALL OTHER THERAPEUTIC PRODUCTS$OPIOIDS,$DRUGS FOR CONSTIPATION$ANALGESICS$ALL OTHER THERAPEUTIC PRODUCTS$ANALGESICS,$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM$VARIOUS$NERVOUS SYSTEM
1717704,36315580,2.80E-13,0.0000128,adult_children_senior_youth,senior,valacyclovir,blood urea increased,Investigations,0,0,0,0
1126658,36517125,2.84E-13,0.000013,adult_senior,senior,hydromorphone,synovitis,Musculoskeletal and connective tissue disorders,$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with antispasmodics,$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
798874,36718321,2.85E-13,0.0000131,adult_children_senior_youth,children,clonazepam,somnolence,Nervous system disorders,Benzodiazepine derivatives,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
1797513,43053888,2.90E-13,0.0000133,adult_senior_youth,senior,ciprofloxacin,clostridium difficile infection,Infections and infestations,$Combinations of antibacterials$Antiinfectives$Fluoroquinolones$Antiinfectives$Combinations of antibacterials$Combinations of antibacterials$Fluoroquinolones,$COMBINATIONS OF ANTIBACTERIALS$ANTIINFECTIVES$QUINOLONE ANTIBACTERIALS$ANTIINFECTIVES$COMBINATIONS OF ANTIBACTERIALS$COMBINATIONS OF ANTIBACTERIALS$ANTIINFECTIVES,$ANTIBACTERIALS FOR SYSTEMIC USE$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$ANTIBACTERIALS FOR SYSTEMIC USE$OTOLOGICALS$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIBACTERIALS FOR SYSTEMIC USE$OPHTHALMOLOGICALS,$ANTIINFECTIVES FOR SYSTEMIC USE$SENSORY ORGANS$ANTIINFECTIVES FOR SYSTEMIC USE$SENSORY ORGANS$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$SENSORY ORGANS
19111620,35708063,2.92E-13,0.0000134,adult_children_senior_youth,youth,folic acid,crohn's disease,$Gastrointestinal disorders$Immune system disorders,$Iron in other combinations$Folic acid and derivatives$Iron in other combinations$Folic acid and derivatives,$IRON PREPARATIONS$VITAMIN B12 AND FOLIC ACID$IRON PREPARATIONS$VITAMIN B12 AND FOLIC ACID,$ANTIANEMIC PREPARATIONS$ANTIANEMIC PREPARATIONS$ANTIANEMIC PREPARATIONS$ANTIANEMIC PREPARATIONS,$BLOOD AND BLOOD FORMING ORGANS$BLOOD AND BLOOD FORMING ORGANS$BLOOD AND BLOOD FORMING ORGANS$BLOOD AND BLOOD FORMING ORGANS
1337068,35809225,2.95E-13,0.0000135,adult_children_senior_youth,senior,ambrisentan,oedema,$General disorders and administration site conditions$Metabolism and nutrition disorders,$Antihypertensives for pulmonary arterial hypertension$Antihypertensives for pulmonary arterial hypertension,$OTHER ANTIHYPERTENSIVES$OTHER ANTIHYPERTENSIVES,$ANTIHYPERTENSIVES$ANTIHYPERTENSIVES,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1153013,37219871,2.98E-13,0.0000137,adult_children_senior_youth,youth,promethazine,pulmonary embolism,"$Respiratory, thoracic and mediastinal disorders$Vascular disorders",$Phenothiazine derivatives$Antihistamines for topical use$Antidotes$Phenothiazine derivatives,"$ANTIHISTAMINES FOR SYSTEMIC USE$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ALL OTHER THERAPEUTIC PRODUCTS$ANTIHISTAMINES FOR SYSTEMIC USE","$ANTIHISTAMINES FOR SYSTEMIC USE$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ALL OTHER THERAPEUTIC PRODUCTS$ANTIHISTAMINES FOR SYSTEMIC USE",$RESPIRATORY SYSTEM$DERMATOLOGICALS$VARIOUS$RESPIRATORY SYSTEM
1119119,35204998,3.03E-13,0.0000139,adult_children_senior_youth,senior,adalimumab,cardiovascular disorder,Cardiac disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
40241331,35708208,3.04E-13,0.0000139,adult_children_senior_youth,youth,rivaroxaban,vomiting,Gastrointestinal disorders,Direct factor Xa inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1316262,35708208,3.04E-13,0.000014,adult_children_senior_youth,children_youth,sildenafil,vomiting,Gastrointestinal disorders,$Sulfonamides$Drugs used in erectile dysfunction,"$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$UROLOGICALS",$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$UROLOGICALS,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1154029,36718371,3.17E-13,0.0000146,adult_children_senior_youth,youth,fentanyl,unresponsive to stimuli,Nervous system disorders,$Opioid anesthetics$Phenylpiperidine derivatives$Opioid anesthetics,"$ANESTHETICS, GENERAL$OPIOIDS$ANESTHETICS, GENERAL",$ANESTHETICS$ANALGESICS$ANESTHETICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1315942,37320313,3.19E-13,0.0000146,adult_senior_youth,adult,docetaxel,hair texture abnormal,Skin and subcutaneous tissue disorders,Taxanes,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1789276,35506636,3.24E-13,0.0000149,adult_children_senior_youth,children,gatifloxacin,hypoglycaemia,Endocrine disorders,$Fluoroquinolones$Fluoroquinolones,$ANTIINFECTIVES$QUINOLONE ANTIBACTERIALS,$OPHTHALMOLOGICALS$ANTIBACTERIALS FOR SYSTEMIC USE,$SENSORY ORGANS$ANTIINFECTIVES FOR SYSTEMIC USE
1551099,36918942,3.25E-13,0.0000149,adult_children_senior_youth,adult_youth,prednisone,depression,Psychiatric disorders,$Corticosteroids acting locally$Glucocorticoids,"$INTESTINAL ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN","$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE","$ALIMENTARY TRACT AND METABOLISM$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
705103,36918942,3.32E-13,0.0000153,adult_children_senior_youth,adult,lamotrigine,depression,Psychiatric disorders,Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
1114220,36313476,3.32E-13,0.0000152,adult_children_senior_youth,senior,naloxone,white blood cell count decreased,Investigations,$Peripheral opioid receptor antagonists$Natural opium alkaloids$Antidotes$Natural opium alkaloids,$DRUGS FOR CONSTIPATION$OPIOIDS$ALL OTHER THERAPEUTIC PRODUCTS$OPIOIDS,$DRUGS FOR CONSTIPATION$ANALGESICS$ALL OTHER THERAPEUTIC PRODUCTS$ANALGESICS,$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM$VARIOUS$NERVOUS SYSTEM
40241331,36718229,3.34E-13,0.0000153,adult_children_senior,senior,rivaroxaban,hemiparesis,Nervous system disorders,Direct factor Xa inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
778711,37219937,3.38E-13,0.0000155,adult_children_senior_youth,youth,cyclobenzaprine,aspiration,"Respiratory, thoracic and mediastinal disorders",Other centrally acting agents,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",MUSCLE RELAXANTS,MUSCULO-SKELETAL SYSTEM
1305058,35708164,3.39E-13,0.0000156,adult_children_senior_youth,adult,methotrexate,abdominal discomfort,Gastrointestinal disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
904453,36919046,3.39E-13,0.0000156,adult_senior_youth,youth,esomeprazole,emotional distress,Psychiatric disorders,$Combinations for eradication of Helicobacter pylori$Proton pump inhibitors$Propionic acid derivatives,"$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$MUSCULO-SKELETAL SYSTEM
912263,36517125,3.44E-13,0.0000158,adult_senior,senior,certolizumab pegol,synovitis,Musculoskeletal and connective tissue disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1312706,35104877,3.46E-13,0.0000159,adult_children_senior_youth,children_senior,alemtuzumab,febrile neutropenia,General disorders and administration site conditions,Selective immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1311078,36718229,3.53E-13,0.0000162,adult_children_senior_youth,children_youth,cytarabine,hemiparesis,Nervous system disorders,$Pyrimidine analogues$Combinations of antineoplastic agents,$ANTIMETABOLITES$OTHER ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AGENTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1395557,42889498,3.59E-13,0.0000165,adult_children_senior_youth,children,fludarabine,graft versus host disease in skin,"Injury, poisoning and procedural complications",Purine analogues,ANTIMETABOLITES,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1115008,36211297,3.63E-13,0.0000167,adult_children_senior_youth,senior,naproxen,fall,"Injury, poisoning and procedural complications","$Antiinflammatory products for vaginal administration$Antiinflammatory preparations, non-steroids for topical use$Propionic acid derivatives$Propionic acid derivatives$Propionic acid derivatives","$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
1124300,36009762,3.70E-13,0.000017,adult_children_senior_youth,children_youth,diclofenac,angioedema,Immune system disorders,"$Antiinflammatory agents, non-steroids and antiinfectives in combination$Antiinflammatory agents, non-steroids$Acetic acid derivatives and related substances$Antiinflammatory preparations, non-steroids for topical use$Acetic acid derivatives and related substances$Other dermatologicals","$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$ANTIINFLAMMATORY AGENTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$OTHER DERMATOLOGICAL PREPARATIONS",$OPHTHALMOLOGICALS$OPHTHALMOLOGICALS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$OTHER DERMATOLOGICAL PREPARATIONS,$SENSORY ORGANS$SENSORY ORGANS$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$DERMATOLOGICALS
1151789,37622460,3.70E-13,0.000017,adult_children_senior_youth,senior,etanercept,thrombosis,Vascular disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
711584,36211496,3.71E-13,0.000017,adult_children_senior_youth,youth,levetiracetam,overdose,"Injury, poisoning and procedural complications",Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
1550023,36416482,3.76E-13,0.0000173,adult_children_senior_youth,children_youth,insulin lispro,ketoacidosis,Metabolism and nutrition disorders,"$Insulins and analogues for injection, intermediate-acting$Insulins and analogues for injection, fast-acting$Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting",$INSULINS AND ANALOGUES$INSULINS AND ANALOGUES$INSULINS AND ANALOGUES,$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
702865,35205259,3.77E-13,0.0000173,adult_senior_youth,youth,meprobamate,pulmonary oedema,"Respiratory, thoracic and mediastinal disorders","$Carbamates$Hypnotics and sedatives in combination, excl. barbiturates$Carbamates",$ANXIOLYTICS$HYPNOTICS AND SEDATIVES$ANXIOLYTICS,$PSYCHOLEPTICS$PSYCHOLEPTICS$PSYCHOLEPTICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1167322,36313594,3.87E-13,0.0000178,adult_children_senior_youth,youth,allopurinol,liver function test abnormal,Investigations,$Preparations inhibiting uric acid production$Preparations inhibiting uric acid production,$ANTIGOUT PREPARATIONS$ANTIGOUT PREPARATIONS,$ANTIGOUT PREPARATIONS$ANTIGOUT PREPARATIONS,$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
929887,36416550,3.88E-13,0.0000178,adult_children_senior_youth,children,lansoprazole,osteopenia,$Metabolism and nutrition disorders$Musculoskeletal and connective tissue disorders,$Proton pump inhibitors$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Proton pump inhibitors,$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1332418,35204911,3.97E-13,0.0000182,adult_senior_youth,youth,amlodipine,bundle branch block left,Cardiac disorders,"$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$Beta blocking agents and calcium channel blockers$Dihydropyridine derivatives$ACE inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$Calcium channel blockers and diuretics$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs), other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers","$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS$ACE INHIBITORS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$CALCIUM CHANNEL BLOCKERS AND DIURETICS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$BETA BLOCKING AGENTS$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1114220,35909508,4.00E-13,0.0000184,adult_children_senior_youth,senior,naloxone,hepatic function abnormal,Hepatobiliary disorders,$Peripheral opioid receptor antagonists$Natural opium alkaloids$Antidotes$Natural opium alkaloids,$DRUGS FOR CONSTIPATION$OPIOIDS$ALL OTHER THERAPEUTIC PRODUCTS$OPIOIDS,$DRUGS FOR CONSTIPATION$ANALGESICS$ALL OTHER THERAPEUTIC PRODUCTS$ANALGESICS,$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM$VARIOUS$NERVOUS SYSTEM
19078219,36918861,4.01E-13,0.0000184,adult_senior_youth,senior,sufentanil,stress,Psychiatric disorders,Opioid anesthetics,"ANESTHETICS, GENERAL",ANESTHETICS,NERVOUS SYSTEM
950637,36110954,4.06E-13,0.0000186,adult_children_senior_youth,children_youth,tacrolimus,skin papilloma,Infections and infestations,"$Agents for dermatitis, excluding corticosteroids$Calcineurin inhibitors",$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$DERMATOLOGICALS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1703687,35104826,4.10E-13,0.0000188,adult_children_senior_youth,children_youth,acyclovir,eosinophilia,Blood and lymphatic system disorders,$Nucleosides and nucleotides excl. reverse transcriptase inhibitors$Antivirals$Antivirals$Antivirals,$DIRECT ACTING ANTIVIRALS$CHEMOTHERAPEUTICS FOR TOPICAL USE$ANTIINFECTIVES$CHEMOTHERAPEUTICS FOR TOPICAL USE,$ANTIVIRALS FOR SYSTEMIC USE$ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE$OPHTHALMOLOGICALS$ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,$ANTIINFECTIVES FOR SYSTEMIC USE$DERMATOLOGICALS$SENSORY ORGANS$DERMATOLOGICALS
742267,35909513,4.18E-13,0.0000192,adult_children_youth,children,topiramate,acute hepatic failure,Hepatobiliary disorders,Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
785788,35809310,4.27E-13,0.0000196,adult_children_senior_youth,senior,olanzapine,drug interaction,General disorders and administration site conditions,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1129625,36718458,4.29E-13,0.0000197,adult_children_senior_youth,children,diphenhydramine,serotonin syndrome,"Injury, poisoning and procedural complications",$Antihistamines for topical use$Aminoalkyl ethers$Antihistamines for topical use$Aminoalkyl ethers,"$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ANTIHISTAMINES FOR SYSTEMIC USE$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ANTIHISTAMINES FOR SYSTEMIC USE","$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ANTIHISTAMINES FOR SYSTEMIC USE$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ANTIHISTAMINES FOR SYSTEMIC USE",$DERMATOLOGICALS$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM
948078,35909443,4.32E-13,0.0000198,adult_children_senior_youth,youth,pantoprazole,cholecystitis chronic,Hepatobiliary disorders,$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Proton pump inhibitors,$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1125315,36919059,4.43E-13,0.0000203,adult_children_senior_youth,children_youth,acetaminophen,aggression,Psychiatric disorders,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
40044817,42889647,4.48E-13,0.0000206,adult_senior_youth,youth,hydrochlorothiazide / lisinopril Oral Tablet,toxicity to various agents,"Injury, poisoning and procedural complications",0,0,0,0
40241331,37219867,4.53E-13,0.0000208,adult_senior_youth,adult,rivaroxaban,pulmonary arterial hypertension,Vascular disorders,Direct factor Xa inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
723013,36009724,4.56E-13,0.0000209,adult_children_senior_youth,children,diazepam,stevens-johnson syndrome,Infections and infestations,Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
800878,36110597,4.64E-13,0.0000213,adult_children_senior_youth,senior,clozapine,pneumonia,Infections and infestations,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1310149,36009735,4.68E-13,0.0000215,adult_children_senior_youth,children_youth,warfarin,dermatitis contact,Immune system disorders,Vitamin K antagonists,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
757688,36919236,4.70E-13,0.0000216,adult_children_senior_youth,youth,aripiprazole,suicide attempt,Psychiatric disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
923645,35909443,4.74E-13,0.0000217,adult_children_senior_youth,youth,omeprazole,cholecystitis chronic,Hepatobiliary disorders,$Proton pump inhibitors$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori,$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1363053,37622529,4.87E-13,0.0000223,adult_children_senior_youth,youth,doxazosin,hypertension,Vascular disorders,Alpha-adrenoreceptor antagonists,"ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",ANTIHYPERTENSIVES,CARDIOVASCULAR SYSTEM
1551099,35707714,4.87E-13,0.0000224,adult_children_senior_youth,children,prednisone,pancreatitis acute,Gastrointestinal disorders,$Corticosteroids acting locally$Glucocorticoids,"$INTESTINAL ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN","$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE","$ALIMENTARY TRACT AND METABOLISM$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
1636780,35205189,4.92E-13,0.0000226,adult_senior,adult,testosterone,myocardial infarction,Vascular disorders,$3-oxoandrosten (4) derivatives$Androgens and estrogens,$ANDROGENS$ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1307863,36416487,4.97E-13,0.0000228,adult_children_senior_youth,children,verapamil,metabolic acidosis,Metabolism and nutrition disorders,$ACE inhibitors and calcium channel blockers$Phenylalkylamine derivatives$Phenylalkylamine derivatives,"$ACE INHIBITORS, COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$CALCIUM CHANNEL BLOCKERS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1154343,36918942,4.99E-13,0.0000229,adult_children_senior_youth,youth,albuterol,depression,Psychiatric disorders,0,0,0,0
1305058,36313091,5.02E-13,0.0000231,adult_children_senior_youth,children_youth,methotrexate,prothrombin time prolonged,Investigations,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1351541,37119542,5.05E-13,0.0000232,adult_youth,youth,leuprolide,dysmenorrhoea,Reproductive system and breast disorders,$Gonadotropin releasing hormone analogues$Gonadotropin releasing hormone analogues,$HORMONES AND RELATED AGENTS$HORMONES AND RELATED AGENTS,$ENDOCRINE THERAPY$ENDOCRINE THERAPY,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1551099,36211465,5.05E-13,0.0000232,adult_children_senior_youth,youth,prednisone,incorrect dose administered,"Injury, poisoning and procedural complications",$Corticosteroids acting locally$Glucocorticoids,"$INTESTINAL ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN","$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE","$ALIMENTARY TRACT AND METABOLISM$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
19044883,35205034,5.05E-13,0.0000232,adult_children_senior_youth,youth,zopiclone,palpitations,Cardiac disorders,Benzodiazepine related drugs,HYPNOTICS AND SEDATIVES,PSYCHOLEPTICS,NERVOUS SYSTEM
1110410,42889647,5.08E-13,0.0000233,adult_children_senior_youth,youth,morphine,toxicity to various agents,"Injury, poisoning and procedural complications",$Antipropulsives$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with antispasmodics,$ANTIPROPULSIVES$OPIOIDS$OPIOIDS$OPIOIDS,"$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$ANALGESICS$ANALGESICS$ANALGESICS",$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1304850,37622529,5.09E-13,0.0000234,adult_children_senior_youth,children,filgrastim,hypertension,Vascular disorders,Colony stimulating factors,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1321636,788391,5.10E-13,0.0000234,adult_children_senior_youth,children,bosentan,liver function test increased,Investigations,$Sulfonamides$Antihypertensives for pulmonary arterial hypertension,"$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$OTHER ANTIHYPERTENSIVES",$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$ANTIHYPERTENSIVES,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
1112807,35607150,5.13E-13,0.0000236,adult_children_senior_youth,children_youth,aspirin,periorbital oedema,Immune system disorders,0,0,0,0
920293,36211303,5.20E-13,0.0000239,adult_children_senior_youth,youth,nitrofurantoin,injury,"Injury, poisoning and procedural complications",$Nitrofuran derivatives$Nitrofuran derivatives,$OTHER ANTIBACTERIALS$OTHER ANTIBACTERIALS,$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIBACTERIALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
1305058,35707991,5.34E-13,0.0000245,adult_children_senior_youth,children_youth,methotrexate,clostridium difficile colitis,Gastrointestinal disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
19041065,36009756,5.54E-13,0.0000254,adult_senior_youth,senior,golimumab,anaphylactic reaction,Immune system disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
735979,36718005,5.56E-13,0.0000255,adult_children_senior_youth,senior,risperidone,cerebrovascular accident,Vascular disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
800878,35205185,5.57E-13,0.0000256,adult_children_senior_youth,youth,clozapine,chest pain,"Respiratory, thoracic and mediastinal disorders","Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
715939,36211197,5.60E-13,0.0000257,adult_children_youth,children,escitalopram,maternal drugs affecting foetus,"Injury, poisoning and procedural complications",Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1769389,35809068,5.61E-13,0.0000258,adult_children_youth,youth,nevirapine,stillbirth,General disorders and administration site conditions,"$Non-nucleoside reverse transcriptase inhibitors$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations",$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS,$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
1119119,36718175,5.63E-13,0.0000259,adult_children_senior_youth,senior,adalimumab,memory impairment,$Nervous system disorders$Psychiatric disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1762711,36313176,5.64E-13,0.0000259,adult_children_senior_youth,senior,ribavirin,platelet count decreased,Investigations,Antivirals for treatment of HCV infections,DIRECT ACTING ANTIVIRALS,ANTIVIRALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
19059796,37622449,5.95E-13,0.0000273,adult_children_senior_youth,youth,gliclazide,hypotension,Vascular disorders,Sulfonylureas,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",DRUGS USED IN DIABETES,ALIMENTARY TRACT AND METABOLISM
1305447,36818729,6.03E-13,0.0000277,adult_children_youth,children_youth,methyldopa,premature baby,"Pregnancy, puerperium and perinatal conditions",0,0,0,0
1398937,36718214,6.05E-13,0.0000278,adult_children_senior_youth,children,clonidine,psychomotor hyperactivity,Nervous system disorders,$Sympathomimetics in glaucoma therapy$Imidazoline receptor agonists in combination with diuretics$Imidazoline receptor agonists$Other antimigraine preparations$Imidazoline receptor agonists in combination with diuretics,"$ANTIGLAUCOMA PREPARATIONS AND MIOTICS$ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION$ANTIADRENERGIC AGENTS, CENTRALLY ACTING$ANTIMIGRAINE PREPARATIONS$ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",$OPHTHALMOLOGICALS$ANTIHYPERTENSIVES$ANTIHYPERTENSIVES$ANALGESICS$ANTIHYPERTENSIVES,$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$NERVOUS SYSTEM$CARDIOVASCULAR SYSTEM
750982,36110597,6.12E-13,0.0000281,adult_children_senior_youth,senior,bupropion,pneumonia,Infections and infestations,$Centrally acting antiobesity products$Other antidepressants,"$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$ANTIDEPRESSANTS","$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$PSYCHOANALEPTICS",$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM
723013,35607294,6.14E-13,0.0000282,adult_children_senior_youth,children,diazepam,strabismus,Eye disorders,Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1547504,35204966,6.16E-13,0.0000283,adult_children_senior_youth,senior,rosiglitazone,cardiac arrest,Cardiac disorders,$Combinations of oral blood glucose lowering drugs$Thiazolidinediones$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
703547,35204966,6.16E-13,0.0000283,adult_children_senior_youth,children_youth,trazodone,cardiac arrest,Cardiac disorders,Other antidepressants,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
723013,36918942,6.19E-13,0.0000284,adult_children_senior_youth,adult,diazepam,depression,Psychiatric disorders,Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1124957,36313476,6.19E-13,0.0000284,adult_children_senior_youth,children_senior,oxycodone,white blood cell count decreased,Investigations,$Natural opium alkaloids$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1305058,35104103,6.31E-13,0.000029,adult_children_senior_youth,children_youth,methotrexate,bone marrow failure,Blood and lymphatic system disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
705944,35809059,6.40E-13,0.0000294,adult_children_senior_youth,senior,methylphenidate,death,General disorders and administration site conditions,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
723013,36516812,6.49E-13,0.0000298,adult_children_senior_youth,senior,diazepam,arthralgia,Musculoskeletal and connective tissue disorders,Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
733301,35204928,6.56E-13,0.0000301,adult_senior_youth,youth,buspirone,bradycardia,Cardiac disorders,Azaspirodecanedione derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1177480,35809005,6.57E-13,0.0000302,adult_children_senior_youth,adult,ibuprofen,injection site pain,General disorders and administration site conditions,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
40241331,36211375,6.63E-13,0.0000304,adult_children_senior_youth,children,rivaroxaban,head injury,"Injury, poisoning and procedural complications",Direct factor Xa inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1149196,36919235,6.84E-13,0.0000314,adult_children_senior_youth,children_youth,cetirizine,suicidal ideation,Psychiatric disorders,Piperazine derivatives,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,RESPIRATORY SYSTEM
1149196,36919059,6.93E-13,0.0000318,adult_children_senior_youth,children,cetirizine,aggression,Psychiatric disorders,Piperazine derivatives,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,RESPIRATORY SYSTEM
1346823,35205276,6.93E-13,0.0000318,adult_children_senior_youth,children,carvedilol,congestive cardiomyopathy,Cardiac disorders,"$Alpha and beta blocking agents$Beta blocking agents, other combinations","$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS, OTHER COMBINATIONS",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
755695,36718458,6.96E-13,0.0000319,adult_children_senior_youth,youth,fluoxetine,serotonin syndrome,"Injury, poisoning and procedural complications",$Antidepressants in combination with psycholeptics$Selective serotonin reuptake inhibitors,$PSYCHOLEPTICS AND PSYCHOANALEPTICS IN COMBINATION$ANTIDEPRESSANTS,$PSYCHOANALEPTICS$PSYCHOANALEPTICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
46221581,35506494,7.11E-13,0.0000326,adult_children_senior_youth,youth,insulin isophane,diabetic ketoacidosis,$Endocrine disorders$Metabolism and nutrition disorders,0,0,0,0
937368,36313985,7.42E-13,0.0000341,adult_children_senior_youth,senior,infliximab,blood cholesterol increased,Investigations,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1503297,37622465,7.58E-13,0.0000348,adult_children_senior_youth,youth,metformin,deep vein thrombosis,Vascular disorders,$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Biguanides$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1305058,35708063,7.60E-13,0.0000349,adult_children_senior_youth,youth,methotrexate,crohn's disease,$Gastrointestinal disorders$Immune system disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
739138,35205243,7.65E-13,0.0000351,adult_children_senior_youth,senior,sertraline,cardiac failure congestive,Cardiac disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1114220,35104074,7.67E-13,0.0000352,adult_children_senior_youth,senior,naloxone,anaemia,Blood and lymphatic system disorders,$Peripheral opioid receptor antagonists$Natural opium alkaloids$Antidotes$Natural opium alkaloids,$DRUGS FOR CONSTIPATION$OPIOIDS$ALL OTHER THERAPEUTIC PRODUCTS$OPIOIDS,$DRUGS FOR CONSTIPATION$ANALGESICS$ALL OTHER THERAPEUTIC PRODUCTS$ANALGESICS,$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM$VARIOUS$NERVOUS SYSTEM
1310149,36919230,7.69E-13,0.0000353,adult_children_senior_youth,youth,warfarin,completed suicide,General disorders and administration site conditions,Vitamin K antagonists,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
791967,36211492,7.79E-13,0.0000358,adult_children_senior_youth,youth,lorazepam,intentional overdose,"Injury, poisoning and procedural complications",$Benzodiazepine derivatives$Benzodiazepine derivatives,$ANXIOLYTICS$ANXIOLYTICS,$PSYCHOLEPTICS$PSYCHOLEPTICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
1334456,37622529,8.10E-13,0.0000372,adult_children_senior_youth,youth,ramipril,hypertension,Vascular disorders,"$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and diuretics$ACE inhibitors, plain","$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, PLAIN",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
931973,35809115,8.13E-13,0.0000373,adult_children_senior_youth,children_youth,protease,condition aggravated,General disorders and administration site conditions,0,0,0,0
1177480,37622460,8.18E-13,0.0000376,adult_children_senior_youth,youth,ibuprofen,thrombosis,Vascular disorders,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
1125315,36919236,8.22E-13,0.0000377,adult_children_senior_youth,youth,acetaminophen,suicide attempt,Psychiatric disorders,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1388796,36110015,8.37E-13,0.0000384,adult_children_senior_youth,children,leucovorin,bacterial infection,Infections and infestations,$Detoxifying agents for antineoplastic treatment$Detoxifying agents for antineoplastic treatment,$ALL OTHER THERAPEUTIC PRODUCTS$ALL OTHER THERAPEUTIC PRODUCTS,$ALL OTHER THERAPEUTIC PRODUCTS$ALL OTHER THERAPEUTIC PRODUCTS,$VARIOUS$VARIOUS
1395557,36110874,8.37E-13,0.0000384,adult_children_senior_youth,youth,fludarabine,cytomegalovirus infection,Infections and infestations,Purine analogues,ANTIMETABOLITES,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1151789,35205243,8.38E-13,0.0000385,adult_children_senior,senior,etanercept,cardiac failure congestive,Cardiac disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
722031,37080784,8.53E-13,0.0000391,adult_children_senior,senior,paroxetine,acute kidney injury,Renal and urinary disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
791967,36919230,8.59E-13,0.0000394,adult_children_senior_youth,youth,lorazepam,completed suicide,General disorders and administration site conditions,$Benzodiazepine derivatives$Benzodiazepine derivatives,$ANXIOLYTICS$ANXIOLYTICS,$PSYCHOLEPTICS$PSYCHOLEPTICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
1312706,36718132,8.61E-13,0.0000395,adult_children_senior_youth,youth,alemtuzumab,headache,Nervous system disorders,Selective immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1551099,35104883,8.63E-13,0.0000396,adult_children_senior_youth,children,prednisone,neutropenia,Blood and lymphatic system disorders,$Corticosteroids acting locally$Glucocorticoids,"$INTESTINAL ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN","$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE","$ALIMENTARY TRACT AND METABOLISM$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
19078187,35406368,8.64E-13,0.0000397,adult_children_youth,children,ifosfamide,hearing impaired,0,Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1149196,37622465,8.75E-13,0.0000402,adult_children_senior_youth,youth,cetirizine,deep vein thrombosis,Vascular disorders,Piperazine derivatives,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,RESPIRATORY SYSTEM
1338512,37219871,8.97E-13,0.0000412,adult_children_senior_youth,senior,doxorubicin,pulmonary embolism,"$Respiratory, thoracic and mediastinal disorders$Vascular disorders",Anthracyclines and related substances,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1353766,35204966,9.04E-13,0.0000415,adult_children_senior_youth,children_youth,propranolol,cardiac arrest,Cardiac disorders,"$Beta blocking agents, other combinations$Beta blocking agents, non-selective$Beta blocking agents, non-selective, and thiazides","$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS AND THIAZIDES",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
19010482,35607313,9.05E-13,0.0000415,adult_children_senior,senior,cyclosporine,abnormal sensation in eye,Eye disorders,$Calcineurin inhibitors$Other ophthalmologicals,$IMMUNOSUPPRESSANTS$OTHER OPHTHALMOLOGICALS,$IMMUNOSUPPRESSANTS$OPHTHALMOLOGICALS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$SENSORY ORGANS
923645,35708139,9.08E-13,0.0000417,adult_children_senior_youth,youth,omeprazole,dyspepsia,Gastrointestinal disorders,$Proton pump inhibitors$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori,$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
766814,35506601,9.08E-13,0.0000417,adult_children_senior_youth,children,quetiapine,gynaecomastia,$Endocrine disorders$Reproductive system and breast disorders,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1500211,37119545,9.25E-13,0.0000424,adult_children_senior_youth,youth,medroxyprogesterone,metrorrhagia,Reproductive system and breast disorders,0,0,0,0
1516800,36211123,9.31E-13,0.0000427,adult_children_senior,children,risedronate,spinal fracture,"Injury, poisoning and procedural complications",0,0,0,0
939259,36009700,9.36E-13,0.000043,adult_children_senior_youth,children,budesonide,asthma,"Respiratory, thoracic and mediastinal disorders","$Corticosteroids, potent (group III)$Corticosteroids$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Corticosteroids acting locally$Glucocorticoids$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics","$CORTICOSTEROIDS, PLAIN$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ADRENERGICS, INHALANTS$INTESTINAL ANTIINFLAMMATORY AGENTS$OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS$ADRENERGICS, INHALANTS","$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$NASAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",$DERMATOLOGICALS$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$ALIMENTARY TRACT AND METABOLISM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
703547,36211288,9.37E-13,0.000043,adult_senior_youth,senior,trazodone,asphyxia,"Injury, poisoning and procedural complications",Other antidepressants,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1550557,36110888,9.46E-13,0.0000434,adult_children_senior_youth,children_youth,prednisolone,epstein-barr virus infection,Infections and infestations,"$Corticosteroids, weak (group I)$Corticosteroids and antiinfectives in combination$Corticosteroids, weak, other combinations$Corticosteroids for local oral treatment$Corticosteroids$Corticosteroids and mydriatics in combination$Corticosteroids$Corticosteroids/antiinfectives/mydriatics in combination$Antidotes$Corticosteroids$Corticosteroids, weak, combinations with antiseptics$Corticosteroids, weak, combinations with antibiotics$Corticosteroids, plain$Corticosteroids$Corticosteroids acting locally$Glucocorticoids$Corticosteroids and antiinfectives in combination$Corticosteroids$Corticosteroids and antiinfectives in combination","$CORTICOSTEROIDS, PLAIN$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS, OTHER COMBINATIONS$STOMATOLOGICAL PREPARATIONS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$ALL OTHER THERAPEUTIC PRODUCTS$CORTICOSTEROIDS$CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS$INTESTINAL ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION","$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$STOMATOLOGICAL PREPARATIONS$NASAL PREPARATIONS$OPHTHALMOLOGICALS$NASAL PREPARATIONS$OPHTHALMOLOGICALS$ALL OTHER THERAPEUTIC PRODUCTS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS$OTOLOGICALS$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE$OTOLOGICALS$VASOPROTECTIVES$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS","$DERMATOLOGICALS$SENSORY ORGANS$DERMATOLOGICALS$ALIMENTARY TRACT AND METABOLISM$RESPIRATORY SYSTEM$SENSORY ORGANS$RESPIRATORY SYSTEM$SENSORY ORGANS$VARIOUS$SENSORY ORGANS$DERMATOLOGICALS$DERMATOLOGICALS$SENSORY ORGANS$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS"
797617,35809059,9.73E-13,0.0000447,adult_children_senior_youth,senior,citalopram,death,General disorders and administration site conditions,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1115008,46276591,9.81E-13,0.000045,adult_children_senior_youth,senior,naproxen,wrong technique in product usage process,"Injury, poisoning and procedural complications","$Antiinflammatory products for vaginal administration$Antiinflammatory preparations, non-steroids for topical use$Propionic acid derivatives$Propionic acid derivatives$Propionic acid derivatives","$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
722031,36919209,9.82E-13,0.0000451,adult_children_senior_youth,youth,paroxetine,sleep disorder,Psychiatric disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1307863,35204981,9.88E-13,0.0000454,adult_children_senior_youth,youth,verapamil,ventricular fibrillation,Cardiac disorders,$ACE inhibitors and calcium channel blockers$Phenylalkylamine derivatives$Phenylalkylamine derivatives,"$ACE INHIBITORS, COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$CALCIUM CHANNEL BLOCKERS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1125315,36254981,9.92E-13,0.0000455,adult_children_senior_youth,children,acetaminophen,extra dose administered,"Injury, poisoning and procedural complications",$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1149380,42890333,9.98E-13,0.0000458,adult_children_senior_youth,adult,fluticasone,upper-airway cough syndrome,"Respiratory, thoracic and mediastinal disorders","$Glucocorticoids$Corticosteroids, potent (group III)$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Corticosteroids$Corticosteroids","$OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS$CORTICOSTEROIDS, PLAIN$ADRENERGICS, INHALANTS$ADRENERGICS, INHALANTS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE","$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$NASAL PREPARATIONS$NASAL PREPARATIONS",$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1501700,35506673,1.01E-12,0.0000465,adult_children_senior_youth,children,levothyroxine,craniopharyngioma,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Thyroid hormones,THYROID PREPARATIONS,THYROID THERAPY,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
722031,35809076,1.02E-12,0.0000466,adult_children_senior_youth,youth,paroxetine,fatigue,General disorders and administration site conditions,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
40222444,36617245,1.06E-12,0.0000487,adult_children_senior_youth,adult,denosumab,metastasis,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Other drugs affecting bone structure and mineralization,DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,DRUGS FOR TREATMENT OF BONE DISEASES,MUSCULO-SKELETAL SYSTEM
1174888,37219893,1.06E-12,0.0000486,adult_children_senior_youth,children_youth,hydrocodone,respiratory arrest,"Respiratory, thoracic and mediastinal disorders",Opium alkaloids and derivatives,"COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",COUGH AND COLD PREPARATIONS,RESPIRATORY SYSTEM
745466,36919235,1.06E-12,0.0000485,adult_children_senior_youth,adult_youth,valproate,suicidal ideation,Psychiatric disorders,0,0,0,0
956874,37219804,1.07E-12,0.000049,adult_children_senior,senior,furosemide,chronic obstructive pulmonary disease,"Respiratory, thoracic and mediastinal disorders","$High-ceiling diuretics and potassium-sparing agents$Sulfonamides, plain$Sulfonamides$Sulfonamides and potassium in combination","$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$HIGH-CEILING DIURETICS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$HIGH-CEILING DIURETICS",$DIURETICS$DIURETICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$DIURETICS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
1715117,37219907,1.09E-12,0.0000502,adult_children_senior_youth,children,aztreonam,cough,"Respiratory, thoracic and mediastinal disorders",Monobactams,OTHER BETA-LACTAM ANTIBACTERIALS,ANTIBACTERIALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
766529,35809131,1.10E-12,0.0000507,adult_children_senior_youth,senior,haloperidol,general physical health deterioration,General disorders and administration site conditions,Butyrophenone derivatives,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1151789,35809025,1.13E-12,0.0000519,adult_children_senior_youth,youth,etanercept,injection site warmth,General disorders and administration site conditions,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1125315,36718301,1.14E-12,0.0000525,adult_children_senior_youth,senior,acetaminophen,confusional state,Nervous system disorders,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1314273,35104397,1.14E-12,0.0000523,adult_children_senior_youth,senior,rituximab,myelodysplastic syndrome,Blood and lymphatic system disorders,Monoclonal antibodies,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
19044883,42889647,1.14E-12,0.0000524,adult_children_senior_youth,youth,zopiclone,toxicity to various agents,"Injury, poisoning and procedural complications",Benzodiazepine related drugs,HYPNOTICS AND SEDATIVES,PSYCHOLEPTICS,NERVOUS SYSTEM
1539403,36718382,1.15E-12,0.0000529,adult_senior_youth,adult,simvastatin,skin burning sensation,Nervous system disorders,"$Dipeptidyl peptidase 4 (DPP-4) inhibitors$HMG CoA reductase inhibitors$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents","$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS",$DRUGS USED IN DIABETES$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS,$ALIMENTARY TRACT AND METABOLISM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
942350,35205240,1.18E-12,0.0000542,adult_children_senior_youth,children_youth,torasemide,cardiac failure,Cardiac disorders,"$Sulfonamides, plain$Sulfonamides","$HIGH-CEILING DIURETICS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",$DIURETICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES
1336926,36919209,1.18E-12,0.0000543,adult_children_senior_youth,adult,tadalafil,sleep disorder,Psychiatric disorders,$Drugs used in erectile dysfunction$Antihypertensives for pulmonary arterial hypertension,$UROLOGICALS$OTHER ANTIHYPERTENSIVES,$UROLOGICALS$ANTIHYPERTENSIVES,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
1781406,35104074,1.19E-12,0.0000547,adult_children_senior_youth,children_youth,stavudine,anaemia,Blood and lymphatic system disorders,"$Nucleoside and nucleotide reverse transcriptase inhibitors$Antivirals for treatment of HIV infections, combinations",$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS,$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
1149380,36918858,1.22E-12,0.0000562,adult_children_senior_youth,youth,fluticasone,anxiety,Psychiatric disorders,"$Glucocorticoids$Corticosteroids, potent (group III)$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Corticosteroids$Corticosteroids","$OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS$CORTICOSTEROIDS, PLAIN$ADRENERGICS, INHALANTS$ADRENERGICS, INHALANTS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE","$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$NASAL PREPARATIONS$NASAL PREPARATIONS",$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1373928,35809310,1.22E-12,0.0000559,adult_children_senior,children,hydralazine,drug interaction,General disorders and administration site conditions,$Hydrazinophthalazine derivatives$Hydrazinophthalazine derivatives and diuretics,"$ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON$ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",$ANTIHYPERTENSIVES$ANTIHYPERTENSIVES,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1551099,37019292,1.22E-12,0.000056,adult_children_senior_youth,children_youth,prednisone,nephrotic syndrome,Renal and urinary disorders,$Corticosteroids acting locally$Glucocorticoids,"$INTESTINAL ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN","$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE","$ALIMENTARY TRACT AND METABOLISM$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
1136601,36919230,1.23E-12,0.0000564,adult_children_senior_youth,youth,benzonatate,completed suicide,General disorders and administration site conditions,Other cough suppressants,"COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",COUGH AND COLD PREPARATIONS,RESPIRATORY SYSTEM
1545958,36718500,1.23E-12,0.0000567,adult_children_senior_youth,adult,atorvastatin,neuropathy peripheral,Nervous system disorders,"$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations","$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS",$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1305058,36416485,1.26E-12,0.0000579,adult_children_senior_youth,children_youth,methotrexate,lactic acidosis,Metabolism and nutrition disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
722031,36718321,1.26E-12,0.0000577,adult_children_senior_youth,youth,paroxetine,somnolence,Nervous system disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1154343,35909441,1.28E-12,0.0000589,adult_children_senior_youth,youth,albuterol,cholecystitis,Hepatobiliary disorders,0,0,0,0
715233,36718352,1.28E-12,0.0000589,adult_children_senior_youth,children,baclofen,clonus,Nervous system disorders,Other centrally acting agents,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",MUSCLE RELAXANTS,MUSCULO-SKELETAL SYSTEM
1308216,37622446,1.28E-12,0.0000588,adult_senior_youth,youth,lisinopril,shock,Vascular disorders,"$ACE inhibitors and diuretics$HMG CoA reductase inhibitors, other combinations$ACE inhibitors, plain$ACE inhibitors and calcium channel blockers","$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, PLAIN$ACE INHIBITORS, COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
19050832,36718354,1.29E-12,0.0000591,adult_children_senior_youth,senior,clobazam,disorientation,Nervous system disorders,Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1332418,36416501,1.29E-12,0.000059,adult_children_senior_youth,children_youth,amlodipine,respiratory failure,Metabolism and nutrition disorders,"$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$Beta blocking agents and calcium channel blockers$Dihydropyridine derivatives$ACE inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$Calcium channel blockers and diuretics$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs), other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers","$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS$ACE INHIBITORS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$CALCIUM CHANNEL BLOCKERS AND DIURETICS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$BETA BLOCKING AGENTS$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1769389,35104883,1.30E-12,0.0000595,adult_children_senior_youth,children,nevirapine,neutropenia,Blood and lymphatic system disorders,"$Non-nucleoside reverse transcriptase inhibitors$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations",$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS,$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
40241331,37420588,1.33E-12,0.0000612,adult_children_senior_youth,children,rivaroxaban,treatment noncompliance,General disorders and administration site conditions,Direct factor Xa inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
715233,36516865,1.35E-12,0.0000618,adult_children_senior_youth,children,baclofen,hypotonia,Nervous system disorders,Other centrally acting agents,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",MUSCLE RELAXANTS,MUSCULO-SKELETAL SYSTEM
1351541,37119544,1.35E-12,0.000062,adult_children_youth,youth,leuprolide,menstrual disorder,Reproductive system and breast disorders,$Gonadotropin releasing hormone analogues$Gonadotropin releasing hormone analogues,$HORMONES AND RELATED AGENTS$HORMONES AND RELATED AGENTS,$ENDOCRINE THERAPY$ENDOCRINE THERAPY,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1503297,35708138,1.36E-12,0.0000623,adult_senior_youth,youth,metformin,gastrointestinal sounds abnormal,Gastrointestinal disorders,$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Biguanides$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1398937,35808822,1.39E-12,0.0000636,adult_children_senior_youth,children_senior,clonidine,application site pruritus,General disorders and administration site conditions,$Sympathomimetics in glaucoma therapy$Imidazoline receptor agonists in combination with diuretics$Imidazoline receptor agonists$Other antimigraine preparations$Imidazoline receptor agonists in combination with diuretics,"$ANTIGLAUCOMA PREPARATIONS AND MIOTICS$ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION$ANTIADRENERGIC AGENTS, CENTRALLY ACTING$ANTIMIGRAINE PREPARATIONS$ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",$OPHTHALMOLOGICALS$ANTIHYPERTENSIVES$ANTIHYPERTENSIVES$ANALGESICS$ANTIHYPERTENSIVES,$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$NERVOUS SYSTEM$CARDIOVASCULAR SYSTEM
1314924,35122884,1.39E-12,0.0000636,adult_children_senior_youth,youth,gemcitabine,cytopenia,Blood and lymphatic system disorders,Pyrimidine analogues,ANTIMETABOLITES,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
40242675,36416606,1.39E-12,0.0000638,adult_children_senior_youth,youth,crizotinib,dehydration,Metabolism and nutrition disorders,Protein kinase inhibitors,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
937368,36516986,1.42E-12,0.0000652,adult_children_senior_youth,youth,infliximab,fistula,Musculoskeletal and connective tissue disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1307046,36718001,1.45E-12,0.0000664,adult_children_senior_youth,children,metoprolol,cerebral infarction,$Nervous system disorders$Vascular disorders,"$Beta blocking agents and calcium channel blockers$Beta blocking agents, other combinations$Beta blocking agents, other combinations$Beta blocking agents and calcium channel blockers$Beta blocking agents, selective$Beta blocking agents, selective, and thiazides$Beta blocking agents, selective, and other diuretics$Beta blocking agents, selective, and thiazides","$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS AND OTHER DIURETICS$BETA BLOCKING AGENTS AND THIAZIDES",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
19077143,35809068,1.48E-12,0.0000678,adult_children_youth,children,17-alpha-hydroxyprogesterone,stillbirth,General disorders and administration site conditions,0,0,0,0
1151789,46276591,1.48E-12,0.000068,adult_children_senior_youth,children,etanercept,wrong technique in product usage process,"Injury, poisoning and procedural complications",Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
766814,36718194,1.49E-12,0.0000682,adult_senior_youth,senior,quetiapine,akinesia,Nervous system disorders,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1301152,36617295,1.49E-12,0.0000683,adult_children_senior_youth,youth,melatonin,malignant neoplasm progression,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Melatonin receptor agonists,HYPNOTICS AND SEDATIVES,PSYCHOLEPTICS,NERVOUS SYSTEM
19030353,36211297,1.51E-12,0.0000695,adult_children_senior,senior,bromazepam,fall,"Injury, poisoning and procedural complications",Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
937368,36110684,1.52E-12,0.00007,adult_children_senior_youth,youth,infliximab,subcutaneous abscess,Infections and infestations,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
19044883,36718182,1.53E-12,0.0000701,adult_senior_youth,youth,zopiclone,mental impairment,Nervous system disorders,Benzodiazepine related drugs,HYPNOTICS AND SEDATIVES,PSYCHOLEPTICS,NERVOUS SYSTEM
1126658,35606961,1.56E-12,0.0000718,adult_senior,senior,hydromorphone,eye disorder,Eye disorders,$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with antispasmodics,$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1713332,36009783,1.57E-12,0.0000722,adult_children_senior_youth,children,amoxicillin,urticaria,Immune system disorders,"$Combinations for eradication of Helicobacter pylori$Combinations of penicillins, incl. beta-lactamase inhibitors$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Penicillins with extended spectrum","$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$BETA-LACTAM ANTIBACTERIALS, PENICILLINS$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$BETA-LACTAM ANTIBACTERIALS, PENICILLINS",$DRUGS FOR ACID RELATED DISORDERS$ANTIBACTERIALS FOR SYSTEMIC USE$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$ANTIBACTERIALS FOR SYSTEMIC USE,$ALIMENTARY TRACT AND METABOLISM$ANTIINFECTIVES FOR SYSTEMIC USE$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ANTIINFECTIVES FOR SYSTEMIC USE
1738521,43053888,1.58E-12,0.0000725,adult_children_senior,senior,doxycycline,clostridium difficile infection,Infections and infestations,$Tetracyclines$Antiinfectives and antiseptics for local oral treatment$Tetracyclines,$TETRACYCLINES$STOMATOLOGICAL PREPARATIONS$TETRACYCLINES,$ANTIBACTERIALS FOR SYSTEMIC USE$STOMATOLOGICAL PREPARATIONS$ANTIBACTERIALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ALIMENTARY TRACT AND METABOLISM$ANTIINFECTIVES FOR SYSTEMIC USE
1149380,36009700,1.59E-12,0.0000729,adult_children_senior_youth,children,fluticasone,asthma,"Respiratory, thoracic and mediastinal disorders","$Glucocorticoids$Corticosteroids, potent (group III)$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Corticosteroids$Corticosteroids","$OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS$CORTICOSTEROIDS, PLAIN$ADRENERGICS, INHALANTS$ADRENERGICS, INHALANTS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE","$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$NASAL PREPARATIONS$NASAL PREPARATIONS",$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1378382,35406391,1.59E-12,0.0000731,adult_senior_youth,youth,paclitaxel,tinnitus,$Ear and labyrinth disorders$Nervous system disorders,Taxanes,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1305447,42889640,1.68E-12,0.0000773,adult_children_youth,youth,methyldopa,maternal exposure during pregnancy,"Injury, poisoning and procedural complications",0,0,0,0
1786055,36313176,1.69E-12,0.0000774,adult_children_senior_youth,senior,deferasirox,platelet count decreased,Investigations,Iron chelating agents,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,VARIOUS
40002705,35809131,1.70E-12,0.0000781,adult_children_senior_youth,youth,acetaminophen / hydrocodone Oral Solution,general physical health deterioration,General disorders and administration site conditions,0,0,0,0
1353766,36516865,1.70E-12,0.0000782,adult_children_senior_youth,children,propranolol,hypotonia,Nervous system disorders,"$Beta blocking agents, other combinations$Beta blocking agents, non-selective$Beta blocking agents, non-selective, and thiazides","$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS AND THIAZIDES",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1151789,36110716,1.73E-12,0.0000794,adult_children_senior_youth,senior,etanercept,cystitis,Infections and infestations,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
757688,35506690,1.76E-12,0.0000808,adult_senior,senior,aripiprazole,inappropriate antidiuretic hormone secretion,$Endocrine disorders$Metabolism and nutrition disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1703687,36110597,1.76E-12,0.0000808,adult_children_senior_youth,senior,acyclovir,pneumonia,Infections and infestations,$Nucleosides and nucleotides excl. reverse transcriptase inhibitors$Antivirals$Antivirals$Antivirals,$DIRECT ACTING ANTIVIRALS$CHEMOTHERAPEUTICS FOR TOPICAL USE$ANTIINFECTIVES$CHEMOTHERAPEUTICS FOR TOPICAL USE,$ANTIVIRALS FOR SYSTEMIC USE$ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE$OPHTHALMOLOGICALS$ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,$ANTIINFECTIVES FOR SYSTEMIC USE$DERMATOLOGICALS$SENSORY ORGANS$DERMATOLOGICALS
749910,42889647,1.77E-12,0.0000811,adult_children_senior_youth,children,carisoprodol,toxicity to various agents,"Injury, poisoning and procedural complications",$Carbamic acid esters$Carbamic acid esters$Carbamic acid esters,"$MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS$MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS$MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",$MUSCLE RELAXANTS$MUSCLE RELAXANTS$MUSCLE RELAXANTS,$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
1154161,36919233,1.79E-12,0.0000822,adult_children_senior_youth,children_youth,montelukast,self-injurious ideation,Psychiatric disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1353766,35205023,1.80E-12,0.0000824,adult_children_senior_youth,children,propranolol,cyanosis,Cardiac disorders,"$Beta blocking agents, other combinations$Beta blocking agents, non-selective$Beta blocking agents, non-selective, and thiazides","$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS AND THIAZIDES",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1762711,37019308,1.80E-12,0.0000824,adult_children_senior_youth,senior,ribavirin,renal disorder,Renal and urinary disorders,Antivirals for treatment of HCV infections,DIRECT ACTING ANTIVIRALS,ANTIVIRALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
950637,35707751,1.81E-12,0.0000832,adult_children_senior_youth,children_youth,tacrolimus,acute graft versus host disease in intestine,Gastrointestinal disorders,"$Agents for dermatitis, excluding corticosteroids$Calcineurin inhibitors",$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$DERMATOLOGICALS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
723013,36918858,1.82E-12,0.0000835,adult_children_senior_youth,youth,diazepam,anxiety,Psychiatric disorders,Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1101554,36919236,1.83E-12,0.0000842,adult_children_senior_youth,youth,colchicine,suicide attempt,Psychiatric disorders,Preparations with no effect on uric acid metabolism,ANTIGOUT PREPARATIONS,ANTIGOUT PREPARATIONS,MUSCULO-SKELETAL SYSTEM
722031,35104103,1.86E-12,0.0000853,adult_senior_youth,senior,paroxetine,bone marrow failure,Blood and lymphatic system disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
722424,36818823,1.86E-12,0.0000855,adult_children_youth,children,interferon beta-1a,normal newborn,"Pregnancy, puerperium and perinatal conditions",Interferons,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1545958,36776613,1.86E-12,0.0000854,adult_children_senior_youth,youth,atorvastatin,seizure,Nervous system disorders,"$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations","$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS",$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1322184,36774644,1.88E-12,0.0000865,adult_senior_youth,youth,clopidogrel,facial paralysis,Nervous system disorders,Platelet aggregation inhibitors excl. heparin,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1395557,35104341,1.89E-12,0.0000867,adult_children_senior_youth,youth,fludarabine,acute lymphocytic leukaemia recurrent,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Purine analogues,ANTIMETABOLITES,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1307046,36311918,1.90E-12,0.0000871,adult_children_senior,children,metoprolol,electrocardiogram qrs complex prolonged,Investigations,"$Beta blocking agents and calcium channel blockers$Beta blocking agents, other combinations$Beta blocking agents, other combinations$Beta blocking agents and calcium channel blockers$Beta blocking agents, selective$Beta blocking agents, selective, and thiazides$Beta blocking agents, selective, and other diuretics$Beta blocking agents, selective, and thiazides","$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS AND OTHER DIURETICS$BETA BLOCKING AGENTS AND THIAZIDES",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1734104,36009724,1.91E-12,0.0000878,adult_children_senior_youth,children,azithromycin,stevens-johnson syndrome,Infections and infestations,$Combinations of antibacterials$Antibiotics$Macrolides,"$COMBINATIONS OF ANTIBACTERIALS$ANTIINFECTIVES$MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",$ANTIBACTERIALS FOR SYSTEMIC USE$OPHTHALMOLOGICALS$ANTIBACTERIALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$SENSORY ORGANS$ANTIINFECTIVES FOR SYSTEMIC USE
1315411,35808914,1.93E-12,0.0000887,adult_children_senior,children,cetuximab,infusion related reaction,Immune system disorders,Monoclonal antibodies,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
735979,36919235,1.95E-12,0.0000896,adult_children_senior_youth,youth,risperidone,suicidal ideation,Psychiatric disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1151789,36517076,1.97E-12,0.0000906,adult_senior,senior,etanercept,metastases to bone,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1154332,36919230,1.99E-12,0.0000914,adult_senior_youth,youth,pseudoephedrine,completed suicide,General disorders and administration site conditions,$Sympathomimetics$Sympathomimetics,$NASAL DECONGESTANTS FOR SYSTEMIC USE$NASAL DECONGESTANTS FOR SYSTEMIC USE,$NASAL PREPARATIONS$NASAL PREPARATIONS,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1503297,35104877,2.03E-12,0.0000932,adult_children_senior_youth,senior,metformin,febrile neutropenia,General disorders and administration site conditions,$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Biguanides$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
40244464,36416501,2.04E-12,0.0000939,adult_children_senior_youth,children_youth,ruxolitinib,respiratory failure,Metabolism and nutrition disorders,Protein kinase inhibitors,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1781406,36312538,2.09E-12,0.0000959,adult_children_youth,children,stavudine,blood creatine phosphokinase increased,Investigations,"$Nucleoside and nucleotide reverse transcriptase inhibitors$Antivirals for treatment of HIV infections, combinations",$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS,$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
1343346,37220014,2.11E-12,0.0000968,adult_children_senior,children,vinorelbine,epistaxis,"Respiratory, thoracic and mediastinal disorders",Vinca alkaloids and analogues,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1338005,35205241,2.12E-12,0.0000972,adult_children_senior_youth,youth,bisoprolol,cardiac failure acute,Cardiac disorders,"$Beta blocking agents, other combinations$Beta blocking agents, selective, and thiazides$Beta blocking agents, selective$ACE inhibitors, other combinations$Beta blocking agents and calcium channel blockers","$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS$ACE INHIBITORS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1305058,36009894,2.12E-12,0.0000973,adult_children_senior_youth,children,methotrexate,chronic graft versus host disease,"Injury, poisoning and procedural complications",$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1518254,37521169,2.12E-12,0.0000971,adult_children_senior_youth,adult_youth,dexamethasone,stem cell transplant,Surgical and medical procedures,"$Corticosteroids$Corticosteroids, moderately potent, other combinations$Corticosteroids$Corticosteroids, combinations for treatment of acne$Corticosteroids/antiinfectives/mydriatics in combination$Corticosteroids and antiinfectives in combination$Corticosteroids and antiinfectives in combination$Corticosteroids$Corticosteroids and antiinfectives in combination$Corticosteroids, moderately potent, combinations with antibiotics$Glucocorticoids$Corticosteroids, plain$Corticosteroids for local oral treatment$Corticosteroids$Corticosteroids, moderately potent (group II)$Corticosteroids","$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$CORTICOSTEROIDS, OTHER COMBINATIONS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$ANTIINFLAMMATORY AGENTS$STOMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS$CORTICOSTEROIDS, PLAIN$CORTICOSTEROIDS","$NASAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$NASAL PREPARATIONS$ANTI-ACNE PREPARATIONS$OPHTHALMOLOGICALS$OTOLOGICALS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$VASOPROTECTIVES$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS FOR SYSTEMIC USE$OPHTHALMOLOGICALS$STOMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OTOLOGICALS","$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$DERMATOLOGICALS$SENSORY ORGANS$SENSORY ORGANS$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS$DERMATOLOGICALS$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$SENSORY ORGANS$DERMATOLOGICALS$SENSORY ORGANS"
1550557,42889647,2.15E-12,0.0000987,adult_children_senior_youth,children,prednisolone,toxicity to various agents,"Injury, poisoning and procedural complications","$Corticosteroids, weak (group I)$Corticosteroids and antiinfectives in combination$Corticosteroids, weak, other combinations$Corticosteroids for local oral treatment$Corticosteroids$Corticosteroids and mydriatics in combination$Corticosteroids$Corticosteroids/antiinfectives/mydriatics in combination$Antidotes$Corticosteroids$Corticosteroids, weak, combinations with antiseptics$Corticosteroids, weak, combinations with antibiotics$Corticosteroids, plain$Corticosteroids$Corticosteroids acting locally$Glucocorticoids$Corticosteroids and antiinfectives in combination$Corticosteroids$Corticosteroids and antiinfectives in combination","$CORTICOSTEROIDS, PLAIN$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS, OTHER COMBINATIONS$STOMATOLOGICAL PREPARATIONS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$ALL OTHER THERAPEUTIC PRODUCTS$CORTICOSTEROIDS$CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS$INTESTINAL ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION","$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$STOMATOLOGICAL PREPARATIONS$NASAL PREPARATIONS$OPHTHALMOLOGICALS$NASAL PREPARATIONS$OPHTHALMOLOGICALS$ALL OTHER THERAPEUTIC PRODUCTS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS$OTOLOGICALS$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE$OTOLOGICALS$VASOPROTECTIVES$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS","$DERMATOLOGICALS$SENSORY ORGANS$DERMATOLOGICALS$ALIMENTARY TRACT AND METABOLISM$RESPIRATORY SYSTEM$SENSORY ORGANS$RESPIRATORY SYSTEM$SENSORY ORGANS$VARIOUS$SENSORY ORGANS$DERMATOLOGICALS$DERMATOLOGICALS$SENSORY ORGANS$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS"
19009405,35708063,2.18E-12,0.000100285,adult_children_senior_youth,youth,vitamin D,crohn's disease,$Gastrointestinal disorders$Immune system disorders,0,0,0,0
1125315,35809005,2.18E-12,0.00010029,adult_children_senior_youth,adult,acetaminophen,injection site pain,General disorders and administration site conditions,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
705944,35809120,2.19E-12,0.000100377,adult_children_senior_youth,senior,methylphenidate,disease progression,General disorders and administration site conditions,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
750982,36718280,2.20E-12,0.000100778,adult_children_senior_youth,senior,bupropion,balance disorder,$General disorders and administration site conditions$Nervous system disorders,$Centrally acting antiobesity products$Other antidepressants,"$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$ANTIDEPRESSANTS","$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$PSYCHOANALEPTICS",$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM
1503297,35909443,2.20E-12,0.00010099,adult_children_senior_youth,youth,metformin,cholecystitis chronic,Hepatobiliary disorders,$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Biguanides$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1327256,35205185,2.24E-12,0.000103041,adult_children_senior_youth,youth,treprostinil,chest pain,"Respiratory, thoracic and mediastinal disorders",Platelet aggregation inhibitors excl. heparin,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
43526465,36315606,2.25E-12,0.000103123,adult_children_senior,children,canagliflozin,glomerular filtration rate decreased,Investigations,$Combinations of oral blood glucose lowering drugs$Sodium-glucose co-transporter 2 (SGLT2) inhibitors,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1305058,36416551,2.26E-12,0.000103658,adult_children_senior_youth,senior,methotrexate,osteoporosis,$Metabolism and nutrition disorders$Musculoskeletal and connective tissue disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
907879,37119784,2.35E-12,0.000108013,adult_senior_youth,youth,miconazole,vulvovaginal pruritus,Reproductive system and breast disorders,$Imidazole derivatives$Imidazole derivatives$Imidazole and triazole derivatives$Imidazole derivatives$Antiinfectives and antiseptics for local oral treatment$Imidazole and triazole derivatives$Antiinfectives$Imidazole derivatives,"$INTESTINAL ANTIINFECTIVES$ANTIMYCOTICS FOR SYSTEMIC USE$ANTIFUNGALS FOR TOPICAL USE$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$STOMATOLOGICAL PREPARATIONS$ANTIFUNGALS FOR TOPICAL USE$ANTIINFECTIVES$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS","$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$ANTIMYCOTICS FOR SYSTEMIC USE$ANTIFUNGALS FOR DERMATOLOGICAL USE$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$STOMATOLOGICAL PREPARATIONS$ANTIFUNGALS FOR DERMATOLOGICAL USE$OTOLOGICALS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS",$ALIMENTARY TRACT AND METABOLISM$ANTIINFECTIVES FOR SYSTEMIC USE$DERMATOLOGICALS$GENITO URINARY SYSTEM AND SEX HORMONES$ALIMENTARY TRACT AND METABOLISM$DERMATOLOGICALS$SENSORY ORGANS$GENITO URINARY SYSTEM AND SEX HORMONES
942350,37219867,2.36E-12,0.000108336,adult_senior_youth,adult,torasemide,pulmonary arterial hypertension,Vascular disorders,"$Sulfonamides, plain$Sulfonamides","$HIGH-CEILING DIURETICS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",$DIURETICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES
1548195,37119780,2.37E-12,0.000108957,adult_senior_youth,senior,estradiol,vulvovaginal burning sensation,Reproductive system and breast disorders,"$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations$Natural and semisynthetic estrogens, plain$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Androgens and estrogens$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, sequential preparations$Androgens and estrogens$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, sequential preparations$Androgens and estrogens$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations$Antiandrogens and estrogens$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Intravaginal contraceptives$Natural and semisynthetic estrogens, plain$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, sequential preparations",$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$ESTROGENS$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$ANTIANDROGENS$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$CONTRACEPTIVES FOR TOPICAL USE$ESTROGENS$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$OTHER GYNECOLOGICALS$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
722031,35104074,2.39E-12,0.000109492,adult_children_senior_youth,senior,paroxetine,anaemia,Blood and lymphatic system disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
948078,35909452,2.39E-12,0.00010956,adult_children_senior_youth,youth,pantoprazole,gallbladder disorder,Hepatobiliary disorders,$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Proton pump inhibitors,$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1310317,36818729,2.42E-12,0.000111275,adult_children_youth,children,cyclophosphamide,premature baby,"Pregnancy, puerperium and perinatal conditions",Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1714165,35104165,2.45E-12,0.000112273,adult_senior,senior,peginterferon alfa-2a,disseminated intravascular coagulation,Blood and lymphatic system disorders,$Interferons$Interferons,$IMMUNOSTIMULANTS$IMMUNOSTIMULANTS,$IMMUNOSTIMULANTS$IMMUNOSTIMULANTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1112807,36718008,2.45E-12,0.000112356,adult_children_senior,children,aspirin,haemorrhage intracranial,Vascular disorders,0,0,0,0
1177480,36718005,2.47E-12,0.000113161,adult_children_senior_youth,senior,ibuprofen,cerebrovascular accident,Vascular disorders,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
797399,36009754,2.47E-12,0.000113263,adult_children_senior_youth,children,gabapentin,toxic epidermal necrolysis,Immune system disorders,Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
722031,35809083,2.49E-12,0.000114108,adult_children_senior_youth,youth,paroxetine,feeling abnormal,General disorders and administration site conditions,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1125315,36918858,2.51E-12,0.00011524,adult_children_senior_youth,youth,acetaminophen,anxiety,Psychiatric disorders,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1119119,36516973,2.52E-12,0.000115864,adult_children_senior_youth,adult,adalimumab,musculoskeletal stiffness,Musculoskeletal and connective tissue disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
985247,36416551,2.54E-12,0.000116667,adult_senior,adult,aluminium hydroxide,osteoporosis,$Metabolism and nutrition disorders$Musculoskeletal and connective tissue disorders,0,0,0,0
1124957,35809058,2.55E-12,0.000117179,adult_children_senior_youth,children,oxycodone,brain death,General disorders and administration site conditions,$Natural opium alkaloids$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
705103,36718530,2.56E-12,0.000117509,adult_children_senior_youth,children_youth,lamotrigine,epilepsy,Nervous system disorders,Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
1754994,35809243,2.57E-12,0.000117867,adult_children_senior_youth,youth,fluconazole,pain,General disorders and administration site conditions,$Combinations of antibacterials$Triazole derivatives$Imidazole and triazole derivatives,$COMBINATIONS OF ANTIBACTERIALS$ANTIMYCOTICS FOR SYSTEMIC USE$ANTIFUNGALS FOR TOPICAL USE,$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIMYCOTICS FOR SYSTEMIC USE$ANTIFUNGALS FOR DERMATOLOGICAL USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$DERMATOLOGICALS
1151789,36211123,2.60E-12,0.000119168,adult_children_senior_youth,senior,etanercept,spinal fracture,"Injury, poisoning and procedural complications",Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1714165,36313550,2.63E-12,0.000120909,adult_children_senior_youth,senior_youth,peginterferon alfa-2a,blood bilirubin increased,Investigations,$Interferons$Interferons,$IMMUNOSTIMULANTS$IMMUNOSTIMULANTS,$IMMUNOSTIMULANTS$IMMUNOSTIMULANTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1177480,37019358,2.64E-12,0.000121122,adult_children_senior_youth,children,ibuprofen,renal tubular necrosis,Renal and urinary disorders,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
766814,36718207,2.67E-12,0.000122768,adult_children_senior_youth,senior,quetiapine,hypokinesia,Nervous system disorders,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
708298,36211347,2.68E-12,0.00012291,adult_children_senior_youth,senior,midazolam,renal injury,"$Injury, poisoning and procedural complications$Renal and urinary disorders",Benzodiazepine derivatives,HYPNOTICS AND SEDATIVES,PSYCHOLEPTICS,NERVOUS SYSTEM
1786055,35104397,2.69E-12,0.000123585,adult_children_senior_youth,senior,deferasirox,myelodysplastic syndrome,Blood and lymphatic system disorders,Iron chelating agents,ALL OTHER THERAPEUTIC PRODUCTS,ALL OTHER THERAPEUTIC PRODUCTS,VARIOUS
718583,36211491,2.70E-12,0.000123797,adult_children_senior_youth,youth,nicotine,accidental overdose,"Injury, poisoning and procedural complications",Drugs used in nicotine dependence,DRUGS USED IN ADDICTIVE DISORDERS,OTHER NERVOUS SYSTEM DRUGS,NERVOUS SYSTEM
1311078,36211181,2.71E-12,0.00012453,adult_children_senior_youth,youth,cytarabine,neurotoxicity,"Injury, poisoning and procedural complications",$Pyrimidine analogues$Combinations of antineoplastic agents,$ANTIMETABOLITES$OTHER ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AGENTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1517824,35204928,2.73E-12,0.00012524,adult_senior_youth,youth,niacin,bradycardia,Cardiac disorders,$Nicotinic acid and derivatives$Nicotinic acid and derivatives$HMG CoA reductase inhibitors in combination with other lipid modifying agents$Nicotinic acid and derivatives,"$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS$PERIPHERAL VASODILATORS",$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$PERIPHERAL VASODILATORS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
950637,35708073,2.73E-12,0.000125317,adult_children_senior_youth,children,tacrolimus,inflammatory bowel disease,Gastrointestinal disorders,"$Agents for dermatitis, excluding corticosteroids$Calcineurin inhibitors",$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$DERMATOLOGICALS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
19026459,36919236,2.80E-12,0.000128515,adult_children_senior_youth,youth,tapentadol,suicide attempt,Psychiatric disorders,Other opioids,OPIOIDS,ANALGESICS,NERVOUS SYSTEM
1353256,35204966,2.90E-12,0.000133039,adult_children_senior_youth,children_youth,propafenone,cardiac arrest,Cardiac disorders,"Antiarrhythmics, class Ic","ANTIARRHYTHMICS, CLASS I AND III",CARDIAC THERAPY,CARDIOVASCULAR SYSTEM
1332418,35708063,2.90E-12,0.000133297,adult_children_senior_youth,adult,amlodipine,crohn's disease,$Gastrointestinal disorders$Immune system disorders,"$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$Beta blocking agents and calcium channel blockers$Dihydropyridine derivatives$ACE inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$Calcium channel blockers and diuretics$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs), other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers","$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS$ACE INHIBITORS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$CALCIUM CHANNEL BLOCKERS AND DIURETICS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$BETA BLOCKING AGENTS$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1177480,36918947,2.93E-12,0.00013441,adult_children_senior_youth,youth,ibuprofen,anhedonia,Psychiatric disorders,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
956874,36314117,2.96E-12,0.000135665,adult_children_senior_youth,children,furosemide,oxygen saturation decreased,Investigations,"$High-ceiling diuretics and potassium-sparing agents$Sulfonamides, plain$Sulfonamides$Sulfonamides and potassium in combination","$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$HIGH-CEILING DIURETICS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$HIGH-CEILING DIURETICS",$DIURETICS$DIURETICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$DIURETICS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
1314002,37219850,2.98E-12,0.000136784,adult_children_senior_youth,youth,atenolol,acute respiratory distress syndrome,"Respiratory, thoracic and mediastinal disorders","$Beta blocking agents, selective, and other diuretics$Beta blocking agents, selective$Beta blocking agents and calcium channel blockers$Beta blocking agents, selective, thiazides and other diuretics$Beta blocking agents, selective, and thiazides$Beta blocking agents, selective, and other diuretics","$BETA BLOCKING AGENTS AND OTHER DIURETICS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS AND OTHER DIURETICS",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
956874,35909517,2.99E-12,0.000137252,adult_children_senior,adult,furosemide,hepatic encephalopathy,$Hepatobiliary disorders$Nervous system disorders,"$High-ceiling diuretics and potassium-sparing agents$Sulfonamides, plain$Sulfonamides$Sulfonamides and potassium in combination","$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$HIGH-CEILING DIURETICS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$HIGH-CEILING DIURETICS",$DIURETICS$DIURETICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$DIURETICS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
755695,35205246,3.07E-12,0.00014108,adult_children_senior_youth,youth,fluoxetine,cardiogenic shock,Vascular disorders,$Antidepressants in combination with psycholeptics$Selective serotonin reuptake inhibitors,$PSYCHOLEPTICS AND PSYCHOANALEPTICS IN COMBINATION$ANTIDEPRESSANTS,$PSYCHOANALEPTICS$PSYCHOANALEPTICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
722031,35809131,3.10E-12,0.000142401,adult_children_senior_youth,senior,paroxetine,general physical health deterioration,General disorders and administration site conditions,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
40002705,35204966,3.11E-12,0.000142625,adult_children_senior_youth,children,acetaminophen / hydrocodone Oral Solution,cardiac arrest,Cardiac disorders,0,0,0,0
766529,35708171,3.11E-12,0.00014297,adult_children_senior_youth,children,haloperidol,dysphagia,Gastrointestinal disorders,Butyrophenone derivatives,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
797617,37019319,3.14E-12,0.000144086,adult_senior_youth,senior,citalopram,renal failure acute,0,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1337620,37219831,3.16E-12,0.000145043,adult_children_senior,children,capecitabine,interstitial lung disease,"$Immune system disorders$Respiratory, thoracic and mediastinal disorders",Pyrimidine analogues,ANTIMETABOLITES,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1124300,36516972,3.17E-12,0.000145722,adult_senior,senior,diclofenac,musculoskeletal disorder,Musculoskeletal and connective tissue disorders,"$Antiinflammatory agents, non-steroids and antiinfectives in combination$Antiinflammatory agents, non-steroids$Acetic acid derivatives and related substances$Antiinflammatory preparations, non-steroids for topical use$Acetic acid derivatives and related substances$Other dermatologicals","$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$ANTIINFLAMMATORY AGENTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$OTHER DERMATOLOGICAL PREPARATIONS",$OPHTHALMOLOGICALS$OPHTHALMOLOGICALS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$OTHER DERMATOLOGICAL PREPARATIONS,$SENSORY ORGANS$SENSORY ORGANS$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$DERMATOLOGICALS
40228152,35809059,3.18E-12,0.000146193,adult_children_senior_youth,children,dabigatran etexilate,death,General disorders and administration site conditions,Direct thrombin inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1301267,35809076,3.19E-12,0.000146597,adult_children_senior_youth,senior,melphalan,fatigue,General disorders and administration site conditions,Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1350504,35104236,3.19E-12,0.000146501,adult_children_senior_youth,children,etoposide,histiocytosis haematophagic,0,Podophyllotoxin derivatives,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1103640,36211188,3.22E-12,0.00014779,adult_children_youth,children_youth,methadone,therapeutic agent toxicity,0,$Drugs used in opioid dependence$Diphenylpropylamine derivatives,$DRUGS USED IN ADDICTIVE DISORDERS$OPIOIDS,$OTHER NERVOUS SYSTEM DRUGS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
1177480,42889647,3.22E-12,0.000147915,adult_children_senior_youth,youth,ibuprofen,toxicity to various agents,"Injury, poisoning and procedural complications","$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
1304107,35104378,3.25E-12,0.000149276,adult_children_senior_youth,youth,imatinib,chronic myeloid leukaemia,Blood and lymphatic system disorders,Protein kinase inhibitors,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1337068,36009735,3.26E-12,0.000149627,adult_children_senior_youth,children_youth,ambrisentan,dermatitis contact,Immune system disorders,$Antihypertensives for pulmonary arterial hypertension$Antihypertensives for pulmonary arterial hypertension,$OTHER ANTIHYPERTENSIVES$OTHER ANTIHYPERTENSIVES,$ANTIHYPERTENSIVES$ANTIHYPERTENSIVES,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1318011,35708417,3.34E-12,0.000153206,adult_children_senior,children,oxaliplatin,colon cancer,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Platinum compounds,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
702865,35204966,3.37E-12,0.000154602,adult_children_senior_youth,youth,meprobamate,cardiac arrest,Cardiac disorders,"$Carbamates$Hypnotics and sedatives in combination, excl. barbiturates$Carbamates",$ANXIOLYTICS$HYPNOTICS AND SEDATIVES$ANXIOLYTICS,$PSYCHOLEPTICS$PSYCHOLEPTICS$PSYCHOLEPTICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1309068,35809083,3.37E-12,0.000154748,adult_senior_youth,youth,minoxidil,feeling abnormal,General disorders and administration site conditions,$Other dermatologicals$Pyrimidine derivatives,"$OTHER DERMATOLOGICAL PREPARATIONS$ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON",$OTHER DERMATOLOGICAL PREPARATIONS$ANTIHYPERTENSIVES,$DERMATOLOGICALS$CARDIOVASCULAR SYSTEM
1177480,36110597,3.40E-12,0.000156233,adult_children_senior_youth,children_senior,ibuprofen,pneumonia,Infections and infestations,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
953076,35809243,3.41E-12,0.000156491,adult_children_senior_youth,youth,famotidine,pain,General disorders and administration site conditions,$H2-receptor antagonists$H2-receptor antagonists,$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1354860,35204985,3.42E-12,0.000156952,adult_children_senior_youth,children_youth,flecainide,ventricular tachycardia,Cardiac disorders,"Antiarrhythmics, class Ic","ANTIARRHYTHMICS, CLASS I AND III",CARDIAC THERAPY,CARDIOVASCULAR SYSTEM
19009405,36516761,3.43E-12,0.000157349,adult_children_senior_youth,senior,vitamin D,bone pain,Musculoskeletal and connective tissue disorders,0,0,0,0
1110410,35909625,3.45E-12,0.000158385,adult_children_senior_youth,youth,morphine,hepatotoxicity,"Injury, poisoning and procedural complications",$Antipropulsives$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with antispasmodics,$ANTIPROPULSIVES$OPIOIDS$OPIOIDS$OPIOIDS,"$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$ANALGESICS$ANALGESICS$ANALGESICS",$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1343916,37019318,3.46E-12,0.000159033,adult_children_senior_youth,senior,epinephrine,renal failure,Renal and urinary disorders,"$Other agents for local oral treatment$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Local hemostatics$Adrenergic and dopaminergic agents$Sympathomimetics in glaucoma therapy$Sympathomimetics, plain$Alpha- and beta-adrenoreceptor agonists$Sympathomimetics in glaucoma therapy","$STOMATOLOGICAL PREPARATIONS$ADRENERGICS, INHALANTS$VITAMIN K AND OTHER HEMOSTATICS$CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES$ANTIGLAUCOMA PREPARATIONS AND MIOTICS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ADRENERGICS, INHALANTS$ANTIGLAUCOMA PREPARATIONS AND MIOTICS",$STOMATOLOGICAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$ANTIHEMORRHAGICS$CARDIAC THERAPY$OPHTHALMOLOGICALS$NASAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OPHTHALMOLOGICALS,$ALIMENTARY TRACT AND METABOLISM$RESPIRATORY SYSTEM$BLOOD AND BLOOD FORMING ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$SENSORY ORGANS
40239330,36009737,3.52E-12,0.000161759,adult_children_senior_youth,senior,telaprevir,drug eruption,Immune system disorders,Antivirals for treatment of HCV infections,DIRECT ACTING ANTIVIRALS,ANTIVIRALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
1177480,35205185,3.59E-12,0.000164846,adult_children_senior_youth,youth,ibuprofen,chest pain,"Respiratory, thoracic and mediastinal disorders","$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
19041843,36918984,3.69E-12,0.000169393,adult_children_senior_youth,children,carbocisteine,hallucination,Psychiatric disorders,Mucolytics,"EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",COUGH AND COLD PREPARATIONS,RESPIRATORY SYSTEM
956874,36919235,3.71E-12,0.000170435,adult_children_senior_youth,adult,furosemide,suicidal ideation,Psychiatric disorders,"$High-ceiling diuretics and potassium-sparing agents$Sulfonamides, plain$Sulfonamides$Sulfonamides and potassium in combination","$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$HIGH-CEILING DIURETICS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$HIGH-CEILING DIURETICS",$DIURETICS$DIURETICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$DIURETICS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
1305058,35204966,3.80E-12,0.000174352,adult_children_senior_youth,children_youth,methotrexate,cardiac arrest,Cardiac disorders,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
781039,35809076,3.92E-12,0.000180047,adult_children_senior_youth,senior,alprazolam,fatigue,General disorders and administration site conditions,Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1742253,35406391,4.03E-12,0.000184775,adult_children_senior_youth,adult_youth,levofloxacin,tinnitus,$Ear and labyrinth disorders$Nervous system disorders,$Fluoroquinolones$Combinations for eradication of Helicobacter pylori$Combinations of antibacterials$Fluoroquinolones,$QUINOLONE ANTIBACTERIALS$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$COMBINATIONS OF ANTIBACTERIALS$ANTIINFECTIVES,$ANTIBACTERIALS FOR SYSTEMIC USE$DRUGS FOR ACID RELATED DISORDERS$ANTIBACTERIALS FOR SYSTEMIC USE$OPHTHALMOLOGICALS,$ANTIINFECTIVES FOR SYSTEMIC USE$ALIMENTARY TRACT AND METABOLISM$ANTIINFECTIVES FOR SYSTEMIC USE$SENSORY ORGANS
1136980,35809131,4.12E-12,0.000189298,adult_senior_youth,youth,ketorolac,general physical health deterioration,General disorders and administration site conditions,"$Acetic acid derivatives and related substances$Sympathomimetics excl. antiglaucoma preparations$Antiinflammatory agents, non-steroids","$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$MYDRIATICS AND CYCLOPLEGICS$ANTIINFLAMMATORY AGENTS",$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$OPHTHALMOLOGICALS$OPHTHALMOLOGICALS,$MUSCULO-SKELETAL SYSTEM$SENSORY ORGANS$SENSORY ORGANS
937368,35707930,4.14E-12,0.000189957,adult_children_senior_youth,children,infliximab,gastroenteritis viral,Gastrointestinal disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
735979,35104691,4.18E-12,0.000191817,adult_children_senior_youth,senior,risperidone,thrombocytopenia,Blood and lymphatic system disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
836208,35809243,4.20E-12,0.000193,adult_children_senior_youth,senior,succinylcholine,pain,General disorders and administration site conditions,Choline derivatives,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",MUSCLE RELAXANTS,MUSCULO-SKELETAL SYSTEM
735979,35506649,4.23E-12,0.000194093,adult_children_senior_youth,children_youth,risperidone,hyperprolactinaemia,Endocrine disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1309944,35205164,4.32E-12,0.000198396,adult_children_senior_youth,adult,amiodarone,coronary artery disease,Vascular disorders,"Antiarrhythmics, class III","ANTIARRHYTHMICS, CLASS I AND III",CARDIAC THERAPY,CARDIOVASCULAR SYSTEM
40171288,36110534,4.37E-12,0.000200708,adult_children_senior_youth,children,tocilizumab,abscess,Infections and infestations,Interleukin inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1154161,36009756,4.39E-12,0.000201381,adult_children_senior_youth,youth,montelukast,anaphylactic reaction,Immune system disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1114220,35104877,4.40E-12,0.000201772,adult_senior,senior,naloxone,febrile neutropenia,General disorders and administration site conditions,$Peripheral opioid receptor antagonists$Natural opium alkaloids$Antidotes$Natural opium alkaloids,$DRUGS FOR CONSTIPATION$OPIOIDS$ALL OTHER THERAPEUTIC PRODUCTS$OPIOIDS,$DRUGS FOR CONSTIPATION$ANALGESICS$ALL OTHER THERAPEUTIC PRODUCTS$ANALGESICS,$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM$VARIOUS$NERVOUS SYSTEM
1545958,36211492,4.41E-12,0.000202285,adult_children_senior_youth,youth,atorvastatin,intentional overdose,"Injury, poisoning and procedural complications","$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations","$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS",$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1344905,36516888,4.47E-12,0.000205129,adult_children_senior_youth,youth,carboplatin,rhabdomyolysis,Musculoskeletal and connective tissue disorders,Platinum compounds,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
766814,35809146,4.48E-12,0.000205712,adult_senior_youth,senior,quetiapine,mobility decreased,Nervous system disorders,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1367500,37019440,4.48E-12,0.000205471,adult_children_senior_youth,children_youth,losartan,proteinuria,Renal and urinary disorders,"$Angiotensin II receptor blockers (ARBs), plain$Angiotensin II receptor blockers (ARBs) and diuretics$Angiotensin II receptor blockers (ARBs) and calcium channel blockers","$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
939259,36312077,4.52E-12,0.000207466,adult_children_senior_youth,adult,budesonide,blood pressure increased,Investigations,"$Corticosteroids, potent (group III)$Corticosteroids$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Corticosteroids acting locally$Glucocorticoids$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics","$CORTICOSTEROIDS, PLAIN$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ADRENERGICS, INHALANTS$INTESTINAL ANTIINFLAMMATORY AGENTS$OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS$ADRENERGICS, INHALANTS","$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$NASAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",$DERMATOLOGICALS$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$ALIMENTARY TRACT AND METABOLISM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
968426,35707714,4.53E-12,0.000207867,adult_children_senior_youth,children_youth,mesalamine,pancreatitis acute,Gastrointestinal disorders,0,0,0,0
797617,35104691,4.55E-12,0.000208664,adult_children_senior_youth,senior,citalopram,thrombocytopenia,Blood and lymphatic system disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1308290,35506628,4.56E-12,0.000209434,adult_children_senior_youth,youth,vincristine,hyperglycaemia,Endocrine disorders,Vinca alkaloids and analogues,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
975125,35809130,4.59E-12,0.000210575,adult_children_senior_youth,youth,hydrocortisone,flushing,Vascular disorders,"$Corticosteroids/antiinfectives/mydriatics in combination$Corticosteroids for local oral treatment$Corticosteroids, plain$Corticosteroids and antiinfectives in combination$Corticosteroids, weak (group I)$Corticosteroids and mydriatics in combination$Corticosteroids, weak, other combinations$Corticosteroids, weak, combinations with antiseptics$Corticosteroids and antiinfectives in combination$Corticosteroids acting locally$Corticosteroids$Corticosteroids$Glucocorticoids$Corticosteroids, weak, combinations with antibiotics$Corticosteroids and antiinfectives in combination$Corticosteroids","$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$STOMATOLOGICAL PREPARATIONS$ANTIINFLAMMATORY AGENTS$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS, PLAIN$ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS, OTHER COMBINATIONS$CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$INTESTINAL ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE","$OPHTHALMOLOGICALS$STOMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OTOLOGICALS$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$OTOLOGICALS$NASAL PREPARATIONS$CORTICOSTEROIDS FOR SYSTEMIC USE$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$VASOPROTECTIVES","$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$SENSORY ORGANS$SENSORY ORGANS$DERMATOLOGICALS$SENSORY ORGANS$DERMATOLOGICALS$DERMATOLOGICALS$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$SENSORY ORGANS$RESPIRATORY SYSTEM$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$DERMATOLOGICALS$SENSORY ORGANS$CARDIOVASCULAR SYSTEM"
906780,36110589,4.60E-12,0.00021126,adult_senior,senior,metoclopramide,lower respiratory tract infection,Infections and infestations,Propulsives,PROPULSIVES,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,ALIMENTARY TRACT AND METABOLISM
1510813,36718132,4.61E-12,0.000211691,adult_children_senior_youth,adult,rosuvastatin,headache,Nervous system disorders,"$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors$Dipeptidyl peptidase 4 (DPP-4) inhibitors$Sulfonamides$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents","$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, PLAIN$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS",$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$DRUGS USED IN DIABETES$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$ALIMENTARY TRACT AND METABOLISM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
924724,35809131,4.68E-12,0.000214768,adult_senior_youth,youth,dicyclomine,general physical health deterioration,General disorders and administration site conditions,"Synthetic anticholinergics, esters with tertiary amino group",DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,ALIMENTARY TRACT AND METABOLISM
1310149,37521795,4.71E-12,0.000216113,adult_children_senior_youth,children_youth,warfarin,lung transplant,Surgical and medical procedures,Vitamin K antagonists,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1125315,35909452,4.72E-12,0.000216793,adult_children_senior_youth,youth,acetaminophen,gallbladder disorder,Hepatobiliary disorders,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1112807,37622455,4.77E-12,0.000219171,adult_children_senior,children,aspirin,embolism,Vascular disorders,0,0,0,0
766814,36718321,4.79E-12,0.000219701,adult_children_senior_youth,youth,quetiapine,somnolence,Nervous system disorders,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1305058,35227885,4.91E-12,0.000225349,adult_children_senior_youth,adult_senior,methotrexate,peripheral swelling,$Cardiac disorders$General disorders and administration site conditions,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1769389,36312538,4.96E-12,0.000227505,adult_children_senior_youth,children,nevirapine,blood creatine phosphokinase increased,Investigations,"$Non-nucleoside reverse transcriptase inhibitors$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations",$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS,$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
711584,36919236,5.01E-12,0.000230189,adult_children_senior_youth,youth,levetiracetam,suicide attempt,Psychiatric disorders,Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
1115008,35909452,5.08E-12,0.000233106,adult_senior_youth,youth,naproxen,gallbladder disorder,Hepatobiliary disorders,"$Antiinflammatory products for vaginal administration$Antiinflammatory preparations, non-steroids for topical use$Propionic acid derivatives$Propionic acid derivatives$Propionic acid derivatives","$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
950637,36009833,5.08E-12,0.000232986,adult_children_senior,senior,tacrolimus,rheumatoid arthritis,Immune system disorders,"$Agents for dermatitis, excluding corticosteroids$Calcineurin inhibitors",$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$DERMATOLOGICALS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
904453,35909441,5.10E-12,0.000234088,adult_children_senior_youth,youth,esomeprazole,cholecystitis,Hepatobiliary disorders,$Combinations for eradication of Helicobacter pylori$Proton pump inhibitors$Propionic acid derivatives,"$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$MUSCULO-SKELETAL SYSTEM
1550557,35708063,5.16E-12,0.000236971,adult_children_senior_youth,youth,prednisolone,crohn's disease,$Gastrointestinal disorders$Immune system disorders,"$Corticosteroids, weak (group I)$Corticosteroids and antiinfectives in combination$Corticosteroids, weak, other combinations$Corticosteroids for local oral treatment$Corticosteroids$Corticosteroids and mydriatics in combination$Corticosteroids$Corticosteroids/antiinfectives/mydriatics in combination$Antidotes$Corticosteroids$Corticosteroids, weak, combinations with antiseptics$Corticosteroids, weak, combinations with antibiotics$Corticosteroids, plain$Corticosteroids$Corticosteroids acting locally$Glucocorticoids$Corticosteroids and antiinfectives in combination$Corticosteroids$Corticosteroids and antiinfectives in combination","$CORTICOSTEROIDS, PLAIN$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS, OTHER COMBINATIONS$STOMATOLOGICAL PREPARATIONS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$ALL OTHER THERAPEUTIC PRODUCTS$CORTICOSTEROIDS$CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS$INTESTINAL ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION","$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$STOMATOLOGICAL PREPARATIONS$NASAL PREPARATIONS$OPHTHALMOLOGICALS$NASAL PREPARATIONS$OPHTHALMOLOGICALS$ALL OTHER THERAPEUTIC PRODUCTS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS$OTOLOGICALS$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE$OTOLOGICALS$VASOPROTECTIVES$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS","$DERMATOLOGICALS$SENSORY ORGANS$DERMATOLOGICALS$ALIMENTARY TRACT AND METABOLISM$RESPIRATORY SYSTEM$SENSORY ORGANS$RESPIRATORY SYSTEM$SENSORY ORGANS$VARIOUS$SENSORY ORGANS$DERMATOLOGICALS$DERMATOLOGICALS$SENSORY ORGANS$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS"
1000772,35809104,5.17E-12,0.000237429,adult_children_senior_youth,youth,granisetron,gait disturbance,General disorders and administration site conditions,Serotonin (5HT3) antagonists,ANTIEMETICS AND ANTINAUSEANTS,ANTIEMETICS AND ANTINAUSEANTS,ALIMENTARY TRACT AND METABOLISM
757688,37219871,5.22E-12,0.000239405,adult_children_senior_youth,adult_youth,aripiprazole,pulmonary embolism,"$Respiratory, thoracic and mediastinal disorders$Vascular disorders",Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
19111620,36516729,5.25E-12,0.00024078,adult_senior_youth,senior_youth,folic acid,bone erosion,Musculoskeletal and connective tissue disorders,$Iron in other combinations$Folic acid and derivatives$Iron in other combinations$Folic acid and derivatives,$IRON PREPARATIONS$VITAMIN B12 AND FOLIC ACID$IRON PREPARATIONS$VITAMIN B12 AND FOLIC ACID,$ANTIANEMIC PREPARATIONS$ANTIANEMIC PREPARATIONS$ANTIANEMIC PREPARATIONS$ANTIANEMIC PREPARATIONS,$BLOOD AND BLOOD FORMING ORGANS$BLOOD AND BLOOD FORMING ORGANS$BLOOD AND BLOOD FORMING ORGANS$BLOOD AND BLOOD FORMING ORGANS
1307046,36416485,5.28E-12,0.000242177,adult_children_senior_youth,youth,metoprolol,lactic acidosis,Metabolism and nutrition disorders,"$Beta blocking agents and calcium channel blockers$Beta blocking agents, other combinations$Beta blocking agents, other combinations$Beta blocking agents and calcium channel blockers$Beta blocking agents, selective$Beta blocking agents, selective, and thiazides$Beta blocking agents, selective, and other diuretics$Beta blocking agents, selective, and thiazides","$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS AND OTHER DIURETICS$BETA BLOCKING AGENTS AND THIAZIDES",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
742185,37019396,5.31E-12,0.00024356,adult_children_senior_youth,senior,atomoxetine,dysuria,Renal and urinary disorders,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
929887,36718323,5.47E-12,0.000250957,adult_children_senior_youth,senior,lansoprazole,sopor,Nervous system disorders,$Proton pump inhibitors$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Proton pump inhibitors,$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
739138,37622449,5.53E-12,0.000253706,adult_children_senior_youth,senior_youth,sertraline,hypotension,Vascular disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
710062,36009754,5.59E-12,0.000256772,adult_senior_youth,senior,amitriptyline,toxic epidermal necrolysis,Immune system disorders,$Non-selective monoamine reuptake inhibitors$Antidepressants in combination with psycholeptics,$ANTIDEPRESSANTS$PSYCHOLEPTICS AND PSYCHOANALEPTICS IN COMBINATION,$PSYCHOANALEPTICS$PSYCHOANALEPTICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
19011440,36110933,5.60E-12,0.000257245,adult_children_senior_youth,children_youth,everolimus,influenza,Infections and infestations,$Protein kinase inhibitors$Selective immunosuppressants,$OTHER ANTINEOPLASTIC AGENTS$IMMUNOSUPPRESSANTS,$ANTINEOPLASTIC AGENTS$IMMUNOSUPPRESSANTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1322184,37220014,5.64E-12,0.000258764,adult_children_senior,children,clopidogrel,epistaxis,"Respiratory, thoracic and mediastinal disorders",Platelet aggregation inhibitors excl. heparin,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
923645,35909625,5.67E-12,0.000260358,adult_children_senior_youth,youth,omeprazole,hepatotoxicity,"Injury, poisoning and procedural complications",$Proton pump inhibitors$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori,$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1308290,35104161,5.72E-12,0.000262624,adult_children_senior_youth,children_youth,vincristine,coagulopathy,Blood and lymphatic system disorders,Vinca alkaloids and analogues,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1112807,35909518,5.73E-12,0.000263129,adult_children_senior_youth,youth,aspirin,hepatic failure,Hepatobiliary disorders,0,0,0,0
1151789,37219804,5.74E-12,0.000263666,adult_senior_youth,senior,etanercept,chronic obstructive pulmonary disease,"Respiratory, thoracic and mediastinal disorders",Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1151789,37019308,5.74E-12,0.000263374,adult_children_senior_youth,senior,etanercept,renal disorder,Renal and urinary disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1351541,36617295,5.75E-12,0.00026376,adult_senior,senior,leuprolide,malignant neoplasm progression,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",$Gonadotropin releasing hormone analogues$Gonadotropin releasing hormone analogues,$HORMONES AND RELATED AGENTS$HORMONES AND RELATED AGENTS,$ENDOCRINE THERAPY$ENDOCRINE THERAPY,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1503297,36818729,5.79E-12,0.00026572,adult_children,children,metformin,premature baby,"Pregnancy, puerperium and perinatal conditions",$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Biguanides$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1350504,37219871,5.84E-12,0.000267938,adult_children_senior_youth,adult,etoposide,pulmonary embolism,"$Respiratory, thoracic and mediastinal disorders$Vascular disorders",Podophyllotoxin derivatives,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1545958,35204928,5.86E-12,0.000269001,adult_children_senior_youth,youth,atorvastatin,bradycardia,Cardiac disorders,"$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations","$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS",$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1703687,35909508,5.87E-12,0.000269457,adult_children_senior_youth,children,acyclovir,hepatic function abnormal,Hepatobiliary disorders,$Nucleosides and nucleotides excl. reverse transcriptase inhibitors$Antivirals$Antivirals$Antivirals,$DIRECT ACTING ANTIVIRALS$CHEMOTHERAPEUTICS FOR TOPICAL USE$ANTIINFECTIVES$CHEMOTHERAPEUTICS FOR TOPICAL USE,$ANTIVIRALS FOR SYSTEMIC USE$ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE$OPHTHALMOLOGICALS$ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,$ANTIINFECTIVES FOR SYSTEMIC USE$DERMATOLOGICALS$SENSORY ORGANS$DERMATOLOGICALS
19010482,35607318,5.90E-12,0.000270778,adult_children_senior,senior,cyclosporine,foreign body sensation in eyes,Eye disorders,$Calcineurin inhibitors$Other ophthalmologicals,$IMMUNOSUPPRESSANTS$OTHER OPHTHALMOLOGICALS,$IMMUNOSUPPRESSANTS$OPHTHALMOLOGICALS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$SENSORY ORGANS
1177480,36313240,5.91E-12,0.000271212,adult_children_senior_youth,senior,ibuprofen,haemoglobin decreased,Investigations,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
1351541,37119769,5.93E-12,0.00027197,adult_children_youth,youth,leuprolide,vaginal discharge,Reproductive system and breast disorders,$Gonadotropin releasing hormone analogues$Gonadotropin releasing hormone analogues,$HORMONES AND RELATED AGENTS$HORMONES AND RELATED AGENTS,$ENDOCRINE THERAPY$ENDOCRINE THERAPY,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1336926,36918942,5.95E-12,0.000273208,adult_children_senior_youth,adult_youth,tadalafil,depression,Psychiatric disorders,$Drugs used in erectile dysfunction$Antihypertensives for pulmonary arterial hypertension,$UROLOGICALS$OTHER ANTIHYPERTENSIVES,$UROLOGICALS$ANTIHYPERTENSIVES,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
709567,36416512,5.98E-12,0.000274397,adult_children_senior_youth,children,lisdexamfetamine,anorexia,0,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
1332418,36718458,6.02E-12,0.000276465,adult_children_senior_youth,youth,amlodipine,serotonin syndrome,"Injury, poisoning and procedural complications","$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers$ACE inhibitors and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Beta blocking agents and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Renin-inhibitors$HMG CoA reductase inhibitors, other combinations$Beta blocking agents and calcium channel blockers$Dihydropyridine derivatives$ACE inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$Calcium channel blockers and diuretics$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations$ACE inhibitors, other combinations$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs), other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$HMG CoA reductase inhibitors, other combinations$ACE inhibitors and calcium channel blockers","$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS, COMBINATIONS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS$ACE INHIBITORS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$CALCIUM CHANNEL BLOCKERS AND DIURETICS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$BETA BLOCKING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$BETA BLOCKING AGENTS$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$CALCIUM CHANNEL BLOCKERS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1311078,36009711,6.10E-12,0.000280028,adult_children_senior_youth,children,cytarabine,hypersensitivity,Immune system disorders,$Pyrimidine analogues$Combinations of antineoplastic agents,$ANTIMETABOLITES$OTHER ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AGENTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1129625,36718362,6.14E-12,0.000281734,adult_children_senior_youth,children,diphenhydramine,myoclonus,Nervous system disorders,$Antihistamines for topical use$Aminoalkyl ethers$Antihistamines for topical use$Aminoalkyl ethers,"$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ANTIHISTAMINES FOR SYSTEMIC USE$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ANTIHISTAMINES FOR SYSTEMIC USE","$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ANTIHISTAMINES FOR SYSTEMIC USE$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ANTIHISTAMINES FOR SYSTEMIC USE",$DERMATOLOGICALS$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM
1762711,36313436,6.15E-12,0.000282238,adult_children_senior_youth,senior_youth,ribavirin,neutrophil count decreased,Investigations,Antivirals for treatment of HCV infections,DIRECT ACTING ANTIVIRALS,ANTIVIRALS FOR SYSTEMIC USE,ANTIINFECTIVES FOR SYSTEMIC USE
923645,35909452,6.28E-12,0.00028845,adult_children_senior_youth,youth,omeprazole,gallbladder disorder,Hepatobiliary disorders,$Proton pump inhibitors$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori,$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1502905,35708208,6.30E-12,0.000289077,adult_children_senior_youth,children_youth,insulin glargine,vomiting,Gastrointestinal disorders,"$Insulins and analogues for injection, long-acting$Insulins and analogues for injection, long-acting",$INSULINS AND ANALOGUES$INSULINS AND ANALOGUES,$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
956874,43053904,6.41E-12,0.000294088,adult_children_senior_youth,youth,furosemide,exposure during pregnancy,"Injury, poisoning and procedural complications","$High-ceiling diuretics and potassium-sparing agents$Sulfonamides, plain$Sulfonamides$Sulfonamides and potassium in combination","$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$HIGH-CEILING DIURETICS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$HIGH-CEILING DIURETICS",$DIURETICS$DIURETICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$DIURETICS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
19012598,35809243,6.42E-12,0.000294858,adult_children_senior_youth,senior,vecuronium,pain,General disorders and administration site conditions,Other quaternary ammonium compounds,"MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",MUSCLE RELAXANTS,MUSCULO-SKELETAL SYSTEM
923645,35708010,6.46E-12,0.000296664,adult_senior_youth,youth,omeprazole,pseudomembranous colitis,Gastrointestinal disorders,$Proton pump inhibitors$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori,$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1350504,35104074,6.51E-12,0.000298628,adult_children_senior_youth,senior,etoposide,anaemia,Blood and lymphatic system disorders,Podophyllotoxin derivatives,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1336926,36314255,6.58E-12,0.000301893,adult_children_senior_youth,youth,tadalafil,brain natriuretic peptide increased,Investigations,$Drugs used in erectile dysfunction$Antihypertensives for pulmonary arterial hypertension,$UROLOGICALS$OTHER ANTIHYPERTENSIVES,$UROLOGICALS$ANTIHYPERTENSIVES,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
757688,36314073,6.61E-12,0.000303617,adult_children_senior_youth,adult,aripiprazole,blood triglycerides increased,Investigations,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1636780,37622465,6.61E-12,0.000303414,adult_senior_youth,adult,testosterone,deep vein thrombosis,Vascular disorders,$3-oxoandrosten (4) derivatives$Androgens and estrogens,$ANDROGENS$ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
956874,36416550,6.67E-12,0.000306338,adult_children_senior,children,furosemide,osteopenia,$Metabolism and nutrition disorders$Musculoskeletal and connective tissue disorders,"$High-ceiling diuretics and potassium-sparing agents$Sulfonamides, plain$Sulfonamides$Sulfonamides and potassium in combination","$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$HIGH-CEILING DIURETICS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$HIGH-CEILING DIURETICS",$DIURETICS$DIURETICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$DIURETICS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
964339,37019321,6.79E-12,0.000311866,adult_children_senior,senior,sulfasalazine,renal impairment,Renal and urinary disorders,$Sulfonamides$Aminosalicylic acid and similar agents,"$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$INTESTINAL ANTIINFLAMMATORY AGENTS","$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",$GENITO URINARY SYSTEM AND SEX HORMONES$ALIMENTARY TRACT AND METABOLISM
19049105,35205240,6.82E-12,0.000313091,adult_children_senior_youth,children_youth,potassium chloride,cardiac failure,Cardiac disorders,$Potassium$Electrolyte solutions$Potassium,$POTASSIUM$I.V. SOLUTION ADDITIVES$POTASSIUM,$MINERAL SUPPLEMENTS$BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS$MINERAL SUPPLEMENTS,$ALIMENTARY TRACT AND METABOLISM$BLOOD AND BLOOD FORMING ORGANS$ALIMENTARY TRACT AND METABOLISM
956874,37520731,6.82E-12,0.000312866,adult_children_senior_youth,children,furosemide,cardiac operation,Surgical and medical procedures,"$High-ceiling diuretics and potassium-sparing agents$Sulfonamides, plain$Sulfonamides$Sulfonamides and potassium in combination","$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$HIGH-CEILING DIURETICS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$HIGH-CEILING DIURETICS",$DIURETICS$DIURETICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$DIURETICS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
722031,36416606,6.83E-12,0.000313569,adult_children_senior_youth,senior,paroxetine,dehydration,Metabolism and nutrition disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1503297,36718323,6.99E-12,0.000320626,adult_senior,senior,metformin,sopor,Nervous system disorders,$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Biguanides$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1140643,42889647,7.02E-12,0.00032231,adult_senior_youth,youth,sumatriptan,toxicity to various agents,"Injury, poisoning and procedural complications",$Selective serotonin (5HT1) agonists$Sulfonamides,"$ANTIMIGRAINE PREPARATIONS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",$ANALGESICS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,$NERVOUS SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES
1125315,36009762,7.04E-12,0.000323353,adult_children_senior_youth,children,acetaminophen,angioedema,Immune system disorders,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1112807,35104281,7.09E-12,0.000325467,adult_children_senior_youth,children,aspirin,haemolytic anaemia,Blood and lymphatic system disorders,0,0,0,0
744740,35104877,7.15E-12,0.000328087,adult_senior_youth,senior,zolpidem,febrile neutropenia,General disorders and administration site conditions,Benzodiazepine related drugs,HYPNOTICS AND SEDATIVES,PSYCHOLEPTICS,NERVOUS SYSTEM
1308842,37019321,7.17E-12,0.000329253,adult_children_senior_youth,youth,valsartan,renal impairment,Renal and urinary disorders,"$Angiotensin II receptor blockers (ARBs), other combinations$HMG CoA reductase inhibitors, other combinations$Angiotensin II receptor blockers (ARBs) and diuretics$Angiotensin II receptor blockers (ARBs), plain$Angiotensin II receptor blockers (ARBs), other combinations$Angiotensin II receptor blockers (ARBs), other combinations$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs) and calcium channel blockers$Angiotensin II receptor blockers (ARBs), other combinations","$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
766814,36718201,7.32E-12,0.000336104,adult_children_senior_youth,children,quetiapine,extrapyramidal disorder,Nervous system disorders,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
766814,35205247,7.34E-12,0.000337047,adult_children_senior_youth,youth,quetiapine,cardiopulmonary failure,"$Cardiac disorders$Respiratory, thoracic and mediastinal disorders","Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
40171288,35104236,7.34E-12,0.000337133,adult_children_senior_youth,children,tocilizumab,histiocytosis haematophagic,0,Interleukin inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1305058,35809315,7.42E-12,0.000340421,adult_children_senior_youth,children_youth,methotrexate,potentiating drug interaction,General disorders and administration site conditions,$Other immunosuppressants$Folic acid analogues,$IMMUNOSUPPRESSANTS$ANTIMETABOLITES,$IMMUNOSUPPRESSANTS$ANTINEOPLASTIC AGENTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
791967,36918937,7.59E-12,0.000348577,adult_children_senior_youth,children,lorazepam,delirium,Psychiatric disorders,$Benzodiazepine derivatives$Benzodiazepine derivatives,$ANXIOLYTICS$ANXIOLYTICS,$PSYCHOLEPTICS$PSYCHOLEPTICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
705944,36313240,7.87E-12,0.00036103,adult_children_senior_youth,senior,methylphenidate,haemoglobin decreased,Investigations,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
1125315,36918942,7.89E-12,0.000362342,adult_children_senior_youth,adult_youth,acetaminophen,depression,Psychiatric disorders,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
996416,36919045,7.95E-12,0.000365061,adult_senior_youth,youth,finasteride,emotional disorder,Psychiatric disorders,$Other dermatologicals$Alpha-adrenoreceptor antagonists$Testosterone-5-alpha reductase inhibitors,$OTHER DERMATOLOGICAL PREPARATIONS$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,$OTHER DERMATOLOGICAL PREPARATIONS$UROLOGICALS$UROLOGICALS,$DERMATOLOGICALS$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1710612,42889640,7.95E-12,0.000364972,adult_children_youth,youth,zidovudine,maternal exposure during pregnancy,"Injury, poisoning and procedural complications","$Antivirals for treatment of HIV infections, combinations$Nucleoside and nucleotide reverse transcriptase inhibitors$Antivirals for treatment of HIV infections, combinations$Antivirals for treatment of HIV infections, combinations",$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS$DIRECT ACTING ANTIVIRALS,$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE$ANTIVIRALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
1304107,35104812,8.05E-12,0.000369382,adult_senior_youth,adult_youth,imatinib,splenomegaly,Blood and lymphatic system disorders,Protein kinase inhibitors,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1314002,37521163,8.07E-12,0.000370306,adult_children_senior_youth,children,atenolol,haemodialysis,Surgical and medical procedures,"$Beta blocking agents, selective, and other diuretics$Beta blocking agents, selective$Beta blocking agents and calcium channel blockers$Beta blocking agents, selective, thiazides and other diuretics$Beta blocking agents, selective, and thiazides$Beta blocking agents, selective, and other diuretics","$BETA BLOCKING AGENTS AND OTHER DIURETICS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS AND OTHER DIURETICS",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1119119,35708208,8.16E-12,0.000374491,adult_children_senior_youth,children_youth,adalimumab,vomiting,Gastrointestinal disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
725131,36211297,8.18E-12,0.000375615,adult_children_senior_youth,senior,mirtazapine,fall,"Injury, poisoning and procedural complications",Other antidepressants,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
974166,35204903,8.23E-12,0.000377683,adult_senior_youth,youth,hydrochlorothiazide,atrioventricular block complete,Cardiac disorders,"$ACE inhibitors, other combinations$Thiazides, combinations with other drugs$Thiazides and potassium in combination$Angiotensin II receptor blockers (ARBs), other combinations$Low-ceiling diuretics and potassium-sparing agents$Angiotensin II receptor blockers (ARBs), other combinations$Renin-inhibitors$Sulfonamides$Angiotensin II receptor blockers (ARBs), other combinations$Thiazides, plain$Renin-inhibitors","$ACE INHIBITORS, COMBINATIONS$LOW-CEILING DIURETICS, THIAZIDES$LOW-CEILING DIURETICS, THIAZIDES$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LOW-CEILING DIURETICS, THIAZIDES$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$DIURETICS$DIURETICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$DIURETICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$DIURETICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1119119,36516895,8.26E-12,0.000379132,adult_senior_youth,senior,adalimumab,foot deformity,Musculoskeletal and connective tissue disorders,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
42873636,36312077,8.37E-12,0.000384273,adult_children_senior_youth,children,mirabegron,blood pressure increased,Investigations,Drugs for urinary frequency and incontinence,UROLOGICALS,UROLOGICALS,GENITO URINARY SYSTEM AND SEX HORMONES
1315942,36516833,8.42E-12,0.000386445,adult_children_senior_youth,children,docetaxel,myositis,Musculoskeletal and connective tissue disorders,Taxanes,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1174888,37622465,8.49E-12,0.000389586,adult_senior_youth,youth,hydrocodone,deep vein thrombosis,Vascular disorders,Opium alkaloids and derivatives,"COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",COUGH AND COLD PREPARATIONS,RESPIRATORY SYSTEM
1308290,42890355,8.55E-12,0.000392394,adult_children_senior_youth,children,vincristine,posterior reversible encephalopathy syndrome,Nervous system disorders,Vinca alkaloids and analogues,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
722424,36211103,8.57E-12,0.000393347,adult_senior_youth,senior,interferon beta-1a,lower limb fracture,"Injury, poisoning and procedural complications",Interferons,IMMUNOSTIMULANTS,IMMUNOSTIMULANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1310149,37522129,8.62E-12,0.000395618,adult_children_senior_youth,adult_youth,warfarin,catheter placement,Surgical and medical procedures,Vitamin K antagonists,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
705944,37019318,8.71E-12,0.000399706,adult_children_senior_youth,senior,methylphenidate,renal failure,Renal and urinary disorders,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
19017742,36516812,8.80E-12,0.000404126,adult_children_senior,children,febuxostat,arthralgia,Musculoskeletal and connective tissue disorders,Preparations inhibiting uric acid production,ANTIGOUT PREPARATIONS,ANTIGOUT PREPARATIONS,MUSCULO-SKELETAL SYSTEM
1742253,36516957,8.92E-12,0.000409349,adult_children_senior_youth,adult,levofloxacin,musculoskeletal pain,Musculoskeletal and connective tissue disorders,$Fluoroquinolones$Combinations for eradication of Helicobacter pylori$Combinations of antibacterials$Fluoroquinolones,$QUINOLONE ANTIBACTERIALS$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$COMBINATIONS OF ANTIBACTERIALS$ANTIINFECTIVES,$ANTIBACTERIALS FOR SYSTEMIC USE$DRUGS FOR ACID RELATED DISORDERS$ANTIBACTERIALS FOR SYSTEMIC USE$OPHTHALMOLOGICALS,$ANTIINFECTIVES FOR SYSTEMIC USE$ALIMENTARY TRACT AND METABOLISM$ANTIINFECTIVES FOR SYSTEMIC USE$SENSORY ORGANS
734354,35809148,8.96E-12,0.000411363,adult_senior_youth,youth,pregabalin,multi-organ failure,"General disorders and administration site conditions
$Pregnancy, puerperium and perinatal conditions
",Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
1539403,36919048,9.16E-12,0.000420244,adult_senior,adult,simvastatin,frustration,0,"$Dipeptidyl peptidase 4 (DPP-4) inhibitors$HMG CoA reductase inhibitors$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents$HMG CoA reductase inhibitors, other combinations$HMG CoA reductase inhibitors in combination with other lipid modifying agents","$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$LIPID MODIFYING AGENTS, PLAIN$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS",$DRUGS USED IN DIABETES$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS$LIPID MODIFYING AGENTS,$ALIMENTARY TRACT AND METABOLISM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1125315,36211297,9.28E-12,0.000426025,adult_children_senior_youth,senior,acetaminophen,fall,"Injury, poisoning and procedural complications",$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
1119119,35809007,9.38E-12,0.000430393,adult_children_senior_youth,children_youth,adalimumab,injection site papule,General disorders and administration site conditions,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
766814,36718193,9.40E-12,0.000431304,adult_children_senior_youth,children,quetiapine,akathisia,$Nervous system disorders$Psychiatric disorders,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
725131,35809131,9.40E-12,0.000431272,adult_children_senior_youth,senior,mirtazapine,general physical health deterioration,General disorders and administration site conditions,Other antidepressants,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
734275,36718526,9.51E-12,0.000436543,adult_children_senior_youth,children_youth,phenobarbital,convulsion,0,"$Barbiturates, combinations$Barbiturates and derivatives",$HYPNOTICS AND SEDATIVES$ANTIEPILEPTICS,$PSYCHOLEPTICS$ANTIEPILEPTICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
1326303,35204963,9.53E-12,0.000437415,adult_children_senior_youth,children_youth,digoxin,supraventricular tachycardia,Cardiac disorders,Digitalis glycosides,CARDIAC GLYCOSIDES,CARDIAC THERAPY,CARDIOVASCULAR SYSTEM
781039,35809104,9.57E-12,0.000439107,adult_children_senior_youth,children_senior,alprazolam,gait disturbance,General disorders and administration site conditions,Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1502905,36211465,9.58E-12,0.000439687,adult_children_senior_youth,children,insulin glargine,incorrect dose administered,"Injury, poisoning and procedural complications","$Insulins and analogues for injection, long-acting$Insulins and analogues for injection, long-acting",$INSULINS AND ANALOGUES$INSULINS AND ANALOGUES,$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1167322,36416698,9.77E-12,0.0004483,adult_children_senior_youth,adult_youth,allopurinol,hyperuricaemia,Metabolism and nutrition disorders,$Preparations inhibiting uric acid production$Preparations inhibiting uric acid production,$ANTIGOUT PREPARATIONS$ANTIGOUT PREPARATIONS,$ANTIGOUT PREPARATIONS$ANTIGOUT PREPARATIONS,$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
1388796,36110716,1.00E-11,0.000460112,adult_children_senior,children,leucovorin,cystitis,Infections and infestations,$Detoxifying agents for antineoplastic treatment$Detoxifying agents for antineoplastic treatment,$ALL OTHER THERAPEUTIC PRODUCTS$ALL OTHER THERAPEUTIC PRODUCTS,$ALL OTHER THERAPEUTIC PRODUCTS$ALL OTHER THERAPEUTIC PRODUCTS,$VARIOUS$VARIOUS
904453,36516728,1.01E-11,0.000463722,adult_children_senior_youth,adult,esomeprazole,bone disorder,Musculoskeletal and connective tissue disorders,$Combinations for eradication of Helicobacter pylori$Proton pump inhibitors$Propionic acid derivatives,"$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$MUSCULO-SKELETAL SYSTEM
986417,36919059,1.02E-11,0.000467736,adult_children_senior_youth,children,polyethylene glycol 3350,aggression,Psychiatric disorders,0,0,0,0
1501700,35606983,1.02E-11,0.000468387,adult_senior_youth,youth,levothyroxine,angle closure glaucoma,Eye disorders,Thyroid hormones,THYROID PREPARATIONS,THYROID THERAPY,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
43013024,36718001,1.02E-11,0.000468392,adult_children_senior_youth,children,apixaban,cerebral infarction,$Nervous system disorders$Vascular disorders,Direct factor Xa inhibitors,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
723013,37219893,1.02E-11,0.000469502,adult_children_senior_youth,youth,diazepam,respiratory arrest,"Respiratory, thoracic and mediastinal disorders",Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1154161,36919230,1.03E-11,0.000473807,adult_children_senior_youth,youth,montelukast,completed suicide,General disorders and administration site conditions,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
19059796,37622446,1.03E-11,0.000471483,adult_senior_youth,youth,gliclazide,shock,Vascular disorders,Sulfonylureas,"BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",DRUGS USED IN DIABETES,ALIMENTARY TRACT AND METABOLISM
1149380,36009704,1.04E-11,0.000477053,adult_children_senior_youth,senior,fluticasone,dermatitis allergic,Skin and subcutaneous tissue disorders,"$Glucocorticoids$Corticosteroids, potent (group III)$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Corticosteroids$Corticosteroids","$OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS$CORTICOSTEROIDS, PLAIN$ADRENERGICS, INHALANTS$ADRENERGICS, INHALANTS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE","$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$NASAL PREPARATIONS$NASAL PREPARATIONS",$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1153013,36919046,1.08E-11,0.000494328,adult_children_senior_youth,youth,promethazine,emotional distress,Psychiatric disorders,$Phenothiazine derivatives$Antihistamines for topical use$Antidotes$Phenothiazine derivatives,"$ANTIHISTAMINES FOR SYSTEMIC USE$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ALL OTHER THERAPEUTIC PRODUCTS$ANTIHISTAMINES FOR SYSTEMIC USE","$ANTIHISTAMINES FOR SYSTEMIC USE$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ALL OTHER THERAPEUTIC PRODUCTS$ANTIHISTAMINES FOR SYSTEMIC USE",$RESPIRATORY SYSTEM$DERMATOLOGICALS$VARIOUS$RESPIRATORY SYSTEM
800878,36110736,1.08E-11,0.000497133,adult_children_senior_youth,senior,clozapine,urinary tract infection,Infections and infestations,"Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
797399,35204928,1.11E-11,0.000509606,adult_children_senior_youth,children_youth,gabapentin,bradycardia,Cardiac disorders,Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
755695,35909469,1.11E-11,0.000508473,adult_senior_youth,senior,fluoxetine,cholestasis,Hepatobiliary disorders,$Antidepressants in combination with psycholeptics$Selective serotonin reuptake inhibitors,$PSYCHOLEPTICS AND PSYCHOANALEPTICS IN COMBINATION$ANTIDEPRESSANTS,$PSYCHOANALEPTICS$PSYCHOANALEPTICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
1192710,36110591,1.12E-11,0.000513638,adult_children_senior,senior,chlorpheniramine,lung infection,Infections and infestations,$Substituted alkylamines$Substituted alkylamines,$ANTIHISTAMINES FOR SYSTEMIC USE$ANTIHISTAMINES FOR SYSTEMIC USE,$ANTIHISTAMINES FOR SYSTEMIC USE$ANTIHISTAMINES FOR SYSTEMIC USE,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
743670,36776613,1.14E-11,0.000524684,adult_children_senior_youth,children_youth,venlafaxine,seizure,Nervous system disorders,Other antidepressants,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
19095164,35708063,1.15E-11,0.000528973,adult_children_senior_youth,youth,cholecalciferol,crohn's disease,$Gastrointestinal disorders$Immune system disorders,"$Bisphosphonates, combinations$Other drugs affecting bone structure and mineralization$Bisphosphonates, combinations$Bisphosphonates, combinations$Vitamin D and analogues$Bisphosphonates, combinations$Vitamin D and analogues$Bisphosphonates, combinations$Bisphosphonates, combinations","$DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION$DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION$DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION$DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION$VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO$DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION$VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO$DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION$DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",$DRUGS FOR TREATMENT OF BONE DISEASES$DRUGS FOR TREATMENT OF BONE DISEASES$DRUGS FOR TREATMENT OF BONE DISEASES$DRUGS FOR TREATMENT OF BONE DISEASES$VITAMINS$DRUGS FOR TREATMENT OF BONE DISEASES$VITAMINS$DRUGS FOR TREATMENT OF BONE DISEASES$DRUGS FOR TREATMENT OF BONE DISEASES,$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$ALIMENTARY TRACT AND METABOLISM$MUSCULO-SKELETAL SYSTEM$ALIMENTARY TRACT AND METABOLISM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
1321636,35809071,1.15E-11,0.000526387,adult_children_senior,children,bosentan,no adverse event,General disorders and administration site conditions,$Sulfonamides$Antihypertensives for pulmonary arterial hypertension,"$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$OTHER ANTIHYPERTENSIVES",$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$ANTIHYPERTENSIVES,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
1551099,36718265,1.15E-11,0.000527984,adult_children_senior_youth,senior,prednisone,tremor,Nervous system disorders,$Corticosteroids acting locally$Glucocorticoids,"$INTESTINAL ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN","$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE","$ALIMENTARY TRACT AND METABOLISM$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
1548195,35809329,1.16E-11,0.000534036,adult_senior,senior,estradiol,drug intolerance,General disorders and administration site conditions,"$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations$Natural and semisynthetic estrogens, plain$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Androgens and estrogens$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, sequential preparations$Androgens and estrogens$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, sequential preparations$Androgens and estrogens$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations$Antiandrogens and estrogens$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Intravaginal contraceptives$Natural and semisynthetic estrogens, plain$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, sequential preparations",$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$ESTROGENS$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$ANTIANDROGENS$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION$CONTRACEPTIVES FOR TOPICAL USE$ESTROGENS$PROGESTOGENS AND ESTROGENS IN COMBINATION$PROGESTOGENS AND ESTROGENS IN COMBINATION,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$OTHER GYNECOLOGICALS$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1154343,36718551,1.17E-11,0.000534963,adult_children_senior_youth,children,albuterol,sleep terror,$Nervous system disorders$Psychiatric disorders,0,0,0,0
1550557,36009901,1.18E-11,0.000543083,adult_children_senior_youth,youth,prednisolone,transplant rejection,"Injury, poisoning and procedural complications","$Corticosteroids, weak (group I)$Corticosteroids and antiinfectives in combination$Corticosteroids, weak, other combinations$Corticosteroids for local oral treatment$Corticosteroids$Corticosteroids and mydriatics in combination$Corticosteroids$Corticosteroids/antiinfectives/mydriatics in combination$Antidotes$Corticosteroids$Corticosteroids, weak, combinations with antiseptics$Corticosteroids, weak, combinations with antibiotics$Corticosteroids, plain$Corticosteroids$Corticosteroids acting locally$Glucocorticoids$Corticosteroids and antiinfectives in combination$Corticosteroids$Corticosteroids and antiinfectives in combination","$CORTICOSTEROIDS, PLAIN$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS, OTHER COMBINATIONS$STOMATOLOGICAL PREPARATIONS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$ALL OTHER THERAPEUTIC PRODUCTS$CORTICOSTEROIDS$CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS$INTESTINAL ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION","$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$STOMATOLOGICAL PREPARATIONS$NASAL PREPARATIONS$OPHTHALMOLOGICALS$NASAL PREPARATIONS$OPHTHALMOLOGICALS$ALL OTHER THERAPEUTIC PRODUCTS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICALS$OTOLOGICALS$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE$OTOLOGICALS$VASOPROTECTIVES$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS","$DERMATOLOGICALS$SENSORY ORGANS$DERMATOLOGICALS$ALIMENTARY TRACT AND METABOLISM$RESPIRATORY SYSTEM$SENSORY ORGANS$RESPIRATORY SYSTEM$SENSORY ORGANS$VARIOUS$SENSORY ORGANS$DERMATOLOGICALS$DERMATOLOGICALS$SENSORY ORGANS$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS"
735843,36211103,1.19E-11,0.000548082,adult_senior_youth,senior,natalizumab,lower limb fracture,"Injury, poisoning and procedural complications",Selective immunosuppressants,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
950637,37080784,1.20E-11,0.000549096,adult_children_senior_youth,senior,tacrolimus,acute kidney injury,Renal and urinary disorders,"$Agents for dermatitis, excluding corticosteroids$Calcineurin inhibitors",$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$OTHER DERMATOLOGICAL PREPARATIONS$IMMUNOSUPPRESSANTS,$DERMATOLOGICALS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1557272,35205025,1.20E-11,0.000553007,adult_children_senior_youth,youth,alendronate,dizziness,Cardiac disorders,0,0,0,0
1151789,36110719,1.20E-11,0.000549063,adult_children_senior_youth,senior_youth,etanercept,kidney infection,Infections and infestations,Tumor necrosis factor alpha (TNF-a) inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1351541,36919050,1.20E-11,0.000553021,adult_children_senior_youth,children,leuprolide,mood altered,Psychiatric disorders,$Gonadotropin releasing hormone analogues$Gonadotropin releasing hormone analogues,$HORMONES AND RELATED AGENTS$HORMONES AND RELATED AGENTS,$ENDOCRINE THERAPY$ENDOCRINE THERAPY,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1124957,36211183,1.20E-11,0.000549918,adult_children_senior_youth,youth,oxycodone,poisoning,"Injury, poisoning and procedural complications",$Natural opium alkaloids$Natural opium alkaloids$Natural opium alkaloids$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
705944,36718265,1.21E-11,0.000555526,adult_children_senior_youth,youth,methylphenidate,tremor,Nervous system disorders,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
1707164,35809243,1.22E-11,0.000560381,adult_children_senior_youth,youth,metronidazole,pain,General disorders and administration site conditions,$Combinations for eradication of Helicobacter pylori$Combinations for eradication of Helicobacter pylori$Other chemotherapeutics$Combinations for eradication of Helicobacter pylori$Imidazole derivatives$Imidazole derivatives$Combinations of antibacterials$Combinations for eradication of Helicobacter pylori$Nitroimidazole derivatives$Combinations of antibacterials$Combinations for eradication of Helicobacter pylori$Antiinfectives and antiseptics for local oral treatment$Nitroimidazole derivatives$Imidazole derivatives$Combinations of antibacterials,"$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$CHEMOTHERAPEUTICS FOR TOPICAL USE$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$OTHER ANTIBACTERIALS$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$COMBINATIONS OF ANTIBACTERIALS$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES$COMBINATIONS OF ANTIBACTERIALS$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$STOMATOLOGICAL PREPARATIONS$AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$COMBINATIONS OF ANTIBACTERIALS",$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE$DRUGS FOR ACID RELATED DISORDERS$ANTIBACTERIALS FOR SYSTEMIC USE$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$ANTIBACTERIALS FOR SYSTEMIC USE$DRUGS FOR ACID RELATED DISORDERS$ANTIPROTOZOALS$ANTIBACTERIALS FOR SYSTEMIC USE$DRUGS FOR ACID RELATED DISORDERS$STOMATOLOGICAL PREPARATIONS$ANTIPROTOZOALS$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$ANTIBACTERIALS FOR SYSTEMIC USE,"$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$DERMATOLOGICALS$ALIMENTARY TRACT AND METABOLISM$ANTIINFECTIVES FOR SYSTEMIC USE$GENITO URINARY SYSTEM AND SEX HORMONES$ANTIINFECTIVES FOR SYSTEMIC USE$ALIMENTARY TRACT AND METABOLISM$ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS$ANTIINFECTIVES FOR SYSTEMIC USE$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS$GENITO URINARY SYSTEM AND SEX HORMONES$ANTIINFECTIVES FOR SYSTEMIC USE"
769935,35708208,1.23E-11,0.000566269,adult_children_senior_youth,children,sodium oxybate,vomiting,Gastrointestinal disorders,$Other general anesthetics$Other nervous system drugs,"$ANESTHETICS, GENERAL$OTHER NERVOUS SYSTEM DRUGS",$ANESTHETICS$OTHER NERVOUS SYSTEM DRUGS,$NERVOUS SYSTEM$NERVOUS SYSTEM
974166,36416581,1.25E-11,0.000574708,adult_children_senior,children,hydrochlorothiazide,hypochloraemia,Metabolism and nutrition disorders,"$ACE inhibitors, other combinations$Thiazides, combinations with other drugs$Thiazides and potassium in combination$Angiotensin II receptor blockers (ARBs), other combinations$Low-ceiling diuretics and potassium-sparing agents$Angiotensin II receptor blockers (ARBs), other combinations$Renin-inhibitors$Sulfonamides$Angiotensin II receptor blockers (ARBs), other combinations$Thiazides, plain$Renin-inhibitors","$ACE INHIBITORS, COMBINATIONS$LOW-CEILING DIURETICS, THIAZIDES$LOW-CEILING DIURETICS, THIAZIDES$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS$LOW-CEILING DIURETICS, THIAZIDES$OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$DIURETICS$DIURETICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$DIURETICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$DIURETICS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1308216,37019321,1.25E-11,0.000573972,adult_children_senior_youth,children,lisinopril,renal impairment,Renal and urinary disorders,"$ACE inhibitors and diuretics$HMG CoA reductase inhibitors, other combinations$ACE inhibitors, plain$ACE inhibitors and calcium channel blockers","$ACE INHIBITORS, COMBINATIONS$LIPID MODIFYING AGENTS, COMBINATIONS$ACE INHIBITORS, PLAIN$ACE INHIBITORS, COMBINATIONS",$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$LIPID MODIFYING AGENTS$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM$AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
743670,36211297,1.26E-11,0.000576486,adult_children_senior_youth,senior,venlafaxine,fall,"Injury, poisoning and procedural complications",Other antidepressants,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
732893,42889647,1.26E-11,0.000580537,adult_children_senior_youth,children,bupivacaine,toxicity to various agents,"Injury, poisoning and procedural complications",$Amides$Amides,"$ANESTHETICS, LOCAL$ANESTHETICS, LOCAL",$ANESTHETICS$ANESTHETICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
1177480,35909428,1.28E-11,0.000589721,adult_children_senior_youth,youth,ibuprofen,bile duct stone,Hepatobiliary disorders,"$Antiinflammatory products for vaginal administration$Other cardiac preparations$Propionic acid derivatives$Antiinflammatory preparations, non-steroids for topical use$Other throat preparations$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Propionic acid derivatives","$OTHER GYNECOLOGICALS$OTHER CARDIAC PREPARATIONS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$OPIOIDS$OPIOIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$CARDIAC THERAPY$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$THROAT PREPARATIONS$ANALGESICS$ANALGESICS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$RESPIRATORY SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
1343916,36009738,1.28E-11,0.000587628,adult_children_senior_youth,senior,epinephrine,drug hypersensitivity,Immune system disorders,"$Other agents for local oral treatment$Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics$Local hemostatics$Adrenergic and dopaminergic agents$Sympathomimetics in glaucoma therapy$Sympathomimetics, plain$Alpha- and beta-adrenoreceptor agonists$Sympathomimetics in glaucoma therapy","$STOMATOLOGICAL PREPARATIONS$ADRENERGICS, INHALANTS$VITAMIN K AND OTHER HEMOSTATICS$CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES$ANTIGLAUCOMA PREPARATIONS AND MIOTICS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ADRENERGICS, INHALANTS$ANTIGLAUCOMA PREPARATIONS AND MIOTICS",$STOMATOLOGICAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$ANTIHEMORRHAGICS$CARDIAC THERAPY$OPHTHALMOLOGICALS$NASAL PREPARATIONS$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OPHTHALMOLOGICALS,$ALIMENTARY TRACT AND METABOLISM$RESPIRATORY SYSTEM$BLOOD AND BLOOD FORMING ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM$SENSORY ORGANS
1501700,36919046,1.28E-11,0.000585742,adult_senior_youth,youth,levothyroxine,emotional distress,Psychiatric disorders,Thyroid hormones,THYROID PREPARATIONS,THYROID THERAPY,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
739138,43053904,1.30E-11,0.00059838,adult_children_youth,children,sertraline,exposure during pregnancy,"Injury, poisoning and procedural complications",Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1353766,35809086,1.33E-11,0.000611939,adult_senior_youth,youth,propranolol,feeling hot,General disorders and administration site conditions,"$Beta blocking agents, other combinations$Beta blocking agents, non-selective$Beta blocking agents, non-selective, and thiazides","$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS AND THIAZIDES",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1338512,36516749,1.33E-11,0.000608975,adult_children_senior_youth,youth,doxorubicin,osteonecrosis,Vascular disorders,Anthracyclines and related substances,CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1310149,35808857,1.34E-11,0.000615235,adult_children_senior_youth,children_youth,warfarin,catheter site pain,General disorders and administration site conditions,Vitamin K antagonists,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1112807,35205173,1.34E-11,0.000613088,adult_children_senior_youth,adult_children,aspirin,coronary artery thrombosis,Vascular disorders,0,0,0,0
750982,36918942,1.34E-11,0.000613878,adult_children_senior_youth,adult_youth,bupropion,depression,Psychiatric disorders,$Centrally acting antiobesity products$Other antidepressants,"$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$ANTIDEPRESSANTS","$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$PSYCHOANALEPTICS",$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM
1124300,37019295,1.34E-11,0.000613383,adult_children_senior_youth,children_youth,diclofenac,tubulointerstitial nephritis,Renal and urinary disorders,"$Antiinflammatory agents, non-steroids and antiinfectives in combination$Antiinflammatory agents, non-steroids$Acetic acid derivatives and related substances$Antiinflammatory preparations, non-steroids for topical use$Acetic acid derivatives and related substances$Other dermatologicals","$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$ANTIINFLAMMATORY AGENTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$OTHER DERMATOLOGICAL PREPARATIONS",$OPHTHALMOLOGICALS$OPHTHALMOLOGICALS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$OTHER DERMATOLOGICAL PREPARATIONS,$SENSORY ORGANS$SENSORY ORGANS$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$DERMATOLOGICALS
798874,36718458,1.35E-11,0.000618113,adult_children_senior_youth,youth,clonazepam,serotonin syndrome,"Injury, poisoning and procedural complications",Benzodiazepine derivatives,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
1154343,36718552,1.35E-11,0.000619363,adult_children_senior_youth,children,albuterol,somnambulism,$Nervous system disorders$Psychiatric disorders,0,0,0,0
1346823,37622442,1.38E-11,0.000635219,adult_children_senior_youth,children,carvedilol,circulatory collapse,Vascular disorders,"$Alpha and beta blocking agents$Beta blocking agents, other combinations","$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS, OTHER COMBINATIONS",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
724394,42889647,1.38E-11,0.000631205,adult_senior_youth,youth,orphenadrine,toxicity to various agents,"Injury, poisoning and procedural complications","$Ethers, chemically close to antihistamines$Ethers chemically close to antihistamines$Ethers, chemically close to antihistamines","$MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS$ANTICHOLINERGIC AGENTS$MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",$MUSCLE RELAXANTS$ANTI-PARKINSON DRUGS$MUSCLE RELAXANTS,$MUSCULO-SKELETAL SYSTEM$NERVOUS SYSTEM$MUSCULO-SKELETAL SYSTEM
1551099,36110874,1.39E-11,0.000637184,adult_children_senior_youth,youth,prednisone,cytomegalovirus infection,Infections and infestations,$Corticosteroids acting locally$Glucocorticoids,"$INTESTINAL ANTIINFLAMMATORY AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN","$ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS$CORTICOSTEROIDS FOR SYSTEMIC USE","$ALIMENTARY TRACT AND METABOLISM$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
1326303,36718301,1.40E-11,0.000640724,adult_children_senior,senior,digoxin,confusional state,Nervous system disorders,Digitalis glycosides,CARDIAC GLYCOSIDES,CARDIAC THERAPY,CARDIOVASCULAR SYSTEM
1777087,36009823,1.40E-11,0.000640344,adult_children_senior_youth,children_youth,hydroxychloroquine,systemic lupus erythematosus,Skin and subcutaneous tissue disorders,Aminoquinolines,ANTIMALARIALS,ANTIPROTOZOALS,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS"
781039,37219907,1.41E-11,0.000647511,adult_children_senior_youth,senior,alprazolam,cough,"Respiratory, thoracic and mediastinal disorders",Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
797617,35809310,1.43E-11,0.000656867,adult_children_senior_youth,senior,citalopram,drug interaction,General disorders and administration site conditions,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
703244,36919046,1.43E-11,0.000658285,adult_children_senior_youth,children,paliperidone,emotional distress,Psychiatric disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1124300,35607150,1.43E-11,0.000658596,adult_children_senior_youth,youth,diclofenac,periorbital oedema,Immune system disorders,"$Antiinflammatory agents, non-steroids and antiinfectives in combination$Antiinflammatory agents, non-steroids$Acetic acid derivatives and related substances$Antiinflammatory preparations, non-steroids for topical use$Acetic acid derivatives and related substances$Other dermatologicals","$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$ANTIINFLAMMATORY AGENTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$OTHER DERMATOLOGICAL PREPARATIONS",$OPHTHALMOLOGICALS$OPHTHALMOLOGICALS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$OTHER DERMATOLOGICAL PREPARATIONS,$SENSORY ORGANS$SENSORY ORGANS$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$DERMATOLOGICALS
904453,36516779,1.45E-11,0.000663609,adult_senior_youth,adult,esomeprazole,arthritis,Musculoskeletal and connective tissue disorders,$Combinations for eradication of Helicobacter pylori$Proton pump inhibitors$Propionic acid derivatives,"$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$MUSCULO-SKELETAL SYSTEM
705944,36110552,1.45E-11,0.000665169,adult_children_senior_youth,senior,methylphenidate,infection,Infections and infestations,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
1777087,36416528,1.46E-11,0.000671261,adult_senior,senior,hydroxychloroquine,feeding disorder,$Metabolism and nutrition disorders$Psychiatric disorders,Aminoquinolines,ANTIMALARIALS,ANTIPROTOZOALS,"ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS"
1501700,35809072,1.48E-11,0.000677104,adult_children_senior_youth,senior,levothyroxine,asthenia,General disorders and administration site conditions,Thyroid hormones,THYROID PREPARATIONS,THYROID THERAPY,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
1397141,35607121,1.48E-11,0.000677767,adult_senior,senior,bevacizumab,eye inflammation,Eye disorders,Monoclonal antibodies,OTHER ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
781039,36110736,1.49E-11,0.000682921,adult_senior_youth,senior,alprazolam,urinary tract infection,Infections and infestations,Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
742267,36919230,1.50E-11,0.000688027,adult_children_senior_youth,adult_youth,topiramate,completed suicide,General disorders and administration site conditions,Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
742267,36919232,1.50E-11,0.000689256,adult_children_senior_youth,youth,topiramate,self injurious behaviour,0,Other antiepileptics,ANTIEPILEPTICS,ANTIEPILEPTICS,NERVOUS SYSTEM
1503297,35506494,1.51E-11,0.000695085,adult_children_senior_youth,children,metformin,diabetic ketoacidosis,$Endocrine disorders$Metabolism and nutrition disorders,$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Biguanides$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs$Combinations of oral blood glucose lowering drugs,"$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS$BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES$DRUGS USED IN DIABETES,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1518254,35809054,1.52E-11,0.000698208,adult_children_senior_youth,children,dexamethasone,pyrexia,General disorders and administration site conditions,"$Corticosteroids$Corticosteroids, moderately potent, other combinations$Corticosteroids$Corticosteroids, combinations for treatment of acne$Corticosteroids/antiinfectives/mydriatics in combination$Corticosteroids and antiinfectives in combination$Corticosteroids and antiinfectives in combination$Corticosteroids$Corticosteroids and antiinfectives in combination$Corticosteroids, moderately potent, combinations with antibiotics$Glucocorticoids$Corticosteroids, plain$Corticosteroids for local oral treatment$Corticosteroids$Corticosteroids, moderately potent (group II)$Corticosteroids","$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$CORTICOSTEROIDS, OTHER COMBINATIONS$DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION$AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE$ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION$CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS$CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN$ANTIINFLAMMATORY AGENTS$STOMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS$CORTICOSTEROIDS, PLAIN$CORTICOSTEROIDS","$NASAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$NASAL PREPARATIONS$ANTI-ACNE PREPARATIONS$OPHTHALMOLOGICALS$OTOLOGICALS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$VASOPROTECTIVES$OPHTHALMOLOGICALS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$CORTICOSTEROIDS FOR SYSTEMIC USE$OPHTHALMOLOGICALS$STOMATOLOGICAL PREPARATIONS$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS$OTOLOGICALS","$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM$DERMATOLOGICALS$SENSORY ORGANS$SENSORY ORGANS$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$SENSORY ORGANS$DERMATOLOGICALS$SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS$SENSORY ORGANS$ALIMENTARY TRACT AND METABOLISM$SENSORY ORGANS$DERMATOLOGICALS$SENSORY ORGANS"
1524674,35809079,1.53E-11,0.000702425,adult_children_senior_youth,children_youth,zoledronic acid,malaise,General disorders and administration site conditions,"$Bisphosphonates, combinations$Bisphosphonates",$DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION$DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,$DRUGS FOR TREATMENT OF BONE DISEASES$DRUGS FOR TREATMENT OF BONE DISEASES,$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
19011440,36316186,1.55E-11,0.000711543,adult_children_senior_youth,children_youth,everolimus,drug level increased,Investigations,$Protein kinase inhibitors$Selective immunosuppressants,$OTHER ANTINEOPLASTIC AGENTS$IMMUNOSUPPRESSANTS,$ANTINEOPLASTIC AGENTS$IMMUNOSUPPRESSANTS,$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS$ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1310149,37320129,1.56E-11,0.000716817,adult_children_senior_youth,youth,warfarin,skin necrosis,Skin and subcutaneous tissue disorders,Vitamin K antagonists,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
725131,35506610,1.60E-11,0.000734417,adult_senior_youth,adult_youth,mirtazapine,diabetes mellitus inadequate control,Endocrine disorders,Other antidepressants,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1557272,35809059,1.61E-11,0.000739602,adult_children_senior_youth,senior,alendronate,death,General disorders and administration site conditions,0,0,0,0
1310149,36416559,1.62E-11,0.000741828,adult_children_senior_youth,children,warfarin,calciphylaxis,Metabolism and nutrition disorders,Vitamin K antagonists,ANTITHROMBOTIC AGENTS,ANTITHROMBOTIC AGENTS,BLOOD AND BLOOD FORMING ORGANS
1129625,36516867,1.62E-11,0.000743342,adult_children_senior_youth,children,diphenhydramine,muscle rigidity,Nervous system disorders,$Antihistamines for topical use$Aminoalkyl ethers$Antihistamines for topical use$Aminoalkyl ethers,"$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ANTIHISTAMINES FOR SYSTEMIC USE$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ANTIHISTAMINES FOR SYSTEMIC USE","$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ANTIHISTAMINES FOR SYSTEMIC USE$ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.$ANTIHISTAMINES FOR SYSTEMIC USE",$DERMATOLOGICALS$RESPIRATORY SYSTEM$DERMATOLOGICALS$RESPIRATORY SYSTEM
742185,36919052,1.63E-11,0.000749965,adult_children_senior_youth,children,atomoxetine,mood swings,Psychiatric disorders,Centrally acting sympathomimetics,"PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS",PSYCHOANALEPTICS,NERVOUS SYSTEM
715233,36211288,1.66E-11,0.000764,adult_senior_youth,senior,baclofen,asphyxia,"Injury, poisoning and procedural complications
",Other centrally acting agents,"MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",MUSCLE RELAXANTS,MUSCULO-SKELETAL SYSTEM
19003999,36009894,1.67E-11,0.000767901,adult_children_senior_youth,children,mycophenolate mofetil,chronic graft versus host disease,"Injury, poisoning and procedural complications",0,0,0,0
735979,36718320,1.67E-11,0.000766591,adult_children_senior_youth,youth,risperidone,sedation,Nervous system disorders,Other antipsychotics,ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
19080959,42889647,1.67E-11,0.000767443,adult_children_senior_youth,youth,nordazepam,toxicity to various agents,"Injury, poisoning and procedural complications",Benzodiazepine derivatives,ANXIOLYTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1321636,35708208,1.67E-11,0.000766141,adult_children_senior_youth,children,bosentan,vomiting,Gastrointestinal disorders,$Sulfonamides$Antihypertensives for pulmonary arterial hypertension,"$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$OTHER ANTIHYPERTENSIVES",$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$ANTIHYPERTENSIVES,$GENITO URINARY SYSTEM AND SEX HORMONES$CARDIOVASCULAR SYSTEM
722031,35204963,1.68E-11,0.000772538,adult_children_senior_youth,children,paroxetine,supraventricular tachycardia,Cardiac disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1314924,35104768,1.70E-11,0.000780061,adult_senior_youth,youth,gemcitabine,metastases to lymph nodes,"Neoplasms benign, malignant and unspecified (incl cysts and polyps)",Pyrimidine analogues,ANTIMETABOLITES,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
40171288,36416550,1.70E-11,0.000778766,adult_senior,senior,tocilizumab,osteopenia,$Metabolism and nutrition disorders$Musculoskeletal and connective tissue disorders,Interleukin inhibitors,IMMUNOSUPPRESSANTS,IMMUNOSUPPRESSANTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
19011773,37622465,1.72E-11,0.000790616,adult_senior_youth,youth,ascorbic acid,deep vein thrombosis,Vascular disorders,"$Organic acids$Ascorbic acid (vitamin C), plain$Ascorbic acid (vitamin C), combinations$Other ophthalmologicals","$ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS$ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS$ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS$OTHER OPHTHALMOLOGICALS",$GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS$VITAMINS$VITAMINS$OPHTHALMOLOGICALS,$GENITO URINARY SYSTEM AND SEX HORMONES$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM$SENSORY ORGANS
1398937,36312077,1.75E-11,0.000804268,adult_children_senior_youth,senior,clonidine,blood pressure increased,Investigations,$Sympathomimetics in glaucoma therapy$Imidazoline receptor agonists in combination with diuretics$Imidazoline receptor agonists$Other antimigraine preparations$Imidazoline receptor agonists in combination with diuretics,"$ANTIGLAUCOMA PREPARATIONS AND MIOTICS$ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION$ANTIADRENERGIC AGENTS, CENTRALLY ACTING$ANTIMIGRAINE PREPARATIONS$ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION",$OPHTHALMOLOGICALS$ANTIHYPERTENSIVES$ANTIHYPERTENSIVES$ANALGESICS$ANTIHYPERTENSIVES,$SENSORY ORGANS$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$NERVOUS SYSTEM$CARDIOVASCULAR SYSTEM
722031,35506609,1.78E-11,0.000818409,adult_children_senior_youth,adult,paroxetine,diabetes mellitus,Endocrine disorders,Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
996416,36918947,1.81E-11,0.00083169,adult_senior_youth,youth,finasteride,anhedonia,Psychiatric disorders,$Other dermatologicals$Alpha-adrenoreceptor antagonists$Testosterone-5-alpha reductase inhibitors,$OTHER DERMATOLOGICAL PREPARATIONS$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY$DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,$OTHER DERMATOLOGICAL PREPARATIONS$UROLOGICALS$UROLOGICALS,$DERMATOLOGICALS$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
750982,36718259,1.83E-11,0.000841853,adult_children_senior,senior,bupropion,parkinsonism,Nervous system disorders,$Centrally acting antiobesity products$Other antidepressants,"$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$ANTIDEPRESSANTS","$ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS$PSYCHOANALEPTICS",$ALIMENTARY TRACT AND METABOLISM$NERVOUS SYSTEM
1149196,36254981,1.86E-11,0.000853029,adult_children_senior_youth,children,cetirizine,extra dose administered,"Injury, poisoning and procedural complications",Piperazine derivatives,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,RESPIRATORY SYSTEM
732893,36517131,1.89E-11,0.000866673,adult_children_youth,youth,bupivacaine,chondrolysis,Musculoskeletal and connective tissue disorders,$Amides$Amides,"$ANESTHETICS, LOCAL$ANESTHETICS, LOCAL",$ANESTHETICS$ANESTHETICS,$NERVOUS SYSTEM$NERVOUS SYSTEM
961047,35708208,1.90E-11,0.000871394,adult_children_senior_youth,children,ranitidine,vomiting,Gastrointestinal disorders,$H2-receptor antagonists$H2-receptor antagonists,$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)$DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),$DRUGS FOR ACID RELATED DISORDERS$DRUGS FOR ACID RELATED DISORDERS,$ALIMENTARY TRACT AND METABOLISM$ALIMENTARY TRACT AND METABOLISM
1748975,36718362,1.91E-11,0.00087697,adult_children_senior_youth,senior,cefepime,myoclonus,Nervous system disorders,$Fourth-generation cephalosporins$Combinations of antibacterials,$OTHER BETA-LACTAM ANTIBACTERIALS$COMBINATIONS OF ANTIBACTERIALS,$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIBACTERIALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
1125315,35708563,1.92E-11,0.000881702,adult_children_senior_youth,children,acetaminophen,lip oedema,Immune system disorders,$Anilides$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics$Anilides$Opioids in combination with non-opioid analgesics$Opioids in combination with non-opioid analgesics,$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS$OTHER ANALGESICS AND ANTIPYRETICS$OPIOIDS$OPIOIDS,$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS$ANALGESICS,$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM$NERVOUS SYSTEM
19018544,37622442,1.93E-11,0.000884998,adult_children_senior,children,calcium,circulatory collapse,Vascular disorders,"$Bisphosphonates, combinations$Multivitamins with minerals$Bisphosphonates, combinations$Ascorbic acid (vitamin C), combinations$Bisphosphonates, combinations$Bisphosphonates, combinations$Bisphosphonates, combinations","$DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION$MULTIVITAMINS, COMBINATIONS$DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION$ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS$DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION$DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION$DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",$DRUGS FOR TREATMENT OF BONE DISEASES$VITAMINS$DRUGS FOR TREATMENT OF BONE DISEASES$VITAMINS$DRUGS FOR TREATMENT OF BONE DISEASES$DRUGS FOR TREATMENT OF BONE DISEASES$DRUGS FOR TREATMENT OF BONE DISEASES,$MUSCULO-SKELETAL SYSTEM$ALIMENTARY TRACT AND METABOLISM$MUSCULO-SKELETAL SYSTEM$ALIMENTARY TRACT AND METABOLISM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
19024728,37219907,1.93E-11,0.000888025,adult_children_senior,children,decitabine,cough,"Respiratory, thoracic and mediastinal disorders",Pyrimidine analogues,ANTIMETABOLITES,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1310317,35809207,1.99E-11,0.000915582,adult_children_senior_youth,children,cyclophosphamide,mucosal inflammation,General disorders and administration site conditions,Nitrogen mustard analogues,ALKYLATING AGENTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1154161,36919236,1.99E-11,0.000913706,adult_children_senior_youth,youth,montelukast,suicide attempt,Psychiatric disorders,$Leukotriene receptor antagonists$Leukotriene receptor antagonists,$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES$DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,$RESPIRATORY SYSTEM$RESPIRATORY SYSTEM
1112807,35205355,2.00E-11,0.000918762,adult_children_senior_youth,youth,aspirin,myocarditis,Cardiac disorders,0,0,0,0
984232,37220014,2.02E-11,0.000928034,adult_children_senior_youth,senior,isotretinoin,epistaxis,"Respiratory, thoracic and mediastinal disorders",$Retinoids for topical use in acne$Retinoids for topical use in acne$Retinoids for treatment of acne,$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR TOPICAL USE$ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE,$ANTI-ACNE PREPARATIONS$ANTI-ACNE PREPARATIONS$ANTI-ACNE PREPARATIONS,$DERMATOLOGICALS$DERMATOLOGICALS$DERMATOLOGICALS
722031,36416527,2.02E-11,0.000929491,adult_children_senior,children,paroxetine,failure to thrive,"Pregnancy, puerperium and perinatal conditions",Selective serotonin reuptake inhibitors,ANTIDEPRESSANTS,PSYCHOANALEPTICS,NERVOUS SYSTEM
1146810,36009738,2.03E-11,0.000932153,adult_senior_youth,senior,piroxicam,drug hypersensitivity,Immune system disorders,"$Oxicams$Antiinflammatory preparations, non-steroids for topical use$Antiinflammatory agents, non-steroids","$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AGENTS",$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$OPHTHALMOLOGICALS,$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$SENSORY ORGANS
1315942,37320310,2.04E-11,0.000935666,adult_senior_youth,adult,docetaxel,hair colour changes,Skin and subcutaneous tissue disorders,Taxanes,PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,ANTINEOPLASTIC AGENTS,ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1589505,36919209,2.05E-11,0.000939044,adult_youth,adult,levonorgestrel,sleep disorder,Psychiatric disorders,"$Progestogens and estrogens, sequential preparations$Emergency contraceptives$Progestogens$Progestogens and estrogens, sequential preparations$Progestogens and estrogens, fixed combinations$Progestogens and estrogens, fixed combinations",$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION$HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE$PROGESTOGENS AND ESTROGENS IN COMBINATION,$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM$SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES$GENITO URINARY SYSTEM AND SEX HORMONES
1314002,35506636,2.07E-11,0.00094961,adult_children_senior_youth,children,atenolol,hypoglycaemia,Endocrine disorders,"$Beta blocking agents, selective, and other diuretics$Beta blocking agents, selective$Beta blocking agents and calcium channel blockers$Beta blocking agents, selective, thiazides and other diuretics$Beta blocking agents, selective, and thiazides$Beta blocking agents, selective, and other diuretics","$BETA BLOCKING AGENTS AND OTHER DIURETICS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS, OTHER COMBINATIONS$BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS$BETA BLOCKING AGENTS AND THIAZIDES$BETA BLOCKING AGENTS AND OTHER DIURETICS",$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS$BETA BLOCKING AGENTS,$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM$CARDIOVASCULAR SYSTEM
1149196,37080784,2.08E-11,0.000956843,adult_senior_youth,senior,cetirizine,acute kidney injury,Renal and urinary disorders,Piperazine derivatives,ANTIHISTAMINES FOR SYSTEMIC USE,ANTIHISTAMINES FOR SYSTEMIC USE,RESPIRATORY SYSTEM
964407,37320214,2.08E-11,0.000956011,adult_children_senior_youth,children,salicylic acid,rash macular,Skin and subcutaneous tissue disorders,"$Other antifungals for topical use$Salicylic acid and derivatives$Salicylic acid and derivatives$Antiinflammatory agents, non-steroids",$ANTIFUNGALS FOR TOPICAL USE$OTHER ANALGESICS AND ANTIPYRETICS$OTHER ANALGESICS AND ANTIPYRETICS$ANTIINFLAMMATORY AGENTS,$ANTIFUNGALS FOR DERMATOLOGICAL USE$ANALGESICS$ANALGESICS$OPHTHALMOLOGICALS,$DERMATOLOGICALS$NERVOUS SYSTEM$NERVOUS SYSTEM$SENSORY ORGANS
766814,37219820,2.11E-11,0.000968552,adult_children_senior_youth,senior,quetiapine,pneumonia aspiration,"Respiratory, thoracic and mediastinal disorders","Diazepines, oxazepines, thiazepines and oxepines",ANTIPSYCHOTICS,PSYCHOLEPTICS,NERVOUS SYSTEM
1705674,37080784,2.12E-11,0.000975318,adult_children_senior_youth,senior,trimethoprim,acute kidney injury,Renal and urinary disorders,"$Combinations of drugs for treatment of tuberculosis$Trimethoprim and derivatives$Combinations of sulfonamides and trimethoprim, incl. derivatives$Combinations of sulfonamides and trimethoprim, incl. derivatives$Combinations of sulfonamides and trimethoprim, incl. derivatives$Combinations of sulfonamides and trimethoprim, incl. derivatives$Combinations of sulfonamides and trimethoprim, incl. derivatives$Combinations of sulfonamides and trimethoprim, incl. derivatives",$DRUGS FOR TREATMENT OF TUBERCULOSIS$SULFONAMIDES AND TRIMETHOPRIM$SULFONAMIDES AND TRIMETHOPRIM$SULFONAMIDES AND TRIMETHOPRIM$SULFONAMIDES AND TRIMETHOPRIM$SULFONAMIDES AND TRIMETHOPRIM$SULFONAMIDES AND TRIMETHOPRIM$SULFONAMIDES AND TRIMETHOPRIM,$ANTIMYCOBACTERIALS$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIBACTERIALS FOR SYSTEMIC USE,$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE
1115008,35909441,2.12E-11,0.000974273,adult_children_senior_youth,youth,naproxen,cholecystitis,Hepatobiliary disorders,"$Antiinflammatory products for vaginal administration$Antiinflammatory preparations, non-steroids for topical use$Propionic acid derivatives$Propionic acid derivatives$Propionic acid derivatives","$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",$OTHER GYNECOLOGICALS$TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS$ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,$GENITO URINARY SYSTEM AND SEX HORMONES$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM$MUSCULO-SKELETAL SYSTEM
1501700,36718362,2.15E-11,0.000988387,adult_children_senior_youth,children,levothyroxine,myoclonus,Nervous system disorders,Thyroid hormones,THYROID PREPARATIONS,THYROID THERAPY,"SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS"
1797513,36918858,2.17E-11,0.000996345,adult_children_senior_youth,youth,ciprofloxacin,anxiety,Psychiatric disorders,$Combinations of antibacterials$Antiinfectives$Fluoroquinolones$Antiinfectives$Combinations of antibacterials$Combinations of antibacterials$Fluoroquinolones,$COMBINATIONS OF ANTIBACTERIALS$ANTIINFECTIVES$QUINOLONE ANTIBACTERIALS$ANTIINFECTIVES$COMBINATIONS OF ANTIBACTERIALS$COMBINATIONS OF ANTIBACTERIALS$ANTIINFECTIVES,$ANTIBACTERIALS FOR SYSTEMIC USE$OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS$ANTIBACTERIALS FOR SYSTEMIC USE$OTOLOGICALS$ANTIBACTERIALS FOR SYSTEMIC USE$ANTIBACTERIALS FOR SYSTEMIC USE$OPHTHALMOLOGICALS,$ANTIINFECTIVES FOR SYSTEMIC USE$SENSORY ORGANS$ANTIINFECTIVES FOR SYSTEMIC USE$SENSORY ORGANS$ANTIINFECTIVES FOR SYSTEMIC USE$ANTIINFECTIVES FOR SYSTEMIC USE$SENSORY ORGANS